Query 016544
Match_columns 387
No_of_seqs 420 out of 3538
Neff 9.9
Searched_HMMs 46136
Date Fri Mar 29 07:48:28 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/016544.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/016544hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0595 Serine/threonine-prote 100.0 5.5E-48 1.2E-52 342.1 19.6 209 156-370 11-230 (429)
2 KOG0598 Ribosomal protein S6 k 100.0 4.8E-48 1E-52 339.4 16.6 216 155-374 25-245 (357)
3 KOG0575 Polo-like serine/threo 100.0 1.2E-46 2.5E-51 349.1 19.7 223 144-370 7-234 (592)
4 KOG0616 cAMP-dependent protein 100.0 3.5E-46 7.5E-51 317.4 17.6 208 156-370 45-257 (355)
5 KOG0192 Tyrosine kinase specif 100.0 1.6E-45 3.5E-50 338.5 20.6 227 145-377 33-270 (362)
6 KOG0591 NIMA (never in mitosis 100.0 2.2E-47 4.7E-52 322.4 6.3 227 156-386 20-258 (375)
7 KOG0581 Mitogen-activated prot 100.0 1.4E-45 3E-50 324.0 16.4 221 156-386 80-312 (364)
8 KOG0615 Serine/threonine prote 100.0 4.9E-46 1.1E-50 329.4 13.1 213 156-373 173-401 (475)
9 KOG0195 Integrin-linked kinase 100.0 1.4E-45 3.1E-50 310.3 14.7 335 30-374 24-410 (448)
10 KOG0592 3-phosphoinositide-dep 100.0 2.7E-44 5.9E-49 328.4 15.7 214 154-370 72-303 (604)
11 KOG0197 Tyrosine kinases [Sign 100.0 4.2E-44 9E-49 328.6 13.8 229 145-385 198-433 (468)
12 KOG0611 Predicted serine/threo 100.0 2.7E-43 5.9E-48 311.2 14.1 210 156-370 54-269 (668)
13 KOG0605 NDR and related serine 100.0 1.6E-42 3.4E-47 316.9 17.8 213 155-370 141-404 (550)
14 KOG0583 Serine/threonine prote 100.0 7.9E-42 1.7E-46 317.0 20.2 212 155-370 17-239 (370)
15 KOG0597 Serine-threonine prote 100.0 1.3E-42 2.8E-47 318.2 13.2 220 156-381 3-227 (808)
16 KOG0600 Cdc2-related protein k 100.0 3.6E-42 7.9E-47 312.0 14.8 211 155-370 117-336 (560)
17 KOG0588 Serine/threonine prote 100.0 8E-42 1.7E-46 318.6 15.9 219 159-382 16-240 (786)
18 KOG0694 Serine/threonine prote 100.0 1.5E-41 3.2E-46 318.8 16.2 212 154-370 367-584 (694)
19 KOG0593 Predicted protein kina 100.0 7.7E-42 1.7E-46 291.6 12.3 207 157-368 4-216 (396)
20 KOG1187 Serine/threonine prote 100.0 2.9E-41 6.3E-46 312.5 16.5 211 143-357 63-281 (361)
21 KOG0659 Cdk activating kinase 100.0 2.6E-40 5.7E-45 277.5 15.9 206 156-367 3-215 (318)
22 KOG0578 p21-activated serine/t 100.0 1.3E-40 2.9E-45 306.5 13.8 223 156-387 274-501 (550)
23 KOG0663 Protein kinase PITSLRE 100.0 2.5E-40 5.4E-45 285.9 14.5 207 156-368 77-292 (419)
24 cd05628 STKc_NDR1 Catalytic do 100.0 7.9E-40 1.7E-44 307.8 19.2 212 156-370 2-252 (363)
25 KOG0198 MEKK and related serin 100.0 2.1E-40 4.6E-45 295.8 14.4 211 154-370 16-239 (313)
26 KOG0585 Ca2+/calmodulin-depend 100.0 1.6E-39 3.5E-44 292.6 15.4 212 156-370 98-335 (576)
27 KOG0194 Protein tyrosine kinas 100.0 2E-39 4.4E-44 302.2 16.5 250 119-374 123-384 (474)
28 cd05626 STKc_LATS2 Catalytic d 100.0 3.9E-39 8.5E-44 304.9 18.6 210 156-368 2-262 (381)
29 KOG1026 Nerve growth factor re 100.0 6E-40 1.3E-44 315.6 12.9 220 158-385 489-734 (774)
30 cd05612 STKc_PRKX_like Catalyt 100.0 5E-39 1.1E-43 293.3 18.0 208 156-370 2-214 (291)
31 KOG0033 Ca2+/calmodulin-depend 100.0 6.7E-41 1.4E-45 278.0 5.0 210 155-370 11-228 (355)
32 PTZ00426 cAMP-dependent protei 100.0 7.8E-39 1.7E-43 297.8 19.5 209 155-370 30-244 (340)
33 cd05599 STKc_NDR_like Catalyti 100.0 3.2E-39 7E-44 304.0 17.0 212 156-370 2-255 (364)
34 KOG0610 Putative serine/threon 100.0 1.1E-38 2.3E-43 283.2 18.9 212 156-370 78-351 (459)
35 cd05625 STKc_LATS1 Catalytic d 100.0 5E-39 1.1E-43 304.5 17.7 212 156-370 2-264 (382)
36 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 5.1E-39 1.1E-43 298.9 17.3 206 156-368 2-212 (333)
37 cd05571 STKc_PKB Catalytic dom 100.0 7.8E-39 1.7E-43 296.3 18.4 205 162-370 2-211 (323)
38 cd05629 STKc_NDR_like_fungal C 100.0 4.3E-39 9.4E-44 304.4 16.9 210 156-368 2-262 (377)
39 PTZ00263 protein kinase A cata 100.0 6.4E-39 1.4E-43 297.6 17.7 208 156-370 19-231 (329)
40 cd05595 STKc_PKB_beta Catalyti 100.0 1.8E-38 3.9E-43 293.8 19.9 205 162-370 2-211 (323)
41 cd05598 STKc_LATS Catalytic do 100.0 4.2E-39 9.2E-44 304.4 15.8 211 156-369 2-259 (376)
42 KOG0193 Serine/threonine prote 100.0 1.4E-39 3E-44 301.1 11.5 234 146-387 385-627 (678)
43 cd05624 STKc_MRCK_beta Catalyt 100.0 8.7E-39 1.9E-43 296.9 16.5 212 156-370 2-224 (331)
44 cd05585 STKc_YPK1_like Catalyt 100.0 2.1E-38 4.6E-43 292.0 18.8 204 163-370 1-209 (312)
45 cd05593 STKc_PKB_gamma Catalyt 100.0 2.6E-38 5.6E-43 293.3 19.4 205 162-370 2-211 (328)
46 KOG0661 MAPK related serine/th 100.0 1.1E-39 2.4E-44 293.8 9.7 215 156-378 11-235 (538)
47 cd05597 STKc_DMPK_like Catalyt 100.0 2.1E-38 4.5E-43 294.4 18.2 212 156-370 2-224 (331)
48 cd05621 STKc_ROCK2 Catalytic d 100.0 1.2E-38 2.7E-43 299.8 16.9 212 155-370 43-263 (370)
49 cd05631 STKc_GRK4 Catalytic do 100.0 4.9E-38 1.1E-42 285.9 20.3 201 157-362 2-209 (285)
50 cd05623 STKc_MRCK_alpha Cataly 100.0 2E-38 4.2E-43 294.8 17.5 212 156-370 2-224 (332)
51 PHA02988 hypothetical protein; 100.0 5.9E-38 1.3E-42 285.0 20.2 218 150-374 15-243 (283)
52 cd05627 STKc_NDR2 Catalytic do 100.0 1E-38 2.2E-43 300.0 15.6 211 156-369 2-251 (360)
53 cd05622 STKc_ROCK1 Catalytic d 100.0 2.5E-38 5.5E-43 297.9 17.9 213 154-370 42-263 (371)
54 KOG0580 Serine/threonine prote 100.0 2E-39 4.4E-44 268.4 9.0 209 156-370 23-238 (281)
55 KOG0589 Serine/threonine prote 100.0 7.2E-39 1.6E-43 293.1 13.0 214 156-374 5-226 (426)
56 KOG0594 Protein kinase PCTAIRE 100.0 2.6E-38 5.5E-43 277.8 15.9 205 156-366 12-233 (323)
57 KOG0582 Ste20-like serine/thre 100.0 1.3E-37 2.8E-42 278.6 20.6 217 151-372 22-250 (516)
58 cd05596 STKc_ROCK Catalytic do 100.0 3.2E-38 7E-43 297.2 17.4 212 155-370 43-263 (370)
59 cd05592 STKc_nPKC_theta_delta 100.0 8.2E-38 1.8E-42 288.5 19.4 204 162-369 2-211 (316)
60 KOG4717 Serine/threonine prote 100.0 4.9E-38 1.1E-42 285.3 16.9 219 157-381 20-246 (864)
61 cd05616 STKc_cPKC_beta Catalyt 100.0 1.2E-37 2.5E-42 288.5 19.9 211 156-370 1-217 (323)
62 cd05584 STKc_p70S6K Catalytic 100.0 9.7E-38 2.1E-42 289.0 19.1 206 161-370 2-216 (323)
63 KOG0032 Ca2+/calmodulin-depend 100.0 1.2E-37 2.5E-42 289.0 19.6 211 154-370 34-254 (382)
64 cd05587 STKc_cPKC Catalytic do 100.0 1.8E-37 3.9E-42 287.4 20.8 211 156-370 1-217 (324)
65 cd05594 STKc_PKB_alpha Catalyt 100.0 5.4E-38 1.2E-42 291.0 17.0 205 162-370 2-212 (325)
66 cd05573 STKc_ROCK_NDR_like Cat 100.0 2.3E-38 5E-43 296.6 14.6 210 156-368 2-244 (350)
67 cd05590 STKc_nPKC_eta Catalyti 100.0 1E-37 2.2E-42 288.4 18.7 205 162-370 2-212 (320)
68 cd05614 STKc_MSK2_N N-terminal 100.0 6.9E-38 1.5E-42 291.2 17.7 201 156-359 1-212 (332)
69 cd05591 STKc_nPKC_epsilon Cata 100.0 1E-37 2.3E-42 288.6 18.5 205 162-370 2-212 (321)
70 cd05601 STKc_CRIK Catalytic do 100.0 2.7E-38 5.8E-43 293.8 14.5 212 156-370 2-225 (330)
71 cd05615 STKc_cPKC_alpha Cataly 100.0 2.3E-37 5.1E-42 286.4 19.5 210 157-370 2-217 (323)
72 cd05575 STKc_SGK Catalytic dom 100.0 1.9E-37 4.1E-42 287.1 18.4 205 162-370 2-212 (323)
73 KOG0201 Serine/threonine prote 100.0 4.2E-39 9E-44 287.8 6.6 225 153-386 11-240 (467)
74 KOG4721 Serine/threonine prote 100.0 1E-38 2.2E-43 292.7 8.9 207 147-370 118-327 (904)
75 KOG0599 Phosphorylase kinase g 100.0 3.1E-38 6.7E-43 266.0 10.7 210 156-370 18-244 (411)
76 KOG0658 Glycogen synthase kina 100.0 3.1E-38 6.8E-43 277.0 11.0 203 152-367 21-239 (364)
77 cd05589 STKc_PKN Catalytic dom 100.0 4.2E-37 9.2E-42 284.9 18.9 209 157-370 1-217 (324)
78 cd05602 STKc_SGK1 Catalytic do 100.0 3.6E-37 7.9E-42 285.4 18.1 205 162-370 2-212 (325)
79 cd05588 STKc_aPKC Catalytic do 100.0 7.7E-37 1.7E-41 283.6 20.2 191 162-356 2-198 (329)
80 cd05604 STKc_SGK3 Catalytic do 100.0 3.2E-37 7E-42 285.8 17.5 205 162-370 2-212 (325)
81 cd05603 STKc_SGK2 Catalytic do 100.0 3.9E-37 8.5E-42 284.8 18.0 205 162-370 2-212 (321)
82 cd05620 STKc_nPKC_delta Cataly 100.0 6E-37 1.3E-41 282.8 19.0 205 162-370 2-212 (316)
83 cd05064 PTKc_EphR_A10 Catalyti 100.0 1.1E-36 2.4E-41 274.3 20.1 214 156-374 6-229 (266)
84 cd05608 STKc_GRK1 Catalytic do 100.0 7.1E-37 1.5E-41 277.6 19.0 193 163-359 1-202 (280)
85 KOG0667 Dual-specificity tyros 100.0 2E-37 4.4E-42 290.6 15.5 203 156-370 187-404 (586)
86 cd05570 STKc_PKC Catalytic dom 100.0 9.2E-37 2E-41 281.8 19.0 205 162-370 2-212 (318)
87 cd05102 PTKc_VEGFR3 Catalytic 100.0 1.4E-36 3.1E-41 283.1 20.4 210 156-370 8-294 (338)
88 cd05619 STKc_nPKC_theta Cataly 100.0 1.2E-36 2.6E-41 280.7 19.5 205 162-370 2-212 (316)
89 PTZ00267 NIMA-related protein 100.0 2.2E-36 4.8E-41 293.6 22.2 215 154-374 66-291 (478)
90 cd05605 STKc_GRK4_like Catalyt 100.0 1.2E-36 2.7E-41 276.7 19.0 204 157-365 2-212 (285)
91 KOG0660 Mitogen-activated prot 100.0 3E-37 6.6E-42 270.4 13.3 208 157-369 24-243 (359)
92 cd05618 STKc_aPKC_iota Catalyt 100.0 1.6E-36 3.5E-41 281.4 19.1 190 162-355 2-197 (329)
93 cd07848 STKc_CDKL5 Catalytic d 100.0 1.7E-36 3.6E-41 276.1 18.7 207 156-366 2-213 (287)
94 cd05582 STKc_RSK_N N-terminal 100.0 4.2E-37 9.1E-42 284.2 14.7 205 161-370 2-214 (318)
95 cd05617 STKc_aPKC_zeta Catalyt 100.0 2.1E-36 4.6E-41 280.4 19.1 191 162-356 2-198 (327)
96 KOG1095 Protein tyrosine kinas 100.0 8.2E-37 1.8E-41 304.1 17.0 212 158-374 695-925 (1025)
97 KOG0690 Serine/threonine prote 100.0 1.8E-37 3.9E-42 267.3 9.6 211 156-370 169-384 (516)
98 cd07871 STKc_PCTAIRE3 Catalyti 100.0 3.1E-36 6.7E-41 274.5 18.3 206 156-368 6-218 (288)
99 KOG0586 Serine/threonine prote 100.0 1.1E-36 2.4E-41 283.0 15.5 214 155-374 56-276 (596)
100 cd05607 STKc_GRK7 Catalytic do 100.0 1.1E-35 2.5E-40 269.2 20.7 191 163-358 1-198 (277)
101 KOG0612 Rho-associated, coiled 100.0 8.3E-38 1.8E-42 306.6 7.1 219 154-375 74-303 (1317)
102 cd06649 PKc_MEK2 Catalytic dom 100.0 1.6E-35 3.5E-40 275.1 21.9 203 155-364 5-212 (331)
103 PTZ00283 serine/threonine prot 100.0 9.4E-36 2E-40 289.5 21.2 219 152-374 29-265 (496)
104 KOG0696 Serine/threonine prote 100.0 2.3E-37 5.1E-42 274.2 8.8 211 156-370 350-566 (683)
105 cd05096 PTKc_DDR1 Catalytic do 100.0 1.4E-35 3E-40 272.3 20.6 206 156-366 6-254 (304)
106 cd05632 STKc_GRK5 Catalytic do 100.0 1.3E-35 2.9E-40 269.9 20.2 205 157-366 2-213 (285)
107 cd05586 STKc_Sck1_like Catalyt 100.0 2E-36 4.4E-41 281.1 14.8 204 163-370 1-213 (330)
108 PRK13184 pknD serine/threonine 100.0 1.7E-35 3.7E-40 296.4 21.9 205 156-363 3-240 (932)
109 KOG0577 Serine/threonine prote 100.0 4.8E-37 1E-41 282.9 9.3 212 156-376 27-247 (948)
110 cd07859 STKc_TDY_MAPK_plant Ca 100.0 1.1E-35 2.5E-40 277.0 18.5 200 156-360 1-214 (338)
111 PHA03212 serine/threonine kina 100.0 2E-35 4.4E-40 279.5 20.4 189 155-356 92-285 (391)
112 cd05048 PTKc_Ror Catalytic Dom 100.0 2.2E-35 4.8E-40 268.1 19.8 214 156-374 6-247 (283)
113 cd05630 STKc_GRK6 Catalytic do 100.0 3E-35 6.5E-40 267.6 20.5 198 157-359 2-206 (285)
114 cd05106 PTKc_CSF-1R Catalytic 100.0 1.7E-35 3.6E-40 279.0 19.3 209 156-369 39-330 (374)
115 KOG0986 G protein-coupled rece 100.0 4.2E-37 9.1E-42 275.5 7.8 196 156-356 186-388 (591)
116 cd05114 PTKc_Tec_Rlk Catalytic 100.0 4.2E-35 9E-40 262.4 20.2 212 156-374 5-222 (256)
117 cd07853 STKc_NLK Catalytic dom 100.0 2.2E-35 4.9E-40 278.5 19.4 207 156-367 1-218 (372)
118 cd05104 PTKc_Kit Catalytic dom 100.0 2.8E-35 6.2E-40 277.7 20.0 206 156-366 36-329 (375)
119 KOG0614 cGMP-dependent protein 100.0 3.4E-37 7.3E-42 279.4 6.1 210 156-370 421-635 (732)
120 cd06625 STKc_MEKK3_like Cataly 100.0 7.1E-35 1.5E-39 261.8 21.2 211 156-369 3-222 (263)
121 cd07869 STKc_PFTAIRE1 Catalyti 100.0 2.8E-35 6.1E-40 270.2 18.8 198 155-359 5-209 (303)
122 cd05580 STKc_PKA Catalytic dom 100.0 6.2E-35 1.4E-39 266.2 20.6 208 156-370 2-214 (290)
123 cd05116 PTKc_Syk Catalytic dom 100.0 7E-35 1.5E-39 261.2 20.4 208 162-374 2-219 (257)
124 cd06650 PKc_MEK1 Catalytic dom 100.0 8.3E-35 1.8E-39 270.4 21.6 200 155-362 5-210 (333)
125 KOG0584 Serine/threonine prote 100.0 4.2E-36 9.1E-41 279.6 12.4 220 148-372 33-262 (632)
126 cd05059 PTKc_Tec_like Catalyti 100.0 5.4E-35 1.2E-39 261.7 19.1 212 156-374 5-222 (256)
127 PLN00034 mitogen-activated pro 100.0 4.6E-35 9.9E-40 274.5 19.2 196 156-361 75-280 (353)
128 cd05052 PTKc_Abl Catalytic dom 100.0 6.7E-35 1.5E-39 262.2 19.3 211 156-373 7-225 (263)
129 cd05068 PTKc_Frk_like Catalyti 100.0 8.2E-35 1.8E-39 261.3 19.8 210 156-372 7-223 (261)
130 cd05090 PTKc_Ror1 Catalytic do 100.0 9.5E-35 2.1E-39 264.0 20.4 213 156-373 6-246 (283)
131 cd05093 PTKc_TrkB Catalytic do 100.0 1.1E-34 2.3E-39 264.4 20.7 212 156-373 6-242 (288)
132 cd05609 STKc_MAST Catalytic do 100.0 1.1E-34 2.4E-39 266.5 20.9 212 156-370 2-232 (305)
133 KOG4236 Serine/threonine prote 100.0 4.9E-36 1.1E-40 273.0 11.5 202 160-370 569-780 (888)
134 cd07862 STKc_CDK6 Catalytic do 100.0 7.5E-35 1.6E-39 265.6 19.4 207 156-369 2-224 (290)
135 cd08529 STKc_FA2-like Catalyti 100.0 1.2E-34 2.6E-39 259.2 20.3 214 157-375 2-222 (256)
136 PF07714 Pkinase_Tyr: Protein 100.0 1.2E-35 2.5E-40 266.5 13.6 210 160-374 4-226 (259)
137 cd05033 PTKc_EphR Catalytic do 100.0 1.4E-34 2.9E-39 260.6 20.4 213 156-373 5-228 (266)
138 cd05062 PTKc_IGF-1R Catalytic 100.0 9.7E-35 2.1E-39 263.1 19.6 214 155-373 6-241 (277)
139 KOG4257 Focal adhesion tyrosin 100.0 1.6E-35 3.5E-40 274.3 14.6 217 160-385 394-621 (974)
140 cd05072 PTKc_Lyn Catalytic dom 100.0 7.3E-35 1.6E-39 261.6 18.6 210 156-372 7-223 (261)
141 cd05113 PTKc_Btk_Bmx Catalytic 100.0 7.6E-35 1.6E-39 260.8 18.5 211 156-373 5-221 (256)
142 KOG1094 Discoidin domain recep 100.0 7.6E-36 1.6E-40 274.7 12.0 206 156-366 539-753 (807)
143 cd05049 PTKc_Trk Catalytic dom 100.0 9E-35 1.9E-39 263.7 19.0 211 156-371 6-242 (280)
144 cd05115 PTKc_Zap-70 Catalytic 100.0 1.8E-34 3.9E-39 258.5 20.7 207 162-374 2-219 (257)
145 KOG0196 Tyrosine kinase, EPH ( 100.0 3.7E-36 8E-41 285.0 9.7 219 157-380 631-863 (996)
146 cd05084 PTKc_Fes Catalytic dom 100.0 1.8E-34 4E-39 257.6 19.9 208 162-374 2-217 (252)
147 cd05105 PTKc_PDGFR_alpha Catal 100.0 2.3E-34 5.1E-39 272.5 21.2 213 156-373 38-360 (400)
148 cd06628 STKc_MAPKKK_Byr2_like 100.0 2.9E-34 6.3E-39 258.5 20.5 215 157-374 2-232 (267)
149 cd06646 STKc_MAP4K5 Catalytic 100.0 1.8E-34 3.9E-39 259.9 19.0 204 155-365 9-220 (267)
150 cd07876 STKc_JNK2 Catalytic do 100.0 1.5E-34 3.2E-39 271.7 19.1 199 155-362 21-230 (359)
151 cd08228 STKc_Nek6 Catalytic do 100.0 3.3E-34 7.2E-39 258.1 20.4 214 156-373 3-227 (267)
152 cd05092 PTKc_TrkA Catalytic do 100.0 3.2E-34 6.9E-39 260.2 20.2 211 156-372 6-243 (280)
153 cd07875 STKc_JNK1 Catalytic do 100.0 1.4E-34 3.1E-39 272.3 18.3 206 155-369 24-240 (364)
154 cd05108 PTKc_EGFR Catalytic do 100.0 4E-34 8.7E-39 264.1 20.7 213 155-373 7-231 (316)
155 KOG0607 MAP kinase-interacting 100.0 2.7E-35 5.9E-40 253.3 11.8 194 160-359 83-296 (463)
156 KOG0574 STE20-like serine/thre 100.0 1.3E-36 2.8E-41 259.5 3.7 218 157-384 35-258 (502)
157 cd05066 PTKc_EphR_A Catalytic 100.0 4.4E-34 9.5E-39 257.4 20.1 214 156-374 5-230 (267)
158 cd05091 PTKc_Ror2 Catalytic do 100.0 2.1E-34 4.6E-39 261.7 17.9 213 157-374 7-247 (283)
159 cd05085 PTKc_Fer Catalytic dom 100.0 6.6E-34 1.4E-38 253.6 20.7 206 162-372 2-213 (250)
160 cd05060 PTKc_Syk_like Catalyti 100.0 6.4E-34 1.4E-38 254.9 20.6 204 162-371 2-216 (257)
161 cd05094 PTKc_TrkC Catalytic do 100.0 4.4E-34 9.6E-39 260.7 19.9 211 156-372 6-244 (291)
162 cd08221 STKc_Nek9 Catalytic do 100.0 6.9E-34 1.5E-38 254.4 20.8 213 157-374 2-221 (256)
163 cd06652 STKc_MEKK2 Catalytic d 100.0 1.1E-33 2.4E-38 254.5 22.1 209 156-367 3-222 (265)
164 cd06631 STKc_YSK4 Catalytic do 100.0 6.2E-34 1.3E-38 256.1 20.4 210 156-368 1-222 (265)
165 PTZ00036 glycogen synthase kin 100.0 2.5E-34 5.5E-39 276.2 18.9 200 155-367 66-284 (440)
166 cd07872 STKc_PCTAIRE2 Catalyti 100.0 3.7E-34 8.1E-39 263.5 19.3 205 156-367 7-218 (309)
167 KOG1989 ARK protein kinase fam 100.0 1E-34 2.3E-39 280.7 16.2 202 155-360 37-264 (738)
168 cd05051 PTKc_DDR Catalytic dom 100.0 5.5E-34 1.2E-38 260.7 20.2 209 155-368 5-248 (296)
169 cd06645 STKc_MAP4K3 Catalytic 100.0 3.9E-34 8.5E-39 257.7 19.0 204 156-366 10-221 (267)
170 PHA03207 serine/threonine kina 100.0 3.4E-34 7.3E-39 272.1 19.4 194 155-360 92-293 (392)
171 cd05032 PTKc_InsR_like Catalyt 100.0 4.3E-34 9.3E-39 258.8 19.3 214 156-374 7-242 (277)
172 cd05098 PTKc_FGFR1 Catalytic d 100.0 4.1E-34 8.9E-39 263.0 19.2 213 156-373 19-262 (307)
173 cd05574 STKc_phototropin_like 100.0 8.4E-34 1.8E-38 262.0 21.2 210 156-368 2-246 (316)
174 cd08219 STKc_Nek3 Catalytic do 100.0 5E-34 1.1E-38 255.2 19.0 213 156-374 1-220 (255)
175 cd05071 PTKc_Src Catalytic dom 100.0 4.9E-34 1.1E-38 256.5 19.0 209 156-372 7-222 (262)
176 cd05067 PTKc_Lck_Blk Catalytic 100.0 6.6E-34 1.4E-38 255.2 19.6 210 156-373 7-223 (260)
177 cd05042 PTKc_Aatyk Catalytic d 100.0 7.7E-34 1.7E-38 256.1 20.0 205 162-371 2-227 (269)
178 cd06653 STKc_MEKK3_like_1 Cata 100.0 9.1E-34 2E-38 255.0 20.4 210 156-368 3-223 (264)
179 cd08229 STKc_Nek7 Catalytic do 100.0 5.5E-34 1.2E-38 256.7 18.9 213 156-372 3-226 (267)
180 cd05101 PTKc_FGFR2 Catalytic d 100.0 6.7E-34 1.4E-38 261.2 19.7 215 154-373 14-259 (304)
181 cd06615 PKc_MEK Catalytic doma 100.0 1.5E-33 3.3E-38 259.2 22.1 200 156-363 2-207 (308)
182 cd05577 STKc_GRK Catalytic dom 100.0 6.3E-34 1.4E-38 257.9 19.1 192 163-359 1-199 (277)
183 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 6.7E-34 1.5E-38 255.2 19.0 211 156-374 7-224 (260)
184 cd00192 PTKc Catalytic domain 100.0 7.3E-34 1.6E-38 254.7 19.2 207 162-373 2-227 (262)
185 cd06643 STKc_SLK Catalytic dom 100.0 1.4E-33 3E-38 256.3 21.2 211 157-374 7-228 (282)
186 cd05099 PTKc_FGFR4 Catalytic d 100.0 1E-33 2.2E-38 261.2 20.5 213 155-372 12-255 (314)
187 cd05148 PTKc_Srm_Brk Catalytic 100.0 4E-34 8.6E-39 256.7 17.4 213 155-374 6-225 (261)
188 cd06654 STKc_PAK1 Catalytic do 100.0 1.1E-33 2.4E-38 258.7 20.5 211 155-373 20-235 (296)
189 cd05036 PTKc_ALK_LTK Catalytic 100.0 9.8E-34 2.1E-38 256.6 20.0 213 156-373 7-241 (277)
190 cd05045 PTKc_RET Catalytic dom 100.0 9.6E-34 2.1E-38 258.4 20.0 211 157-372 2-248 (290)
191 cd05089 PTKc_Tie1 Catalytic do 100.0 9.6E-34 2.1E-38 259.3 20.0 211 156-373 3-238 (297)
192 cd07874 STKc_JNK3 Catalytic do 100.0 3.2E-34 7E-39 269.0 17.3 200 155-363 17-227 (355)
193 cd05578 STKc_Yank1 Catalytic d 100.0 3.1E-34 6.8E-39 257.0 16.5 199 156-359 1-204 (258)
194 KOG0666 Cyclin C-dependent kin 100.0 1.6E-35 3.4E-40 253.9 7.5 197 155-356 24-242 (438)
195 cd06613 STKc_MAP4K3_like Catal 100.0 1.6E-33 3.4E-38 252.8 20.9 207 156-369 4-219 (262)
196 cd05034 PTKc_Src_like Catalyti 100.0 7.1E-34 1.5E-38 255.1 18.6 210 155-371 6-222 (261)
197 cd06651 STKc_MEKK3 Catalytic d 100.0 2.7E-33 5.9E-38 252.2 22.3 209 155-366 2-221 (266)
198 cd06630 STKc_MEKK1 Catalytic d 100.0 1.3E-33 2.8E-38 254.3 20.2 203 156-361 1-215 (268)
199 cd05061 PTKc_InsR Catalytic do 100.0 1.3E-33 2.8E-38 257.3 20.3 215 155-374 6-242 (288)
200 cd05097 PTKc_DDR_like Catalyti 100.0 1.3E-33 2.9E-38 258.1 20.4 206 156-366 6-245 (295)
201 cd06655 STKc_PAK2 Catalytic do 100.0 1.2E-33 2.7E-38 258.3 20.2 213 153-373 17-234 (296)
202 cd05039 PTKc_Csk_like Catalyti 100.0 1.4E-33 3E-38 252.5 20.1 205 156-371 7-217 (256)
203 cd05109 PTKc_HER2 Catalytic do 100.0 1.3E-33 2.8E-38 256.1 20.0 213 156-374 8-232 (279)
204 cd05056 PTKc_FAK Catalytic dom 100.0 1.7E-33 3.6E-38 254.1 20.6 213 156-374 7-229 (270)
205 cd06644 STKc_STK10_LOK Catalyt 100.0 2.5E-33 5.3E-38 255.9 21.8 212 156-374 13-235 (292)
206 KOG2345 Serine/threonine prote 100.0 1.1E-34 2.4E-39 241.5 11.5 201 152-356 18-243 (302)
207 cd05065 PTKc_EphR_B Catalytic 100.0 1.5E-33 3.2E-38 254.3 19.9 210 157-371 6-229 (269)
208 cd05069 PTKc_Yes Catalytic dom 100.0 1.3E-33 2.9E-38 253.3 19.5 210 156-373 7-223 (260)
209 cd05054 PTKc_VEGFR Catalytic d 100.0 1.5E-33 3.2E-38 262.3 20.5 203 156-363 8-285 (337)
210 cd06609 STKc_MST3_like Catalyt 100.0 1.4E-33 3.1E-38 255.1 19.7 212 156-374 2-218 (274)
211 cd05088 PTKc_Tie2 Catalytic do 100.0 7.7E-34 1.7E-38 260.6 18.1 207 156-369 8-239 (303)
212 cd05111 PTK_HER3 Pseudokinase 100.0 2.6E-33 5.6E-38 254.1 21.3 213 156-374 8-232 (279)
213 cd06656 STKc_PAK3 Catalytic do 100.0 1E-33 2.2E-38 259.1 18.7 212 155-374 19-235 (297)
214 cd06610 STKc_OSR1_SPAK Catalyt 100.0 2.4E-33 5.3E-38 252.3 20.9 214 156-374 2-227 (267)
215 cd05611 STKc_Rim15_like Cataly 100.0 1.8E-33 3.8E-38 252.4 19.8 202 161-370 2-209 (260)
216 cd06611 STKc_SLK_like Catalyti 100.0 1.2E-33 2.6E-38 256.3 18.9 213 156-375 6-229 (280)
217 cd05035 PTKc_Axl_like Catalyti 100.0 2.1E-33 4.6E-38 253.5 20.2 214 157-374 1-236 (273)
218 cd05082 PTKc_Csk Catalytic dom 100.0 1.5E-33 3.3E-38 252.3 19.0 203 156-370 7-216 (256)
219 cd05073 PTKc_Hck Catalytic dom 100.0 2.1E-33 4.5E-38 252.0 19.9 207 156-370 7-220 (260)
220 PTZ00284 protein kinase; Provi 100.0 1.4E-33 3E-38 273.8 20.1 202 153-366 127-357 (467)
221 PTZ00266 NIMA-related protein 100.0 1.8E-33 4E-38 283.0 21.5 203 155-360 13-249 (1021)
222 cd05063 PTKc_EphR_A2 Catalytic 100.0 2.5E-33 5.5E-38 252.6 20.2 213 156-373 6-230 (268)
223 KOG4250 TANK binding protein k 100.0 1.8E-34 3.8E-39 272.0 13.0 206 157-369 15-243 (732)
224 cd05572 STKc_cGK_PKG Catalytic 100.0 2.2E-33 4.8E-38 252.1 19.7 201 163-368 1-208 (262)
225 cd08218 STKc_Nek1 Catalytic do 100.0 2E-33 4.4E-38 251.4 19.4 214 156-374 1-221 (256)
226 cd05633 STKc_GRK3 Catalytic do 100.0 3E-33 6.6E-38 253.6 20.5 191 163-359 2-201 (279)
227 cd05046 PTK_CCK4 Pseudokinase 100.0 2.5E-33 5.5E-38 253.5 20.0 210 156-370 6-235 (275)
228 cd05613 STKc_MSK1_N N-terminal 100.0 2.4E-33 5.2E-38 255.7 19.9 200 157-359 2-213 (290)
229 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 5.1E-33 1.1E-37 250.3 21.8 215 156-374 3-228 (267)
230 cd05050 PTKc_Musk Catalytic do 100.0 2.1E-33 4.6E-38 255.8 19.5 212 156-372 6-251 (288)
231 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 1.8E-33 3.8E-38 256.1 18.9 203 156-366 2-219 (286)
232 cd08223 STKc_Nek4 Catalytic do 100.0 3.4E-33 7.3E-38 250.1 20.4 213 156-373 1-221 (257)
233 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 4.4E-33 9.6E-38 253.1 21.4 195 157-357 6-213 (283)
234 cd05075 PTKc_Axl Catalytic dom 100.0 2.4E-33 5.3E-38 253.2 19.5 212 158-373 2-234 (272)
235 cd08227 PK_STRAD_alpha Pseudok 100.0 5.2E-33 1.1E-37 257.9 22.1 205 161-369 4-225 (327)
236 KOG0579 Ste20-like serine/thre 100.0 4.4E-35 9.5E-40 271.9 8.0 214 157-377 34-258 (1187)
237 smart00219 TyrKc Tyrosine kina 100.0 3.7E-33 8E-38 249.7 20.1 212 158-374 2-225 (258)
238 KOG0608 Warts/lats-like serine 100.0 3.2E-34 6.9E-39 266.2 13.3 210 157-369 631-886 (1034)
239 cd06640 STKc_MST4 Catalytic do 100.0 3.6E-33 7.8E-38 252.9 20.1 210 156-372 5-219 (277)
240 cd05055 PTKc_PDGFR Catalytic d 100.0 4.1E-33 8.8E-38 255.7 20.5 206 156-366 36-256 (302)
241 cd06626 STKc_MEKK4 Catalytic d 100.0 6E-33 1.3E-37 249.4 21.2 215 156-374 1-227 (264)
242 cd05083 PTKc_Chk Catalytic dom 100.0 2.9E-33 6.3E-38 250.2 19.0 204 156-372 7-216 (254)
243 cd05100 PTKc_FGFR3 Catalytic d 100.0 2.9E-33 6.3E-38 260.4 19.7 221 146-373 5-256 (334)
244 PF00069 Pkinase: Protein kina 100.0 9.1E-34 2E-38 254.0 15.6 196 157-357 1-202 (260)
245 cd05053 PTKc_FGFR Catalytic do 100.0 2E-33 4.3E-38 256.6 18.1 214 155-373 12-254 (293)
246 cd05043 PTK_Ryk Pseudokinase d 100.0 4.4E-33 9.6E-38 252.7 20.2 215 154-373 5-239 (280)
247 cd07863 STKc_CDK4 Catalytic do 100.0 2.3E-33 5E-38 255.5 18.3 205 156-367 1-220 (288)
248 cd07878 STKc_p38beta_MAPK11 Ca 100.0 1.4E-33 3.1E-38 263.4 17.2 202 155-366 15-228 (343)
249 KOG0199 ACK and related non-re 100.0 6E-34 1.3E-38 267.0 14.5 213 156-374 111-336 (1039)
250 cd05112 PTKc_Itk Catalytic dom 100.0 6.4E-33 1.4E-37 248.2 20.7 209 156-371 5-219 (256)
251 KOG4279 Serine/threonine prote 100.0 2.7E-34 5.8E-39 269.1 12.1 210 160-376 580-802 (1226)
252 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 8.9E-33 1.9E-37 249.2 21.7 203 162-369 2-225 (269)
253 cd05040 PTKc_Ack_like Catalyti 100.0 3.2E-33 7E-38 250.2 18.7 201 162-368 2-215 (257)
254 cd05095 PTKc_DDR2 Catalytic do 100.0 5.4E-33 1.2E-37 254.2 20.4 206 156-366 6-246 (296)
255 cd07868 STKc_CDK8 Catalytic do 100.0 4.2E-33 9.2E-38 257.4 19.8 190 160-358 6-220 (317)
256 cd07873 STKc_PCTAIRE1 Catalyti 100.0 3.7E-33 8E-38 255.9 19.2 204 156-366 7-217 (301)
257 cd05107 PTKc_PDGFR_beta Cataly 100.0 5.3E-33 1.1E-37 263.2 20.5 209 156-369 38-357 (401)
258 cd06629 STKc_MAPKKK_Bck1_like 100.0 6E-33 1.3E-37 250.6 19.8 205 156-363 2-221 (272)
259 cd06632 STKc_MEKK1_plant Catal 100.0 6.7E-33 1.5E-37 248.1 19.9 207 157-368 2-216 (258)
260 cd06612 STKc_MST1_2 Catalytic 100.0 6.5E-33 1.4E-37 248.0 19.5 205 155-368 3-213 (256)
261 cd05606 STKc_beta_ARK Catalyti 100.0 7.7E-33 1.7E-37 250.9 20.0 190 163-358 2-200 (278)
262 KOG0984 Mitogen-activated prot 100.0 8.7E-34 1.9E-38 230.0 12.2 213 157-376 48-275 (282)
263 cd05058 PTKc_Met_Ron Catalytic 100.0 8E-33 1.7E-37 248.4 19.9 208 162-374 2-223 (262)
264 cd07847 STKc_CDKL1_4 Catalytic 100.0 6.7E-33 1.5E-37 252.1 19.6 206 156-366 2-213 (286)
265 cd05057 PTKc_EGFR_like Catalyt 100.0 1.3E-32 2.8E-37 249.5 21.3 210 156-371 8-229 (279)
266 cd05041 PTKc_Fes_like Catalyti 100.0 9.5E-33 2.1E-37 246.3 20.1 205 162-371 2-213 (251)
267 cd08220 STKc_Nek8 Catalytic do 100.0 1E-32 2.2E-37 246.7 20.2 213 156-374 1-221 (256)
268 cd06642 STKc_STK25-YSK1 Cataly 100.0 2.8E-33 6E-38 253.6 16.5 209 157-372 6-219 (277)
269 KOG0695 Serine/threonine prote 100.0 6.6E-34 1.4E-38 246.4 11.7 196 156-355 251-452 (593)
270 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 5.8E-33 1.3E-37 252.5 18.5 196 156-359 6-207 (284)
271 KOG4645 MAPKKK (MAP kinase kin 100.0 4.7E-35 1E-39 290.8 5.0 222 151-376 1231-1464(1509)
272 KOG4278 Protein tyrosine kinas 100.0 9E-34 1.9E-38 262.7 13.0 215 147-370 261-483 (1157)
273 cd06623 PKc_MAPKK_plant_like C 100.0 1.1E-32 2.5E-37 247.5 19.9 210 156-371 2-220 (264)
274 cd06619 PKc_MKK5 Catalytic dom 100.0 1.3E-32 2.9E-37 249.4 20.5 190 156-357 2-196 (279)
275 cd05579 STKc_MAST_like Catalyt 100.0 6.4E-33 1.4E-37 249.1 18.1 205 163-370 1-217 (265)
276 cd06659 STKc_PAK6 Catalytic do 100.0 3.2E-33 6.9E-38 255.7 16.3 203 159-369 25-232 (297)
277 cd06648 STKc_PAK_II Catalytic 100.0 1.7E-32 3.8E-37 249.4 20.9 209 157-373 21-234 (285)
278 cd06614 STKc_PAK Catalytic dom 100.0 1.3E-32 2.8E-37 250.4 20.1 215 153-375 17-237 (286)
279 cd07832 STKc_CCRK Catalytic do 100.0 1.5E-32 3.3E-37 249.8 20.1 207 156-367 1-214 (286)
280 cd06647 STKc_PAK_I Catalytic d 100.0 9E-33 2E-37 252.3 18.6 212 155-374 19-235 (293)
281 cd06641 STKc_MST3 Catalytic do 100.0 2.1E-32 4.5E-37 247.9 20.7 210 157-373 6-220 (277)
282 cd07861 STKc_CDK1_euk Catalyti 100.0 1.3E-32 2.8E-37 250.2 19.2 199 156-360 1-208 (285)
283 cd05086 PTKc_Aatyk2 Catalytic 100.0 2.4E-32 5.1E-37 246.3 20.5 204 162-370 2-225 (268)
284 cd05044 PTKc_c-ros Catalytic d 100.0 6.6E-33 1.4E-37 249.9 16.9 206 162-372 2-232 (269)
285 cd08217 STKc_Nek2 Catalytic do 100.0 1.7E-32 3.7E-37 246.3 19.5 212 157-373 2-229 (265)
286 cd06607 STKc_TAO Catalytic dom 100.0 2.3E-32 5.1E-37 251.3 20.7 208 156-372 16-232 (307)
287 cd07841 STKc_CDK7 Catalytic do 100.0 1.5E-32 3.2E-37 251.5 19.2 206 157-367 2-216 (298)
288 cd06658 STKc_PAK5 Catalytic do 100.0 6.9E-33 1.5E-37 252.9 16.9 201 160-368 27-232 (292)
289 KOG0983 Mitogen-activated prot 100.0 1.7E-33 3.7E-38 237.5 11.7 211 157-374 94-315 (391)
290 cd06624 STKc_ASK Catalytic dom 100.0 5.4E-32 1.2E-36 243.9 22.5 197 155-358 8-215 (268)
291 PHA03211 serine/threonine kina 100.0 1.6E-32 3.4E-37 263.2 20.0 189 154-355 168-363 (461)
292 cd07867 STKc_CDC2L6 Catalytic 100.0 1.7E-32 3.8E-37 253.3 19.6 190 160-358 6-220 (317)
293 cd05103 PTKc_VEGFR2 Catalytic 100.0 3.4E-32 7.4E-37 254.0 21.7 212 156-372 8-301 (343)
294 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 3.5E-32 7.7E-37 246.0 21.1 179 176-365 45-233 (274)
295 cd05047 PTKc_Tie Catalytic dom 100.0 3.3E-32 7.1E-37 245.7 20.8 203 162-371 2-229 (270)
296 cd05583 STKc_MSK_N N-terminal 100.0 1E-32 2.2E-37 251.4 17.6 199 157-358 2-212 (288)
297 cd06639 STKc_myosinIIIB Cataly 100.0 3.9E-32 8.5E-37 247.9 21.5 216 151-374 18-253 (291)
298 cd07846 STKc_CDKL2_3 Catalytic 100.0 9.5E-33 2.1E-37 251.2 17.3 202 156-362 2-209 (286)
299 KOG0604 MAP kinase-activated p 100.0 5.9E-34 1.3E-38 243.0 8.6 202 156-370 62-283 (400)
300 cd06605 PKc_MAPKK Catalytic do 100.0 6.9E-33 1.5E-37 249.2 15.8 194 156-357 2-202 (265)
301 KOG0662 Cyclin-dependent kinas 100.0 1.6E-33 3.5E-38 223.8 10.0 205 156-366 3-215 (292)
302 cd06635 STKc_TAO1 Catalytic do 100.0 5.2E-32 1.1E-36 250.1 21.7 208 157-373 27-243 (317)
303 cd05581 STKc_PDK1 Catalytic do 100.0 1.6E-32 3.6E-37 248.6 18.1 212 156-370 2-238 (280)
304 cd06917 STKc_NAK1_like Catalyt 100.0 2.3E-32 5.1E-37 247.5 19.0 203 157-366 3-214 (277)
305 cd06627 STKc_Cdc7_like Catalyt 100.0 9.6E-32 2.1E-36 240.0 22.6 214 156-374 1-219 (254)
306 cd06638 STKc_myosinIIIA Cataly 100.0 2.7E-32 5.9E-37 248.2 19.4 209 153-369 16-244 (286)
307 cd07833 STKc_CDKL Catalytic do 100.0 2.3E-32 5.1E-37 248.8 18.9 204 156-363 2-211 (288)
308 cd05110 PTKc_HER4 Catalytic do 100.0 3.7E-32 7.9E-37 249.5 19.9 213 155-373 7-231 (303)
309 cd06637 STKc_TNIK Catalytic do 100.0 2.7E-32 5.8E-37 246.4 18.6 204 155-366 6-228 (272)
310 cd07850 STKc_JNK Catalytic dom 100.0 2.5E-32 5.4E-37 256.0 18.9 203 155-366 16-229 (353)
311 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 3.9E-32 8.5E-37 247.0 19.5 195 156-355 5-213 (284)
312 PHA03390 pk1 serine/threonine- 100.0 5.1E-32 1.1E-36 244.0 19.9 183 163-361 24-213 (267)
313 PHA03210 serine/threonine kina 100.0 1.5E-32 3.2E-37 267.9 17.6 196 155-354 148-368 (501)
314 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 9.3E-32 2E-36 241.6 21.5 190 162-362 2-218 (262)
315 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 6.6E-32 1.4E-36 245.5 20.6 196 155-356 4-213 (284)
316 cd08530 STKc_CNK2-like Catalyt 100.0 4.1E-32 8.9E-37 242.7 18.2 211 157-374 2-221 (256)
317 cd07870 STKc_PFTAIRE2 Catalyti 100.0 4.9E-32 1.1E-36 247.2 18.9 198 155-359 5-209 (291)
318 cd06608 STKc_myosinIII_like Ca 100.0 6.2E-32 1.3E-36 244.1 19.1 213 154-374 5-238 (275)
319 cd07836 STKc_Pho85 Catalytic d 100.0 8.7E-32 1.9E-36 244.6 20.2 205 156-367 1-214 (284)
320 cd05122 PKc_STE Catalytic doma 100.0 1.5E-31 3.2E-36 238.1 21.2 210 157-374 2-217 (253)
321 cd07844 STKc_PCTAIRE_like Cata 100.0 5.9E-32 1.3E-36 246.7 18.8 196 156-358 6-208 (291)
322 cd05074 PTKc_Tyro3 Catalytic d 100.0 8.6E-32 1.9E-36 243.2 19.7 210 157-370 1-232 (273)
323 cd05123 STKc_AGC Catalytic dom 100.0 9.9E-32 2.1E-36 239.5 19.8 203 163-369 1-208 (250)
324 PHA03209 serine/threonine kina 100.0 5.6E-32 1.2E-36 253.7 19.1 185 155-354 66-256 (357)
325 cd07839 STKc_CDK5 Catalytic do 100.0 2E-32 4.4E-37 248.8 15.6 193 157-355 2-201 (284)
326 cd08215 STKc_Nek Catalytic dom 100.0 1.1E-31 2.4E-36 240.0 20.0 214 156-374 1-223 (258)
327 cd06636 STKc_MAP4K4_6 Catalyti 100.0 7E-32 1.5E-36 245.0 19.0 206 153-366 14-238 (282)
328 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 1E-31 2.3E-36 240.6 19.8 193 162-367 2-220 (259)
329 cd08528 STKc_Nek10 Catalytic d 100.0 8.6E-32 1.9E-36 242.7 19.3 212 156-372 1-231 (269)
330 cd06617 PKc_MKK3_6 Catalytic d 100.0 1E-31 2.2E-36 244.0 19.9 209 156-372 2-226 (283)
331 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 1.6E-31 3.6E-36 243.3 21.1 194 156-357 2-206 (287)
332 cd07843 STKc_CDC2L1 Catalytic 100.0 7.1E-32 1.5E-36 246.4 18.7 206 156-367 6-220 (293)
333 cd08225 STKc_Nek5 Catalytic do 100.0 4.5E-32 9.7E-37 242.7 16.8 210 157-371 2-219 (257)
334 cd06657 STKc_PAK4 Catalytic do 100.0 1E-31 2.2E-36 245.1 19.1 204 160-371 25-233 (292)
335 cd07840 STKc_CDK9_like Catalyt 100.0 1.1E-31 2.3E-36 244.2 19.0 207 157-368 1-216 (287)
336 cd06633 STKc_TAO3 Catalytic do 100.0 2.5E-31 5.4E-36 245.1 21.6 207 157-372 23-238 (313)
337 cd07845 STKc_CDK10 Catalytic d 100.0 1.2E-31 2.6E-36 246.9 18.9 208 156-369 8-224 (309)
338 KOG0596 Dual specificity; seri 100.0 3E-32 6.5E-37 249.9 14.4 210 155-372 361-588 (677)
339 cd07860 STKc_CDK2_3 Catalytic 100.0 1.2E-31 2.7E-36 243.6 18.4 205 156-366 1-213 (284)
340 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 1.6E-31 3.5E-36 242.7 19.2 198 156-358 5-216 (284)
341 cd07842 STKc_CDK8_like Catalyt 100.0 1.3E-31 2.8E-36 247.3 18.7 200 157-360 2-222 (316)
342 cd06606 STKc_MAPKKK Catalytic 100.0 4.6E-31 9.9E-36 236.0 21.6 198 157-358 2-207 (260)
343 cd07855 STKc_ERK5 Catalytic do 100.0 5.8E-32 1.3E-36 251.6 15.1 205 155-364 5-222 (334)
344 PLN00009 cyclin-dependent kina 100.0 4.3E-31 9.3E-36 241.3 19.9 205 156-366 3-216 (294)
345 cd07835 STKc_CDK1_like Catalyt 100.0 2.7E-31 5.8E-36 241.3 18.4 203 157-365 1-211 (283)
346 cd08216 PK_STRAD Pseudokinase 100.0 4.7E-31 1E-35 243.4 20.3 199 159-361 6-217 (314)
347 KOG1006 Mitogen-activated prot 100.0 1E-33 2.2E-38 237.9 2.1 214 156-376 65-292 (361)
348 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 1.7E-31 3.8E-36 239.3 16.6 189 162-361 2-213 (258)
349 cd07837 STKc_CdkB_plant Cataly 100.0 4.3E-31 9.3E-36 241.4 19.4 205 156-366 2-224 (295)
350 PHA02882 putative serine/threo 100.0 6.8E-31 1.5E-35 240.0 20.7 200 155-358 12-237 (294)
351 cd05610 STKc_MASTL Catalytic d 100.0 4.5E-31 9.8E-36 265.2 21.3 143 156-301 5-152 (669)
352 cd07865 STKc_CDK9 Catalytic do 100.0 5.9E-31 1.3E-35 242.1 19.6 206 156-366 13-236 (310)
353 cd06616 PKc_MKK4 Catalytic dom 100.0 4.8E-31 1E-35 240.3 18.7 194 157-358 6-214 (288)
354 cd06634 STKc_TAO2 Catalytic do 100.0 4.7E-31 1E-35 242.7 18.7 208 156-372 16-232 (308)
355 cd07834 STKc_MAPK Catalytic do 100.0 2.3E-31 5.1E-36 247.2 16.7 209 156-369 1-222 (330)
356 cd07852 STKc_MAPK15 Catalytic 100.0 3.7E-31 8E-36 246.5 17.7 206 155-366 7-225 (337)
357 KOG0603 Ribosomal protein S6 k 100.0 9.8E-32 2.1E-36 251.4 13.7 201 154-369 321-529 (612)
358 cd07849 STKc_ERK1_2_like Catal 100.0 4E-31 8.6E-36 246.2 17.8 198 155-359 5-215 (336)
359 cd07880 STKc_p38gamma_MAPK12 C 100.0 6.7E-31 1.4E-35 245.3 19.0 202 156-367 16-229 (343)
360 cd07877 STKc_p38alpha_MAPK14 C 100.0 5.9E-31 1.3E-35 245.8 18.5 204 154-367 16-231 (345)
361 cd07858 STKc_TEY_MAPK_plant Ca 100.0 5.2E-31 1.1E-35 245.5 18.1 199 155-359 5-214 (337)
362 KOG0200 Fibroblast/platelet-de 100.0 4.1E-31 8.8E-36 261.8 18.3 221 147-374 290-543 (609)
363 cd07838 STKc_CDK4_6_like Catal 100.0 1.4E-30 3E-35 236.9 20.3 204 157-367 1-219 (287)
364 KOG3653 Transforming growth fa 100.0 2.3E-31 5E-36 240.1 14.6 215 157-378 212-466 (534)
365 cd08226 PK_STRAD_beta Pseudoki 100.0 1.2E-30 2.7E-35 242.1 20.0 202 162-367 5-223 (328)
366 cd07864 STKc_CDK12 Catalytic d 100.0 5.1E-31 1.1E-35 241.7 17.2 209 155-368 7-232 (302)
367 cd07831 STKc_MOK Catalytic dom 100.0 9.8E-31 2.1E-35 237.4 18.9 201 157-366 1-211 (282)
368 PTZ00024 cyclin-dependent prot 100.0 8.8E-31 1.9E-35 243.8 18.8 205 159-367 13-247 (335)
369 cd07857 STKc_MPK1 Catalytic do 100.0 9.8E-31 2.1E-35 243.2 18.5 205 157-366 2-222 (332)
370 cd05118 STKc_CMGC Catalytic do 100.0 1.1E-30 2.5E-35 237.0 18.2 205 157-367 1-212 (283)
371 KOG1025 Epidermal growth facto 100.0 1.7E-31 3.7E-36 254.5 12.9 211 155-371 696-918 (1177)
372 cd06618 PKc_MKK7 Catalytic dom 100.0 3.2E-30 7E-35 235.8 20.3 211 155-373 15-238 (296)
373 cd07829 STKc_CDK_like Catalyti 100.0 1.4E-30 3E-35 236.3 16.9 203 158-366 2-211 (282)
374 cd07866 STKc_BUR1 Catalytic do 100.0 1.4E-30 3E-35 239.8 16.1 208 155-367 8-240 (311)
375 KOG2052 Activin A type IB rece 100.0 7.7E-31 1.7E-35 235.1 13.8 220 155-381 211-469 (513)
376 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 4E-30 8.7E-35 238.5 18.8 197 153-359 8-211 (328)
377 cd08222 STKc_Nek11 Catalytic d 100.0 1.7E-30 3.8E-35 233.0 15.7 213 157-374 2-225 (260)
378 cd07851 STKc_p38 Catalytic dom 100.0 2E-30 4.3E-35 242.1 16.1 204 155-368 15-230 (343)
379 KOG0671 LAMMER dual specificit 100.0 1.8E-31 3.8E-36 235.2 8.3 200 154-365 88-320 (415)
380 cd07879 STKc_p38delta_MAPK13 C 100.0 2.4E-30 5.3E-35 241.4 16.6 202 156-368 16-229 (342)
381 KOG0664 Nemo-like MAPK-related 100.0 8.4E-33 1.8E-37 233.3 -0.0 205 157-366 55-270 (449)
382 cd07830 STKc_MAK_like Catalyti 100.0 7.3E-30 1.6E-34 231.8 19.0 202 157-366 1-211 (283)
383 KOG1151 Tousled-like protein k 100.0 3.6E-31 7.8E-36 236.9 9.8 201 156-357 464-687 (775)
384 cd05576 STKc_RPK118_like Catal 100.0 4.1E-30 9E-35 227.4 16.6 176 166-356 4-184 (237)
385 KOG1152 Signal transduction se 100.0 3.6E-31 7.9E-36 243.7 9.0 195 156-356 562-771 (772)
386 smart00221 STYKc Protein kinas 100.0 2.5E-29 5.5E-34 219.9 19.8 212 158-374 2-222 (225)
387 cd07854 STKc_MAPK4_6 Catalytic 100.0 5.3E-30 1.1E-34 239.2 16.3 204 155-366 5-231 (342)
388 KOG0669 Cyclin T-dependent kin 100.0 3E-32 6.5E-37 227.5 0.5 206 157-367 19-242 (376)
389 KOG0587 Traf2- and Nck-interac 100.0 2.5E-29 5.4E-34 241.9 17.0 211 156-374 20-248 (953)
390 PLN00113 leucine-rich repeat r 100.0 6.1E-29 1.3E-33 262.0 20.1 185 156-356 691-880 (968)
391 KOG1035 eIF-2alpha kinase GCN2 100.0 9.2E-30 2E-34 252.2 11.0 205 155-367 479-829 (1351)
392 smart00220 S_TKc Serine/Threon 100.0 2.6E-28 5.7E-33 215.7 19.0 198 165-369 2-202 (244)
393 KOG0665 Jun-N-terminal kinase 100.0 2.7E-29 5.8E-34 216.6 7.7 203 155-366 17-229 (369)
394 KOG1165 Casein kinase (serine/ 100.0 8.1E-28 1.8E-32 208.5 14.9 224 152-384 25-270 (449)
395 PLN03224 probable serine/threo 100.0 2.3E-27 4.9E-32 227.6 18.2 200 154-356 144-435 (507)
396 KOG0670 U4/U6-associated splic 99.9 1.4E-28 3.1E-33 224.1 7.4 204 156-370 433-651 (752)
397 KOG0668 Casein kinase II, alph 99.9 3.6E-28 7.9E-33 200.4 9.1 197 156-366 39-246 (338)
398 KOG1027 Serine/threonine prote 99.9 9.3E-29 2E-33 236.9 4.8 192 157-358 511-719 (903)
399 PLN03225 Serine/threonine-prot 99.9 3.6E-27 7.7E-32 231.6 15.7 193 153-355 130-380 (566)
400 KOG1345 Serine/threonine kinas 99.9 1.1E-27 2.4E-32 202.2 6.0 218 146-375 13-250 (378)
401 KOG1024 Receptor-like protein 99.9 1.6E-26 3.5E-31 204.3 9.3 221 157-385 286-527 (563)
402 KOG1163 Casein kinase (serine/ 99.9 1.9E-25 4E-30 185.8 10.8 205 156-369 16-236 (341)
403 cd00180 PKc Catalytic domain o 99.9 5E-24 1.1E-28 183.8 19.1 179 163-347 1-187 (215)
404 KOG0576 Mitogen-activated prot 99.9 4.8E-26 1E-30 213.3 1.7 208 156-370 16-231 (829)
405 KOG1164 Casein kinase (serine/ 99.9 1.1E-23 2.4E-28 194.3 15.9 208 156-370 19-253 (322)
406 KOG1167 Serine/threonine prote 99.9 1.9E-24 4.1E-29 193.3 10.1 200 156-366 37-291 (418)
407 PRK09188 serine/threonine prot 99.9 1.7E-23 3.7E-28 192.8 15.9 167 149-329 12-195 (365)
408 PLN00181 protein SPA1-RELATED; 99.9 1.1E-24 2.3E-29 224.3 7.9 146 207-356 29-217 (793)
409 KOG1290 Serine/threonine prote 99.9 2.7E-23 5.8E-28 188.7 15.1 126 155-287 78-222 (590)
410 KOG4412 26S proteasome regulat 99.9 5.8E-24 1.3E-28 168.1 8.8 109 34-142 66-175 (226)
411 COG0515 SPS1 Serine/threonine 99.9 3.9E-21 8.4E-26 177.5 21.0 211 157-370 2-231 (384)
412 smart00750 KIND kinase non-cat 99.9 6.2E-22 1.3E-26 166.8 12.1 115 235-366 1-117 (176)
413 PRK10359 lipopolysaccharide co 99.9 2.8E-22 6E-27 172.1 9.4 168 156-348 32-216 (232)
414 KOG4412 26S proteasome regulat 99.9 1.1E-22 2.5E-27 160.8 5.7 108 30-137 96-203 (226)
415 PRK12274 serine/threonine prot 99.9 8.6E-21 1.9E-25 159.5 13.4 186 159-358 6-211 (218)
416 KOG0603 Ribosomal protein S6 k 99.9 1E-22 2.3E-27 191.2 2.1 196 163-373 2-206 (612)
417 cd05147 RIO1_euk RIO kinase fa 99.8 5.5E-21 1.2E-25 162.2 11.0 137 161-303 3-167 (190)
418 KOG0590 Checkpoint kinase and 99.8 1.5E-21 3.2E-26 191.6 3.9 160 197-360 368-531 (601)
419 cd05145 RIO1_like RIO kinase f 99.8 1.1E-19 2.4E-24 154.7 14.0 138 161-304 3-168 (190)
420 PRK10345 hypothetical protein; 99.8 8.3E-20 1.8E-24 156.4 12.3 136 157-301 4-158 (210)
421 PHA02743 Viral ankyrin protein 99.8 5.3E-20 1.1E-24 152.8 10.2 108 29-136 46-158 (166)
422 KOG0509 Ankyrin repeat and DHH 99.8 5.1E-20 1.1E-24 172.4 9.1 115 29-143 67-182 (600)
423 KOG0512 Fetal globin-inducing 99.8 1.4E-19 3.1E-24 142.2 7.4 97 31-127 88-185 (228)
424 PHA02741 hypothetical protein; 99.8 5.8E-19 1.3E-23 147.2 9.5 102 30-131 50-157 (169)
425 PF14531 Kinase-like: Kinase-l 99.8 1.9E-19 4.1E-24 159.3 6.8 217 156-381 13-276 (288)
426 PF12796 Ank_2: Ankyrin repeat 99.8 1.1E-18 2.4E-23 129.4 10.0 87 44-134 1-87 (89)
427 PHA02859 ankyrin repeat protei 99.8 1.6E-18 3.4E-23 149.5 11.7 98 39-136 86-189 (209)
428 PHA02791 ankyrin-like protein; 99.8 1.4E-18 3E-23 155.6 11.2 100 34-135 24-123 (284)
429 PHA02791 ankyrin-like protein; 99.8 1.6E-18 3.4E-23 155.2 11.4 91 40-130 61-152 (284)
430 KOG1166 Mitotic checkpoint ser 99.8 8.3E-19 1.8E-23 175.9 10.4 195 149-352 692-901 (974)
431 KOG0502 Integral membrane anky 99.8 1.1E-18 2.4E-23 142.5 8.3 105 33-137 153-257 (296)
432 PHA02736 Viral ankyrin protein 99.8 6.2E-19 1.3E-23 145.0 6.8 99 34-132 49-152 (154)
433 PHA02741 hypothetical protein; 99.8 1.6E-18 3.4E-23 144.7 9.3 110 33-142 14-135 (169)
434 PHA02878 ankyrin repeat protei 99.8 3.8E-18 8.3E-23 166.1 11.6 107 29-135 156-264 (477)
435 KOG0508 Ankyrin repeat protein 99.8 7.9E-19 1.7E-23 158.3 5.9 104 29-132 106-209 (615)
436 PHA02874 ankyrin repeat protei 99.8 5.7E-18 1.2E-22 163.0 11.9 109 29-137 113-221 (434)
437 KOG0509 Ankyrin repeat and DHH 99.8 2.7E-18 5.8E-23 161.0 9.2 116 23-142 99-215 (600)
438 KOG0606 Microtubule-associated 99.7 1.4E-18 3E-23 171.6 7.0 179 149-370 77-274 (1205)
439 PHA02859 ankyrin repeat protei 99.7 8.1E-18 1.8E-22 145.1 10.7 105 33-137 44-156 (209)
440 PRK14879 serine/threonine prot 99.7 3.9E-17 8.5E-22 141.7 14.8 134 161-302 2-143 (211)
441 PHA02946 ankyin-like protein; 99.7 8.7E-18 1.9E-22 161.0 11.6 109 29-138 61-172 (446)
442 PHA02875 ankyrin repeat protei 99.7 1E-17 2.3E-22 160.3 12.0 101 36-136 98-198 (413)
443 PLN03192 Voltage-dependent pot 99.7 8.4E-18 1.8E-22 173.2 11.7 111 29-139 547-688 (823)
444 TIGR03724 arch_bud32 Kae1-asso 99.7 3.3E-17 7.1E-22 140.8 13.5 130 163-303 2-139 (199)
445 PHA02884 ankyrin repeat protei 99.7 1.1E-17 2.3E-22 149.8 10.6 91 44-134 37-132 (300)
446 PHA02795 ankyrin-like protein; 99.7 7.4E-18 1.6E-22 156.8 9.3 98 37-134 185-290 (437)
447 PHA02884 ankyrin repeat protei 99.7 2.4E-17 5.2E-22 147.6 11.3 98 29-126 55-157 (300)
448 PHA02875 ankyrin repeat protei 99.7 2E-17 4.4E-22 158.4 11.3 106 29-134 124-230 (413)
449 PHA02716 CPXV016; CPX019; EVM0 99.7 1.5E-17 3.2E-22 165.1 10.6 109 29-137 201-350 (764)
450 PHA02743 Viral ankyrin protein 99.7 1.1E-17 2.4E-22 138.9 8.3 109 29-137 9-126 (166)
451 PHA03095 ankyrin-like protein; 99.7 2.3E-17 5.1E-22 160.7 11.7 111 29-139 36-152 (471)
452 KOG1240 Protein kinase contain 99.7 2.2E-18 4.7E-23 170.5 4.1 194 156-355 24-240 (1431)
453 KOG0512 Fetal globin-inducing 99.7 2.3E-17 5.1E-22 129.9 8.9 94 44-137 67-161 (228)
454 PHA02878 ankyrin repeat protei 99.7 3.7E-17 8E-22 159.2 12.0 112 29-142 190-303 (477)
455 PHA02798 ankyrin-like protein; 99.7 2E-17 4.3E-22 161.5 10.0 107 29-135 60-177 (489)
456 KOG4177 Ankyrin [Cell wall/mem 99.7 1E-17 2.2E-22 169.5 7.5 105 28-132 528-632 (1143)
457 PRK09605 bifunctional UGMP fam 99.7 1.7E-16 3.6E-21 156.4 15.7 135 157-303 335-477 (535)
458 smart00090 RIO RIO-like kinase 99.7 7.5E-17 1.6E-21 141.5 11.7 140 157-303 30-198 (237)
459 PHA03095 ankyrin-like protein; 99.7 3.6E-17 7.7E-22 159.5 10.4 104 29-132 211-316 (471)
460 KOG4158 BRPK/PTEN-induced prot 99.7 6E-17 1.3E-21 144.5 9.8 170 208-385 274-486 (598)
461 PHA03100 ankyrin repeat protei 99.7 7.6E-17 1.6E-21 157.5 11.0 109 30-138 166-282 (480)
462 PRK01723 3-deoxy-D-manno-octul 99.7 4.9E-16 1.1E-20 136.6 14.3 139 157-303 37-192 (239)
463 PHA02716 CPXV016; CPX019; EVM0 99.7 1E-16 2.2E-21 159.1 11.0 85 29-113 164-254 (764)
464 PHA03100 ankyrin repeat protei 99.7 1.1E-16 2.3E-21 156.5 10.8 107 29-135 95-205 (480)
465 KOG4214 Myotrophin and similar 99.7 7.6E-17 1.6E-21 113.4 6.9 77 37-113 31-107 (117)
466 KOG0508 Ankyrin repeat protein 99.7 1.2E-16 2.5E-21 144.5 9.6 130 13-142 54-186 (615)
467 PHA02874 ankyrin repeat protei 99.7 2.8E-16 6E-21 151.3 12.1 104 30-133 58-184 (434)
468 KOG0514 Ankyrin repeat protein 99.7 1.1E-16 2.4E-21 140.1 7.4 86 40-125 340-426 (452)
469 PHA02876 ankyrin repeat protei 99.7 2.8E-16 6.2E-21 159.6 11.3 114 29-142 364-479 (682)
470 KOG1023 Natriuretic peptide re 99.7 2E-16 4.4E-21 148.8 9.2 165 204-370 1-178 (484)
471 cd05144 RIO2_C RIO kinase fami 99.7 6.2E-16 1.4E-20 132.7 11.3 134 157-303 17-175 (198)
472 PHA02730 ankyrin-like protein; 99.7 3.3E-16 7.3E-21 152.7 10.3 108 29-137 368-493 (672)
473 KOG0510 Ankyrin repeat protein 99.7 2.5E-16 5.4E-21 151.0 8.3 113 30-142 296-413 (929)
474 PHA02917 ankyrin-like protein; 99.6 5.3E-16 1.1E-20 154.6 10.9 106 29-134 21-166 (661)
475 PHA02798 ankyrin-like protein; 99.6 7.4E-16 1.6E-20 150.5 10.9 107 29-135 98-215 (489)
476 PHA02989 ankyrin repeat protei 99.6 8.2E-16 1.8E-20 150.4 11.0 105 29-134 59-175 (494)
477 PHA02917 ankyrin-like protein; 99.6 1.1E-15 2.3E-20 152.4 11.8 105 29-133 385-513 (661)
478 PHA02736 Viral ankyrin protein 99.6 1.4E-16 3.1E-21 130.9 4.6 105 33-139 10-126 (154)
479 PHA02989 ankyrin repeat protei 99.6 9.5E-16 2.1E-20 149.9 11.1 108 29-136 97-215 (494)
480 KOG1033 eIF-2alpha kinase PEK/ 99.6 5.1E-17 1.1E-21 150.3 1.2 120 224-349 330-457 (516)
481 PHA02795 ankyrin-like protein; 99.6 1.1E-15 2.4E-20 142.3 10.0 111 29-141 140-256 (437)
482 PF12796 Ank_2: Ankyrin repeat 99.6 1.2E-15 2.7E-20 113.0 8.4 64 40-103 26-89 (89)
483 PF13637 Ank_4: Ankyrin repeat 99.6 8.1E-16 1.8E-20 102.1 6.4 54 40-93 1-54 (54)
484 PHA02946 ankyin-like protein; 99.6 1.3E-15 2.8E-20 146.1 10.4 112 29-141 94-210 (446)
485 PHA02730 ankyrin-like protein; 99.6 1.1E-15 2.4E-20 149.1 9.8 103 32-134 32-145 (672)
486 PF13857 Ank_5: Ankyrin repeat 99.6 2.4E-16 5.2E-21 105.2 3.5 55 59-113 1-56 (56)
487 KOG4214 Myotrophin and similar 99.6 8.4E-16 1.8E-20 108.2 5.5 92 43-135 5-96 (117)
488 PHA02876 ankyrin repeat protei 99.6 2.9E-15 6.3E-20 152.3 11.6 108 29-136 296-405 (682)
489 KOG0514 Ankyrin repeat protein 99.6 2E-15 4.4E-20 132.4 8.4 120 22-142 284-410 (452)
490 KOG0510 Ankyrin repeat protein 99.6 2E-15 4.3E-20 144.9 9.0 100 34-133 267-368 (929)
491 cd05119 RIO RIO kinase family, 99.6 8.3E-15 1.8E-19 124.5 11.6 133 161-303 3-164 (187)
492 KOG0502 Integral membrane anky 99.6 6.9E-16 1.5E-20 126.3 4.1 129 3-132 156-284 (296)
493 KOG0505 Myosin phosphatase, re 99.6 3.1E-15 6.8E-20 137.7 8.4 71 73-143 198-268 (527)
494 cd05120 APH_ChoK_like Aminogly 99.6 1.8E-14 3.9E-19 117.7 11.8 131 160-302 3-138 (155)
495 KOG0195 Integrin-linked kinase 99.6 7.2E-15 1.6E-19 125.1 8.9 102 33-134 60-161 (448)
496 KOG0590 Checkpoint kinase and 99.6 2.1E-16 4.6E-21 155.4 -0.5 202 154-359 19-235 (601)
497 KOG4177 Ankyrin [Cell wall/mem 99.6 6.1E-15 1.3E-19 149.6 9.8 111 32-142 499-609 (1143)
498 cd00204 ANK ankyrin repeats; 99.6 2.1E-14 4.7E-19 113.0 11.0 100 36-135 3-102 (126)
499 PLN03192 Voltage-dependent pot 99.6 1.2E-14 2.7E-19 149.9 11.5 96 36-131 521-616 (823)
500 PHA02792 ankyrin-like protein; 99.6 7.5E-15 1.6E-19 141.9 9.2 103 30-132 362-479 (631)
No 1
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-48 Score=342.06 Aligned_cols=209 Identities=33% Similarity=0.599 Sum_probs=190.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...++||+|+|++||. ++..||||.+.+... ..+.++.+..|+.+|+.++|||||++++++..++.+|+|||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 566677899999999974 678999999987654 56778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC------CCEEEEeecCccccc
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLT 304 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~------~~~kl~Dfg~~~~~~ 304 (387)
||.||+|.+|+++.+.+++..+..++.||+.||++||+++ ||||||||.|||++.. -.+||+|||+|+...
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999999999999999999999999999999999 9999999999999865 458999999999876
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
. ........|++.|||||++...+|+.|+|+||+|+++|++++|+.||...+..++...|..+.
T Consensus 167 ~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~ 230 (429)
T KOG0595|consen 167 P--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN 230 (429)
T ss_pred c--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc
Confidence 3 344455679999999999999999999999999999999999999999999999999887776
No 2
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-48 Score=339.35 Aligned_cols=216 Identities=31% Similarity=0.482 Sum_probs=198.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +++.+|+|++++..+......+....|.++|..++||+||.++..|++...+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 3677888999999998873 68899999999988877777888999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.||.|..++++++.+++..+..++.+|+.||.|||++| ||||||||+|||++.+|+++|+|||+++..... ..
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999864433 33
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......||+.|||||++.+.+++..+|+||||+++|||++|.+||.+.+...+.++|..++.+.+
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP 245 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC
Confidence 44457899999999999999999999999999999999999999999999999999998883433
No 3
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.2e-46 Score=349.14 Aligned_cols=223 Identities=29% Similarity=0.477 Sum_probs=204.0
Q ss_pred CCCccccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 144 ~~~~~ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
.++..-.++....|...+.||+|+|..+|. +|..||+|++.+.........+.+.+|+++.++++|||||+++++
T Consensus 7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~ 86 (592)
T KOG0575|consen 7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF 86 (592)
T ss_pred CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence 344444455557799999999999988873 689999999999888888888999999999999999999999999
Q ss_pred EeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 219 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
|++...+|+|.|+|..++|..++++.+++++.++..+++||+.||.|||+++ |+|||||..|+|++++.++||+|||
T Consensus 87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence 9999999999999999999999999899999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+|....... .......|||.|+|||++....++..+||||+||+||.||.|++||...+-.+++.+|+...
T Consensus 164 LAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~ 234 (592)
T KOG0575|consen 164 LATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE 234 (592)
T ss_pred eeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC
Confidence 998877543 33445679999999999999999999999999999999999999999999999999998888
No 4
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-46 Score=317.36 Aligned_cols=208 Identities=28% Similarity=0.526 Sum_probs=194.3
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|- -+|.-+|+|++.+...-..++.+...+|..+|+.+.||+++++++.|.+...+|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 67777899999999875 3688999999998877777788889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++||.|.+++++.+++++..++.++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||+|+.... .
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---R- 197 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC---c-
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999987642 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....|||.|+|||++++.++..++|+|||||++|||+.|.+||.+.++..++++|..++
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~ 257 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK 257 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc
Confidence 334679999999999999999999999999999999999999999999999999999998
No 5
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-45 Score=338.53 Aligned_cols=227 Identities=43% Similarity=0.745 Sum_probs=195.8
Q ss_pred CCccccCccccCcccceeecccEEEEEE---EcCeE-EEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe
Q 016544 145 VPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (387)
Q Consensus 145 ~~~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 220 (387)
...++++...+.+.. .+|.|+||.|| |.|+. ||+|.+......... .+.|.+|+.+|.+++|||||+++|++.
T Consensus 33 ~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred ccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 345666666554443 49999998776 88998 999999877655544 789999999999999999999999999
Q ss_pred eCC-ceEEEEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEe
Q 016544 221 QSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 296 (387)
Q Consensus 221 ~~~-~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~D 296 (387)
... ..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++| ||||||||+|||++.++ ++||+|
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECC
Confidence 887 79999999999999999988 5679999999999999999999999985 99999999999999997 999999
Q ss_pred ecCccccccCCCCCcccCCCCCccccccccc--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCC
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP 373 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~ 373 (387)
||+++...... ...+...||+.|||||++. ...++.++||||||+++|||+||+.||.+..+..+...+...+ ||+
T Consensus 188 FGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 188 FGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP 266 (362)
T ss_pred Cccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99998765332 3333467899999999999 5699999999999999999999999999999988888876555 888
Q ss_pred CCCC
Q 016544 374 FKAP 377 (387)
Q Consensus 374 ~~~~ 377 (387)
++..
T Consensus 267 ~p~~ 270 (362)
T KOG0192|consen 267 IPKE 270 (362)
T ss_pred CCcc
Confidence 7653
No 6
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.2e-47 Score=322.43 Aligned_cols=227 Identities=26% Similarity=0.458 Sum_probs=196.0
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeee-EEeeCCc-eEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~-~~~~~~~-~~lv 228 (387)
+|.+.+.||+|+||.|| ++|..+|.|.+.=.. -+....+....|+.+|++++|||||++++ .|..+.. ++|+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 57788899999999887 589999999998433 35666788899999999999999999999 5555555 8999
Q ss_pred EEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPV-PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
||+|.+|+|.+.++. ...+++..+++++.|++.||..+|+..|. .|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999863 34499999999999999999999995432 3899999999999999999999999999988
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhh
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 383 (387)
+.. .....+.+|||.||+||.+.+.+|+.+|||||+||++|||++-++||.+.+-.+++++|..+..||++ ..-|+.
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~~~YS~ 255 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--DEHYST 255 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--HHHhhh
Confidence 754 33345678999999999999999999999999999999999999999999999999999999877764 255665
Q ss_pred ccc
Q 016544 384 GLK 386 (387)
Q Consensus 384 ~l~ 386 (387)
+|+
T Consensus 256 ~l~ 258 (375)
T KOG0591|consen 256 DLR 258 (375)
T ss_pred HHH
Confidence 554
No 7
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-45 Score=323.97 Aligned_cols=221 Identities=29% Similarity=0.441 Sum_probs=191.7
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-eEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~lv~ 229 (387)
++.....||+|..|+|+ ++++.+|+|.+... .++...+++.+|+++++..+||+||.+||.|..++. +.|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 34455689999999886 47899999999543 356778889999999999999999999999999995 99999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||++|||..++...+.+++.....++.+|++||.|||+ ++ ||||||||+|||++..|.+||+|||.+......
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999998899999999999999999999996 77 999999999999999999999999999876543
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CCCcHHHHHHccCCCCCCCChhhhhh
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK-----HDNEVPKAYAARQRPPFKAPAKLYAR 383 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 383 (387)
....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||... +..+++..|..+..|.++. ..|++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence 445678999999999999999999999999999999999999999874 4556677777666555533 24666
Q ss_pred ccc
Q 016544 384 GLK 386 (387)
Q Consensus 384 ~l~ 386 (387)
+++
T Consensus 310 ef~ 312 (364)
T KOG0581|consen 310 EFR 312 (364)
T ss_pred HHH
Confidence 654
No 8
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.9e-46 Score=329.42 Aligned_cols=213 Identities=27% Similarity=0.430 Sum_probs=185.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
.|...+.||+|+||.|. .+|+.||||++++....... .....++|+++|++++|||||+++++|......|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 56778899999999885 47999999999876554322 2334679999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCcccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLL 303 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~ 303 (387)
+||||++||+|.+.+-.++.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999988999999999999999999999999 9999999999999976 67999999999987
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHccCCCC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPP 373 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~ 373 (387)
+ +........|||.|.|||++.+...+ .++|+||+||++|-+++|.+||.+..... +.++|..+..+-
T Consensus 330 g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 330 G--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred c--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 5 34445567899999999999876433 37899999999999999999999877766 899998888433
No 9
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-45 Score=310.34 Aligned_cols=335 Identities=27% Similarity=0.405 Sum_probs=267.1
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+-|.|..|-.|.+||||||+.|+..+++.|+..|+.+|+.+.-..||||+|+.+|+.++|+.|++..+|+|..|..|.||
T Consensus 24 ehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntp 103 (448)
T KOG0195|consen 24 EHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTP 103 (448)
T ss_pred ccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCc
Confidence 44556666678899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCc-----------------------cccccCCCCccccCcc-------------
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPM-----------------------HVKHAREVPEYEIDPH------------- 153 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~-----------------------~~~~~~~~~~~ei~~~------------- 153 (387)
|||||..|...+++-|++.|+.+..-+. +...+..++..+....
T Consensus 104 lhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr 183 (448)
T KOG0195|consen 104 LHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSR 183 (448)
T ss_pred hhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCccccccccccccccccccccccc
Confidence 9999999999999999999987643221 1222223332221111
Q ss_pred -------ccCcc-cceeecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 -------ELDFT-NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 -------~~~~~-~~~~lg~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+++. ...+-.+|..+.+.|.|..+++|++..... .....+.|..|.-.++.+.||||+.+++.|.....+
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 11110 011123466677889999999999875433 233346789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE--eecCcc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA--DFGVSK 301 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~--Dfg~~~ 301 (387)
.++..||+.|||..++++... ++..++.+++.+++.|++|||+..|. |.---|.+..++++++.+++|. |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee
Confidence 999999999999999997654 67789999999999999999999852 3344689999999999887765 322221
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
.. .....+|.|++||.++..+-. .++|+|||++++|||.|++.||.+.++.++-.+|...+ |+-+
T Consensus 342 qe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i 410 (448)
T KOG0195|consen 342 QE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI 410 (448)
T ss_pred ec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC
Confidence 10 112347889999999886543 57999999999999999999999999999999998877 4443
No 10
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-44 Score=328.39 Aligned_cols=214 Identities=29% Similarity=0.522 Sum_probs=195.8
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
..+|..++.||.|+|..|+. .++.||||++.+..+-.+..++....|..+|.++ +||+|++|+..|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 34788888999999988863 6889999999888777777778889999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+||+++|+|.++|++-+.+++..+..++.||+.||+|||++| ||||||||+|||++.+++++|+|||.|..+....
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999998775432
Q ss_pred CC------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DR------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. ....++||..|.+||++.....++.+|+|+|||++|+|++|.+||.+.++.-+.++|+.-.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 21 1145789999999999999999999999999999999999999999999999999998877
No 11
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-44 Score=328.62 Aligned_cols=229 Identities=33% Similarity=0.552 Sum_probs=195.0
Q ss_pred CCccccCccccCcccceeecccEEEEEE---EcCe-EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe
Q 016544 145 VPEYEIDPHELDFTNSVEITKGTFILAF---WRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (387)
Q Consensus 145 ~~~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 220 (387)
...|++++..+. ..++||+|.||.|. |+|. +||+|.++..... .+.|.+|+++|++++|++||+++++|.
T Consensus 198 ~d~wei~r~~l~--l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELK--LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHH--HHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 345566555444 35689999999774 7776 9999999875433 356889999999999999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 221 QSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 221 ~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
.++.++||||||+.|+|.++++. ...+...+.+.++.|||+||+||++++ +|||||-.+|||++++..+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccc
Confidence 98999999999999999999987 345899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 377 (387)
+|+......-.......-+..|.|||.+....++.+||||||||+|||++| |+.||.+++..++++.+..|.|-|-
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--- 425 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--- 425 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---
Confidence 999544333333344445788999999999999999999999999999998 9999999999999999999986554
Q ss_pred hhhhhhcc
Q 016544 378 AKLYARGL 385 (387)
Q Consensus 378 ~~~~~~~l 385 (387)
|..||+.+
T Consensus 426 P~~CP~~v 433 (468)
T KOG0197|consen 426 PEGCPDEV 433 (468)
T ss_pred CCCCCHHH
Confidence 24455543
No 12
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.7e-43 Score=311.15 Aligned_cols=210 Identities=27% Similarity=0.516 Sum_probs=196.2
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|. ..|+.||||.+++..+.++...-.+++|+++|..++||||+.+|.+|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 45666789999999886 3689999999999999998888899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|..+|.|++|+.+.+.+++.++..+++||++|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+.. ...
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~--~kf 208 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KKF 208 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--ccH
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999988764 345
Q ss_pred cccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.+.+.|+|.|.+||++.|.+|. +.+|-|||||++|.|+.|..||+|.+...++.+|..+.
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc
Confidence 5667899999999999999885 88999999999999999999999999999999998887
No 13
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=1.6e-42 Score=316.94 Aligned_cols=213 Identities=29% Similarity=0.446 Sum_probs=192.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|.-+|+|++++........++..+.|.++|....+|+||+||-.|++...+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 3677788999999999874 78999999999887777888899999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc----
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV---- 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 305 (387)
||++||++..+|.+.+.+++..+..++.+++-|++.+|++| ||||||||+|+|||..|++||+|||++.-+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999742211
Q ss_pred -----------------CCCCC-----c--------------------ccCCCCCcccccccccCCCCCCchhHHHHHHH
Q 016544 306 -----------------KEDRP-----L--------------------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343 (387)
Q Consensus 306 -----------------~~~~~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 343 (387)
..+.. . ...+|||-|+|||++.+..|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00000 0 12569999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 344 LQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+||||.|.+||...++.+++.+|..-.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999999999999999998766
No 14
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.9e-42 Score=316.96 Aligned_cols=212 Identities=30% Similarity=0.508 Sum_probs=187.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH--HHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~ 226 (387)
-.|...+.||.|+||.|+. +|..||+|++........ ...+.+.+|+.+++++. ||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3677788999999999873 679999998776432211 34456778999999998 999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-CCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 305 (387)
+||||+.||+|.+++.+.+++.+.++..+++|+++|++|||++| |+||||||+|||++.+ +++||+|||++....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 99999999999999999889999999999999999999999999 9999999999999999 999999999998764
Q ss_pred CCCCCcccCCCCCcccccccccCCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
..+.......||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+.+...+..+|..+.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE 239 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence 2344555678999999999999987 76 78999999999999999999999998888999987776
No 15
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=1.3e-42 Score=318.19 Aligned_cols=220 Identities=29% Similarity=0.520 Sum_probs=196.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|.+.+.||+|+||+||. +.+.||+|.+.+... .++..+.+++|+++++.++||||+.++++|+....+++|+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 466678899999999984 567899999987643 45667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.| +|..++...+.++++.+..++.++++||.|||+++ |+|||+||.|||++.++.+|++|||+++..+.. ...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 9976 99999999999999999999999999999999999 999999999999999999999999999987653 344
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhh
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 381 (387)
.+...|||.|||||.+.+.+|+..+|+|||||++||+++|++||...+-.++.+.|.....++++.....|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f 227 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSF 227 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHH
Confidence 45678999999999999999999999999999999999999999999988999999888855544443333
No 16
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.6e-42 Score=312.02 Aligned_cols=211 Identities=27% Similarity=0.451 Sum_probs=187.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l 227 (387)
..|...+.||+|+||.||. +|+.||+|+++......+ ...-..+|+.+|+++.||||++|.+...+. +.+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3566778899999999984 689999999987654443 334457799999999999999999988876 68999
Q ss_pred EEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+|||+. +|.-++...+ .+++.++..++.||+.||+|||++| |+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999976 9998888754 4999999999999999999999999 999999999999999999999999999998877
Q ss_pred CCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+..+.|..|.|||.+.|. .|++++|+||.||||.||++|++.|.+.++.+-+.+|-.-.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc 336 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC 336 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence 77777888889999999999986 78999999999999999999999999999988888885544
No 17
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=8e-42 Score=318.57 Aligned_cols=219 Identities=27% Similarity=0.393 Sum_probs=194.2
Q ss_pred cceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 159 NSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 159 ~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.++.||.|+-|.|. .+|+.+|||++.+...-.......+.+|+-+|+.+.||||+++|+++.....+|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 35679999998875 4899999999987644455556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
+|-|.+++-+++++++.++.++++||+.|+.|+|..+ |+||||||+|+|++..+++||+|||||..-. .+.....
T Consensus 96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklLeT 170 (786)
T KOG0588|consen 96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLLET 170 (786)
T ss_pred CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CCccccc
Confidence 9999999999999999999999999999999999999 9999999999999999999999999997643 3455566
Q ss_pred CCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhh
Q 016544 314 QDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 382 (387)
..|+|.|.|||++.|.+|. .++||||+|||||.||||++||.+.+-..++.+++.|.-..++..+...-
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQ 240 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQ 240 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHH
Confidence 7899999999999999885 78999999999999999999999999999999999988544444444433
No 18
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-41 Score=318.83 Aligned_cols=212 Identities=27% Similarity=0.416 Sum_probs=192.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~l 227 (387)
..+|...+.||+|+||+|.. +++.+|||++++..+-..+.++....|..++.... ||.++.++.+|+.+.++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 34688888999999999863 67899999999988888888999999999999885 9999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||+.||++..+ +..+.+++..+..++..|+.||.|||++| ||+||||.+|||+|..|.+||+|||+++......
T Consensus 447 vmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999995443 33456999999999999999999999999 9999999999999999999999999998755443
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+.+.|||.|||||++.+..|+.++|+|||||+||||+.|+.||.+.+.+++...|+...
T Consensus 523 -~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~ 584 (694)
T KOG0694|consen 523 -DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE 584 (694)
T ss_pred -CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 35556789999999999999999999999999999999999999999999999999998877
No 19
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=7.7e-42 Score=291.62 Aligned_cols=207 Identities=22% Similarity=0.410 Sum_probs=178.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.....+|+|+||+|+. +|+.||||++.+.. +++...+-..+|+++|++++|||+|.++++|...+.+++|+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 45566799999999984 68999999998643 3455566678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
|+..-|.++-.-...++...+..++.|++.|+.|+|+++ +|||||||+|||++.+|.+||||||+|+..... ....
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~Y 158 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNY 158 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-cchh
Confidence 977444443333445899999999999999999999999 999999999999999999999999999988753 3444
Q ss_pred ccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 312 TCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
+.++.|..|.|||.+.| .+|++++||||+||++.||++|.+.|.+.++-+.+-.|..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 55677999999999998 6899999999999999999999999999998777666643
No 20
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-41 Score=312.52 Aligned_cols=211 Identities=36% Similarity=0.566 Sum_probs=182.6
Q ss_pred CCCCccccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 143 REVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 143 ~~~~~~ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
..+...++..++.+|.....||+|+||.||. +|..||||.+....... ..+|.+|+.++.+++|||+|+++||
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 3455667778888999999999999999984 45899999887553321 3559999999999999999999999
Q ss_pred EeeCC-ceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 219 VTQSS-PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 219 ~~~~~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
|.+.+ ..+||+||+++|+|.+++.... +++|..+.+|+.++++||+|||+..+.+||||||||+|||+|++.++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99988 4999999999999999998654 79999999999999999999999887789999999999999999999999
Q ss_pred eecCccccccCCCCCcccC-CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 296 DFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
|||+|+..... ....... .||.+|+|||+...+..+.++|||||||++.|++||+.|....
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99999655431 2222222 7899999999999999999999999999999999999988754
No 21
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=2.6e-40 Score=277.51 Aligned_cols=206 Identities=28% Similarity=0.500 Sum_probs=179.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.+|+|+||+||. +|+.||||+++.....++-... ..+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~t-alREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRT-ALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHH-HHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 455667899999999984 7899999999877655444444 4569999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|++. +|+..++.+. .++..++..++.++++|++|||+++ |+||||||.|+|++.+|.+||+|||+++.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9965 9999998654 4999999999999999999999999 999999999999999999999999999988765433
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.. ..+.|..|.|||.+.|. .|+..+|+||.|||+.||+-|.+-|.|.++-+-+..|-
T Consensus 158 ~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If 215 (318)
T KOG0659|consen 158 QT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF 215 (318)
T ss_pred cc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence 33 23568899999999875 78999999999999999999999999999877766663
No 22
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-40 Score=306.49 Aligned_cols=223 Identities=25% Similarity=0.471 Sum_probs=196.9
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|..-..||.|.-|.|| .+++.||||.+...... ..+-+.+|+.+|+..+|+|||.+++.|...+.+++|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46666788988877665 36789999999765433 34567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++||+|.+.+.... +++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 351 ym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred ecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 999999999988754 899999999999999999999999 99999999999999999999999999987765543 3
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 387 (387)
....+|||.|||||++....|++++||||||++++||+.|++||-..++-..+..|...+.|.+..+ +.++++|||
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~-~klS~~~kd 501 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNP-EKLSPELKD 501 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCc-cccCHHHHH
Confidence 4457899999999999999999999999999999999999999999999999999999999999876 666666653
No 23
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=2.5e-40 Score=285.90 Aligned_cols=207 Identities=30% Similarity=0.486 Sum_probs=180.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|.....|+.|+||.||. ++..||+|+++.+....+-....+ +|++++.+++|||||.+-.+.... +.+|+|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsL-REIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSL-REINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhH-HHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 466677899999999984 578999999987765554444544 599999999999999999888754 569999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||+. +|..++..-+ ++...++..++.|+++|+.|||.++ |+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999965 9999998754 6999999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
....+..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|.|.+..+-+.+|-.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 3444556679999999999886 689999999999999999999999999999888888743
No 24
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=7.9e-40 Score=307.77 Aligned_cols=212 Identities=26% Similarity=0.432 Sum_probs=184.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +++.||+|++.+...........+..|+.++.+++||+|+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 467778999999998873 578999999976544344555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999865432110
Q ss_pred --------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 309 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHccC
Q 016544 357 KHDNEVPKAYAARQ 370 (387)
Q Consensus 357 ~~~~~~~~~i~~~~ 370 (387)
.+..+...++....
T Consensus 239 ~~~~~~~~~i~~~~ 252 (363)
T cd05628 239 ETPQETYKKVMNWK 252 (363)
T ss_pred CCHHHHHHHHHcCc
Confidence 88888888887643
No 25
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-40 Score=295.81 Aligned_cols=211 Identities=29% Similarity=0.519 Sum_probs=174.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC--ceE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~ 226 (387)
..++...+.||+|+||.|+. +|...|||.+.... . ...+.+.+|+.+|.+++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~-~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--S-PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--c-hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 34577788999999999873 36899999887552 1 22677999999999999999999999755444 699
Q ss_pred EEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 304 (387)
+.|||+++|+|.+++.+.+ .+++..+..+.+||++||.|||++| |+||||||+|||++. ++.+||+|||++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999877 7999999999999999999999999 999999999999999 7999999999988765
Q ss_pred c--CCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHHccC
Q 016544 305 V--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~-~~~~~~~~~i~~~~ 370 (387)
. ..........||+.|||||++..+ ...+++|||||||++.||+||.+||.+ ....+.+-.|....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC
Confidence 3 112223456799999999999953 344699999999999999999999998 44444444444443
No 26
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-39 Score=292.60 Aligned_cols=212 Identities=27% Similarity=0.437 Sum_probs=176.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC-----------HHHHHHHHHHHHHHHcCCCCcceeeeeEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------DDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 219 (387)
+|+..++||+|.||.|.. +++.||||++.+..... -...+..++|+.+|+++.|||||+|+++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 688889999999998863 68999999997633211 11235788999999999999999999998
Q ss_pred eeC--CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 220 TQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 220 ~~~--~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
.+. ..+|+|+|||..|.+...-.....+++.+++.++++++.||+|||.+| ||||||||+|+|++.+|++||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence 764 579999999998877643333323899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCCCC----cccCCCCCcccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 298 GVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 298 g~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
|.+.......... .....|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....++..+|++.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998763322211 12357999999999998742 346899999999999999999999999999999999877
Q ss_pred C
Q 016544 370 Q 370 (387)
Q Consensus 370 ~ 370 (387)
.
T Consensus 335 p 335 (576)
T KOG0585|consen 335 P 335 (576)
T ss_pred c
Confidence 6
No 27
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2e-39 Score=302.21 Aligned_cols=250 Identities=27% Similarity=0.487 Sum_probs=209.9
Q ss_pred HHHHHHHHhhCCCCCCCCccccccCCCCccccCccccCcccceeecccEEEEEEE------cC---eEEEEEEcCcccCC
Q 016544 119 HEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW------RG---IQVAVKKLGEEVIS 189 (387)
Q Consensus 119 ~~~~~~L~~~g~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~~~lg~G~~~~v~~------~g---~~vavK~~~~~~~~ 189 (387)
.+++.+....-..+........++.....|++...++.+. +.||+|.||.|+. ++ ..||+|........
T Consensus 123 ~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~ 200 (474)
T KOG0194|consen 123 SELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL 200 (474)
T ss_pred HHHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence 3555555555555544445567788888999988888877 7899999998863 12 23899998865556
Q ss_pred CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHh
Q 016544 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHE 268 (387)
Q Consensus 190 ~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~ 268 (387)
..+...++.+|++++++++|||||++||++..+.++++|||+|.||+|.+++++.+. ++..+...++.+++.||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 678889999999999999999999999999999999999999999999999998775 9999999999999999999999
Q ss_pred CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH
Q 016544 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 269 ~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 348 (387)
++ +|||||-.+|+|++.++.+||+|||+++......... ....-+.+|+|||.+....++.++|||||||++||++
T Consensus 281 k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 281 KN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred CC---CcchhHhHHHheecCCCeEEeCccccccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 99 9999999999999999999999999987654211111 1123468999999999999999999999999999999
Q ss_pred c-CCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 349 E-GCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 349 t-g~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
+ |..||.+....++..+|...+ |.++
T Consensus 357 ~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred ccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 8 899999999999999995544 4444
No 28
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=3.9e-39 Score=304.94 Aligned_cols=210 Identities=24% Similarity=0.377 Sum_probs=180.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. ++..||+|++...........+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 366778899999999874 578999999976544445556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999998753311000
Q ss_pred --------------------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHH
Q 016544 309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (387)
Q Consensus 309 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 344 (387)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001124689999999999998999999999999999
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 345 QEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|||++|+.||...+..+...++..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHc
Confidence 999999999998877776666654
No 29
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=6e-40 Score=315.62 Aligned_cols=220 Identities=30% Similarity=0.500 Sum_probs=187.5
Q ss_pred ccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 158 TNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
...++||+|.||+|+. ....||||.+++. .+....++|++|+.++..++|||||+++|+|..++.+++
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3356899999999973 3468999999865 345578899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc--------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEE
Q 016544 228 VTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 293 (387)
|+|||..|||.+|+... .+++..+.+.|+.||+.||.||-++. +|||||-.+|+||.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 99999999999999632 12778899999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccCCCCCcc-cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 294 VADFGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
|+|||+++..-..+-.... ...-+++|||||.+..++||++||||||||+|||+++ |+.||.+.+++++++.|+.++-
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 9999999754332221111 1223689999999999999999999999999999997 9999999999999999998885
Q ss_pred CCCCCChhhhhhcc
Q 016544 372 PPFKAPAKLYARGL 385 (387)
Q Consensus 372 ~~~~~~~~~~~~~l 385 (387)
++. ++.||.++
T Consensus 724 --L~~-Pe~CP~~v 734 (774)
T KOG1026|consen 724 --LSC-PENCPTEV 734 (774)
T ss_pred --ccC-CCCCCHHH
Confidence 322 35666654
No 30
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=5e-39 Score=293.32 Aligned_cols=208 Identities=26% Similarity=0.456 Sum_probs=182.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 466778999999998873 478999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765322
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+++..+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 214 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK 214 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 122457899999999999889999999999999999999999999988888888886665
No 31
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=6.7e-41 Score=277.96 Aligned_cols=210 Identities=24% Similarity=0.435 Sum_probs=186.3
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|.|.+|+ -+|+.+|+|++....+... ..+.+.+|+.+.+.++||||+++.+.+.+.+..|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 357777889999998775 4788999998876555433 5678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~ 306 (387)
|+|+|++|-.-+-..-.+++..+..+++||+++|.|+|.++ |||||+||+|+++-.. .-+||+|||++...+
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999665544445789999999999999999999999 9999999999999643 348999999998776
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
....+....|||+|||||++...+++..+|||+.||++|-|+.|.+||.+.+...++++|..+.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~ 228 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA 228 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence 5667778899999999999999999999999999999999999999999999999999999888
No 32
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=7.8e-39 Score=297.83 Aligned_cols=209 Identities=25% Similarity=0.430 Sum_probs=183.3
Q ss_pred cCcccceeecccEEEEEEE---c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW---R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~---~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. . +..||+|.+...........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 3677788999999998863 1 257999998755443444566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.++..+.+++..+.
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 244 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 223468999999999999889999999999999999999999999988877788887655
No 33
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=3.2e-39 Score=303.95 Aligned_cols=212 Identities=27% Similarity=0.461 Sum_probs=182.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. +|+.||||++.............+.+|+.+++.++||||+++++++..+..+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 567788999999998873 578999999976543344455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 309 (387)
|+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998654221100
Q ss_pred ------------------------------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCC
Q 016544 310 ------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353 (387)
Q Consensus 310 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 353 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00123589999999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHccC
Q 016544 354 FTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 354 f~~~~~~~~~~~i~~~~ 370 (387)
|.+.+..+...++....
T Consensus 239 f~~~~~~~~~~~i~~~~ 255 (364)
T cd05599 239 FCSDNPQETYRKIINWK 255 (364)
T ss_pred CCCCCHHHHHHHHHcCC
Confidence 99888777777775543
No 34
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.1e-38 Score=283.18 Aligned_cols=212 Identities=24% Similarity=0.412 Sum_probs=186.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|..|.||. .+..+|+|++.+......+...+.+.|.+||..+.||.++.||+.|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 455667899999999884 347899999998877777778888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC--
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK-- 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 306 (387)
||+||+|..+++++. .+++..+..++.+++-||+|||-.| ||.|||||+|||+.++|++-|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998754 3999999999999999999999999 999999999999999999999999986432110
Q ss_pred ------------------------------C-C----------------------CCcccCCCCCcccccccccCCCCCC
Q 016544 307 ------------------------------E-D----------------------RPLTCQDTSCRYVAPEVFKNEEYDT 333 (387)
Q Consensus 307 ------------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 333 (387)
. . .....++||-.|+|||++.|..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0012356888999999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 334 ~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
++|||+|||++|||+.|.-||.|.+..+.+.+|+...
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~ 351 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP 351 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC
Confidence 9999999999999999999999999999999997665
No 35
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=5e-39 Score=304.46 Aligned_cols=212 Identities=25% Similarity=0.385 Sum_probs=180.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. ++..||+|.+.+...........+.+|+.++++++||||+++++.+.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 366778999999998874 578899999876544344556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988878999999999999999999999999 99999999999999999999999999753210000
Q ss_pred --------------------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHH
Q 016544 309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (387)
Q Consensus 309 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 344 (387)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001123589999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 345 QEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|||++|++||.+.++.+...++....
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~ 264 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQ 264 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccC
Confidence 99999999999888777777765533
No 36
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=5.1e-39 Score=298.93 Aligned_cols=206 Identities=31% Similarity=0.491 Sum_probs=181.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|++.............+..|+.++..++||||+++++++......|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 467788999999998873 478999999976544344455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999875432 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 212 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence 2334678999999999999999999999999999999999999998887777776654
No 37
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=7.8e-39 Score=296.32 Aligned_cols=205 Identities=27% Similarity=0.420 Sum_probs=178.5
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|+.||+|++.............+..|+.++++++||||+++++++...+.+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 589999998873 578999999976544444555677889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
|.+++...+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 9999998888999999999999999999999999 999999999999999999999999998753221 122233468
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+....
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999999999999999999999999999999999887777777775544
No 38
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=4.3e-39 Score=304.38 Aligned_cols=210 Identities=26% Similarity=0.428 Sum_probs=180.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. +|..||+|.+.+.........+.+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 567778999999999873 678999999875433334456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 309 (387)
|+++|+|.+++...+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998633210000
Q ss_pred ---------------------------------------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHH
Q 016544 310 ---------------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (387)
Q Consensus 310 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 344 (387)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00123589999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 345 QEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|||++|.+||.+.+..+...++..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHc
Confidence 999999999998877777777754
No 39
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=6.4e-39 Score=297.57 Aligned_cols=208 Identities=26% Similarity=0.444 Sum_probs=183.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.++++++||||+++++++..++.++++||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 577788999999998873 578999999876543334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.+++|.+++.+.+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765322
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.++.+++..+.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 231 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 122457899999999999999999999999999999999999999888877888876654
No 40
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=1.8e-38 Score=293.83 Aligned_cols=205 Identities=27% Similarity=0.423 Sum_probs=178.6
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|..||+|.+.............+.+|+.+++.++||||+++++++.....+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 589999998873 578999999976544444556677889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
|..++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999988653221 122233468
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+....
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 999999999999899999999999999999999999999888777777776554
No 41
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=4.2e-39 Score=304.39 Aligned_cols=211 Identities=25% Similarity=0.386 Sum_probs=179.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||+|+||.|+. +++.||+|.+.+...........+.+|+.++++++||||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 467788999999998873 578999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999743210000
Q ss_pred ----------------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH
Q 016544 309 ----------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 309 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 348 (387)
.......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011246899999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcHHHHHHcc
Q 016544 349 EGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~ 369 (387)
+|+.||.+.+..+...++...
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~ 259 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINW 259 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhcc
Confidence 999999988877776666543
No 42
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-39 Score=301.11 Aligned_cols=234 Identities=29% Similarity=0.526 Sum_probs=196.4
Q ss_pred CccccCccccCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 222 (387)
.+|+|...+ +.....||+|.||+|| |.| .||||++..... .++..+.|++|+.++++-+|.||+-+.|+|...
T Consensus 385 ~~WeIp~~e--v~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEE--VLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHH--hhccceeccccccceeeccccc-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 355555443 3445689999999987 444 799999987655 456889999999999999999999999999877
Q ss_pred CceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
.. .||+.||+|-+|+.+++.. ..+...+...|++|+++|+.|||.++ |||+|||..||++.+++.|||+|||++.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 66 9999999999999999753 44888999999999999999999999 9999999999999999999999999986
Q ss_pred ccccC-CCCCcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCCCC
Q 016544 302 LLTVK-EDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA 376 (387)
Q Consensus 302 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~ 376 (387)
.-... .........+...|||||+++.. +|+..+||||||+++|||+||..||.....+.++-++-.|- +|....
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence 54332 22333445678899999999754 78999999999999999999999999888888888876664 788888
Q ss_pred ChhhhhhcccC
Q 016544 377 PAKLYARGLKE 387 (387)
Q Consensus 377 ~~~~~~~~l~~ 387 (387)
+...+|.+|++
T Consensus 617 ~~s~~pk~mk~ 627 (678)
T KOG0193|consen 617 IRSNCPKAMKR 627 (678)
T ss_pred hhccCHHHHHH
Confidence 77788877653
No 43
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=8.7e-39 Score=296.93 Aligned_cols=212 Identities=22% Similarity=0.333 Sum_probs=180.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|.+.+...........+.+|..++..++|++|+++++++...+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 567788999999998762 567899999875433334445668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999987 456899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+...++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~ 224 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC
Confidence 2233468999999999876 467889999999999999999999999888777777776654
No 44
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=2.1e-38 Score=292.01 Aligned_cols=204 Identities=26% Similarity=0.411 Sum_probs=177.5
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||+|+||.|+. ++..||+|.+.............+..|+.++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999998873 4778999998765444445566788899999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 317 (387)
.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 999998888999999999999999999999999 9999999999999999999999999987543221 222334689
Q ss_pred CcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+++....
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP 209 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 99999999999999999999999999999999999999888777777776544
No 45
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=2.6e-38 Score=293.30 Aligned_cols=205 Identities=27% Similarity=0.433 Sum_probs=178.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|..||+|++.+...........+.+|+.+++.++||||+++++++.....+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 589999998873 578999999986544445556778889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
|..++.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999998753221 122233468
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 211 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC
Confidence 999999999999899999999999999999999999999887777777765444
No 46
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-39 Score=293.85 Aligned_cols=215 Identities=24% Similarity=0.391 Sum_probs=182.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCC-ceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~-~~~lv 228 (387)
.|...++||.|+||.|+. .|..||||.+++....-++ .-. .+|++.|++++ ||||+++.+++.+.. .+|+|
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 577788999999999874 6788999999876554333 333 45999999998 999999999998887 89999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||+. .|.++++.. ..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc--
Confidence 999965 999999865 45999999999999999999999999 99999999999999888999999999987653
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc-CCCCCCCCh
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPA 378 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~ 378 (387)
..+.+.++.|..|.|||++.. +-|+.+.|+||+|||++|+.+-++.|.|.++.+-+.+|..- +.|.....+
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 355667788999999999865 57899999999999999999999999999988777777433 255444433
No 47
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=2.1e-38 Score=294.43 Aligned_cols=212 Identities=23% Similarity=0.352 Sum_probs=179.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +++.||+|++.+.........+.+.+|..++..++||||+++++++..++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 567788999999998863 578999999875433334445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+ ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999976 446899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~ 224 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 2233458999999999873 357789999999999999999999999887777777775543
No 48
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=1.2e-38 Score=299.77 Aligned_cols=212 Identities=25% Similarity=0.353 Sum_probs=180.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|+..+.||+|+||.|+. ++..||+|.+.+...........+.+|+.+++.++||||+++++++..+..+++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4677888999999998873 57899999987543333344566888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999999764 5889999999999999999999999 999999999999999999999999999765433222
Q ss_pred CcccCCCCCcccccccccCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+......+|....
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 22345689999999999764 37789999999999999999999999888777788876544
No 49
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=4.9e-38 Score=285.94 Aligned_cols=201 Identities=26% Similarity=0.417 Sum_probs=172.0
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+||.|+. +|..||+|.+.............+.+|+.++++++|++|+++++++...+..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 55677899999998863 5789999998765443333445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999999888643 35889999999999999999999999 999999999999999999999999998765322 2
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 22334689999999999999999999999999999999999999987665433
No 50
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=2e-38 Score=294.77 Aligned_cols=212 Identities=23% Similarity=0.345 Sum_probs=179.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. .+..+|+|.+.+...........+..|..++..++|++|+++++++.....+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 567778999999998863 467899999865333333445568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999987 456899999999999999999999999 999999999999999999999999998754332222
Q ss_pred CcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+...++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~ 224 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 223356899999999986 3467889999999999999999999999988888888886655
No 51
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=5.9e-38 Score=284.96 Aligned_cols=218 Identities=19% Similarity=0.312 Sum_probs=182.3
Q ss_pred cCccccCcccceeecccEEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----C
Q 016544 150 IDPHELDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (387)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~v---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~ 222 (387)
++..+++......++.|+++.+ .++|+.||||.+...........+.+.+|+.++++++||||+++++++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 3444444454457888887765 47899999999987655555556788999999999999999999999876 3
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
..++++|||+++|+|.+++.+...+++.....++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence 46899999999999999999887899999999999999999999985 6 8899999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..++...+.... ++++
T Consensus 172 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 172 ILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred hhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 654221 22356889999999976 688999999999999999999999999988878877775544 4444
No 52
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=1e-38 Score=299.97 Aligned_cols=211 Identities=26% Similarity=0.436 Sum_probs=182.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|++.............++.|..++..++||+|+++++.+.....+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 466778899999998873 578999999975443344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999864321100
Q ss_pred --------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 309 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134689999999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHcc
Q 016544 357 KHDNEVPKAYAAR 369 (387)
Q Consensus 357 ~~~~~~~~~i~~~ 369 (387)
.++.....++...
T Consensus 239 ~~~~~~~~~i~~~ 251 (360)
T cd05627 239 ETPQETYRKVMNW 251 (360)
T ss_pred CCHHHHHHHHHcC
Confidence 8888888877653
No 53
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=2.5e-38 Score=297.89 Aligned_cols=213 Identities=25% Similarity=0.355 Sum_probs=180.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|...+.||+|+||.|+. ++..||+|.+...........+.+.+|..+++.++||||+++++.+.....+++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 34788889999999998873 5789999998654333334455678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999998764 4888999999999999999999999 99999999999999999999999999876543322
Q ss_pred CCcccCCCCCcccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+......+|....
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 2233456899999999997643 7889999999999999999999999888777788886654
No 54
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2e-39 Score=268.36 Aligned_cols=209 Identities=28% Similarity=0.469 Sum_probs=188.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|..++.||+|-||.||. ++..||+|++.+..+.......++++|+++...++||||+++|++|.++..+|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 677788999999998874 567899999987766666666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH--HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|...|+|...++ ....+++..+..++.|++.|+.|+|..+ +|||||||+|+|++..+.+||+|||-+-.-. .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999998 5566999999999999999999999999 9999999999999999999999999886543 2
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||.-|++||...+..++..+|+|++|++.||++.|.+||...+..+.+++|..-.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~ 238 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD 238 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc
Confidence 23344578999999999999999999999999999999999999999999999999997766
No 55
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7.2e-39 Score=293.15 Aligned_cols=214 Identities=26% Similarity=0.462 Sum_probs=190.6
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-eEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~lv~ 229 (387)
+|...+.+|+|+||.++ .++..+++|.+......... .+...+|+.++.++.|||||.+.+.|..++. .+|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56667889999999775 36789999999876654443 3467889999999999999999999999888 99999
Q ss_pred EccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+|++||+|.+.+.+.. .++++.++.|+.|++.|+.|||++. |+|||||+.||+++.++.|+|.|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998654 3899999999999999999999988 9999999999999999999999999999887543
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......||+.|++||++.+.+|..++|||||||++|||++-+++|...+...++.+|..+.-.|+
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl 226 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL 226 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC
Confidence 344567899999999999999999999999999999999999999999999999999988885555
No 56
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=2.6e-38 Score=277.85 Aligned_cols=205 Identities=30% Similarity=0.513 Sum_probs=175.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCc-ceeeeeEEeeCC------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------ 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~------ 223 (387)
.|...+.+|+|+||+||. +|+.||+|+++.+....+ .-....+|+.+++.++|+| |+++++++....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 355666799999999874 689999999986543211 2234577999999999999 999999999877
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
.+++|+||++ -+|..++.... .++...++.+++||+.||+|||+++ |+||||||.|||+++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7999999995 59999998755 4777889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
|+.+..+. ...+...+|..|.|||++.+. .|++..||||+|||++||+++++.|.+.++.+.+.+|
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I 233 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI 233 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 99766442 334445678899999999987 7899999999999999999999999999987777666
No 57
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-37 Score=278.60 Aligned_cols=217 Identities=28% Similarity=0.432 Sum_probs=183.8
Q ss_pred CccccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
......|.....||.|.-+.|+ -.+..||||++..+.-.. ....+++|+..+..++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 3444467777899999776665 367999999998765433 378899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 226 MIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|+||.||.+||+.+++... ..+++..+..|++++++||.|||.+| .||||||+.|||++.+|.+||+|||.+..+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999864 33899999999999999999999999 999999999999999999999999987544
Q ss_pred ccCCCCC--c-ccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 304 TVKEDRP--L-TCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 304 ~~~~~~~--~-~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.....+. . ....|++.|||||++... .|+.|+||||||++..||.+|+.||....+..++..-..+..|
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 3322211 1 456899999999997553 7889999999999999999999999999998887776555544
No 58
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=3.2e-38 Score=297.21 Aligned_cols=212 Identities=25% Similarity=0.346 Sum_probs=180.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|.+.+...........+.+|+.+++.++||||+++++++..+..+++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 3677788999999998873 57899999987543333334456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999999988764 5888899999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+......+|....
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 23345689999999998753 47889999999999999999999999988877888886654
No 59
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=8.2e-38 Score=288.52 Aligned_cols=204 Identities=30% Similarity=0.485 Sum_probs=173.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.++..........+.+..|..++... +||||+++++++.....+++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999998873 4678999999765433334445556677777654 8999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 99999988888999999999999999999999998 9999999999999999999999999987543222 2233456
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+...
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 899999999999989999999999999999999999999998887777777543
No 60
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-38 Score=285.33 Aligned_cols=219 Identities=25% Similarity=0.446 Sum_probs=189.1
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|-|.+|. ++|..||||++.+...+. .....+.+|+.+|+.++|||||++|++......+|||+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3445679999999875 689999999999887654 4456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-CCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
-.+|+|.+|+.+.. .+.+..+.+++.||+.|+.|+|+.. +|||||||+|+.+ .+-|-+||.|||++..+..+.
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 99999999997653 4999999999999999999999998 9999999999865 577899999999998776543
Q ss_pred CcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhh
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 381 (387)
......|+..|-|||++.|..|. +++||||||||+|.|++|++||+..++.+.+-+|...+...++.....|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eC 246 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKEC 246 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHH
Confidence 33445789999999999999887 6899999999999999999999999999999999877755544444333
No 61
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=1.2e-37 Score=288.52 Aligned_cols=211 Identities=29% Similarity=0.447 Sum_probs=180.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. ++..||+|.+.+.........+.+..|..++..+ +||+|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 366678899999998873 4679999998865443444455667788888777 5899999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-CC
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998753322 22
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|+|||||++|+|+||+.||.+.+...+.+.+....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 2234568999999999999999999999999999999999999999988888888876654
No 62
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=9.7e-38 Score=288.99 Aligned_cols=206 Identities=27% Similarity=0.455 Sum_probs=176.5
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 161 ~~lg~G~~~~v~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+.||+|+||.|+. .++.||+|.+..... ........+..|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4689999998873 467899999875432 1223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcc
Confidence 999999999998888899999999999999999999999 999999999999999999999999998643222 1222
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......++..+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 216 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK 216 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 33468999999999999889999999999999999999999999888777777776554
No 63
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-37 Score=288.95 Aligned_cols=211 Identities=29% Similarity=0.490 Sum_probs=190.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~l 227 (387)
...|...+.||+|.||.++. +|..+|+|.+.+...........+.+|+.+|+++. ||||+.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34577778999999998873 58999999998877666556678999999999998 9999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC----CCEEEEeecCcccc
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 303 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~~~~~ 303 (387)
|||++.||.|.+.+... .+++.++..+++|++.++.|||+.| |+||||||+|+|+... +.++++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999876 4999999999999999999999999 9999999999999743 47999999999887
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. ........||+.|+|||++....++..+|+||+||++|.|++|.+||.+.+......+|..+.
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~ 254 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD 254 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence 65 445566789999999999999999999999999999999999999999999999999998886
No 64
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=1.8e-37 Score=287.39 Aligned_cols=211 Identities=30% Similarity=0.468 Sum_probs=180.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC-CcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. ++..||+|++...........+.+..|..++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 366778999999998873 457899999976544344455677889999999975 56888999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 99999999999988888999999999999999999999998 999999999999999999999999998643221 12
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|+|||||++|+|+||+.||.+.+..++...+....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 2233468999999999999999999999999999999999999999888888888876554
No 65
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=5.4e-38 Score=290.99 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=177.6
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|..||+|.+.............+..|+.+++.++||||+++++++.....+++||||+++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999998873 678999999986554444556677889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
|..++.....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...... ........
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 99999888889999999999999999999997 67 999999999999999999999999998653221 12223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC
Confidence 8999999999999899999999999999999999999999887777777765544
No 66
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=2.3e-38 Score=296.59 Aligned_cols=210 Identities=29% Similarity=0.467 Sum_probs=183.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|++.............+..|+.++..++||||+++++++.++..+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 467788999999998873 478999999976544333455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC---
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 307 (387)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999998878999999999999999999999998 9999999999999999999999999987654332
Q ss_pred -------------------------CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 308 -------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 308 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 0122334689999999999999999999999999999999999999998887777
Q ss_pred HHHHHc
Q 016544 363 PKAYAA 368 (387)
Q Consensus 363 ~~~i~~ 368 (387)
..++..
T Consensus 239 ~~~i~~ 244 (350)
T cd05573 239 YNKIIN 244 (350)
T ss_pred HHHHhc
Confidence 777765
No 67
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=1e-37 Score=288.39 Aligned_cols=205 Identities=28% Similarity=0.454 Sum_probs=176.8
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +++.||+|.+.+.........+.+..|..++..+ +||||+++++++...+.+|+||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 589999998873 5789999998765433334456677788888776 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++.+...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998653221 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 8999999999999899999999999999999999999999988888888886654
No 68
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=6.9e-38 Score=291.22 Aligned_cols=201 Identities=23% Similarity=0.413 Sum_probs=171.5
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+||.||. ++..||+|++.+... ......+.+..|+.+++.+ +||+|+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 366778999999998873 578899999875332 2233456678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++||||+++|+|.+++.+...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
..........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.....
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 333333345689999999999875 478899999999999999999999975433
No 69
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=1e-37 Score=288.58 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=177.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.+...........+.+..|..++..+ +||||+++++++...+.+|+||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 589999998873 4679999999765444445556677888888866 7999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC 157 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753322 22223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.....+++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 7899999999999899999999999999999999999999988888888887655
No 70
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=2.7e-38 Score=293.75 Aligned_cols=212 Identities=27% Similarity=0.404 Sum_probs=183.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|.+...........+.+..|+.+++.++||||+++++++.....+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 467788999999998873 678999999986544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 66999999999999999999999999 999999999999999999999999999765433322
Q ss_pred CcccCCCCCccccccccc------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......+|+.|+|||++. +..++.++|||||||++|+|++|+.||...+......++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 225 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 223346889999999987 4567889999999999999999999999888777777776554
No 71
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=2.3e-37 Score=286.36 Aligned_cols=210 Identities=29% Similarity=0.459 Sum_probs=179.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
|...+.||+|+||.|+. +|..||+|++.+.........+.+..|..++..+. |++|+++++++.....+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 55667899999998873 57899999987654333444566778888888885 6788899999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999987543221 12
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...+.+.+....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 233457899999999999899999999999999999999999999988877788776654
No 72
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=1.9e-37 Score=287.07 Aligned_cols=205 Identities=30% Similarity=0.474 Sum_probs=173.2
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +|+.||+|++.............+..|.. +++.++||||+++++.+.....+++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 589999998862 57899999987543333333344455544 567889999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 99999998888999999999999999999999999 999999999999999999999999998653222 22223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++.+++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999888777777776554
No 73
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-39 Score=287.82 Aligned_cols=225 Identities=29% Similarity=0.470 Sum_probs=196.6
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
....|+....||+|.||.||. .++.||+|++..+.. +...+.+++|+.++.+++++||.++|+.+..+..+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 344677778999999999984 578999999986543 4567889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||||.||++.+.++....+.+....-++++++.|+.|||+++ .+|||||+.|||+..+|.+||+|||.+-......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999999998877788888999999999999999999 9999999999999999999999999998776554
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhccc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 386 (387)
... ..+.|||.|||||++.+..|+.++||||||++.+||.+|.+||.+..++.++-.|-+...|.+.. .+++.++
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~---~~S~~~k 240 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG---DFSPPFK 240 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc---ccCHHHH
Confidence 444 56789999999999999999999999999999999999999999999988887775555555533 5555444
No 74
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=1e-38 Score=292.70 Aligned_cols=207 Identities=35% Similarity=0.511 Sum_probs=178.8
Q ss_pred ccccCccccCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
.||+.... +...+.||.|+-|.|+ ..+..||||+++.- -..+++-|++++||||+.+.|+|....
T Consensus 118 ~WeiPFe~--IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEE--ISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHH--hhhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 45554332 2344568999888776 57899999988632 134788999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
-+|||||||..|-|..+++...+++......|..+|+.|+.|||.+. |||||||.-||||+.+..+||+|||.++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999999989999999999999999999999999 999999999999999999999999998876
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
... ...-.+.||..|||||++...+.+.|+|||||||+|||||||..||.+.+...|+.-+-.+-
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs 327 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS 327 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc
Confidence 543 33334679999999999999999999999999999999999999999988887777664443
No 75
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=3.1e-38 Score=266.02 Aligned_cols=210 Identities=26% Similarity=0.477 Sum_probs=181.4
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccC-----CCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVI-----SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
.|...+.+|.|.-.++. .+|...|+|++..... ......+.-++|+.+|+++ .||+|+++.++|+++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 35556678888876553 5788999998753211 1234456678899999998 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+|+|+|.|+.|.|.+++.+.-.+++++..+|++|+.+|++|||.++ ||||||||+|||++++.+++|+|||++..+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999888999999999999999999999999 9999999999999999999999999998876
Q ss_pred cCCCCCcccCCCCCccccccccc------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.+ .......|||+|+|||.+. ...|+..+|+||+|||||.|+.|.+||-.....-++..|..++
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 54 3444567999999999884 3478889999999999999999999999887777888888887
No 76
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=3.1e-38 Score=277.02 Aligned_cols=203 Identities=29% Similarity=0.480 Sum_probs=171.0
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC---
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 223 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--- 223 (387)
...+.|...+.+|+|+||.|+. .+..||||+...+.. .-.+|+.+|+.+.|||||++..+|....
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 3456788889999999999984 578999998764421 1246999999999999999999887432
Q ss_pred --ceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-CCEEEEe
Q 016544 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVAD 296 (387)
Q Consensus 224 --~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~D 296 (387)
...+|||||+. +|.++++. +..++.-.++-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||||
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicD 169 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICD 169 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEecc
Confidence 35689999976 99998874 456888889999999999999999998 9999999999999965 8999999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
||+|+..... .+..++.+|..|.|||.+.|. .|+.+.||||.||++.||+-|++-|.|.+....+..|.
T Consensus 170 FGSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi 239 (364)
T KOG0658|consen 170 FGSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII 239 (364)
T ss_pred CCcceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH
Confidence 9999987644 334556789999999999885 78999999999999999999999999988766665553
No 77
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=4.2e-37 Score=284.89 Aligned_cols=209 Identities=28% Similarity=0.430 Sum_probs=175.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH---HcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
|...+.||+|+||.|+. +|+.||+|.+.+.........+.+..|..++ +.++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45567899999998873 5789999999765433334455677776665 456799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++++|..++.. +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-G 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-C
Confidence 999999999988865 45899999999999999999999999 999999999999999999999999998643222 1
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..++...+....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE 217 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 22234568999999999999999999999999999999999999999888777888776655
No 78
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=3.6e-37 Score=285.44 Aligned_cols=205 Identities=29% Similarity=0.458 Sum_probs=171.6
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH-HHHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|++.............+..|. .+++.++||||+++++++...+.+++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 589999998873 4678999998754332222233344444 4567889999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 99999988888899999999999999999999999 999999999999999999999999998653222 12223456
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+..+++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 8999999999999999999999999999999999999999888777777776554
No 79
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=7.7e-37 Score=283.65 Aligned_cols=191 Identities=27% Similarity=0.492 Sum_probs=168.0
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|++++...........+..|..+++.+ +||||+++++++.....+|+||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 589999998873 5789999999876555555567788999999988 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998642211 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 89999999999999999999999999999999999999963
No 80
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=3.2e-37 Score=285.81 Aligned_cols=205 Identities=29% Similarity=0.470 Sum_probs=173.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +|+.||+|++.+...........+..|.. +++.++||||+++++.+...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 589999998873 57899999987653333334445555555 467789999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998653222 12223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+..++..++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999888777777776554
No 81
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=3.9e-37 Score=284.79 Aligned_cols=205 Identities=29% Similarity=0.459 Sum_probs=172.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||.|+||.|+. +|..||+|++.+...........+..|.. +++.++||||+++++.+...+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999998873 57899999987543333333444555554 678889999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 99999988778999999999999999999999998 999999999999999999999999998653222 12223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+...+...+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Confidence 7899999999999899999999999999999999999999887777777776543
No 82
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=6e-37 Score=282.75 Aligned_cols=205 Identities=29% Similarity=0.463 Sum_probs=173.7
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +|..||+|.+...........+.+..|..++... .||+|+++++++...+.+|+||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 589999998873 5789999999764332223345566777777754 8999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++...+.+++.++..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (316)
T cd05620 82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccC
Confidence 99999988888999999999999999999999999 999999999999999999999999998643211 22223456
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT 212 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 8999999999999999999999999999999999999999888777777775443
No 83
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=1.1e-36 Score=274.29 Aligned_cols=214 Identities=26% Similarity=0.407 Sum_probs=179.5
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. .+..||+|.+.... .......+.+|+.++++++||||+++++++..+...++
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 566778899999998852 35689999997642 33445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
||||+++++|.+++... ..+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999874 46899999999999999999999999 999999999999999999999999987553222
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.........++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+..++.+.+..+.+++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA 229 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence 1111112334678999999999999999999999999999875 9999999888888888866654443
No 84
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=7.1e-37 Score=277.58 Aligned_cols=193 Identities=27% Similarity=0.429 Sum_probs=165.8
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||+|+||.||. +|+.||+|.+...........+.+..|+.+++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999998873 5789999998765444444456678899999999999999999999999999999999999999
Q ss_pred HHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 238 ~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
..++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988753 345899999999999999999999999 99999999999999999999999999876543322 2233
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
..+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 4678999999999999999999999999999999999999986543
No 85
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=2e-37 Score=290.62 Aligned_cols=203 Identities=30% Similarity=0.397 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-C-----CcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H-----PNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~l~~~~~~~~~ 224 (387)
+|.+.+.||+|+||.|. .+++.||||+++.. .....+-..|+.+|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 57778899999999775 36899999999854 445566677999999996 3 289999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC--CEEEEeecCc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVS 300 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfg~~ 300 (387)
+|||+|.++ -+|.++++.+. .++...+..++.||+.||.+||+.+ |||+||||+|||+.... .+||+|||+|
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999994 59999999764 4889999999999999999999999 99999999999998544 6999999999
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+..... ...+.-+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.|.++.+.+..|..-.
T Consensus 339 c~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 339 CFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred cccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 875432 224556788999999999999999999999999999999999999999999988886655
No 86
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=9.2e-37 Score=281.83 Aligned_cols=205 Identities=30% Similarity=0.476 Sum_probs=176.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.+.+...........+..|..+++.+ +||||+++++++...+.+++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999998873 4679999999865443444556677888998888 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.+.+.+++.++..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .......
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 99999988888999999999999999999999999 9999999999999999999999999986432221 1222345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...+...+....
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~ 212 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE 212 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 7899999999999999999999999999999999999999888777777775544
No 87
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=1.4e-36 Score=283.11 Aligned_cols=210 Identities=30% Similarity=0.486 Sum_probs=169.1
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC-C
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~ 223 (387)
+|...+.||.|+||.||.. +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 5677789999999988642 3579999987532 234456788999999999 899999999988764 4
Q ss_pred ceEEEEEccCCCCHHHHHHHc-----------------------------------------------------------
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 244 (387)
.++++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999998752
Q ss_pred ---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcc
Q 016544 245 ---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRY 320 (387)
Q Consensus 245 ---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y 320 (387)
.++++.++..++.|+++||.|||+.+ |+||||||+|||++.++.++|+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23677788999999999999999998 999999999999999999999999998764322111 11223456789
Q ss_pred cccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH-HHHHHccC
Q 016544 321 VAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAARQ 370 (387)
Q Consensus 321 ~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~-~~~i~~~~ 370 (387)
+|||++.+..++.++|||||||++|||++ |..||.+....+. ...+..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 99999999899999999999999999997 9999988665443 34443333
No 88
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=1.2e-36 Score=280.71 Aligned_cols=205 Identities=29% Similarity=0.458 Sum_probs=173.1
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.+...........+.+..|..++... +||||+++++++...+.+++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 589999998873 4678999998765332233345566677777764 8999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... .......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 99999988778999999999999999999999999 9999999999999999999999999986532221 1223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN 212 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 7899999999999899999999999999999999999999888777777765443
No 89
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=2.2e-36 Score=293.60 Aligned_cols=215 Identities=23% Similarity=0.352 Sum_probs=182.4
Q ss_pred ccCcccceeecccEEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
...|...+.||+|++|.|+. + +..||+|.+... .......+++|+.+++.++||||+++++++...+.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 33478888999999998863 2 567899976432 34455678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
||||+++|+|.+++.. ..++++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999999988753 345889999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 304 TVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 304 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..++..+..+++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 43221 122334689999999999999999999999999999999999999998888888888877665443
No 90
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=1.2e-36 Score=276.70 Aligned_cols=204 Identities=28% Similarity=0.425 Sum_probs=172.8
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||+|+||.|+. ++..||+|.+.............+.+|+.+++.++||||+++++.+.....++++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 56678899999998863 5789999998764443333345577899999999999999999999998999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 9999999888654 34899999999999999999999998 999999999999999999999999998765322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 365 (387)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.......+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 22234578999999999988899999999999999999999999998765444333
No 91
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3e-37 Score=270.35 Aligned_cols=208 Identities=30% Similarity=0.479 Sum_probs=177.1
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-----CCceE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----~~~~~ 226 (387)
|...+.||.|.||.|. .+|..||||++... +...-..++..+|+++++.++|+||+.+++.+.. -..+|
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 3335679999999774 47899999999754 3455556777889999999999999999998865 24689
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|+|+| +.+|.+.++.+..++...+..++.|++.||.|+|+.+ |+||||||+|++++.+..+||+|||+|+.....
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 999999 5699999999888999999999999999999999999 999999999999999999999999999877543
Q ss_pred -CCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 307 -EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 307 -~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
.....+.++.|..|.|||++.. ..|+.+.||||.|||+.||++|++-|.|.+...-++.|..-
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 1233366778999999998755 58999999999999999999999999998876666666443
No 92
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=1.6e-36 Score=281.37 Aligned_cols=190 Identities=28% Similarity=0.498 Sum_probs=166.8
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +++.||+|.+.+...........+..|..++.++ +||||+++++++.....+++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 589999998863 5789999999876555555566788899988877 7999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (329)
T cd05618 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFC 157 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998653222 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 8999999999999999999999999999999999999995
No 93
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1.7e-36 Score=276.12 Aligned_cols=207 Identities=23% Similarity=0.396 Sum_probs=174.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+|+.|+. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 467788999999998863 578899999875432 23345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++++++..+......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9998777666555556899999999999999999999999 9999999999999999999999999997764333333
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....+++.|+|||++.+..++.++|+|||||++|+|++|++||.+.+.......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33456789999999999988999999999999999999999999987655444433
No 94
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=4.2e-37 Score=284.20 Aligned_cols=205 Identities=26% Similarity=0.398 Sum_probs=176.5
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 161 ~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+.||+|+||.|+. +|..||+|++...... ......+..|+.++++++||||+++++++..++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 4689999998862 5789999999754332 223345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcc
Q 016544 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (387)
Q Consensus 233 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 312 (387)
++++|.+++.+...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999999988878999999999999999999999999 9999999999999999999999999987643321 2223
Q ss_pred cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~ 214 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 3467899999999999889999999999999999999999999888777777776554
No 95
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=2.1e-36 Score=280.44 Aligned_cols=191 Identities=28% Similarity=0.492 Sum_probs=167.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|++.+.........+.+..|..++.++ +||+|+++++++.....+|+||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 589999998863 5689999999876554555667788999999888 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++...+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998643221 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 89999999999999999999999999999999999999964
No 96
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.2e-37 Score=304.06 Aligned_cols=212 Identities=34% Similarity=0.540 Sum_probs=182.8
Q ss_pred ccceeecccEEEEEEE------cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 158 TNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~------~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+....||+|.||.||. .| ..||+|.+.+. .+.....+|.+|..+|..+.|||||+++|++.+....+|
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3345799999999984 23 35999988754 456778899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 228 VTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
++|||++|+|..|+++. ..++..+.+.++.||++|+.||++++ +|||||..+|+|++....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999875 33889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccC-CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 301 KLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 301 ~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
+.+...+-...... .-+..|||||.+..+.|+.++|||||||++||++| |..||.+.++.++..-++.++|-+.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 84432222222111 33578999999999999999999999999999998 9999999999999998888884443
No 97
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-37 Score=267.29 Aligned_cols=211 Identities=28% Similarity=0.408 Sum_probs=192.9
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|. .+|+-+|+|+++++.+-..+.+..-..|-.+|+..+||.+..+.-.|+..+++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 46667789999999885 3688999999999988888888888889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|..||.|.-++.+...+++..+..+...|+.||.|||+++ ||.||||.+|.|++++|++||+|||+++..-.. ...
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence 9999999999999888999999999999999999999999 999999999999999999999999998754332 334
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+.|||.|+|||++....|+..+|+|.+||++|||++|+.||...+.+.+.+-|....
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed 384 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED 384 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh
Confidence 456789999999999999999999999999999999999999999999999999997776
No 98
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=3.1e-36 Score=274.54 Aligned_cols=206 Identities=28% Similarity=0.482 Sum_probs=171.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. ++..||+|.+...... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 477788999999998874 5789999998754221 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+ +|.+++...+. +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 9975 99998876543 788999999999999999999999 9999999999999999999999999987543221 2
Q ss_pred CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+.+..+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 218 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2233456889999999876 4688999999999999999999999998776666655543
No 99
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.1e-36 Score=283.03 Aligned_cols=214 Identities=29% Similarity=0.511 Sum_probs=190.4
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
-.|.....||+|.|+.|. .++..||+|.+.+....... .+.+.+|+++|+.++|||||+++.+...+..+|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 356667789999999886 36899999999987665444 445889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.+|.+.+++...+...+.++..++.|+++|++|||+++ |+|||||.+|+|++.+.++||+|||++.++... .
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~ 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG--L 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc--c
Confidence 99999999999999999888999999999999999999999 999999999999999999999999999887633 3
Q ss_pred CcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
......|++.|.|||++.+.++. +.+|+||+|+++|.|+.|.+||.+.+-.++-.++..++ |.++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~ 276 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF 276 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc
Confidence 34456789999999999998764 88999999999999999999999988888888887777 5555
No 100
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=1.1e-35 Score=269.23 Aligned_cols=191 Identities=28% Similarity=0.455 Sum_probs=162.8
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||+|+||.|+. +|+.||+|.+.............+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 68999998863 5889999998754433333334556799999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
.+++...+ .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 98886543 4788889999999999999999999 999999999999999999999999998765432 1223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
++..|+|||++.+..++.++|+|||||++|+|++|+.||.+..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 7889999999999889999999999999999999999998654
No 101
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.3e-38 Score=306.60 Aligned_cols=219 Identities=25% Similarity=0.355 Sum_probs=192.8
Q ss_pred ccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|.+.+.||+|+||.|. .+++.||+|++++-..-.......|..|..+|..-..+.|+.+.-.|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3468888999999999764 36889999999864333334457799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||||+||+|-.++.+.+++++..+..++..|+-||..||+.| +|||||||+|||++..|++||+|||.+-.+...+.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999999999999888999999999999999999999999 99999999999999999999999998876665555
Q ss_pred CCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 375 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~ 375 (387)
......+|||-|++||++.. +.|++.+|+||+||++|||+.|.-||.-.+-.+.+.+|...+ ...||
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 55566789999999999953 468999999999999999999999999999999999998886 44443
No 102
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1.6e-35 Score=275.08 Aligned_cols=203 Identities=28% Similarity=0.421 Sum_probs=175.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|..+|+|.+.... .....+.+.+|+.++++++||||+++++++..++.+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4677888999999998863 57889999987542 3455677999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.....+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 99999999999998878999999999999999999999863 2999999999999999999999999998755322
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..++..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 212 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2233467899999999999899999999999999999999999998766554433
No 103
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=9.4e-36 Score=289.52 Aligned_cols=219 Identities=24% Similarity=0.347 Sum_probs=183.4
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC---
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 223 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--- 223 (387)
....+|...+.||+|+||.||. +|..||||.+..... .......+.+|+.++..+.|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3445888899999999998863 578999999876544 3445567888999999999999999988775432
Q ss_pred -----ceEEEEEccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 224 -----PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 224 -----~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998652 35889999999999999999999998 999999999999999999999
Q ss_pred EeecCccccccCC-CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 295 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..++..+..++
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999987654321 112233568999999999999999999999999999999999999999888778888887766544
Q ss_pred C
Q 016544 374 F 374 (387)
Q Consensus 374 ~ 374 (387)
+
T Consensus 265 ~ 265 (496)
T PTZ00283 265 L 265 (496)
T ss_pred C
Confidence 3
No 104
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-37 Score=274.22 Aligned_cols=211 Identities=31% Similarity=0.480 Sum_probs=189.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|.....||+|+||.|.. +...+|||++++..+-..+.++--..|.++|... +-|.++++..+|+..+++|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 566677899999998864 3457999999998776666667677788888887 4678999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.||+|-.++++-+.+.+..+..++.+|+-||-+||++| ||.||||.+|||++..|++||+|||+++.- .....
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-i~~~~ 505 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IFDGV 505 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc-ccCCc
Confidence 99999999999999999999999999999999999999999 999999999999999999999999998753 23345
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......|||.|+|||++...+|+.++|+||+||++|||+.|++||.+.+.+++.+.|....
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn 566 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN 566 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc
Confidence 5566789999999999999999999999999999999999999999999999999997665
No 105
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=1.4e-35 Score=272.35 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=171.2
Q ss_pred CcccceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCccee
Q 016544 156 DFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (387)
.|...+.||+|+||.|+. ++..||+|.+.... .......+.+|+.++.+++||||++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 466778899999998873 23479999987542 3455677899999999999999999
Q ss_pred eeeEEeeCCceEEEEEccCCCCHHHHHHHcC-------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 016544 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (387)
Q Consensus 215 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 275 (387)
+++++......+++|||+++++|.+++.... .+++.+...++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986532 2567788999999999999999999 99
Q ss_pred eCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCC
Q 016544 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP 352 (387)
Q Consensus 276 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~ 352 (387)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999998755332211 1122334778999999998899999999999999999986 678
Q ss_pred CCCCCCCCcHHHHH
Q 016544 353 PFTMKHDNEVPKAY 366 (387)
Q Consensus 353 pf~~~~~~~~~~~i 366 (387)
||.+.+..++...+
T Consensus 241 p~~~~~~~~~~~~~ 254 (304)
T cd05096 241 PYGELTDEQVIENA 254 (304)
T ss_pred CCCcCCHHHHHHHH
Confidence 99887777666554
No 106
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=1.3e-35 Score=269.95 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=173.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.++. +++.||+|.+.............+.+|+.++++++|++|+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55667899999998864 5789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999999888653 35899999999999999999999999 999999999999999999999999998654322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......++..|+|||++.+..++.++|+|||||++|+|++|..||.+.......+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 223346789999999999889999999999999999999999999876654443333
No 107
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=2e-36 Score=281.10 Aligned_cols=204 Identities=27% Similarity=0.435 Sum_probs=171.2
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||+|+||.||. +|..||+|++.+..............|..++... .||+|+++++.+.....+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999998873 5789999998754333333344455566776655 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.||++||+|||+++ |+||||||+|||++.++.++|+|||++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCc
Confidence 999999998888999999999999999999999999 999999999999999999999999998653322 2222345
Q ss_pred CCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..++.+++..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 689999999998764 47899999999999999999999999888777777776554
No 108
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.7e-35 Score=296.37 Aligned_cols=205 Identities=21% Similarity=0.345 Sum_probs=173.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|++...........+++.+|+.++++++||||+++++++..++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 467778999999998873 478999999986655555666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-----------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
|++|++|.+++... ...+...++.++.|+++||+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998641 12456678899999999999999998 99999999999999999999999999
Q ss_pred ccccccCCC-----------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 300 SKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 300 ~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
+........ .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 976521110 001124589999999999999999999999999999999999999987655444
Q ss_pred H
Q 016544 363 P 363 (387)
Q Consensus 363 ~ 363 (387)
.
T Consensus 240 ~ 240 (932)
T PRK13184 240 S 240 (932)
T ss_pred h
Confidence 3
No 109
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-37 Score=282.91 Aligned_cols=212 Identities=27% Similarity=0.459 Sum_probs=189.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
-|...++||.|+||.||+ +...||||+++-..-...+..+++..|+.+|+++.|||++.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366677899999999985 567899999986665667778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||- ||-.+++.- ..++.+-++..|+.+.++||+|||+++ .||||||..|||+++.|.+||+|||.+....+
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 995 599988875 346889999999999999999999999 99999999999999999999999999877543
Q ss_pred CcccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 376 (387)
...++|||.|||||++.. ++|+-++||||||++..||..+++|+..++....+-.|..+..|.+..
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs 247 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS 247 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC
Confidence 355789999999998854 589999999999999999999999999999999999998888887753
No 110
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=1.1e-35 Score=276.98 Aligned_cols=200 Identities=27% Similarity=0.457 Sum_probs=166.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~ 225 (387)
+|+..+.||+|+||.|+. +|..||+|.+..... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 366778899999998863 578999999874322 2233456788999999999999999999886432 47
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|+||||+. ++|.+++.....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 99999995 699999988878999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCC--CCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 306 KED--RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 306 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 211 12233568899999999876 57889999999999999999999999876543
No 111
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2e-35 Score=279.55 Aligned_cols=189 Identities=24% Similarity=0.359 Sum_probs=165.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +++.||+|.... ..+.+|+.++++++||||++++++|......++++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4688889999999998874 578999996532 34678999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|++. ++|.+++.....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9995 699999988778999999999999999999999999 999999999999999999999999998654322222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 23345689999999999998999999999999999999999988754
No 112
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=2.2e-35 Score=268.15 Aligned_cols=214 Identities=31% Similarity=0.519 Sum_probs=179.6
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|+..+.||.|+||.|+.. ...||+|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4666778999999887631 2579999987542 345567789999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
+++|||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999999999764 34778889999999999999999999 9999999999999999
Q ss_pred CCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
+.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..++...+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432221 11223345788999999988889999999999999999998 999999988888888887
Q ss_pred ccCCCCC
Q 016544 368 ARQRPPF 374 (387)
Q Consensus 368 ~~~~~~~ 374 (387)
.+..++.
T Consensus 241 ~~~~~~~ 247 (283)
T cd05048 241 SRQLLPC 247 (283)
T ss_pred cCCcCCC
Confidence 6664443
No 113
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=3e-35 Score=267.60 Aligned_cols=198 Identities=29% Similarity=0.460 Sum_probs=169.7
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+||.|+. +++.||+|.+.............+..|+.++++++|++|+++++.+...+.++++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 45567899999998864 5789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++...+ .+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999886533 4889999999999999999999998 9999999999999999999999999986543221
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~ 206 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence 22234678999999999998999999999999999999999999987543
No 114
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=1.7e-35 Score=279.03 Aligned_cols=209 Identities=29% Similarity=0.472 Sum_probs=171.1
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||+|+||.|+. ++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 577788999999998863 12479999997543 234456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc------------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------ 244 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~------------------------------------------------------------ 244 (387)
.++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998642
Q ss_pred ----------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC-ccc
Q 016544 245 ----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTC 313 (387)
Q Consensus 245 ----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 313 (387)
.++++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 13677888999999999999999998 9999999999999999999999999987653322111 112
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
..+++.|+|||++.+..++.++|||||||++|+|++ |+.||..........++...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~ 330 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc
Confidence 234567999999998899999999999999999997 99999877665544444333
No 115
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-37 Score=275.49 Aligned_cols=196 Identities=31% Similarity=0.495 Sum_probs=174.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|+.-+.||+|+||.|+ .+|+.+|.|++.+..+....-.....+|..++.+++.+.||.+--.|+..+.+++|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 46667789999999775 4789999998876655443333445779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
.|.||+|.-++...+ .+++..+..++.+|+.||++||+.+ ||.|||||+|||+|+.|+++|+|+|+|..+. ..
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~--~g 340 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP--EG 340 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC--CC
Confidence 999999999997765 5999999999999999999999999 9999999999999999999999999998765 34
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.+....+||.+|||||++.+..|+.+.|+|||||++|||+.|+.||..
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 555666899999999999999999999999999999999999999975
No 116
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=4.2e-35 Score=262.41 Aligned_cols=212 Identities=32% Similarity=0.545 Sum_probs=178.3
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||+|+|+.++. .+..+|+|.+..... ....+..|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 355667899999987763 346899998764422 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999753 45889999999999999999999999 9999999999999999999999999887653322222
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..++.+.+..+.++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 222 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR 222 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence 222345668999999998889999999999999999999 9999999888888888877665443
No 117
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=2.2e-35 Score=278.53 Aligned_cols=207 Identities=26% Similarity=0.424 Sum_probs=174.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~ 225 (387)
+|...+.||+|+||.|+. +|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 356678899999998873 57899999986542 23344567888999999999999999999998776 78
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|+|+||+. ++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999995 589998887778999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.++...+..|.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 333333344578899999999875 47889999999999999999999999887766665553
No 118
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=2.8e-35 Score=277.69 Aligned_cols=206 Identities=29% Similarity=0.445 Sum_probs=169.0
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||+|+||.|+. .+..||||+++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 567788999999998863 245899999875432 23446788899999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-----------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------- 245 (387)
.++||||+++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 246 ----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3677888999999999999999998 999999999999999999999999998765432211
Q ss_pred C-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHH
Q 016544 310 P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i 366 (387)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+........++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~ 329 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH
Confidence 1 112234567999999999999999999999999999997 99999876554333333
No 119
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-37 Score=279.40 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=191.0
Q ss_pred CcccceeecccEEEEEE---EcCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
++.....||.|+||.|. .+++. +|+|++++..+-+....+.+..|.++|...+.|.||++|-.|.++..+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 34445578999999764 45555 89999998888778888889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
-|-||.|+..+...+.+...++..++.-+++|++|||+++ ||.|||||+|++++.+|.+||.|||+|+.+..+ ...
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KT 576 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKT 576 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-Cce
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999887643 333
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
-.+.|||.|.|||++....++.++|.||||+++|||++|.+||.+.++...+..|.++-
T Consensus 577 -wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 577 -WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred -eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 34678999999999999999999999999999999999999999999999999998876
No 120
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=7.1e-35 Score=261.83 Aligned_cols=211 Identities=30% Similarity=0.512 Sum_probs=177.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
+|...+.||.|+++.++. ++..||+|.+....... ....+.+.+|+.++++++||||+++++++..+..++++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 467788999999987763 57899999987543222 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
+||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCc--ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 309 RPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 309 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........++...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 222 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc
Confidence 111 2234678899999999988999999999999999999999999877665555554433
No 121
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=2.8e-35 Score=270.21 Aligned_cols=198 Identities=28% Similarity=0.528 Sum_probs=165.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.|+. ++..||+|++..... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3677888999999998863 578999999875422 122345677999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+. ++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 9995 5888887654 45889999999999999999999999 999999999999999999999999998754322 1
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 222334578899999998764 578899999999999999999999987544
No 122
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=6.2e-35 Score=266.21 Aligned_cols=208 Identities=29% Similarity=0.504 Sum_probs=180.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+|+.++. +++.||+|.+.............+.+|+++++++.||||+++++++.....++++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 466778899999987762 578999999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999998888999999999999999999999998 999999999999999999999999998765433
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.....+++..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 223357889999999988888999999999999999999999998877666667765443
No 123
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=7e-35 Score=261.15 Aligned_cols=208 Identities=27% Similarity=0.427 Sum_probs=175.5
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
+||+|+||.|+. ++..+|+|++.... ......+.+..|+.+++.+.||||+++++++.. ...+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999988763 46889999987543 344556788999999999999999999998864 567899999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC--cc
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 312 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~ 312 (387)
++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999988778999999999999999999999999 9999999999999999999999999987654332211 11
Q ss_pred cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...++..|+|||.+....++.++|+|||||++|||++ |..||...+..++.+.+..+.++++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 219 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence 2233578999999988888999999999999999998 9999998888888888877665554
No 124
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=8.3e-35 Score=270.41 Aligned_cols=200 Identities=30% Similarity=0.467 Sum_probs=173.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.|+. ++..+|+|.+.... .......+.+|++++++++||||++++++|...+.+++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4677888999999998874 57789999887542 3445567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+.+++|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999888899999999999999999999985 5 999999999999999999999999998654321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
......++..|+|||++.+..++.++|+|||||++|+|++|+.||.......+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 22234578899999999998899999999999999999999999987655443
No 125
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=4.2e-36 Score=279.57 Aligned_cols=220 Identities=26% Similarity=0.520 Sum_probs=184.4
Q ss_pred cccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCc-ccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 148 YEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 148 ~ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
.+.++...-......||+|+|-+||. +|..||--.++. ...+.+...++|..|+.+|+.|+||||+++|.++.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 34444444455566899999998884 567777433221 233456778999999999999999999999999987
Q ss_pred CCc--eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeec
Q 016544 222 SSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 298 (387)
Q Consensus 222 ~~~--~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg 298 (387)
... +-+|+|.+..|+|..|+++.+.++.+....|++||++||.|||++.| ||||||||.+||+|+ ..|.+||+|+|
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchh
Confidence 654 88999999999999999999999999999999999999999999985 799999999999998 55889999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCCcHHHHHHccCCC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRP 372 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~ 372 (387)
+|..... .......|||.|||||... ..|...+||||||++++||+|+.+||... ++.+|++++..|..|
T Consensus 192 LAtl~r~---s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 192 LATLLRK---SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP 262 (632)
T ss_pred HHHHhhc---cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence 9987643 2333468999999999988 58999999999999999999999999864 457889998888744
No 126
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=5.4e-35 Score=261.71 Aligned_cols=212 Identities=30% Similarity=0.515 Sum_probs=176.6
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+|+.|+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 466778899999998763 3458999998654322 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999764 45889999999999999999999999 9999999999999999999999999987553221111
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...++.++...+....++..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 112223457999999998899999999999999999999 8999998888888888876654443
No 127
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=4.6e-35 Score=274.45 Aligned_cols=196 Identities=26% Similarity=0.426 Sum_probs=162.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.||. +|+.||+|.+.... .......+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 455667899999998873 47899999986432 34456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|... ...++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999998653 23566778889999999999999999 9999999999999999999999999987654321 12
Q ss_pred cccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 311 LTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
.....|+..|+|||.+.. ...+.++|||||||++|+|++|+.||......+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 280 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 233468999999998753 234568999999999999999999998544333
No 128
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=6.7e-35 Score=262.16 Aligned_cols=211 Identities=30% Similarity=0.497 Sum_probs=176.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. .+..||+|.+... ......+.+|+.++++++||||+++++++..+..++++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 456667899999987753 4789999998743 2234678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++.... .+++..+..++.|++++|+|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997643 4888999999999999999999998 99999999999999999999999999876543322
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
........++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 22122234567999999999899999999999999999998 999999877777777775544433
No 129
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=8.2e-35 Score=261.26 Aligned_cols=210 Identities=29% Similarity=0.457 Sum_probs=176.7
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+++.++. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 466778999999987763 457899999875432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.... .+++.....++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997654 5899999999999999999999998 999999999999999999999999998776522211
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+...+...+....++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 1111223457999999999899999999999999999999 99999988877777777655433
No 130
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=9.5e-35 Score=264.02 Aligned_cols=213 Identities=29% Similarity=0.484 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|+..+.||+|+||.|+. .+..|++|.+... ........+.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 355567899999998864 3468999998743 23445567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc-----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 227 IVTEYLPKGDLRAFLKRK-----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
++|||+.+++|.+++... ..+++.+...++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 999999999999998632 23678888999999999999999998 9999999999999999
Q ss_pred CCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
+.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+...+.+.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876532221 11122334677999999998889999999999999999998 999999887777777776
Q ss_pred ccCCCC
Q 016544 368 ARQRPP 373 (387)
Q Consensus 368 ~~~~~~ 373 (387)
....++
T Consensus 241 ~~~~~~ 246 (283)
T cd05090 241 KRQLLP 246 (283)
T ss_pred cCCcCC
Confidence 655443
No 131
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=1.1e-34 Score=264.40 Aligned_cols=212 Identities=30% Similarity=0.507 Sum_probs=178.7
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||.|+|+.++. ++..+|+|.+... .....+.+.+|+.++++++||||+++++++.....+
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 567778899999998863 2356899988643 344566789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC-------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
+++|||+++++|.+++...+ .+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999997543 3889999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 293 KVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 293 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
+|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||......++...+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999875432211 11122334678999999998889999999999999999998 999999888888888887766
Q ss_pred CCC
Q 016544 371 RPP 373 (387)
Q Consensus 371 ~~~ 373 (387)
.+.
T Consensus 240 ~~~ 242 (288)
T cd05093 240 VLQ 242 (288)
T ss_pred cCC
Confidence 443
No 132
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=1.1e-34 Score=266.50 Aligned_cols=212 Identities=27% Similarity=0.427 Sum_probs=179.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. .+..|++|.+.............+.+|+.+++.++||||+++++.+..+..++++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 466678899999988762 467899999876544334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988888999999999999999999999998 99999999999999999999999998864211100
Q ss_pred ------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 ------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....++..++..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 00112346778999999998889999999999999999999999999888888888776654
No 133
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-36 Score=272.98 Aligned_cols=202 Identities=26% Similarity=0.463 Sum_probs=178.0
Q ss_pred ceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.+.||+|.||+|| .+|+.||||++.+..+..... ..+++|+.+|+.+.||+||.+--.|+..+.+|+|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~- 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH- 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence 4679999999998 479999999999877765444 779999999999999999999999999999999999995
Q ss_pred CCHHHHHH--HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCccccccCCCC
Q 016544 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 235 ~sL~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|++.+.+- +.+.+++.....++.||+.||.|||-++ |+|+||||+|||+... ..+||+|||+|++++.. .
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 57766663 4577999999999999999999999999 9999999999999754 46999999999998644 3
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+|||.|+|||+++...|.++-|+||.|||+|--+.|..||.. ++++-.+|++..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAa 780 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAA 780 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccc
Confidence 34457899999999999999999999999999999999999999974 477888888777
No 134
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=7.5e-35 Score=265.62 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=169.2
Q ss_pred CcccceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEee-----
Q 016544 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ----- 221 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~----- 221 (387)
+|...+.||+|+||.||. .|..||+|.+........ ....+.+|+.+++.+ .||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 577788999999998873 357899998875433221 223445677776665 69999999998853
Q ss_pred CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
...++++|||+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 356899999996 5999998763 34889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
+...... .......+++.|+|||.+.+..++.++|||||||++|+|++|++||.+.+..+.+.++...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~ 224 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence 8765432 2223345789999999999889999999999999999999999999998887777777544
No 135
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=1.2e-34 Score=259.22 Aligned_cols=214 Identities=27% Similarity=0.430 Sum_probs=182.7
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+++.++. ++..|++|.+...... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 55667899999987763 5789999998754333 44566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-N 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-c
Confidence 9999999999764 45889999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+......++..+..++++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS 222 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 223345788899999999988999999999999999999999999988877777887777666654
No 136
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=1.2e-35 Score=266.47 Aligned_cols=210 Identities=38% Similarity=0.690 Sum_probs=175.5
Q ss_pred ceeecccEEEEEE---Ec------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 160 SVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~---~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+.||.|.||.|+ +. +..|+||.+... ......+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4679999999876 34 678999999643 345557889999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++|+|.+++... ..+++.++..|+.|++.||.|||+++ ++|+||+++||+++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999986 56999999999999999999999998 99999999999999999999999999876622211
Q ss_pred -CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 -RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...........|+|||.+....++.++||||||+++||+++ |+.||.+.+..++..++..+.++++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee
Confidence 11122335678999999998889999999999999999999 7899999988888889877766554
No 137
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=1.4e-34 Score=260.59 Aligned_cols=213 Identities=32% Similarity=0.509 Sum_probs=180.0
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||+|+||.||. +...||+|.+.... .......+..|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 567788999999998873 13579999987542 34456678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++... +.+++.++..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 45899999999999999999999998 999999999999999999999999999876422
Q ss_pred CCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 307 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......++...+....+++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 211 1122334678999999999899999999999999999998 999999888888888886655433
No 138
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=9.7e-35 Score=263.15 Aligned_cols=214 Identities=25% Similarity=0.423 Sum_probs=176.0
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.+|+....||+|+||.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3577788999999998863 24679999986432 23345668899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
.++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999997532 2466788899999999999999998 999999999999999999999
Q ss_pred EeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+..+.+.....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999987543222111 112234678999999998889999999999999999999 79999988887777777665543
Q ss_pred C
Q 016544 373 P 373 (387)
Q Consensus 373 ~ 373 (387)
+
T Consensus 241 ~ 241 (277)
T cd05062 241 D 241 (277)
T ss_pred C
Confidence 3
No 139
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-35 Score=274.30 Aligned_cols=217 Identities=27% Similarity=0.485 Sum_probs=187.8
Q ss_pred ceeecccEEEEEEE-------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 160 SVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+.||.|.||.||. .| ..||||.-+.+ ...+..+.|..|+.+|+.+.||||++++|+|.+ ...+||||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 45789999998763 22 36888877654 344557889999999999999999999999975 57899999
Q ss_pred ccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
.++-|.|..|++.+.. ++......++.||+.||.|||+.. +|||||-.+|||+.....+||+|||+++......-.
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999987654 888999999999999999999999 999999999999999999999999999987755444
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
..+...-++.|||||.+.-+.++.++|||.|||++||++. |..||.+..+.+++-.|.+|.|+|. |+.||+.|
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCPp~L 621 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCPPAL 621 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCChHH
Confidence 4444445778999999999999999999999999999985 9999999999999999999998887 45666654
No 140
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=7.3e-35 Score=261.55 Aligned_cols=210 Identities=30% Similarity=0.504 Sum_probs=177.2
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||.|+||.++. ++..||+|.+.... ...+.+.+|+.++++++||||+++++.+...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 566678899999998863 46789999876432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999753 34788899999999999999999998 999999999999999999999999999765432222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.......+...+....++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2222345678999999998889999999999999999998 99999988877778777655443
No 141
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=7.6e-35 Score=260.78 Aligned_cols=211 Identities=30% Similarity=0.511 Sum_probs=176.7
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||+|+|+.++. .+..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 456677899999988763 234699998875432 235688899999999999999999999988899999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 35899999999999999999999998 9999999999999999999999999987553322211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.....++..|++||.+.+..++.++|+|||||++|+|++ |..||......++..++..+.++.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC
Confidence 122234677999999998889999999999999999998 999999888777888887766544
No 142
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=7.6e-36 Score=274.69 Aligned_cols=206 Identities=29% Similarity=0.470 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
...+++.||+|.||.+.. .+..||||+++... ......+|..|+++|.+++||||++++|+|..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 355677899999998753 34899999998763 345578899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++|+|.+|+.++.. +......+|+.||++||+||.+.+ +|||||.++|+|++.++++||+|||+++..-..+..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999987632 355667789999999999999998 999999999999999999999999999854333222
Q ss_pred Ccc-cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH--cCCCCCCCCCCCcHHHHH
Q 016544 310 PLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI--EGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell--tg~~pf~~~~~~~~~~~i 366 (387)
..+ ...-+++|||||.+.-++++.++|+|+||+++||++ +...||...+++++.++.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~ 753 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA 753 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh
Confidence 222 223468999999999999999999999999999986 699999999999888775
No 143
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=9e-35 Score=263.67 Aligned_cols=211 Identities=31% Similarity=0.494 Sum_probs=178.2
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||.|+|+.|+. ++..||+|.+.... ..+..+.+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 466677899999998873 13689999987542 334567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC--------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
+++|||+++++|.+++...+ .+++.++..++.|++.|+.|||+++ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997643 3678889999999999999999999 999999999999999999
Q ss_pred EEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 292 LKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
++|+|||++........ .......+++.|+|||.+.+..+++++|||||||++|+|++ |..||.+.+..+....+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432211 11122334678999999999999999999999999999998 99999988888888888765
Q ss_pred CC
Q 016544 370 QR 371 (387)
Q Consensus 370 ~~ 371 (387)
..
T Consensus 241 ~~ 242 (280)
T cd05049 241 RL 242 (280)
T ss_pred Cc
Confidence 53
No 144
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=1.8e-34 Score=258.48 Aligned_cols=207 Identities=25% Similarity=0.431 Sum_probs=172.0
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||.|+||.|+. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 479999988763 24579999987542 34455678999999999999999999998864 578999999999
Q ss_pred CCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC--c
Q 016544 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--L 311 (387)
Q Consensus 235 ~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~ 311 (387)
++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... .
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999975 446899999999999999999999998 9999999999999999999999999987554322211 1
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....+++.|+|||.+.+..++.++|+|||||++|++++ |..||.+....++...+..+.++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence 12223568999999988889999999999999999996 9999999888888887777665544
No 145
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-36 Score=285.00 Aligned_cols=219 Identities=32% Similarity=0.542 Sum_probs=190.5
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+.+.||.|.||.|+. ....||||.++.. ..++...+|..|+.||-++.||||++|-|+......+.||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34456899999999874 3468999999854 3577788899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+|||++|+|..||.++ +.++.-+...+++.|+.||.||-+.+ +|||||..+|||++.+-..|++|||+++.+....
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999999865 56999999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCcccC--CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC--CCCCCCChhh
Q 016544 308 DRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKL 380 (387)
Q Consensus 308 ~~~~~~~--~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 380 (387)
....+.. .-+.+|.|||.+..++++.++||||||++|||.++ |+.||=++++.++++.|..+= .||++.|...
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 3333333 23679999999999999999999999999999885 999999999999999998777 4555555443
No 146
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=1.8e-34 Score=257.60 Aligned_cols=208 Identities=31% Similarity=0.510 Sum_probs=172.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||.|+||.||. +++.||+|.+.... ..+....+.+|+.++++++||||+++++++......++||||+.+++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 589999988863 67889999886432 34555778999999999999999999999999999999999999999
Q ss_pred HHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc-ccC
Q 016544 237 LRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQ 314 (387)
Q Consensus 237 L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 314 (387)
|.+++...+ .+++.+++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999997654 4889999999999999999999998 99999999999999999999999999875432111111 111
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+....+++.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 23456999999998889999999999999999997 9999988777666666655444443
No 147
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=2.3e-34 Score=272.54 Aligned_cols=213 Identities=27% Similarity=0.435 Sum_probs=171.9
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||+|+||.|+.. +..||||++.... .....+.+.+|+.+++++. ||||+++++++.....
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 6777789999999988631 2469999997542 3344567899999999996 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc------------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------ 244 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~------------------------------------------------------------ 244 (387)
+|+||||+++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988642
Q ss_pred ------------------------------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC
Q 016544 245 ------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288 (387)
Q Consensus 245 ------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~ 288 (387)
..+++.++..++.|++.||.|||+.+ ++|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 12667778899999999999999998 999999999999999
Q ss_pred CCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc-HHHH
Q 016544 289 SGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE-VPKA 365 (387)
Q Consensus 289 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~-~~~~ 365 (387)
++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... +...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 999999999998765332211 1122345678999999999889999999999999999997 999998765443 3444
Q ss_pred HHccCCCC
Q 016544 366 YAARQRPP 373 (387)
Q Consensus 366 i~~~~~~~ 373 (387)
+..+.+++
T Consensus 353 ~~~~~~~~ 360 (400)
T cd05105 353 IKSGYRMA 360 (400)
T ss_pred HhcCCCCC
Confidence 44433433
No 148
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=2.9e-34 Score=258.51 Aligned_cols=215 Identities=32% Similarity=0.537 Sum_probs=178.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
|.....||.|+|+.++. ++..+|+|.+....... ....+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56677899999988763 56899999886543322 12346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++++||+++++|.+++.+.+.++...+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999998888999999999999999999999998 99999999999999999999999999876542
Q ss_pred CCC-----CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KED-----RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+......++.....|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC
Confidence 111 111123467889999999998899999999999999999999999998766555555544444443
No 149
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.8e-34 Score=259.90 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=171.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.++. ++..||+|++.... ......+.+|+.++++++||||+++++.+......++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 3678888999999998763 57889999986432 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++...+++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT-IA 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc-cc
Confidence 99999999999988788999999999999999999999998 999999999999999999999999998765322 11
Q ss_pred CcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 365 (387)
......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||....+......
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~ 220 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence 122345788999999885 34577899999999999999999999976655444333
No 150
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.5e-34 Score=271.69 Aligned_cols=199 Identities=27% Similarity=0.401 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. .|..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 3678888999999998863 578999999875532 3344566788999999999999999999986543
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+.+ +|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999965 67666643 4788899999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 222334678999999999999999999999999999999999999987765443
No 151
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=3.3e-34 Score=258.11 Aligned_cols=214 Identities=24% Similarity=0.437 Sum_probs=177.4
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.|+ .++..||+|.+.............+.+|+.+++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 56777889999998776 2678999998875444455666778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988853 234788999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHccCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~ 373 (387)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+...+.....|+
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227 (267)
T ss_pred h-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence 1 112234578899999999988899999999999999999999999975432 34555554444444
No 152
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=3.2e-34 Score=260.20 Aligned_cols=211 Identities=29% Similarity=0.479 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
++.....||+|+||.|+. ++..+|+|.+... .......+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 455677899999998874 3568999987643 344567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC---------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 290 (387)
+++|||+++++|.+++...+ .+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 99999999999999997643 3788899999999999999999999 99999999999999999
Q ss_pred CEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHc
Q 016544 291 NLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 291 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~ 368 (387)
.++|+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||......+....+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999987543221111 112234678999999999899999999999999999998 9999988877777777766
Q ss_pred cCCC
Q 016544 369 RQRP 372 (387)
Q Consensus 369 ~~~~ 372 (387)
+..+
T Consensus 240 ~~~~ 243 (280)
T cd05092 240 GREL 243 (280)
T ss_pred CccC
Confidence 5543
No 153
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.4e-34 Score=272.26 Aligned_cols=206 Identities=26% Similarity=0.360 Sum_probs=171.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------C
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 223 (387)
.+|...+.||+|+||.|+. .+..||||++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4688888999999998863 578899999876432 234456678899999999999999999987643 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+.+ +|.+++.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999965 78777754 3788899999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++...
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 322 2223346789999999999999999999999999999999999999988776666666443
No 154
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=4e-34 Score=264.09 Aligned_cols=213 Identities=25% Similarity=0.487 Sum_probs=174.4
Q ss_pred cCcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+|+..+.||+|+||.|+. ++. .||+|.+... ......+.+..|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4677888999999998863 233 4899998743 2344556788999999999999999999998764 57
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++++||+.+|+|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 89999999999999998743 4888899999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 305 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
...... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+..+.+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 332211 112234668999999999999999999999999999998 999999877666655555444433
No 155
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-35 Score=253.27 Aligned_cols=194 Identities=26% Similarity=0.454 Sum_probs=164.0
Q ss_pred ceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccC
Q 016544 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 160 ~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.+.||.|.|+.|. ++|..+|||++.+. ......+..+|++++.+. .|+||++++++|+++..+|||||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 3568999998764 68999999999765 344567778899999998 59999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC---EEEEeecCccccccCCC--
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~-- 308 (387)
||+|..++++...+++.++.++.++|+.||.+||.+| |.||||||+|||-..... +||+||.+..-+....+
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999888999999999999999999999999 999999999999875544 89999988653321111
Q ss_pred ----CCcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 309 ----RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 309 ----~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
-......|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.|.=.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 1123456888999999763 23688999999999999999999999987543
No 156
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-36 Score=259.52 Aligned_cols=218 Identities=28% Similarity=0.463 Sum_probs=190.2
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.+...||.|+||.|+ ..|+.+|+|.+..+ ...+++..|+.++++...|++|++||.|.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 5667789999999875 57999999988643 3468889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHH-HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|..||..+.+. ++.++++.++..+++.-+.||+|||... -||||||..|||++.+|.+||+|||.+..+...- ..
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 99999999997 4567999999999999999999999988 8999999999999999999999999986654321 12
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 384 (387)
.....|||.|||||++..-.|..++||||||++..||..|++||.+..+...+-.|-....|.|..| +.++++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KP-E~WS~~ 258 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKP-EEWSSE 258 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCCh-HhhhhH
Confidence 2446799999999999999999999999999999999999999999999988888877777777664 555544
No 157
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=4.4e-34 Score=257.45 Aligned_cols=214 Identities=32% Similarity=0.514 Sum_probs=178.3
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.++. .+..+|+|.+.... .....+.+..|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 456678899999987763 23379999987542 23455688999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++.+. +.+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999865 45899999999999999999999999 999999999999999999999999998765433
Q ss_pred CCCCc--ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..... ....++..|++||.+.+..++.++|+|||||++|++++ |..||.+.+..+....+....+++.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC
Confidence 22111 11223567999999998889999999999999999886 9999998887778888776654443
No 158
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=2.1e-34 Score=261.71 Aligned_cols=213 Identities=25% Similarity=0.461 Sum_probs=177.6
Q ss_pred cccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
|...+.||.|+||.|+.. +..||+|.+.... .....+.+..|+.++..++||||+++++++......+
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 555678999999887642 4789999997542 3344567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC
Q 016544 227 IVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 290 (387)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998532 23778888999999999999999999 99999999999999999
Q ss_pred CEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHc
Q 016544 291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 291 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~ 368 (387)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++.+.+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999875432221 11122345678999999988889999999999999999998 9999999888888888877
Q ss_pred cCCCCC
Q 016544 369 RQRPPF 374 (387)
Q Consensus 369 ~~~~~~ 374 (387)
...+++
T Consensus 242 ~~~~~~ 247 (283)
T cd05091 242 RQVLPC 247 (283)
T ss_pred CCcCCC
Confidence 775543
No 159
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=6.6e-34 Score=253.62 Aligned_cols=206 Identities=32% Similarity=0.523 Sum_probs=172.5
Q ss_pred eecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 162 ~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
.||.|+|+.||. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++|||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 579999988863 56789999987543 344455788999999999999999999999999999999999999999
Q ss_pred HHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
.+++... ..+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++...............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9998754 45789999999999999999999999 9999999999999999999999999986543222211122234
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
++.|+|||++.+..++.++|+||||+++|++++ |..||.+.........+....++
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~ 213 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 567999999998889999999999999999998 99999988777777777555443
No 160
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=6.4e-34 Score=254.89 Aligned_cols=204 Identities=29% Similarity=0.506 Sum_probs=171.6
Q ss_pred eecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||+|+||.|+. .+..+|+|.+...... ...+.+..|+.+++++.||||+++++++.. ...+++|||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 589999998752 2268999999865432 445678899999999999999999998764 56899999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc--
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-- 311 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 311 (387)
+++|.+++.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+++..........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999998778999999999999999999999998 99999999999999999999999999876543322111
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..++.+.+....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~ 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc
Confidence 11223467999999998899999999999999999998 9999998887777777766554
No 161
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=4.4e-34 Score=260.73 Aligned_cols=211 Identities=30% Similarity=0.483 Sum_probs=176.0
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.++. ++..+++|.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 455667899999988763 2356899988643 234446788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
++||||+++++|.+++...+ .+++..++.++.|++.||+|||+++ ++|+||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999997542 3788899999999999999999999 9999999999999999
Q ss_pred CCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
+.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|+| |..||...+..+..+.+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999875433211 11222345778999999999899999999999999999999 999998888877777776
Q ss_pred ccCCC
Q 016544 368 ARQRP 372 (387)
Q Consensus 368 ~~~~~ 372 (387)
.+..+
T Consensus 240 ~~~~~ 244 (291)
T cd05094 240 QGRVL 244 (291)
T ss_pred CCCCC
Confidence 65543
No 162
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=6.9e-34 Score=254.42 Aligned_cols=213 Identities=22% Similarity=0.379 Sum_probs=181.8
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.++ .++..+++|.+...... ......+.+|+.++++++|+||+++++++.+...++++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6677889999998654 35789999998654433 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999865 34889999999999999999999998 99999999999999999999999999876543321
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+..+..++.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 22334578899999999988889999999999999999999999998888888888876654443
No 163
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=1.1e-33 Score=254.49 Aligned_cols=209 Identities=29% Similarity=0.484 Sum_probs=173.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 226 (387)
+|...+.||.|+||.++. +|..||+|.+.... .......+.+.+|+.+++++.||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 567788999999998863 57899999875322 22334567889999999999999999999988764 4688
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
++|||+++++|.+++.+...+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999988777899999999999999999999999 999999999999999999999999998754321
Q ss_pred CC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 307 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+........++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence 11 11222357889999999998889999999999999999999999998765555444443
No 164
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=6.2e-34 Score=256.13 Aligned_cols=210 Identities=26% Similarity=0.492 Sum_probs=175.9
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
+|+..+.||.|+|+.++. +|..+|+|.+...... .......+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 466778899999998863 6788999988643221 233346688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE- 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 307 (387)
+||+++++|.+++.+.+.+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999988778899999999999999999999998 9999999999999999999999999987543211
Q ss_pred ----CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 308 ----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 308 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 222 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA 222 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh
Confidence 1112234578899999999998899999999999999999999999987665544444433
No 165
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=2.5e-34 Score=276.21 Aligned_cols=200 Identities=26% Similarity=0.415 Sum_probs=163.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 222 (387)
.+|...+.||+|+||.|+. ++..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3688889999999998873 57899999885431 2235699999999999999999887432
Q ss_pred -CceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEe
Q 016544 223 -SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 296 (387)
Q Consensus 223 -~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~D 296 (387)
..+++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 246789999965 77777642 355899999999999999999999999 99999999999999665 699999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99998654322 22234678999999998764 68999999999999999999999999887766655554
No 166
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=3.7e-34 Score=263.47 Aligned_cols=205 Identities=28% Similarity=0.485 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. ++..||+|.+...... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 577788999999998874 5778999998754322 223456779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+ +|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 9975 8888887654 4788999999999999999999999 9999999999999999999999999987543322 1
Q ss_pred CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
......+++.|+|||.+.+ ..++.++|+|||||++|+|+||++||.+.+..+....+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2223456889999999865 467889999999999999999999999877666655553
No 167
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=1e-34 Score=280.65 Aligned_cols=202 Identities=22% Similarity=0.408 Sum_probs=167.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeE-Eee---C--
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQ---S-- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~-~~~---~-- 222 (387)
.+.++.+.|.+|||+.||. .|.+||+|++-. .++...+..++|+.+|++++ |+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3566778899999998884 348999998853 36788899999999999996 9999999993 221 1
Q ss_pred -CceEEEEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 223 -SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 223 -~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
-.++|.||||.||+|-+++.. ...|++.++++|+.|+++|+.+||... .||||||||.+||||+.+++.||||||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 247899999999999999974 345999999999999999999999997 5799999999999999999999999999
Q ss_pred ccccccCCCCCc--------ccCCCCCcccccccc---cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 300 SKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 300 ~~~~~~~~~~~~--------~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
+........... -....|+.|.|||++ .+.+.++|+|||+|||+||.|+....||.+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 864332221111 112368999999986 5678999999999999999999999999976433
No 168
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=5.5e-34 Score=260.67 Aligned_cols=209 Identities=29% Similarity=0.455 Sum_probs=175.9
Q ss_pred cCcccceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcce
Q 016544 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 213 (387)
.+|...+.||+|+||.++. .+..||+|.+.... .....+.+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3567778999999998874 23568999987543 235567889999999999999999
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcC-----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~ 282 (387)
++++++..+...+++||++.+++|.+++.+.. .+++..++.++.|++.||.|||+++ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 99999999999999999999999999998765 6889999999999999999999998 999999999
Q ss_pred CEEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCC
Q 016544 283 NILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHD 359 (387)
Q Consensus 283 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~ 359 (387)
||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999875432221 11223345678999999998889999999999999999998 7899988777
Q ss_pred CcHHHHHHc
Q 016544 360 NEVPKAYAA 368 (387)
Q Consensus 360 ~~~~~~i~~ 368 (387)
.+++..+..
T Consensus 240 ~~~~~~~~~ 248 (296)
T cd05051 240 QQVIENAGH 248 (296)
T ss_pred HHHHHHHHh
Confidence 776666644
No 169
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=3.9e-34 Score=257.69 Aligned_cols=204 Identities=25% Similarity=0.399 Sum_probs=172.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.++... ......+.+|+.+++.++||||+++++.+...+..+++||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 577778899999988763 57899999986442 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++.++..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++...... ...
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998655322 122
Q ss_pred cccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....++..|+|||.+. ...++.++|+|||||++|+|++|..||....+......+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 23346789999999974 446788999999999999999999999876655444443
No 170
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3.4e-34 Score=272.09 Aligned_cols=194 Identities=25% Similarity=0.357 Sum_probs=167.5
Q ss_pred cCcccceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
.+|...+.||.|+||.||. .+..||+|.+... ....+|+.++++++||||+++++++......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3688889999999998873 2467999987643 234579999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||++. ++|.+++.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999995 689999977778999999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 308 DRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 308 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 221 22346899999999999999999999999999999999999999876543
No 171
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=4.3e-34 Score=258.79 Aligned_cols=214 Identities=28% Similarity=0.456 Sum_probs=177.9
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.|+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 566778999999998862 23679999986442 234456788899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999997532 2577889999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 296 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 296 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
|||+++....... .......++..|+|||.+.+..++.++|+|||||++|++++ |..||.+.+..++.+.+..+..++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999875543221 11222345778999999988889999999999999999998 999999888888888887555444
Q ss_pred C
Q 016544 374 F 374 (387)
Q Consensus 374 ~ 374 (387)
+
T Consensus 242 ~ 242 (277)
T cd05032 242 L 242 (277)
T ss_pred C
Confidence 3
No 172
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4.1e-34 Score=262.97 Aligned_cols=213 Identities=29% Similarity=0.498 Sum_probs=175.9
Q ss_pred CcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC
Q 016544 156 DFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 222 (387)
+|...+.||+|+||.|+.. +..+|+|.+.... .......+..|+.+++.+ +||||+++++++...
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 5788889999999988732 2469999997542 234456788899999999 799999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill 286 (387)
+..+++|||+.+++|.+++.... .+++.+++.++.|++.||+|||+++ ++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997642 3788899999999999999999998 9999999999999
Q ss_pred CCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHH
Q 016544 287 DDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (387)
Q Consensus 287 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~ 364 (387)
+.++.++|+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++.+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999987553221111 112234568999999998889999999999999999998 999998877777777
Q ss_pred HHHccCCCC
Q 016544 365 AYAARQRPP 373 (387)
Q Consensus 365 ~i~~~~~~~ 373 (387)
.+....++.
T Consensus 254 ~~~~~~~~~ 262 (307)
T cd05098 254 LLKEGHRMD 262 (307)
T ss_pred HHHcCCCCC
Confidence 765555443
No 173
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=8.4e-34 Score=261.97 Aligned_cols=210 Identities=26% Similarity=0.428 Sum_probs=178.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.+|. ++..||+|.+...........+.+..|+.+++.++||||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 466778899999998763 478999999987655444566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999764 45899999999999999999999998 99999999999999999999999998865432211
Q ss_pred C----------------------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 309 R----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 309 ~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235688899999999988999999999999999999999999988777
Q ss_pred cHHHHHHc
Q 016544 361 EVPKAYAA 368 (387)
Q Consensus 361 ~~~~~i~~ 368 (387)
....++..
T Consensus 239 ~~~~~~~~ 246 (316)
T cd05574 239 ETFSNILK 246 (316)
T ss_pred HHHHHHhc
Confidence 66666653
No 174
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=5e-34 Score=255.24 Aligned_cols=213 Identities=26% Similarity=0.428 Sum_probs=179.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.++ .++..+|+|.+.... .....+.+..|+.+++.++||||+++++.+..++.++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 35667889999998775 267899999986432 23455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999999988653 34788999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||++.+..+++++|+||||+++|+|++|..||...+.......+..+..+++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL 220 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC
Confidence 122234578889999999998899999999999999999999999998777777777766654443
No 175
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=4.9e-34 Score=256.46 Aligned_cols=209 Identities=32% Similarity=0.486 Sum_probs=173.2
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+|+.|+. .+..||+|++..... ..+.+.+|+.++++++||||+++++.+. ....+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 477778899999987763 335799999975432 1256888999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999863 34788999999999999999999998 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
......++..|+|||...+..++.++|+|||||++|+|+| |+.||.+....++..++....++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC
Confidence 2223345678999999988889999999999999999999 99999988777777777655433
No 176
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=6.6e-34 Score=255.22 Aligned_cols=210 Identities=30% Similarity=0.503 Sum_probs=175.1
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||.|+||.++. ++..||+|.+...... ...+.+|+.++++++||||+++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 466678899999998863 6789999998754332 356888999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+.+++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998753 34888999999999999999999998 999999999999999999999999998765422222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
......++..|+|||.+.+..++.++|+||||+++|++++ |++||.+.+..++.+.+....+++
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence 2222345678999999998889999999999999999999 999999888777777776554443
No 177
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=7.7e-34 Score=256.10 Aligned_cols=205 Identities=27% Similarity=0.457 Sum_probs=165.2
Q ss_pred eecccEEEEEEE----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
+||+|+||.|+. . ...+++|.+.... .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 589999998863 2 3478888876432 344456788899999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCC-----CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-
Q 016544 235 GDLRAFLKRKGA-----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (387)
Q Consensus 235 ~sL~~~l~~~~~-----l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 308 (387)
++|.+++..... .++.....++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 456778899999999999999999 99999999999999999999999999865322111
Q ss_pred CCcccCCCCCcccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.......+++.|+|||++.. ..++.++|||||||++|+|++ |..||....+.+...++.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence 11122345678999998743 356789999999999999998 8999998877777766655553
No 178
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=9.1e-34 Score=254.96 Aligned_cols=210 Identities=31% Similarity=0.528 Sum_probs=174.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 226 (387)
+|...+.||+|+||.++. ++..||+|.+.... .........+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 577788999999987763 57899999875321 12334556789999999999999999999998764 4588
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+++||+++++|.+++.+.+.+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999988777899999999999999999999999 999999999999999999999999998754321
Q ss_pred C--CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 307 E--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 307 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
. ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+........++..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 223 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc
Confidence 1 1111234578899999999988889999999999999999999999987765555555443
No 179
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=5.5e-34 Score=256.68 Aligned_cols=213 Identities=24% Similarity=0.446 Sum_probs=176.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.++. ++..+|||.+.............+.+|+.+++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 466677899999987762 688999998876544445556788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999864 344889999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHccCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRP 372 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~ 372 (387)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+... ....+++.....|
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC
Confidence 21 12234578899999999988899999999999999999999999976543 2444455444333
No 180
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=6.7e-34 Score=261.19 Aligned_cols=215 Identities=28% Similarity=0.500 Sum_probs=178.4
Q ss_pred ccCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEe
Q 016544 154 ELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~ 220 (387)
..+|...+.||.|+||.|+.. +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 345677789999999988622 3479999987542 234457788999999999 7999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 016544 221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (387)
Q Consensus 221 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Ni 284 (387)
.....+++|||+.+++|.+++.+.. .+++.++..++.|+++||.|||+++ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997632 3677888999999999999999999 99999999999
Q ss_pred EeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH
Q 016544 285 LRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 362 (387)
Q Consensus 285 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~ 362 (387)
+++.++.++|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 9999999999999998765432221 1222345678999999998889999999999999999998 8999998888888
Q ss_pred HHHHHccCCCC
Q 016544 363 PKAYAARQRPP 373 (387)
Q Consensus 363 ~~~i~~~~~~~ 373 (387)
.+.+....++.
T Consensus 249 ~~~~~~~~~~~ 259 (304)
T cd05101 249 FKLLKEGHRMD 259 (304)
T ss_pred HHHHHcCCcCC
Confidence 88876665443
No 181
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=1.5e-33 Score=259.22 Aligned_cols=200 Identities=30% Similarity=0.459 Sum_probs=172.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.|+. ++..+|+|.+.... .......+.+|++++++++||||+++++++..++.++++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 477788999999998863 57889999887532 34455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+.+.+++..+..++.|+++||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999999988889999999999999999999998 46 999999999999999999999999998654322
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 122345788999999998888999999999999999999999999765544433
No 182
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=6.3e-34 Score=257.85 Aligned_cols=192 Identities=29% Similarity=0.479 Sum_probs=164.9
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+||.||. +|..||+|.+.............+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 58889988763 5789999998764433333445667899999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
.+++.+.. .+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99998765 5899999999999999999999999 99999999999999999999999999876543 22223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 67889999999888889999999999999999999999987654
No 183
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=6.7e-34 Score=255.20 Aligned_cols=211 Identities=33% Similarity=0.511 Sum_probs=175.5
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||+|+|+.++. .+..+|+|.+...... .+.+.+|+.++++++||+++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 466778899999988762 4568999998764332 246889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999763 34889999999999999999999998 999999999999999999999999998765432222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..++...+....+++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 2222334667999999988889999999999999999999 9999998888888888866544443
No 184
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=7.3e-34 Score=254.67 Aligned_cols=207 Identities=33% Similarity=0.577 Sum_probs=177.7
Q ss_pred eecccEEEEEEE---c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW---R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~---~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||.|+||.++. . +..|++|.+...... ...+.+.+|+.+++.++|+||+++++++......+++|||++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 589999987752 2 778999999765332 256788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 234 KGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 234 ~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999875 66999999999999999999999998 9999999999999999999999999997665
Q ss_pred cCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 305 VKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 305 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..++.+.+..+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP 227 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 4321 11223446788999999998889999999999999999999 699999988888888887655443
No 185
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=1.4e-33 Score=256.27 Aligned_cols=211 Identities=29% Similarity=0.430 Sum_probs=175.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.+.||||+++++.+......++++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 45567799999998863 4678899988643 344567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|..++.+ ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999999998765 456899999999999999999999998 9999999999999999999999999986543221 12
Q ss_pred cccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....+++.|+|||++. +..++.++|+|||||++|+|++|++||...+..+...++.....+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC
Confidence 23345788999999984 34577899999999999999999999998777666666655544443
No 186
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1e-33 Score=261.23 Aligned_cols=213 Identities=29% Similarity=0.497 Sum_probs=176.2
Q ss_pred cCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee
Q 016544 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 221 (387)
.+|...+.||+|+||.|+.. ...+|+|.+.... .......+..|+.+++++ .||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 35677889999999988642 3469999987542 234456788899999999 69999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nil 285 (387)
.+.++++|||+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 99999999999999999999753 23788889999999999999999998 999999999999
Q ss_pred eCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHH
Q 016544 286 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 363 (387)
++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999998765422111 1112234567999999998889999999999999999999 99999988877778
Q ss_pred HHHHccCCC
Q 016544 364 KAYAARQRP 372 (387)
Q Consensus 364 ~~i~~~~~~ 372 (387)
..+..+..+
T Consensus 247 ~~~~~~~~~ 255 (314)
T cd05099 247 KLLREGHRM 255 (314)
T ss_pred HHHHcCCCC
Confidence 777665543
No 187
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=4e-34 Score=256.72 Aligned_cols=213 Identities=31% Similarity=0.490 Sum_probs=180.2
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+|+..+.||.|+|+.++. .+..+++|.+.... ......+..|+.+++.++||||+++++++......+++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3577788999999988763 46889999987542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999763 34889999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
. .....++..|++||.+.+..++.++|+||||+++|+|++ |+.||.+.+..++...+....+++.
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC 225 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC
Confidence 1 123345678999999998889999999999999999998 8999998888888888876554443
No 188
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.1e-33 Score=258.72 Aligned_cols=211 Identities=24% Similarity=0.451 Sum_probs=175.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|+..+.||.|+|+.++. ++..|++|.+..... ...+.+.+|+.+++.+.||||+++++.+......++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 4677788999999988763 578999998875432 23466888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+. .+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~ 171 (296)
T cd06654 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (296)
T ss_pred cccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence 999999999998753 5789999999999999999999999 9999999999999999999999999887543221 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+.....++
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC
Confidence 1223457889999999999889999999999999999999999998776544433443333333
No 189
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=9.8e-34 Score=256.59 Aligned_cols=213 Identities=29% Similarity=0.446 Sum_probs=174.0
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+|+.+|. .+..|++|.+... ........+..|+.+++.++|+||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 566778899999987762 3467999988643 2334456688899999999999999999999988999
Q ss_pred EEEEEccCCCCHHHHHHHcC-------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC---CEEEE
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVA 295 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~ 295 (387)
+++|||+++++|.+++.+.. .+++..+..++.||+.||+|||+++ ++|+||||+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999997653 3788999999999999999999999 99999999999998654 58999
Q ss_pred eecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 296 DFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
|||+++......... ......++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+...+...+....++.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999987653221111 111223567999999998899999999999999999997 999999888777777776555433
No 190
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=9.6e-34 Score=258.37 Aligned_cols=211 Identities=29% Similarity=0.506 Sum_probs=174.1
Q ss_pred cccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
|+..+.||+|+||.+|. ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 56677899999998864 12568999887543 2344567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc------------------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 016544 227 IVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~ 282 (387)
+++||+.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence 999999999999998642 23678889999999999999999998 999999999
Q ss_pred CEEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 016544 283 NILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (387)
Q Consensus 283 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~ 360 (387)
||+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999987543222111 122234678999999988889999999999999999998 99999988877
Q ss_pred cHHHHHHccCCC
Q 016544 361 EVPKAYAARQRP 372 (387)
Q Consensus 361 ~~~~~i~~~~~~ 372 (387)
++.+.+....++
T Consensus 237 ~~~~~~~~~~~~ 248 (290)
T cd05045 237 RLFNLLKTGYRM 248 (290)
T ss_pred HHHHHHhCCCCC
Confidence 777776554433
No 191
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=9.6e-34 Score=259.26 Aligned_cols=211 Identities=33% Similarity=0.515 Sum_probs=172.4
Q ss_pred CcccceeecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||.|+||.++. ++ ..+++|.++.. ......+.+.+|+.++.++ +||||+++++++...+.+++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 466777899999998763 23 35788887632 2334456788999999999 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
++||+++++|.+++.+.. .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999997542 3778899999999999999999998 999999999999999999
Q ss_pred EEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
+||+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+...+..++..+.
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999998642211 11111223557999999998889999999999999999997 999999888777777776554
Q ss_pred CCC
Q 016544 371 RPP 373 (387)
Q Consensus 371 ~~~ 373 (387)
+++
T Consensus 236 ~~~ 238 (297)
T cd05089 236 RME 238 (297)
T ss_pred CCC
Confidence 433
No 192
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=3.2e-34 Score=269.02 Aligned_cols=200 Identities=26% Similarity=0.353 Sum_probs=166.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. .+..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 3678888999999998863 578999999875432 3344566778999999999999999999886543
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..+++|||+++ +|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999965 77777654 3788899999999999999999999 999999999999999999999999998764
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
... .......+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+..
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 322 2223346789999999999989999999999999999999999999876644333
No 193
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=3.1e-34 Score=256.99 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=175.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+.+.........+.+.+|+.++++++||||+++++++......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 366778899999987652 478999999987655555567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.+++|.+++....++++.++..++.|++++|.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 9999999999988778999999999999999999999998 9999999999999999999999999987654332 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 2334577889999999988889999999999999999999999998774
No 194
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=1.6e-35 Score=253.88 Aligned_cols=197 Identities=27% Similarity=0.441 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CCc
Q 016544 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~ 224 (387)
.+|.....||+|+||.||.. ...+|+|++..+.-.++-+ ....+|+.+++.++||||+.+..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 46777888999999999853 3479999998664333333 345669999999999999999999987 788
Q ss_pred eEEEEEccCCCCHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC----CCEEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVA 295 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~ 295 (387)
+++++||.+. +|+.+++- ...++...+..|++||+.|+.|||+++ |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999975 99999862 234889999999999999999999999 9999999999999987 899999
Q ss_pred eecCccccccCCCC--CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 296 DFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 296 Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
|||+++.+...-.. .....+.|+.|.|||.+.|. .|+++.|+||.|||+.||+|-++.|.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999988754222 22344568999999999886 688999999999999999999999975
No 195
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=1.6e-33 Score=252.84 Aligned_cols=207 Identities=30% Similarity=0.453 Sum_probs=175.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.+|.|+|+.++. ++..+++|.+.... ....+.+.+|+.++++++||||+++++++.....++++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 567778899999987762 46789999987542 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999999876 67999999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred CcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 310 PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.++......+...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS 219 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 12234567889999999876 7889999999999999999999999887766555555444
No 196
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=7.1e-34 Score=255.09 Aligned_cols=210 Identities=31% Similarity=0.492 Sum_probs=177.1
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+|...+.||.|+|+.++. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++......+++||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3567778999999998863 456799999875432 23568889999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++.... .+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997643 5889999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.......+++....+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 11122234567999999998889999999999999999998 9999998887778888766543
No 197
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=2.7e-33 Score=252.16 Aligned_cols=209 Identities=31% Similarity=0.528 Sum_probs=174.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 225 (387)
.+|...+.||+|+||.++. ++..|++|.+...... .......+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4678888999999998763 5789999988654322 233456788999999999999999999988753 568
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988777999999999999999999999998 99999999999999999999999999875432
Q ss_pred CC--CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 306 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.. ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||..........++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 11 11112345788999999999988999999999999999999999999876655444444
No 198
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=1.3e-33 Score=254.31 Aligned_cols=203 Identities=29% Similarity=0.576 Sum_probs=171.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||.|+||.++. ++..||+|.+...... .....+.+..|+.++++++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 366678899999998873 6789999998743321 22345788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 306 (387)
|+||+++++|.+++.+.+++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988888999999999999999999999999 99999999999998776 5999999998765432
Q ss_pred CCC---CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 307 EDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 307 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 111 1122356889999999988888999999999999999999999997655433
No 199
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1.3e-33 Score=257.26 Aligned_cols=215 Identities=25% Similarity=0.400 Sum_probs=175.8
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3577778999999998874 13479999886442 23334567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
.+++|||+++|+|.+++.... ..+...+..++.|++.||.|||+++ ++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 2455678889999999999999998 999999999999999999999
Q ss_pred EeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
+|||+++......... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.+++.+.+..+..+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987543322111 112234677999999998889999999999999999998 89999988888887777666544
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
..
T Consensus 241 ~~ 242 (288)
T cd05061 241 DQ 242 (288)
T ss_pred CC
Confidence 43
No 200
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=1.3e-33 Score=258.11 Aligned_cols=206 Identities=28% Similarity=0.475 Sum_probs=171.0
Q ss_pred CcccceeecccEEEEEEEc-------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeee
Q 016544 156 DFTNSVEITKGTFILAFWR-------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~-------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~ 216 (387)
+|...+.||+|+||.|+.. ...||+|.++... .......+.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 5667788999999988731 2358999987542 344566789999999999999999999
Q ss_pred eEEeeCCceEEEEEccCCCCHHHHHHHcC------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 016544 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (387)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Ni 284 (387)
+++......++||||+.+++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532 3677888999999999999999999 99999999999
Q ss_pred EeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCc
Q 016544 285 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNE 361 (387)
Q Consensus 285 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~~~ 361 (387)
+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875432211 11122234678999999998889999999999999999987 788999877766
Q ss_pred HHHHH
Q 016544 362 VPKAY 366 (387)
Q Consensus 362 ~~~~i 366 (387)
+...+
T Consensus 241 ~~~~~ 245 (295)
T cd05097 241 VIENT 245 (295)
T ss_pred HHHHH
Confidence 66554
No 201
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.2e-33 Score=258.34 Aligned_cols=213 Identities=24% Similarity=0.469 Sum_probs=178.1
Q ss_pred cccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
....|+..+.||.|+|+.++ .+|+.|++|.+..... ...+.+.+|+.+++.++||||+++++++.....+++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 33467888899999998876 3678999998864422 234668889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+||+.+++|.+++... .+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999999988764 5899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.++......+.....+.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc
Confidence 2 1222357789999999998889999999999999999999999998877655555554444333
No 202
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=1.4e-33 Score=252.49 Aligned_cols=205 Identities=35% Similarity=0.617 Sum_probs=176.3
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+|...+.||.|+||.|+ ..|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++......+++|||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 55667789999998876 4789999999975422 4567889999999999999999999999889999999999
Q ss_pred CCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 233 ~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998765 5899999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
....+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..++...+..+.+
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 217 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 2234567999999998889999999999999999997 9999998877777776655443
No 203
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=1.3e-33 Score=256.05 Aligned_cols=213 Identities=24% Similarity=0.481 Sum_probs=175.0
Q ss_pred CcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|...+.||.|+||.+|. +|. .||+|.+.... .....+.+..|..+++.++||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 566678899999998863 343 48999987542 34455678899999999999999999999875 4578
Q ss_pred EEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++||+++|+|.+++... +.+++.++..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999764 45899999999999999999999999 99999999999999999999999999876643
Q ss_pred CCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.......+...+..+..++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 22111 112234678999999998889999999999999999998 9999988777767776666554443
No 204
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=1.7e-33 Score=254.05 Aligned_cols=213 Identities=25% Similarity=0.475 Sum_probs=176.2
Q ss_pred CcccceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||.|+||.++.. ...|++|...... .....+.+.+|+.+++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4667789999999988631 2368999886442 24456788999999999999999999998875 55789
Q ss_pred EEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999998754 4899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.........+++.|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+..+....+..+.+++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM 229 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 2222222234567999999988889999999999999999986 9999998888888888776665543
No 205
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=2.5e-33 Score=255.93 Aligned_cols=212 Identities=27% Similarity=0.411 Sum_probs=176.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 477778899999998873 5789999998643 44556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|..++.+ ...+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 9999999988765 455899999999999999999999998 999999999999999999999999987653322 11
Q ss_pred CcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...+..+...++.....|.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC
Confidence 122345678899999985 34567899999999999999999999988776666666654444433
No 206
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-34 Score=241.46 Aligned_cols=201 Identities=24% Similarity=0.408 Sum_probs=168.7
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC----
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---- 222 (387)
..+..|++.+.+|.|||..|+. ++..+|+|++.-. ..+..+...+|++..++++||||++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 3455799999999999987763 6789999998744 345667788999999999999999999877544
Q ss_pred -CceEEEEEccCCCCHHHHHHHc---C-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 223 -SPMMIVTEYLPKGDLRAFLKRK---G-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 223 -~~~~lv~e~~~~~sL~~~l~~~---~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
...|++++|...|||.+.+.+. + .+++.+.+.|+.++++||.+||+..| ++.||||||.|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEec
Confidence 3499999999999999999752 3 49999999999999999999999985 6999999999999999999999999
Q ss_pred cCccccccCCC--------CCcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 298 GVSKLLTVKED--------RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 298 g~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
|++........ +.+....+|..|.|||.+. +...+.++|||||||++|+|+.|..||..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 99865432211 1123456899999999985 44678899999999999999999999963
No 207
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=1.5e-33 Score=254.29 Aligned_cols=210 Identities=31% Similarity=0.527 Sum_probs=174.8
Q ss_pred cccceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
|...+.||+|+||.++. ++ ..||+|.+.... .......+..|+.+++.++||||+++++++..+...+++
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 55677899999988763 22 369999987542 355567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+++++|.+++... +.+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999764 45899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCc-cc-C--CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 308 DRPL-TC-Q--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 308 ~~~~-~~-~--~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.... .. . ..+..|+|||.+.+..++.++|+|||||++||+++ |..||.+.+..++...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~ 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 2111 11 1 12457999999999899999999999999999986 9999998887777777755443
No 208
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=1.3e-33 Score=253.25 Aligned_cols=210 Identities=32% Similarity=0.497 Sum_probs=172.9
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|.....||.|+|+.++. .+..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 366677899999988763 335799998865432 2356788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997643 3788999999999999999999998 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
......++..|+|||...+..++.++|+||||+++|+|++ |+.||.+..+.+...++.....++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 2222345678999999998889999999999999999999 999999888777777776654443
No 209
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=1.5e-33 Score=262.27 Aligned_cols=203 Identities=31% Similarity=0.508 Sum_probs=166.8
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC-C
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~ 223 (387)
+|...+.||.|+||.||.. ++.||+|++.... .....+.+..|+.+++++ +||||+++++++... .
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4677789999999998742 3689999987542 233456678899999999 799999999988654 5
Q ss_pred ceEEEEEccCCCCHHHHHHHc-----------------------------------------------------------
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 244 (387)
.++++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCccc
Q 016544 245 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYV 321 (387)
Q Consensus 245 --~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~ 321 (387)
.++++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788889999999999999999998 99999999999999999999999999976532221 1112234567899
Q ss_pred ccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHH
Q 016544 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (387)
Q Consensus 322 aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 363 (387)
|||++.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~ 285 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH
Confidence 9999999999999999999999999997 99999876554443
No 210
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.4e-33 Score=255.09 Aligned_cols=212 Identities=30% Similarity=0.457 Sum_probs=179.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..+..+++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 456667899999988763 57899999987542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++... ++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 99999999999875 6899999999999999999999998 99999999999999999999999999877654321 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....+++.|+|||.+.+..++.++|+||||+++|+|+||+.||...++......+.....|.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 218 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL 218 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC
Confidence 2234567889999999998899999999999999999999999988776666666655544443
No 211
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=7.7e-34 Score=260.61 Aligned_cols=207 Identities=32% Similarity=0.537 Sum_probs=170.4
Q ss_pred CcccceeecccEEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. ++. .+++|.+... ........+.+|+.++.++ +||||+++++++..++.+++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 456677899999998763 333 4677776532 2344567788999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
+|||+++++|.+++.+.+ .+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 3678899999999999999999998 999999999999999999
Q ss_pred EEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|+| |..||.+.+..+..+.+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999986432111 1111223567999999988888999999999999999998 99999988777777766444
No 212
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=2.6e-33 Score=254.09 Aligned_cols=213 Identities=25% Similarity=0.468 Sum_probs=173.3
Q ss_pred CcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|...+.||.|+|+.+|. ++. .+++|.+... .......++..|+..+.++.||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 456667899999998863 343 5888887533 223445677888889999999999999998764 5578
Q ss_pred EEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999764 45899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
... .......++..|+|||.+.+..++.++|+|||||++||+++ |..||.+.....+.+.+..+.+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 221 11223446678999999998889999999999999999998 9999998877766666665555443
No 213
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1e-33 Score=259.12 Aligned_cols=212 Identities=24% Similarity=0.454 Sum_probs=176.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|+..+.||.|+||.++. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 4678888999999988762 688999999865432 23466788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+. .+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 96 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 170 (297)
T cd06656 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (297)
T ss_pred cccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-c
Confidence 999999999998754 4788999999999999999999998 9999999999999999999999999987643322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||.+.+..++.++|+|||||++|++++|..||.+.++......+...+.|+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 235 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCC
Confidence 12234578889999999998899999999999999999999999987665544444444444443
No 214
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=2.4e-33 Score=252.26 Aligned_cols=214 Identities=29% Similarity=0.476 Sum_probs=180.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+||.++. ++..+++|.+...... ...+.+.+|+.+++.++|+||+++++.+......++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 567788899999987762 5678999998754332 255778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
++++++|.+++... +.+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999764 34899999999999999999999999 9999999999999999999999999987655432
Q ss_pred CC---CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.. ......++..|+|||++... .++.++|+|||||++|+|++|+.||...+......++.....+.+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSL 227 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCc
Confidence 22 12233578899999998876 788999999999999999999999998887777777665554444
No 215
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=1.8e-33 Score=252.43 Aligned_cols=202 Identities=28% Similarity=0.431 Sum_probs=168.7
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-HcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
+.||.|+||.++. +|+.||+|.+.............+..|..++ ....|||++++++++.....+++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 3588999988763 5789999998754332233333445555544 445899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 999999998888999999999999999999999998 99999999999999999999999998875432 1223
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.+++.|++||.+.+..++.++|+||||+++|+|++|..||...+...+...+..+.
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 46788999999988888999999999999999999999999888777777765544
No 216
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=1.2e-33 Score=256.31 Aligned_cols=213 Identities=26% Similarity=0.392 Sum_probs=178.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+... .....+.+..|+.++++++||||+++++.+......++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 467778899999987753 4789999998633 44556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999999998764 45899999999999999999999999 9999999999999999999999999876543221 1
Q ss_pred CcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+..+...++.....|.+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 222345788999999975 335677999999999999999999999988877777777666555443
No 217
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=2.1e-33 Score=253.55 Aligned_cols=214 Identities=26% Similarity=0.430 Sum_probs=174.7
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc----
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---- 224 (387)
|...+.||+|+||.|+. .+..||+|.+..... .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 34567899999998863 136799999875432 34456778999999999999999999998865543
Q ss_pred --eEEEEEccCCCCHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 225 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 225 --~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence 79999999999999998542 24788899999999999999999998 99999999999999999999999
Q ss_pred ecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 297 FGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 297 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+..+.++.+.+..+..+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99987654332211 112234668999999988889999999999999999999 9999998888888887766654443
No 218
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=1.5e-33 Score=252.28 Aligned_cols=203 Identities=32% Similarity=0.573 Sum_probs=170.3
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe-eCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~ 231 (387)
+|...+.||+|+|+.++ ..|..||+|.+... ...+.+.+|+.++++++|++++++++++. .....++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46667789999998765 57889999988643 22456889999999999999999999764 45678999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+.. .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999998644 3788999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+..|+|||++.+..++.++|+|||||++|+|++ |+.||......++...+..+.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~ 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 12234567999999998889999999999999999997 999999877777777765543
No 219
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=2.1e-33 Score=252.02 Aligned_cols=207 Identities=29% Similarity=0.479 Sum_probs=173.8
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+|+.++. .+..+++|.+... ....+.+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 567778999999998873 4567999988643 2345678899999999999999999999887 778999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999763 34778889999999999999999998 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
......++..|+|||.+.+..++.++|+|||||++|++++ |+.||.+.+...+...+..+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 220 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 2223345677999999998889999999999999999998 999999888777777765543
No 220
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=1.4e-33 Score=273.81 Aligned_cols=202 Identities=20% Similarity=0.270 Sum_probs=164.7
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC------CcceeeeeEEee
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH------PNVVQFLGAVTQ 221 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~~ 221 (387)
...+|...+.||+|+||.|+. .+..||||++... ......+..|+.+++.+.| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 345688889999999999874 4788999998642 1223445567777776654 458889998876
Q ss_pred C-CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCC---------
Q 016544 222 S-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG--------- 290 (387)
Q Consensus 222 ~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~--------- 290 (387)
+ ..+++|||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 5 4688999988 77999999888889999999999999999999998 47 99999999999998765
Q ss_pred -------CEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 291 -------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 291 -------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 49999999875422 2223456899999999999999999999999999999999999999987766555
Q ss_pred HHH
Q 016544 364 KAY 366 (387)
Q Consensus 364 ~~i 366 (387)
..+
T Consensus 355 ~~i 357 (467)
T PTZ00284 355 HLM 357 (467)
T ss_pred HHH
Confidence 544
No 221
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1.8e-33 Score=282.99 Aligned_cols=203 Identities=22% Similarity=0.397 Sum_probs=166.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l 227 (387)
.+|.+.+.||.|+||.|+. .+..||+|.+..... .......+..|+.++++++||||++++++|... ..+|+
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 3688889999999998873 567899999875543 334456788999999999999999999988653 56899
Q ss_pred EEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCCEEeCC-----------
Q 016544 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDD----------- 288 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~iiH~Dlkp~Nill~~----------- 288 (387)
||||+++++|.+++.. .+.+++..++.|+.||+.||.|||+.++ .+|+|+||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999875 2468999999999999999999998541 23999999999999964
Q ss_pred ------CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 289 ------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 289 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
.+.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|+||..||...+..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 234899999998765422 12233468999999999865 35789999999999999999999999865543
No 222
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=2.5e-33 Score=252.57 Aligned_cols=213 Identities=31% Similarity=0.523 Sum_probs=177.6
Q ss_pred CcccceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||+|+||.+|. ++ ..+++|.+.... .....+.+..|+.++++++||||+++.+++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 566678899999988762 22 379999986542 23445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++... +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 56899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcc--cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 307 EDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
...... ....++.|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..++...+....+++
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence 221111 1223457999999998889999999999999999997 999998888888888887655443
No 223
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-34 Score=272.04 Aligned_cols=206 Identities=28% Similarity=0.462 Sum_probs=170.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------ce
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------PM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~~ 225 (387)
|...+.||+|+||.|+. +|..||||.+++.. .....+..-+|++++++++|||||+++++-+... ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 33456799999998873 68999999998754 3455677889999999999999999998765443 46
Q ss_pred EEEEEccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC--CCCC--EEEEeec
Q 016544 226 MIVTEYLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGN--LKVADFG 298 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~--~kl~Dfg 298 (387)
.++||||.||||...+.+. ..+++.+.+.++.+++.||.|||+++ |+||||||.||++- .+|. -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999753 34999999999999999999999999 99999999999975 3333 6999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC----CCcHHHHHHcc
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKH----DNEVPKAYAAR 369 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~----~~~~~~~i~~~ 369 (387)
.|+.... .....+..||..|++||.+.. ..|+..+|.|||||++|++.||..||.... ..++...+...
T Consensus 170 ~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 170 AARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred ccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 9987653 346677889999999999984 788999999999999999999999996422 33355555433
No 224
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=2.2e-33 Score=252.07 Aligned_cols=201 Identities=27% Similarity=0.435 Sum_probs=172.5
Q ss_pred ecccEEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+|+.++ . ++..||+|.+...........+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 5777777654 3 3789999999766554455567899999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 317 (387)
.+++.+...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 999988777899999999999999999999998 9999999999999999999999999987654332 12223568
Q ss_pred CcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--CCcHHHHHHc
Q 016544 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH--DNEVPKAYAA 368 (387)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~--~~~~~~~i~~ 368 (387)
+.|++||.+.+..++.++|+||||+++|+|++|..||.... ...+..++..
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 208 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc
Confidence 88999999988889999999999999999999999998766 4555666653
No 225
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=2e-33 Score=251.39 Aligned_cols=214 Identities=24% Similarity=0.439 Sum_probs=181.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+||.++. +|..||+|.+...... .....++.+|+.++++++||||+++++++...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 366778999999987764 6789999998754332 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+.+++|.+++.... .+++.++..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999999997643 4788999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||++.+..++.++|+|||||++|+|++|+.||......+...++..+..++.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV 221 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC
Confidence 111223467889999999998899999999999999999999999988777777777777665544
No 226
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=3e-33 Score=253.61 Aligned_cols=191 Identities=25% Similarity=0.417 Sum_probs=158.0
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHc---CCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK---IRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||+|+||.||. ++..+|+|.+.+...........+.+|..+++. ..||+|+.+++.+...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 78999998873 578999999876544333222333445444433 4799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 999999988888999999999999999999999999 9999999999999999999999999986543221 1224
Q ss_pred CCCCccccccccc-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 315 DTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 315 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.+++.|+|||.+. +..++.++|+|||||++|+|++|+.||.....
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 5789999999986 45688999999999999999999999976543
No 227
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=2.5e-33 Score=253.51 Aligned_cols=210 Identities=30% Similarity=0.485 Sum_probs=177.1
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.++. ....|++|.+... ......+.+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 566778899999998863 2457999988643 2334567789999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 226 MIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
+++|||+++++|.+++.... .+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999998655 6899999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
||++...............++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.....+...+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 99986543222222233345677999999988888999999999999999998 899999887777777775444
No 228
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=2.4e-33 Score=255.73 Aligned_cols=200 Identities=25% Similarity=0.413 Sum_probs=168.2
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 226 (387)
|+..+.||.|+||.++. +|..||+|.+...... .....+.+..|+.+++++ +|++|+++++++..+..++
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56677899999997762 6789999998754321 223346678899999999 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|+||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999988888999999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 22222334578899999998753 467889999999999999999999975433
No 229
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=5.1e-33 Score=250.25 Aligned_cols=215 Identities=26% Similarity=0.462 Sum_probs=177.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +|..||+|.++..........+.+.+|+.++++++|++|+++++++...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 567778899999987762 588999999875444445556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999864 234788999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~ 374 (387)
.. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... .++.+.+..+..++.
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL 228 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC
Confidence 21 12223567889999999998899999999999999999999999965432 234444444444443
No 230
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=2.1e-33 Score=255.84 Aligned_cols=212 Identities=31% Similarity=0.490 Sum_probs=176.3
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.++. .+..||+|.+.... .......+.+|+.+++++.||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 566778899999988764 45789999987542 344456788999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~N 283 (387)
++++||+.+++|.+++.... .+++.+++.++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999997432 2677888999999999999999998 9999999999
Q ss_pred EEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 016544 284 ILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 361 (387)
Q Consensus 284 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~ 361 (387)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 11112234667999999998899999999999999999997 999999888888
Q ss_pred HHHHHHccCCC
Q 016544 362 VPKAYAARQRP 372 (387)
Q Consensus 362 ~~~~i~~~~~~ 372 (387)
+...+..+..+
T Consensus 241 ~~~~~~~~~~~ 251 (288)
T cd05050 241 VIYYVRDGNVL 251 (288)
T ss_pred HHHHHhcCCCC
Confidence 88877665543
No 231
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=1.8e-33 Score=256.06 Aligned_cols=203 Identities=27% Similarity=0.474 Sum_probs=169.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+||.++. .|..||+|.+.... .......+.+|+.++++++||||+++++.+...+.+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 456677899999988753 57899999886432 34445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999998763 3589999999999999999999974 6 999999999999999999999999998654322
Q ss_pred CCCCcccCCCCCcccccccccCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 219 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH
Confidence 122234678899999986543 478999999999999999999999876655554443
No 232
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=3.4e-33 Score=250.05 Aligned_cols=213 Identities=27% Similarity=0.404 Sum_probs=176.1
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~ 229 (387)
+|...+.||.|+++.++ .+++.||+|.+..... .....+.+.+|+.++++++|||++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 36677889999998776 2567899999865433 23445678889999999999999999998764 44689999
Q ss_pred EccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 230 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||+++++|.+++... ..+++.++..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999763 34899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..+..|+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP 221 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 22233457889999999999889999999999999999999999998777666666665555444
No 233
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=4.4e-33 Score=253.08 Aligned_cols=195 Identities=28% Similarity=0.507 Sum_probs=163.2
Q ss_pred cccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cce
Q 016544 157 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 225 (387)
|...+.||+|+||.|+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 36677899999998842 46789999987542 233456788899999999999999999988653 358
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++|||+.+++|.+++... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999999764 4899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 306 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
.... ......++..|+|||.+.+..++.++||||||+++|+|+||..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 2211 112233466799999999888999999999999999999999998653
No 234
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=2.4e-33 Score=253.17 Aligned_cols=212 Identities=27% Similarity=0.444 Sum_probs=171.8
Q ss_pred ccceeecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------Cc
Q 016544 158 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~ 224 (387)
...+.||+|+||.|+. .+ ..+|+|.+.... ......+.+..|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456899999998873 22 269999887543 2445567889999999999999999999977432 24
Q ss_pred eEEEEEccCCCCHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 225 MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
.+++|||+++++|.+++... ..+++.....++.|++.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 78999999999999988421 23788999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 299 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
++......... .......++.|++||.+.+..+++++|+|||||++|+|++ |+.||.+....++...+..+.+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 98765432211 1122235678999999999899999999999999999999 899999888777888777665443
No 235
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=5.2e-33 Score=257.87 Aligned_cols=205 Identities=18% Similarity=0.341 Sum_probs=165.2
Q ss_pred eeeccc--EEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 161 VEITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 161 ~~lg~G--~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
..||+| +|+.|+ .+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 468888 555554 3678999999875533 23455678889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC--
Q 016544 234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (387)
Q Consensus 234 ~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 309 (387)
+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999753 34889999999999999999999999 999999999999999999999999865432211110
Q ss_pred ----CcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 310 ----PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 310 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..............+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 225 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC
Confidence 0112245677999999976 46889999999999999999999999877665554444333
No 236
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-35 Score=271.85 Aligned_cols=214 Identities=25% Similarity=0.394 Sum_probs=185.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.+..+||.|.||.||. .+...|.|++. ..+++..+.|.-|+.||....||+||++++.|..++.++++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45566899999999984 23456667764 35678889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|.||....++-+- ..+++.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+.... .....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 9999999888764 45999999999999999999999999 9999999999999999999999999875422 22333
Q ss_pred cccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 377 (387)
...+.|||.|||||+.. ..+|+.++||||||+++.||..+.+|....++..++-+|..-..|.+--|
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence 45678999999999874 45889999999999999999999999999999999999988877777554
No 237
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=3.7e-33 Score=249.71 Aligned_cols=212 Identities=34% Similarity=0.589 Sum_probs=178.4
Q ss_pred ccceeecccEEEEEEE---c------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 158 TNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~---~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
+..+.||.|+||.++. . +..||+|.+.... .....+.+..|+.+++.++|+||+++++++...+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3456799999987752 2 3789999997543 223567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|||+++++|.+++..... +++.++..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999986544 899999999999999999999998 999999999999999999999999998765543
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.........+++.|+|||.+.+..++.++|+||||+++|+|++ |++||...+...+.+.+.....++.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK 225 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 2222212336788999999988889999999999999999998 8999998887778888776665443
No 238
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.2e-34 Score=266.17 Aligned_cols=210 Identities=25% Similarity=0.400 Sum_probs=181.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||-|.||.|.. +...+|+|.+.+...-....+...+.|..||.....+.||+||..|++.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 66677899999998753 3467999998876655566677788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc-------
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT------- 304 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~------- 304 (387)
++||++-.+|-+.+-+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||.|||++.-+.
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999999999999999999999999999999999 9999999999999999999999999874221
Q ss_pred --cCCC----CC----------------------------cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcC
Q 016544 305 --VKED----RP----------------------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350 (387)
Q Consensus 305 --~~~~----~~----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg 350 (387)
.++. .. ....+||+.|+|||++....++..+|+||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 1100 00 0125699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcHHHHHHcc
Q 016544 351 CPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~ 369 (387)
++||...++.+...+|.+=
T Consensus 868 ~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINW 886 (1034)
T ss_pred CCCccCCCCCcceeeeeeh
Confidence 9999998888877766443
No 239
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=3.6e-33 Score=252.87 Aligned_cols=210 Identities=29% Similarity=0.480 Sum_probs=176.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|+..+.||.|+||.++. ++..||+|.+.... .......+.+|+.+++++.||||+++++++.++...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 355667899999988763 57899999987542 23445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.. +++++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 9999999999875 46889999999999999999999998 99999999999999999999999999876543221 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||...++......+.....|
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP 219 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC
Confidence 22335678899999999888999999999999999999999999987776666655444333
No 240
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=4.1e-33 Score=255.68 Aligned_cols=206 Identities=28% Similarity=0.459 Sum_probs=171.5
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||.|+||.|+. .+..||+|.++... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 577778999999998753 23579999987542 234456789999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+++|||+.+++|.+++.+... +++.+...++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999976432 889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHH
Q 016544 303 LTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 303 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i 366 (387)
....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+........+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 5432211 1112345678999999999889999999999999999998 99999876655444333
No 241
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=6e-33 Score=249.37 Aligned_cols=215 Identities=26% Similarity=0.479 Sum_probs=177.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..|++|.+...... ....+.+..|+.+++.++|+||+++++.+.....+++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 366778899999987753 5789999998765433 4567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999988777889999999999999999999999 9999999999999999999999999987654332221
Q ss_pred c---ccCCCCCcccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHccCCCCC
Q 016544 311 L---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~---~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~ 374 (387)
. ....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...... .....+.....+.+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 1 1245678999999998766 788999999999999999999999866433 33333444334444
No 242
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=2.9e-33 Score=250.19 Aligned_cols=204 Identities=32% Similarity=0.580 Sum_probs=172.0
Q ss_pred CcccceeecccEEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+|+..+.||+|+||.++. .+..||+|.+.... ..+.+.+|+.++++++||||+++++++..+ ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 467778999999988764 77899999986432 235788899999999999999999998764 479999999
Q ss_pred CCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 233 ~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999997653 3788899999999999999999998 999999999999999999999999998654321
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+..+.++
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 216 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC
Confidence 112234567999999998889999999999999999997 99999988877777777665443
No 243
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.9e-33 Score=260.37 Aligned_cols=221 Identities=30% Similarity=0.521 Sum_probs=180.0
Q ss_pred CccccCccccCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcc
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 212 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 212 (387)
+.|++.. .+|+..+.||+|+||.++.. +..||+|.+... ......+.+.+|+.+++++ +||||
T Consensus 5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 4455543 35778889999999887621 236899988743 2344567788999999999 79999
Q ss_pred eeeeeEEeeCCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 016544 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (387)
Q Consensus 213 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 276 (387)
+++++++...+.+++++||+.+++|.+++.+.. .+++.++..++.|++.||.|||+++ ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999999999999999999999997532 3677888999999999999999999 999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf 354 (387)
|||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999998765432111 1122234567999999999899999999999999999998 99999
Q ss_pred CCCCCCcHHHHHHccCCCC
Q 016544 355 TMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~ 373 (387)
.+.+..++...+.....++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~ 256 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMD 256 (334)
T ss_pred CCCCHHHHHHHHHcCCCCC
Confidence 9888788877776655443
No 244
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=9.1e-34 Score=254.05 Aligned_cols=196 Identities=32% Similarity=0.593 Sum_probs=169.5
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||+|+||.|+. ++..||+|.+...... .........|+.++++++||||+++++++......+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 45678899999999874 5678999999865332 22223345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+.+++|.+++.....++..++..++.|+++||.+||+++ ++|+||||+||+++.++.++|+|||.+.... ......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999997788999999999999999999999999 9999999999999999999999999987542 122333
Q ss_pred ccCCCCCccccccccc-CCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 312 TCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
....++..|+|||++. +..++.++|+||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4456788999999998 788899999999999999999999999987
No 245
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=2e-33 Score=256.62 Aligned_cols=214 Identities=29% Similarity=0.497 Sum_probs=176.6
Q ss_pred cCcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCC
Q 016544 155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 223 (387)
.+|...+.||+|+||.|+.. ...+|+|.+.... .......+.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 35667788999999887632 2579999987542 234456788999999999 7999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 287 (387)
.++++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ |+|+||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999999642 34788899999999999999999998 99999999999999
Q ss_pred CCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHH
Q 016544 288 DSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 365 (387)
Q Consensus 288 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~ 365 (387)
.++.++|+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....++.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999987654322111 122234577999999998889999999999999999997 9999998877777777
Q ss_pred HHccCCCC
Q 016544 366 YAARQRPP 373 (387)
Q Consensus 366 i~~~~~~~ 373 (387)
+..+..+.
T Consensus 247 ~~~~~~~~ 254 (293)
T cd05053 247 LKEGYRME 254 (293)
T ss_pred HHcCCcCC
Confidence 76555443
No 246
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=4.4e-33 Score=252.66 Aligned_cols=215 Identities=27% Similarity=0.411 Sum_probs=176.9
Q ss_pred ccCcccceeecccEEEEEEE----c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CC
Q 016544 154 ELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~----~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~ 223 (387)
..+|...+.||+|+||.|+. . +..|++|.+... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34677778999999998762 2 578999988643 345556778899999999999999999998765 46
Q ss_pred ceEEEEEccCCCCHHHHHHHc--------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
..++++||+.+++|.+++... ..+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999753 34889999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 296 DFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|++++ |+.||...+..++...+..+.++.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 999987553322111 112234667999999998889999999999999999998 999999887777777666554433
No 247
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=2.3e-33 Score=255.54 Aligned_cols=205 Identities=30% Similarity=0.486 Sum_probs=164.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEeeC-----
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQS----- 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~----- 222 (387)
+|...+.||+|+||.|+. +|+.||+|.+........ ....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 366778999999998863 578999999875432221 122345566666655 799999999988643
Q ss_pred CceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
..++++||++. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 35899999997 4899888764 34899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
...... .......++..|+|||++.+..++.++|||||||++|+|++|++||.+........++.
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence 765432 12223457889999999998899999999999999999999999998876665555543
No 248
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=1.4e-33 Score=263.42 Aligned_cols=202 Identities=28% Similarity=0.429 Sum_probs=167.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------C
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 223 (387)
..|+..+.||.|+||.|+. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 3677888999999998863 567899999875432 223345677899999999999999999987543 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999988 7799888764 45899999999999999999999999 999999999999999999999999998764
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 322 233457899999999877 46889999999999999999999999876655555544
No 249
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6e-34 Score=266.97 Aligned_cols=213 Identities=28% Similarity=0.504 Sum_probs=183.0
Q ss_pred CcccceeecccEEEEEE---Ec---C--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAF---WR---G--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~---g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+.+..++||.|.||+|. |+ | ..||||.++..... ....+|.+|+.+|.+++|||+++|||+..+ ..+.+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 44556789999999886 42 2 57999999876543 267889999999999999999999999987 77899
Q ss_pred EEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|||+++.|||.+.+.+ +..+.......++.||+.||.||.+++ +|||||-.+|+|+-....+||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999987 344888899999999999999999999 99999999999999988999999999988765
Q ss_pred CCCCCc--ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.++... ....-.+.|+|||.+...+|+.++|+|+|||++|||+| |+.||.|.+...|+++|..+.|-+-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR 336 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence 544321 12234678999999999999999999999999999997 9999999999999999986665444
No 250
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=6.4e-33 Score=248.16 Aligned_cols=209 Identities=31% Similarity=0.568 Sum_probs=175.5
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+||.++. .+..+|+|.+...... ...+..|+++++++.||+|+++++++......++++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 455667899999988763 4788999998755432 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..+..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999764 45889999999999999999999998 9999999999999999999999999987553322211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......++.+.+..+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 219 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR 219 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC
Confidence 222234578999999998889999999999999999998 9999998777777777765543
No 251
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-34 Score=269.09 Aligned_cols=210 Identities=33% Similarity=0.559 Sum_probs=172.3
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
...||+|+||+||. +...+|||.+.... ....+-+..|+.+-++++|.|||+++|.+..++.+-|.||-++|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 34689999999985 34689999987543 33456688899999999999999999999999999999999999
Q ss_pred CCHHHHHHH-cCCC--ChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeecCccccccCCCCC
Q 016544 235 GDLRAFLKR-KGAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 235 ~sL~~~l~~-~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|||.+++.. .+++ .+.+...+.+||++||.|||++. |||||||-+|+|++ ..|.+||+|||.++....- .-.
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 999999975 4677 67788889999999999999999 99999999999998 5688999999998876532 223
Q ss_pred cccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH-H-HccCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA-Y-AARQRPPFKA 376 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~-i-~~~~~~~~~~ 376 (387)
...+.||..|||||++..+ .|++++|||||||++.||.||++||........... + .-...|++++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE 802 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH
Confidence 3456799999999999775 688999999999999999999999986554443222 1 1122676643
No 252
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=8.9e-33 Score=249.21 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=162.6
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||+|+||.||. .+..+|+|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 589999988763 235799998875432 23345688899999999999999999999998999999999999
Q ss_pred CCHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 235 ~sL~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
++|.+++.... ..++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997532 2456777889999999999999998 999999999999999999999999998653322111
Q ss_pred -CcccCCCCCcccccccccCC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 310 -PLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 310 -~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||....+.+........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc
Confidence 11223467789999998642 35789999999999999996 99999887766655444333
No 253
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=3.2e-33 Score=250.24 Aligned_cols=201 Identities=31% Similarity=0.525 Sum_probs=171.1
Q ss_pred eecccEEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||+|++|.++. .+ ..||+|.+...... ...+.+..|+.++++++||||+++++.+.. ...++++||++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 578999987762 12 36999999876443 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC--
Q 016544 234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (387)
Q Consensus 234 ~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 309 (387)
+++|.+++.+.. .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999998754 5889999999999999999999998 999999999999999999999999998766432211
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~ 368 (387)
......++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+..++.+.+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 1112345778999999998889999999999999999998 9999988887777777654
No 254
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=5.4e-33 Score=254.18 Aligned_cols=206 Identities=28% Similarity=0.461 Sum_probs=170.7
Q ss_pred CcccceeecccEEEEEEEc---------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCccee
Q 016544 156 DFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~---------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (387)
+|+..+.||.|+||.|+.. +..||+|.+.... .....+.+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4777788999999988742 3469999987542 3445577899999999999999999
Q ss_pred eeeEEeeCCceEEEEEccCCCCHHHHHHHcC-----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 016544 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (387)
Q Consensus 215 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~N 283 (387)
+++++...+..+++|||+++++|.+++.... .+++.++..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999997642 2566789999999999999999999 9999999999
Q ss_pred EEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 016544 284 ILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDN 360 (387)
Q Consensus 284 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~~ 360 (387)
|+++.++.++|+|||++.......... ......++.|++||...+..++.++|+|||||++|||++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987553322111 111233578999999888889999999999999999998 88999887766
Q ss_pred cHHHHH
Q 016544 361 EVPKAY 366 (387)
Q Consensus 361 ~~~~~i 366 (387)
++....
T Consensus 241 ~~~~~~ 246 (296)
T cd05095 241 QVIENT 246 (296)
T ss_pred HHHHHH
Confidence 665543
No 255
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=4.2e-33 Score=257.39 Aligned_cols=190 Identities=26% Similarity=0.466 Sum_probs=154.6
Q ss_pred ceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEEEE
Q 016544 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e 230 (387)
...||+|+||.|+. .+..||+|.+..... ...+.+|+.++++++||||+++++++.. +..++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 35799999998873 346899999875432 2346779999999999999999998864 456899999
Q ss_pred ccCCCCHHHHHHHc---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----CCCCCEEEEee
Q 016544 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Df 297 (387)
|+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +..+.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 995 5898887532 24788899999999999999999999 9999999999999 45678999999
Q ss_pred cCccccccCCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
|+++....... .......+|+.|+|||++.+. .++.++|+|||||++|+|++|++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99976543211 122345678999999999774 57899999999999999999999997543
No 256
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=3.7e-33 Score=255.91 Aligned_cols=204 Identities=25% Similarity=0.481 Sum_probs=168.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.||. ++..||+|.+...... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 577788999999998873 4788999998654322 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 996 5999888764 45889999999999999999999999 9999999999999999999999999987543222 1
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......+++.|+|||.+.+. .++.++|||||||++|+|++|++||...+..+....+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22233467899999998764 5788999999999999999999999887665544444
No 257
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=5.3e-33 Score=263.19 Aligned_cols=209 Identities=30% Similarity=0.460 Sum_probs=169.4
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~ 224 (387)
++...+.||.|+||.|+. .+..||+|++.... .....+.+..|+.++.++. ||||+++++++...+.
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 455677899999998873 23589999997543 2334457889999999997 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-----------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------- 245 (387)
.++||||+.+|+|.+++.+..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996532
Q ss_pred ---------------------------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 016544 246 ---------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (387)
Q Consensus 246 ---------------------------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill 286 (387)
.+++.....++.|++.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 2456677889999999999999998 9999999999999
Q ss_pred CCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHH
Q 016544 287 DDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (387)
Q Consensus 287 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~ 364 (387)
+.++.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999876432211 11112345778999999998889999999999999999998 999998766555544
Q ss_pred HHHcc
Q 016544 365 AYAAR 369 (387)
Q Consensus 365 ~i~~~ 369 (387)
.....
T Consensus 353 ~~~~~ 357 (401)
T cd05107 353 NAIKR 357 (401)
T ss_pred HHHHc
Confidence 44333
No 258
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=6e-33 Score=250.64 Aligned_cols=205 Identities=31% Similarity=0.496 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
+|...+.||.|+|+.+|. +|..||+|.+...... .....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466777899999998873 5789999987642211 1123456888999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+++||||+.+++|.+++.+.+.++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988888999999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCC-CCcccCCCCCcccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 304 TVKED-RPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 304 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
..... .......++..|+|||.+.+.. ++.++|+||||+++|++++|..||......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 221 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence 32211 1122235688999999987654 788999999999999999999999765544333
No 259
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=6.7e-33 Score=248.11 Aligned_cols=207 Identities=29% Similarity=0.480 Sum_probs=175.5
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
|+..+.||+|+||.++. ++..|++|.+..... ..++..+.+.+|+.+++.++||||+++++++.....+++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 55667899999988763 578999998864322 23445677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999999988877899999999999999999999998 9999999999999999999999999987654332
Q ss_pred CcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
......++..|++||.+.... ++.++|+||||+++|+|++|+.||..........++..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 223345788899999987766 88999999999999999999999987665555555443
No 260
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=6.5e-33 Score=248.01 Aligned_cols=205 Identities=28% Similarity=0.443 Sum_probs=174.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+|+.++. ++..+++|.+.... ..+.+.+|+.++++++||||+++++.+......++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 3577778899999987652 36899999986431 2578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999999976 345899999999999999999999998 99999999999999999999999999876543321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||...++......+..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~ 213 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN 213 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc
Confidence 22234467889999999998899999999999999999999999988766555544433
No 261
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=7.7e-33 Score=250.86 Aligned_cols=190 Identities=25% Similarity=0.424 Sum_probs=157.3
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH---HHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL---ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||.|+||.||. +++.||+|.+.+...........+..|. ..++...||+|+++++.+......++||||+.+
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 78999988872 5789999998765443222222233343 344455799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 999999988888999999999999999999999998 9999999999999999999999999987543221 1234
Q ss_pred CCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
.++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 578999999999754 68899999999999999999999998763
No 262
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=100.00 E-value=8.7e-34 Score=230.02 Aligned_cols=213 Identities=25% Similarity=0.424 Sum_probs=173.4
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.....+||+|+||.+. ++|+..|+|.+.... . ....+++.+|+++..+. .+|.+|.+||....++.+++.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3445689999998763 689999999998643 2 34456677788877665 79999999999999999999999
Q ss_pred ccCCCCHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
.|. .||..+.. ..+.+++...-+|+..++.||+|||++- .+||||+||+|||++..|++|+||||.+-.+..+
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 995 58877664 3455889889999999999999999974 4999999999999999999999999998766433
Q ss_pred CCCCcccCCCCCcccccccccC----CCCCCchhHHHHHHHHHHHHcCCCCCC-CCCCCcHHHHHHccCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKA 376 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~ 376 (387)
- ..+...|--.|||||.+.. ..|+-++||||||+++.||.+++.||. ..++.+.+++++....|-++.
T Consensus 203 i--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 203 I--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred h--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 2 2222346677999999854 378899999999999999999999997 477788889988777665543
No 263
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=8e-33 Score=248.39 Aligned_cols=208 Identities=31% Similarity=0.523 Sum_probs=167.1
Q ss_pred eecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe-eCCceEEEEEcc
Q 016544 162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232 (387)
Q Consensus 162 ~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~~ 232 (387)
.||+|+||.++. .+..||+|.+... ......+.+.+|..+++.++||||+++++++. .++..++++||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 579999988762 2357999988532 23445677888999999999999999999775 455689999999
Q ss_pred CCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC---
Q 016544 233 PKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--- 308 (387)
Q Consensus 233 ~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 308 (387)
.+++|.+++.+.. ..++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999997643 3677788899999999999999998 99999999999999999999999999875432111
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+..+..++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 11112335678999999988889999999999999999999 6778887777677776665554443
No 264
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=6.7e-33 Score=252.09 Aligned_cols=206 Identities=26% Similarity=0.431 Sum_probs=171.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+....||.|+|+.++. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++......+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 466677899999988763 578999998865432 12233557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|..++.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999888888777667999999999999999999999998 99999999999999999999999999876643321 2
Q ss_pred cccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 223456788999999876 45788999999999999999999999987765544443
No 265
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=1.3e-32 Score=249.53 Aligned_cols=210 Identities=28% Similarity=0.517 Sum_probs=176.0
Q ss_pred CcccceeecccEEEEEEE-----cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|...+.||.|+||.++. +| ..+|+|.+.... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 566678899999998764 22 369999887553 24556778899999999999999999999987 7899
Q ss_pred EEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999874 45899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCc-ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 306 KEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 306 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
...... ....++..|+|||.+....++.++|+||||+++|++++ |+.||.+....++.+.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Confidence 221111 11223567999999988889999999999999999998 9999999888888887776653
No 266
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=9.5e-33 Score=246.30 Aligned_cols=205 Identities=30% Similarity=0.504 Sum_probs=170.7
Q ss_pred eecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 162 ~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
.||.|+||.++. .++.|++|.+..... ......+.+|+++++++.||||+++++++......+++|||+.+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 578888877652 388999999876533 24556789999999999999999999999999999999999999999
Q ss_pred HHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc-ccCC
Q 016544 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQD 315 (387)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~ 315 (387)
.+++... ..++......++.+++.+|.|||+++ ++|+||||+||+++.++.++|+|||++........... ....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999764 45788999999999999999999999 99999999999999999999999999875432111111 1122
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.+..|+|||.+.+..++.++|+|||||++|+|+| |..||...........+....+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~ 213 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR 213 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC
Confidence 3567999999998889999999999999999998 8999998877777777655443
No 267
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1e-32 Score=246.70 Aligned_cols=213 Identities=24% Similarity=0.446 Sum_probs=179.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..+|+|.+...... ....+.+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 366778899999987762 6789999998765433 3446778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 307 (387)
|+++++|.+++... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999764 34889999999999999999999998 99999999999998554 57999999987654322
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......++.....+++
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI 221 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC
Confidence 22224578899999999988889999999999999999999999998887777777766554443
No 268
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=2.8e-33 Score=253.59 Aligned_cols=209 Identities=29% Similarity=0.488 Sum_probs=175.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+|+.+|. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 55567799999988763 46789999987442 234557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+++++|.+++.. +.+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999999998865 45889999999999999999999998 9999999999999999999999999987654321 122
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
....++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+.....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP 219 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC
Confidence 2335678899999999988999999999999999999999999877766666555444333
No 269
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.6e-34 Score=246.38 Aligned_cols=196 Identities=28% Similarity=0.473 Sum_probs=177.7
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+|..|. .+.+.+|+|+++++...+.+...-.+.|..+..+. +||.+|-+..+|+.+.++|+|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 56677889999997653 46789999999998888877777788899998887 6999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.||+|--+++++.+++++.+..+...|+-||.|||+.| ||.||||.+|+|++..|++||.|+|+.+.--. ...
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~-~gd 406 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-PGD 406 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC-CCc
Confidence 99999999999999889999999999999999999999999 99999999999999999999999999876433 334
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
..+.+.|||.|+|||++++..|..++|+|+|||+++||+.|+.||.
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 4456789999999999999999999999999999999999999996
No 270
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=5.8e-33 Score=252.45 Aligned_cols=196 Identities=26% Similarity=0.439 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||+|+||.++. +|..||+|.+.... .....+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 566778899999998863 47899999886432 23445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+.+.+++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999887789999999999999999999997 46 999999999999999999999999987654221
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
......++..|+|||.+.+..++.++|+|||||++|++++|..||.....
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 11234578899999999888899999999999999999999999987654
No 271
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-35 Score=290.83 Aligned_cols=222 Identities=25% Similarity=0.411 Sum_probs=187.2
Q ss_pred CccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
...+.+|..+..||.|.||.||- +|.-.|+|.+.-.... ......+.+|.+++..++|||+|++||+-......
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34455777888999999999984 6888999988754433 44556788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+|.||||++|+|.+.+...+..++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999999988776777777788899999999999999 99999999999999999999999999987665
Q ss_pred CCCC---CcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHccCCCCCCC
Q 016544 306 KEDR---PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKA 376 (387)
Q Consensus 306 ~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~ 376 (387)
.... ......||+.|||||++.+. ....+.|||||||++.||+||+.||...+++. |.-++..+..|.++.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch
Confidence 4311 12456799999999999875 45678999999999999999999999877654 555666777777744
No 272
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9e-34 Score=262.71 Aligned_cols=215 Identities=29% Similarity=0.524 Sum_probs=184.0
Q ss_pred ccccCccccCcccceeecccEEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
.||++..+ ++-...||-|.||.|| |. .-.||||.+++. ...+++|..|+.+|+.++|||+|+++|+|..
T Consensus 261 kWEmeRtd--ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 261 KWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred hhhccchh--eeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 56655443 3445689999998776 43 468999999865 3457889999999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
+..+|||+|||..|.|.+|+.++.. ++.-..+.++.||.+|++||..++ +|||||-.+|+|+.++..+|++|||+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999987644 666777889999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
++++....-........++.|.|||-+....++.++|||+|||+|||+.| |-.||.+.+-..++.-..++-
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY 483 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence 99887554444444445788999999999999999999999999999997 999999988877777765554
No 273
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=1.1e-32 Score=247.46 Aligned_cols=210 Identities=30% Similarity=0.455 Sum_probs=177.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. ++..|++|.+..... ......+.+|+..+.+++||||+++++++......++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 456677899999987653 488999999876532 2456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.....+++...+.++.|+++++.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999987889999999999999999999999 98 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---CCcHHHHHHccCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH---DNEVPKAYAARQR 371 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~---~~~~~~~i~~~~~ 371 (387)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+..+.+.....
T Consensus 157 ~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (264)
T cd06623 157 C-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220 (264)
T ss_pred c-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC
Confidence 1 23356788999999999889999999999999999999999998774 2334445443333
No 274
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=1.3e-32 Score=249.40 Aligned_cols=190 Identities=27% Similarity=0.439 Sum_probs=163.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+|+.++. ++..||+|.+.... .....+.+.+|+.+++++.||||+++++.+......+++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 355667899999988763 57899999986542 34455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999999754 34678889999999999999999999 999999999999999999999999998754322 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
.....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 22346788999999999988999999999999999999999999753
No 275
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=6.4e-33 Score=249.08 Aligned_cols=205 Identities=32% Similarity=0.513 Sum_probs=175.4
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+|+.++. +|..+++|.+...........+.+.+|+.++++++||||+++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 47788876652 4889999998765444445667889999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-------CC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-------RP 310 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~~ 310 (387)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999998778999999999999999999999998 99999999999999999999999999875433211 02
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....++..|++||.+.+...+.++|+||||+++|++++|..||......+....+..+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 223456788999999988888999999999999999999999999888777777776644
No 276
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=3.2e-33 Score=255.75 Aligned_cols=203 Identities=24% Similarity=0.424 Sum_probs=170.5
Q ss_pred cceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
....||.|+||.++. ++..||+|.+..... ...+.+.+|+.+++.+.||||+++++++..++..++++||++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 344689999987752 578999999864322 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
+++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 9999998765 45889999999999999999999999 9999999999999999999999999986543221 11223
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
..++..|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 232 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 232 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Confidence 45788999999999888999999999999999999999999877766666655443
No 277
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=1.7e-32 Score=249.44 Aligned_cols=209 Identities=25% Similarity=0.460 Sum_probs=175.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+...+.||.|++|.++. ++..+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 44456899999988762 5678999987532 233445688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+++++|.+++.. ..++..++..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 999999999887 56899999999999999999999999 99999999999999999999999998765432211 11
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++.....++.....+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK 234 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC
Confidence 22457889999999998889999999999999999999999998877777777766554333
No 278
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=1.3e-32 Score=250.35 Aligned_cols=215 Identities=26% Similarity=0.467 Sum_probs=180.4
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
....|.....+|.|+++.++. .+..+++|.+..... ..+.+.+|+.++++++|+||+++++.+......++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 334567777899999987763 478899999875422 45678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
++||+++++|.+++.... .++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999999999876 7999999999999999999999998 999999999999999999999999987654432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
.. ......++..|++||.+.+..++.++|+|||||++|+|++|+.||...++......+.....+...
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK 237 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 21 222334678899999999888999999999999999999999999987776666666555544443
No 279
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=1.5e-32 Score=249.75 Aligned_cols=207 Identities=30% Similarity=0.495 Sum_probs=174.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +|..||+|.+...... ......+.+|+.++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 366778899999987763 5789999998765432 2344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+ +++|.+++.. ...+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 9999999875 345899999999999999999999999 999999999999999999999999998766543332
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.+.++.....++.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 214 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH
Confidence 33445678899999998764 46889999999999999999999998776655555543
No 280
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=9e-33 Score=252.30 Aligned_cols=212 Identities=25% Similarity=0.468 Sum_probs=175.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.++. ++..|++|.+... .....+.+.+|+.+++.++||||+++++.+......++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4677778999999998763 5788999998643 2233467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+. .+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999999998764 4788999999999999999999999 99999999999999999999999998865543222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|++||.+.+..++.++|+|||||++|++++|+.||...+.......+...+.|.+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCC
Confidence 22234578889999999888899999999999999999999999987665444444433444443
No 281
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.1e-32 Score=247.88 Aligned_cols=210 Identities=30% Similarity=0.503 Sum_probs=176.7
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.||. ++..||+|.+.... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 55667899999998873 56899999886432 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999999999875 45889999999999999999999998 9999999999999999999999999987554321 112
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....|.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT 220 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC
Confidence 23356788999999988888999999999999999999999998877766666665554443
No 282
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=1.3e-32 Score=250.15 Aligned_cols=199 Identities=30% Similarity=0.513 Sum_probs=165.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. ++..||+|.+...... ......+.+|+.+++++.||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 366778899999988764 5789999998754322 2233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|++ ++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 5898888653 45889999999999999999999999 9999999999999999999999999987543321
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
.......+++.|+|||++.+. .++.++|+|||||++|+|+||++||.+.+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 222233467889999988764 5688999999999999999999999876543
No 283
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=2.4e-32 Score=246.32 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=161.6
Q ss_pred eecccEEEEEEE----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||+|+||.|+. ++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+......+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999998863 22 246677665432 234457789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-CC
Q 016544 235 GDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (387)
Q Consensus 235 ~sL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 309 (387)
++|.+++.+.. ..+......++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999997642 3566677889999999999999998 9999999999999999999999999875422111 11
Q ss_pred CcccCCCCCcccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...++.+...++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 225 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc
Confidence 1123456788999998753 245788999999999999996 688998877777776665444
No 284
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=6.6e-33 Score=249.92 Aligned_cols=206 Identities=29% Similarity=0.493 Sum_probs=169.1
Q ss_pred eecccEEEEEEEc-----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 162 ~lg~G~~~~v~~~-----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.||.|+||.||.. +..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999988731 2579999886432 22345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-----CEEEEeec
Q 016544 231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG 298 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-----~~kl~Dfg 298 (387)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999742 23778899999999999999999998 99999999999999877 89999999
Q ss_pred CccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 299 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
++......... ......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+..+.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc
Confidence 98754322111 1112234678999999999899999999999999999998 99999887777777776655533
No 285
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=1.7e-32 Score=246.27 Aligned_cols=212 Identities=24% Similarity=0.434 Sum_probs=177.2
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~ 229 (387)
|.....||.|+||.++. ++..+|+|.+..... .....+.+..|+.+++.++||||+++++.+.. ....+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 55667899999988762 578899999875433 34556778899999999999999999998764 34689999
Q ss_pred EccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHH-----hCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 230 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
||+++++|.+++.. ..++++.+++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999975 356899999999999999999999 777 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...+.+.+..+..+.
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR 229 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC
Confidence 77653322 1223457889999999999888999999999999999999999999887777777776655443
No 286
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=2.3e-32 Score=251.29 Aligned_cols=208 Identities=29% Similarity=0.470 Sum_probs=173.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||.|+||.++. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 477778899999988763 588999999875544455556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. |++.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 996 578777764 456899999999999999999999998 999999999999999999999999998654322
Q ss_pred CcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
....+++.|+|||.+. ...++.++||||||+++|+|++|..||.+.+.......+.....|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 232 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Confidence 2235678899999884 356788999999999999999999999887665555555444333
No 287
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=1.5e-32 Score=251.48 Aligned_cols=206 Identities=30% Similarity=0.488 Sum_probs=172.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
|...+.||.|+|+.++. +|+.||+|.+...... .......+..|+.++++++|+||+++++++..+..+++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 55667899999987763 5789999999765433 1233456778999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+ +++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 889999998766 7999999999999999999999999 99999999999999999999999999876543321
Q ss_pred CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.++.+...++.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~ 216 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH
Confidence 2222345778999999865 457889999999999999999999998877766555553
No 288
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=6.9e-33 Score=252.93 Aligned_cols=201 Identities=25% Similarity=0.458 Sum_probs=170.1
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
...||.|+|+.++. ++..||+|.+... .....+.+.+|+.+++.++||||+++++.+...+..+++|||+++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 45689999988762 5789999988643 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++.. +.+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... ......
T Consensus 104 ~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 178 (292)
T cd06658 104 GALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSL 178 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCcee
Confidence 999998865 45889999999999999999999998 9999999999999999999999999986543221 112234
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 232 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 578899999999988899999999999999999999999998776665555543
No 289
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-33 Score=237.47 Aligned_cols=211 Identities=28% Similarity=0.465 Sum_probs=172.0
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
......+|.|+-|.|. -.|...|||.+.+. .+.+..+++.+.+.++...+ .|+||+.+|+|..+..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3345578998887653 35799999999865 45667778888888877765 8999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
.|. ..+..++.+ .+++++..+-++..-+++||.||-++. +|+|||+||+|||+|+.|++||||||++.++-. ..
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--Sk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SK 246 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cc
Confidence 984 466777665 566888888889999999999999876 499999999999999999999999999876543 33
Q ss_pred CcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCC-CCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~ 374 (387)
..+...|-+.|||||.+.-. .|..++||||||++++||.||+.||.+. .+.+++-+|.....|.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L 315 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL 315 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC
Confidence 34445678899999999654 6888999999999999999999999984 45677888877544444
No 290
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=5.4e-32 Score=243.91 Aligned_cols=197 Identities=32% Similarity=0.570 Sum_probs=163.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.++.....||+|+||.|+. ++..|++|.+... .....+.+.+|+.++++++|+||+++++++..++.+++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444556899999998863 4578999988643 2344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCC--ChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 305 (387)
||+++++|.+++... ..+ +...+..++.|++.||.|||+.+ |+|+||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999764 445 77888899999999999999998 999999999999986 67899999999875532
Q ss_pred CCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
.. .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 162 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 IN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 21 222234578899999998664 37889999999999999999999997543
No 291
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.6e-32 Score=263.17 Aligned_cols=189 Identities=23% Similarity=0.298 Sum_probs=161.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
...|.....||+|+||.||. .+..||||.... ..+.+|+.++++++||||+++++++...+..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 34688889999999998874 467899996431 2356799999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||++. ++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99995 6888888754 45999999999999999999999999 9999999999999999999999999997654322
Q ss_pred CC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 308 DR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 308 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 21 1223468999999999999999999999999999999999876653
No 292
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.7e-32 Score=253.25 Aligned_cols=190 Identities=26% Similarity=0.468 Sum_probs=153.8
Q ss_pred ceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEEEE
Q 016544 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e 230 (387)
...||+|+||.||. .+..||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 35799999998873 336899998875422 2346789999999999999999998854 457899999
Q ss_pred ccCCCCHHHHHHHc---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----CCCCCEEEEee
Q 016544 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Df 297 (387)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 985 5888877521 23788889999999999999999999 9999999999999 45678999999
Q ss_pred cCccccccCCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
|+++....... .......+|+.|+|||++.+. .++.++|||||||++|+|+||++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99986543221 122334578899999998774 57899999999999999999999997543
No 293
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=3.4e-32 Score=253.98 Aligned_cols=212 Identities=29% Similarity=0.482 Sum_probs=168.4
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC-C
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~ 223 (387)
+|...+.||.|+||.|+. .++.||||.+.... .......+.+|+.++.++ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 577888999999998873 35789999997543 233456788899999999 689999999988654 4
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----------------------------------------------------------
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG---------------------------------------------------------- 245 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------------------- 245 (387)
.++++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999986421
Q ss_pred ---------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCC
Q 016544 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQD 315 (387)
Q Consensus 246 ---------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~ 315 (387)
.+++..+..++.|+++||+|||+++ |+||||||+||+++.++.++|+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2567788899999999999999998 999999999999999999999999998764322111 111223
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc-HHHHHHccCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE-VPKAYAARQRP 372 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~-~~~~i~~~~~~ 372 (387)
+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+..... +...+..+.++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 301 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC
Confidence 4667999999988889999999999999999996 999998765443 33334344343
No 294
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=3.5e-32 Score=245.97 Aligned_cols=179 Identities=24% Similarity=0.400 Sum_probs=148.4
Q ss_pred eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHH-cCCCChHHHHH
Q 016544 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254 (387)
Q Consensus 176 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~ 254 (387)
..|++|.+... .......+.+|+.+++.++||||+++++++......++||||+++++|..++.+ .+.+++..+..
T Consensus 45 ~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~ 121 (274)
T cd05076 45 LRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121 (274)
T ss_pred eeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH
Confidence 35899988643 233446688899999999999999999999999999999999999999999876 45689999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-------CEEEEeecCccccccCCCCCcccCCCCCccccccccc
Q 016544 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327 (387)
Q Consensus 255 i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 327 (387)
++.|++.||+|||+++ |+||||||+||+++..+ .++++|||++...... ....++..|+|||.+.
T Consensus 122 i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhc
Confidence 9999999999999998 99999999999998643 3799999987543211 1234577899999887
Q ss_pred C-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcHHHH
Q 016544 328 N-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 328 ~-~~~~~~~Dv~slG~il~ell-tg~~pf~~~~~~~~~~~ 365 (387)
+ ..++.++|+|||||++||++ +|+.||....+.+....
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 6 46789999999999999985 79999988766555443
No 295
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=3.3e-32 Score=245.66 Aligned_cols=203 Identities=33% Similarity=0.552 Sum_probs=166.4
Q ss_pred eecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||.|+||.|+. ++ ..+++|.+... ......+.+..|+.++.++ +||||+++++++...+..+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 479999987763 23 35788888743 2344556788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 234 ~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
+++|.+++.... .+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997542 3678899999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
|++...... ........+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+..+.+..+.+
T Consensus 157 gl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 229 (270)
T cd05047 157 GLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229 (270)
T ss_pred CCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence 997532211 11111223567999999988889999999999999999997 9999998877777777655443
No 296
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=1e-32 Score=251.36 Aligned_cols=199 Identities=26% Similarity=0.416 Sum_probs=167.0
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 226 (387)
|...+.||.|+|+.+|. ++..||+|.+.+.... .....+.+..|+.++.++ +||+|+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 55677899999988763 4578999998753221 223345678899999999 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+||||+.+++|.+++.....+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999988777899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
.........++..|++||.+.+.. .+.++|+||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 222222345788999999987754 7789999999999999999999996543
No 297
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=3.9e-32 Score=247.86 Aligned_cols=216 Identities=29% Similarity=0.398 Sum_probs=174.1
Q ss_pred CccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC--
Q 016544 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-- 222 (387)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-- 222 (387)
.....+|.....||.|+|+.++. +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 33456788888999999998763 57899999986431 2235677899999998 799999999998754
Q ss_pred ---CceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 223 ---SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 223 ---~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
..+++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 358999999999999998863 345889999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCCCCCcccCCCCCcccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|||++........ ......++..|+|||.+... .++.++|+|||||++|+|++|++||...........+....
T Consensus 171 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 171 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred ecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999876542211 11223568889999998653 36789999999999999999999999877666666665554
Q ss_pred CCCC
Q 016544 371 RPPF 374 (387)
Q Consensus 371 ~~~~ 374 (387)
.+.+
T Consensus 250 ~~~~ 253 (291)
T cd06639 250 PPTL 253 (291)
T ss_pred CCCC
Confidence 4444
No 298
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=9.5e-33 Score=251.16 Aligned_cols=202 Identities=27% Similarity=0.460 Sum_probs=169.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..+...++++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 466678899999988763 47899999987543322 344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.++......+++.+++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999999988777666899999999999999999999998 9999999999999999999999999987654332 22
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
.....++..|+|||++.+. .++.++|+||||+++|+|++|++||...+..+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~ 209 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ 209 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 2334568889999998764 467899999999999999999999986654333
No 299
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=5.9e-34 Score=243.05 Aligned_cols=202 Identities=28% Similarity=0.426 Sum_probs=163.0
Q ss_pred Ccccc-eeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC----Cc
Q 016544 156 DFTNS-VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----SP 224 (387)
Q Consensus 156 ~~~~~-~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~----~~ 224 (387)
+|++. ..||-|.-|.|. .+|+.+|+|++... ...++|++.--+. .|||||.++++|... ..
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34443 357887777653 47889999998632 2345666654443 799999999988753 45
Q ss_pred eEEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecC
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~ 299 (387)
+.+|||.|+||.|...+++++. +++.++..|++||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999988765 999999999999999999999999 999999999999974 44699999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHHHHccC
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQ 370 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~i~~~~ 370 (387)
|+.-... ........||.|.|||++...+|+..+|+||+||++|-|++|.+||..+.. ..+..+|..++
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 9865432 223334569999999999999999999999999999999999999986544 33567777777
No 300
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=6.9e-33 Score=249.20 Aligned_cols=194 Identities=32% Similarity=0.520 Sum_probs=167.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +++.+++|.+..... ......+.+|+.+++++.||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 355567899999987753 478999999876432 3455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+.+++|.+++... ..+++.....++.|++.+|.|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999999876 678999999999999999999999 88 99999999999999999999999999865532211
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
. ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 145778899999999989999999999999999999999999754
No 301
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-33 Score=223.82 Aligned_cols=205 Identities=26% Similarity=0.494 Sum_probs=174.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||+|+. ++..||+|.++...-+.+ .-....+|+-+++.++|.|||++++...++..+.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 345567899999999984 467899999876543322 23445679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||. .+|..+... ++.++...+..++.|+++||.++|+++ ++|||+||.|.|++.+|.+|++|||+++.++.+. .
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 995 599999876 566999999999999999999999999 9999999999999999999999999999876542 2
Q ss_pred CcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell-tg~~pf~~~~~~~~~~~i 366 (387)
-.+....|..|.+|.++.+.+ |+++.|+||.||++.|+. .|++.|.+.+..+.+++|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri 215 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence 233345688999999998864 788999999999999998 599999998888877777
No 302
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=5.2e-32 Score=250.11 Aligned_cols=208 Identities=28% Similarity=0.467 Sum_probs=174.8
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+|+.++. ++..||+|.+........+....+..|+.++++++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66777899999987763 5789999998765444555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+.+ +|.+++.. ..++++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 965 78777754 456899999999999999999999999 999999999999999999999999987654321
Q ss_pred cccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
....+++.|+|||.+. ...++.++|+|||||++|+|++|..||...........+.....++
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT 243 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC
Confidence 2235788899999974 4568889999999999999999999998877777777776665443
No 303
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=1.6e-32 Score=248.61 Aligned_cols=212 Identities=26% Similarity=0.500 Sum_probs=181.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||.|+|+.++. +|..||+|++.............+..|+.+++++. ||||+++++++......+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 466778899999988763 68899999997654445555677889999999998 999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 308 (387)
|++++++|.+++.+.+.+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998878999999999999999999999999 99999999999999999999999999876543221
Q ss_pred ------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 ------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......++..|+|||.+.+..++.++|+||||++++++++|+.||...+.....+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 11223456788999999988888999999999999999999999999877666666665433
No 304
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=2.3e-32 Score=247.46 Aligned_cols=203 Identities=28% Similarity=0.500 Sum_probs=170.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC---CCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv 228 (387)
|+..+.||.|+||.++. ++..||+|.+.... .......+.+|+.++++++ |||++++++++......+++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 55667899999987763 67899999987542 2334567888999999986 99999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++++|.+++... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 9999999999998664 6899999999999999999999999 9999999999999999999999999987665432
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 222334578899999998754 5688999999999999999999999877655544444
No 305
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=9.6e-32 Score=239.98 Aligned_cols=214 Identities=28% Similarity=0.531 Sum_probs=182.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. .+..|++|.+...... ....+.+.+|+++++++.|||++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 356678899999988764 5789999999865432 3456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999988888999999999999999999999998 999999999999999999999999998766543221
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......++.....+.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC
Confidence 2234568889999999888888999999999999999999999987776555555554444444
No 306
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=2.7e-32 Score=248.19 Aligned_cols=209 Identities=28% Similarity=0.386 Sum_probs=168.9
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEe-----e
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----Q 221 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-----~ 221 (387)
...+|...+.||+|+|+.++. +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 445778888999999998863 57899999876421 2235677899999999 6999999999874 3
Q ss_pred CCceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
+..++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence 4568999999999999998753 245788889999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
|++...... ........+++.|+|||++.. ..++.++|+|||||++|+|++|+.||..........++...
T Consensus 169 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 169 GVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred CceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 998765432 122233457889999999853 35788999999999999999999999877665555444333
No 307
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=2.3e-32 Score=248.79 Aligned_cols=204 Identities=29% Similarity=0.503 Sum_probs=172.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+..... .....+.+.+|+.++++++|+||+++++++...+..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 466778899999987763 478999999875432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++++.+..+..+...+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9988777766666666899999999999999999999999 9999999999999999999999999987665443323
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
.....++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 3345567889999999888 7889999999999999999999999876544333
No 308
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=3.7e-32 Score=249.52 Aligned_cols=213 Identities=25% Similarity=0.498 Sum_probs=172.3
Q ss_pred cCcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+|...+.||.|+||.+|. +|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3566677899999998874 233 57999887542 234445688899999999999999999998754 56
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++++||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 78999999999999998754 4889999999999999999999998 9999999999999999999999999997654
Q ss_pred cCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 305 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....+...+..+.+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 32221 1122334678999999998899999999999999999997 999998876666666655544443
No 309
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=2.7e-32 Score=246.39 Aligned_cols=204 Identities=27% Similarity=0.418 Sum_probs=166.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS------ 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~------ 222 (387)
-.|...+.||.|+||.++. .++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3466677899999998863 56789999986432 1235678899999998 699999999998753
Q ss_pred CceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
..++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4589999999999999999863 35889999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
....... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 7643221 22233457889999999863 35788999999999999999999999876655444444
No 310
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=2.5e-32 Score=255.98 Aligned_cols=203 Identities=27% Similarity=0.378 Sum_probs=168.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. +|..||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 3577888999999998863 688999999875432 2334456778999999999999999999886443
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..|+||||+. ++|.+.+... ++...+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 4799999995 5888888754 888999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+......++
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 169 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred CCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 432 1122345688899999999999999999999999999999999999876654444444
No 311
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=3.9e-32 Score=247.00 Aligned_cols=195 Identities=27% Similarity=0.527 Sum_probs=164.3
Q ss_pred CcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cc
Q 016544 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~ 224 (387)
-|+..+.||+|+||.++. .+..||+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 456778899999998862 46789999987542 344556789999999999999999999998775 56
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+++|||+++++|.+++.+.. .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 899999999999999997653 4899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 304 TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 304 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
...... ......++..|+|||.+.+..++.++|+|||||++|+|+++..|+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 433221 1123345677999999998889999999999999999999877653
No 312
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=5.1e-32 Score=243.99 Aligned_cols=183 Identities=25% Similarity=0.463 Sum_probs=154.9
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
+|.|+||.++. ++..+|+|.+....... .|......+ +||||+++++.+...+..++||||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 69999998763 57889999987543221 122222222 69999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccCCCCCcccCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
|.+++.....+++.++..++.|+++||.|||+.+ ++|+||||+||+++.++ .++|+|||++...... ....
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~ 167 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYD 167 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCC
Confidence 9999988778999999999999999999999999 99999999999999988 9999999998765322 1235
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
++..|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 7889999999999899999999999999999999999998665443
No 313
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.5e-32 Score=267.89 Aligned_cols=196 Identities=18% Similarity=0.273 Sum_probs=155.0
Q ss_pred cCcccceeecccEEEEEEEc------CeEEEEE--------------EcCcccCCCHHHHHHHHHHHHHHHcCCCCccee
Q 016544 155 LDFTNSVEITKGTFILAFWR------GIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~------g~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (387)
.+|...+.||+|+||.||.. +..++.| .+.+...........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 46888899999999988741 1111111 111111122334566889999999999999999
Q ss_pred eeeEEeeCCceEEEEEccCCCCHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 215 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
+++++......|++++++. ++|.+++.... .....++..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 9999999999999999995 57777765421 2345667889999999999999999 9999999999999999
Q ss_pred CCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 016544 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf 354 (387)
+.+||+|||++..+............|++.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999876543332333456899999999999999999999999999999999987644
No 314
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=9.3e-32 Score=241.61 Aligned_cols=190 Identities=23% Similarity=0.388 Sum_probs=157.4
Q ss_pred eecccEEEEEEEc-----------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 162 EITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 162 ~lg~G~~~~v~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.||+|+||.||.. ...|++|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 5789999877642 235899987643 23345678889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-------EEEEe
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVAD 296 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-------~kl~D 296 (387)
.+++|||+++++|..++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++. ++++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999988764 45899999999999999999999998 999999999999987664 89999
Q ss_pred ecCccccccCCCCCcccCCCCCccccccccc-CCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcH
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 362 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell-tg~~pf~~~~~~~~ 362 (387)
||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence 9988654321 2234678899999987 457889999999999999997 69999987654443
No 315
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=6.6e-32 Score=245.46 Aligned_cols=196 Identities=29% Similarity=0.507 Sum_probs=163.2
Q ss_pred cCcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CC
Q 016544 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~ 223 (387)
..|...+.||+|+||.++. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3566778899999998864 4678999998643 34456778999999999999999999998754 34
Q ss_pred ceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 689999999999999999764 45899999999999999999999999 99999999999999999999999999886
Q ss_pred cccCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 303 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 303 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
........ .....++..|+|||++.+..++.++|+|||||++|||++|..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 54322211 1122234569999999988899999999999999999998877654
No 316
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=4.1e-32 Score=242.74 Aligned_cols=211 Identities=28% Similarity=0.480 Sum_probs=179.8
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+|+.++. ++..+++|.+...... ......+..|+.++++++||||+++++++......++++||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 56677899999987753 5789999998764432 34456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 232 LPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 232 ~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876 345888999999999999999999999 999999999999999999999999998765433
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..++...+..+..+++
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 22224567899999999998899999999999999999999999998887777777766665554
No 317
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=4.9e-32 Score=247.21 Aligned_cols=198 Identities=26% Similarity=0.511 Sum_probs=162.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+|+.|+. +|..||+|.+...... .....+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4677888999999998864 5789999998654322 12235677999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9995 677777654 345788889999999999999999998 9999999999999999999999999987543221
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 112233468899999998764 578899999999999999999999986543
No 318
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=6.2e-32 Score=244.12 Aligned_cols=213 Identities=29% Similarity=0.422 Sum_probs=173.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCC----
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS---- 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~---- 223 (387)
.-+|+..+.||.|+++.++. ++..+++|.+.... ...+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 34677788999999987753 56789999986432 2346788999999999 6999999999997654
Q ss_pred --ceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 224 --~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
.++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999999865 246899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
|++....... .......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||..........++.....+
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 9987543322 12223457889999998854 24677899999999999999999999877666666666555444
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
.+
T Consensus 237 ~~ 238 (275)
T cd06608 237 TL 238 (275)
T ss_pred CC
Confidence 43
No 319
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=8.7e-32 Score=244.58 Aligned_cols=205 Identities=28% Similarity=0.578 Sum_probs=169.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. +|..||+|.+..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 366778899999987763 578999999875432 2223556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+++ +|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9975 8988887543 4899999999999999999999998 9999999999999999999999999987543321
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
. ......++..|++||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+...++.
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 1 11223457889999998664 56889999999999999999999999887776666554
No 320
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=1.5e-31 Score=238.14 Aligned_cols=210 Identities=30% Similarity=0.509 Sum_probs=177.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+++.++. ++..+++|++..... ...+.+.+|+.+++++.||+|+++++++......++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 56667899999887763 478899999975432 3457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... ..+++..+..++.|++.+|.+||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999999876 56899999999999999999999998 99999999999999999999999999876654321
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+.+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 217 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL 217 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc
Confidence 2334578889999999988889999999999999999999999988765555555544333333
No 321
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=5.9e-32 Score=246.66 Aligned_cols=196 Identities=27% Similarity=0.514 Sum_probs=163.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. +++.||+|.+...... .....+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 577778999999988863 5789999998754321 112345679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+ +|.+++... ..+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 9975 999988764 45889999999999999999999999 9999999999999999999999999986543221 1
Q ss_pred CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122235788999999876 457889999999999999999999997654
No 322
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=8.6e-32 Score=243.20 Aligned_cols=210 Identities=29% Similarity=0.457 Sum_probs=169.7
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----- 223 (387)
|...+.||+|+||.++. ++..||+|.+..... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 34556799999987762 368899999976543 3445677889999999999999999999886532
Q ss_pred -ceEEEEEccCCCCHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 224 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 224 -~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
..++++||+.+++|..++... ..++......++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence 247889999999999887532 13788889999999999999999998 99999999999999999999999
Q ss_pred ecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 297 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+++........ ......+++.|++||.+.+..++.++|||||||++|+|++ |++||.+.+..++...+....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9998765332211 1122334578999999998889999999999999999999 999999887777777766554
No 323
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=9.9e-32 Score=239.48 Aligned_cols=203 Identities=32% Similarity=0.501 Sum_probs=175.9
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+|+.++. ++..+++|.+.............+..|+.++++++||||+++++.+..+..++++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 57888877652 4789999999876655555677889999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 317 (387)
.+++.....+++.....++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 999998877999999999999999999999998 9999999999999999999999999987654322 122334567
Q ss_pred CcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
..|++||.+.+...+.++|+||||+++|++++|..||...+.....+.+...
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 8899999999888899999999999999999999999877766667776553
No 324
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=5.6e-32 Score=253.74 Aligned_cols=185 Identities=25% Similarity=0.391 Sum_probs=157.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.||. ++..||+|..... ....|+.++++++||||+++++++......++|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4688889999999998874 4568999985432 1245899999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|++. ++|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 9995 588888865 455899999999999999999999999 999999999999999999999999998653221
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf 354 (387)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222345789999999999999999999999999999999855444
No 325
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=2e-32 Score=248.81 Aligned_cols=193 Identities=25% Similarity=0.508 Sum_probs=161.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+|+.++. +|..||+|.+..... .......+.+|+.++++++||||+++++++.+....++++||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 56677899999988763 588999999865432 222334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+. ++|.+++.. .+.+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RC 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CC
Confidence 96 588888765 456899999999999999999999999 9999999999999999999999999987654322 22
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
.....+++.|+|||.+.+. .++.++|+|||||++|+|+||..||.
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 2234567889999998775 46889999999999999999988854
No 326
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=1.1e-31 Score=239.97 Aligned_cols=214 Identities=26% Similarity=0.472 Sum_probs=181.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..+++|.+..... .......+..|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 356677899999987752 478999999875433 33556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.+. ..+++.++..++.+++.||.+||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999764 56899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
. .......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..++...+.....+++
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI 223 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 2 122234578889999999988899999999999999999999999988877777777766554444
No 327
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=7e-32 Score=245.03 Aligned_cols=206 Identities=27% Similarity=0.422 Sum_probs=167.0
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee-----
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----- 221 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----- 221 (387)
..-.|+..+.+|.|+|+.++. .++.+|+|.+... ......+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 334677778999999998863 5789999987543 23345678899999998 69999999999853
Q ss_pred -CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 222 -SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 222 -~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
...++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 35689999999999999999763 34788888999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
++....... .......+++.|+|||.+. ...++.++|+|||||++|+|++|..||....+......+
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 167 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred chhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 987543221 1223345788999999986 346788999999999999999999999876654444433
No 328
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=1e-31 Score=240.61 Aligned_cols=193 Identities=25% Similarity=0.433 Sum_probs=159.7
Q ss_pred eecccEEEEEEE---c--C----------eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 162 EITKGTFILAFW---R--G----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 162 ~lg~G~~~~v~~---~--g----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
.||+|+|+.|+. . + ..+++|.+.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 589999987752 1 2 247888765432 115778899999999999999999999988 7789
Q ss_pred EEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-------CEEEEeec
Q 016544 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFG 298 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-------~~kl~Dfg 298 (387)
+||||+++++|.+++.... .++...+..++.|++.||.|||+++ |+|+||||+||+++.++ .++|+|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999998765 6899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
++..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+.......+.
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~ 220 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ 220 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh
Confidence 9876432 1223456789999999876 78899999999999999999 688998776554444443
No 329
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=8.6e-32 Score=242.71 Aligned_cols=212 Identities=23% Similarity=0.426 Sum_probs=174.1
Q ss_pred CcccceeecccEEEEEEE------cCeEEEEEEcCcccC-------CCHHHHHHHHHHHHHHHc-CCCCcceeeeeEEee
Q 016544 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI-------SDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ 221 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~ 221 (387)
+|+..+.||.|+|+.++. .+..+|+|.+..... ........+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 366677899999987762 357899998753221 223445667788888865 799999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988753 3358899999999999999999996 56 99999999999999999999999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...........+.....+
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 99987654332 233445788999999999988999999999999999999999999877766666666555533
No 330
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=1e-31 Score=243.96 Aligned_cols=209 Identities=27% Similarity=0.452 Sum_probs=163.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|+..+.||.|+||.|+. +|..||+|.+...... .. ...+..|... ++..+||||+++++++..++.++++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 467778899999998874 5889999998754322 22 2344445554 66678999999999999999999999
Q ss_pred EccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 230 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
||++ ++|.+++.. ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 688888764 23588999999999999999999997 7 9999999999999999999999999987653
Q ss_pred cCCCCCcccCCCCCcccccccccC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CCcHHHHHHccCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKH-DNEVPKAYAARQRP 372 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~ 372 (387)
.. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+.+..+..+..+
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd06617 156 DS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226 (283)
T ss_pred cc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC
Confidence 22 11122356788999998865 356889999999999999999999997533 22334444333333
No 331
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=1.6e-31 Score=243.29 Aligned_cols=194 Identities=29% Similarity=0.459 Sum_probs=163.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|...+.||.|+++.++. ++..+|+|.+.... .......+.+|++++++++||||+++++++... ..++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 356677899999987762 57899999987542 234456788999999999999999999988654 468999
Q ss_pred EEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
|||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 344788899999999999999999999 9999999999999999999999999986543
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
.... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2211 1234677899999999989999999999999999999999999865
No 332
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=7.1e-32 Score=246.41 Aligned_cols=206 Identities=29% Similarity=0.456 Sum_probs=170.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|...+.||.|+||.++. +++.+++|.+...... ......+.+|+.++++++||||+++++++... ...+++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 577778899999988763 5788999998754332 22234567799999999999999999998877 889999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||+. ++|.+++.... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 49999887644 4899999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...+......++.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 122233467889999998765 46889999999999999999999999877666655553
No 333
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=4.5e-32 Score=242.71 Aligned_cols=210 Identities=24% Similarity=0.427 Sum_probs=175.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+|+.++. +|..+|+|.+...... ....+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 56677899999987763 5788999998754332 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-EEEEeecCccccccCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKED 308 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~ 308 (387)
+++++|.+++.+.. .+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997643 3788999999999999999999998 999999999999998764 69999999876543222
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC
Confidence 22234578899999999888899999999999999999999999988776666666655543
No 334
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=1e-31 Score=245.14 Aligned_cols=204 Identities=23% Similarity=0.412 Sum_probs=170.5
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
...||.|+||.++. +|..||+|.+... .......+.+|+.+++.++|+||+++++.+......+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 35689999987763 5789999987532 233456688899999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 999998754 45889999999999999999999998 9999999999999999999999999886543221 122334
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.+++.|++||.+.+..++.++|+||||+++|+|++|..||.+....+....+.....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 233 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 233 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Confidence 578899999999888889999999999999999999999998766655555543333
No 335
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=1.1e-31 Score=244.19 Aligned_cols=207 Identities=31% Similarity=0.480 Sum_probs=172.2
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 229 (387)
|...+.||.|+||.++. +|..+|+|.+.... ........+.+|+.++++++|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 44567899999987763 46899999998653 2333446678899999999999999999999988 7899999
Q ss_pred EccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++ +|.+++... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99964 899988765 56899999999999999999999998 99999999999999999999999999876654432
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......++..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 223334567889999987653 578899999999999999999999988776665555543
No 336
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=2.5e-31 Score=245.07 Aligned_cols=207 Identities=28% Similarity=0.460 Sum_probs=171.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.....||.|+||.++. +|..|++|.+...........+.+..|+.+++.++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 34445699999988764 5789999998765444555567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+. +++.+++.. ..++++.++..++.|++.++.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 578777765 456899999999999999999999999 99999999999999999999999998754321
Q ss_pred cccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.....++..|+|||++. ...++.++|+|||||++|+|++|..||...+......++.....|
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence 12345788899999984 456788999999999999999999999887766666666544443
No 337
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=99.98 E-value=1.2e-31 Score=246.85 Aligned_cols=208 Identities=32% Similarity=0.498 Sum_probs=170.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|...+.||.|+|+.++. +|..||+|.+....... .....+.+|+.++++++|+||+++++++... ..+++|
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 577778899999998763 57899999986543222 1123456799999999999999999998765 468999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99996 4898888763 56899999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
.......+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||...++.+.+..+...
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~ 224 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 12222334778999999876 45788999999999999999999999988877777766553
No 338
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.98 E-value=3e-32 Score=249.89 Aligned_cols=210 Identities=25% Similarity=0.339 Sum_probs=171.7
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..|++.+.||+||-..||. +.+.||+|++..... +......|.+|+..|.++ .|.+|++++++-..++.+|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4688889999999877763 457899998875543 567788999999999999 5999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+-+ .+|..++++... .+...+..+..|++.++.++|.+| |||.||||.|+|+-. |.+||+|||+|..+.....
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 9874 599999987655 333477889999999999999999 999999999999986 6899999999988765533
Q ss_pred CC-cccCCCCCcccccccccCC-----------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 309 RP-LTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 309 ~~-~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.- .....||+.||+||.+... +.++++||||||||+|+|+.|+.||..-. ..++++.....|
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P 588 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDP 588 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCC
Confidence 22 3557899999999998532 36789999999999999999999998632 134444444444
No 339
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=99.98 E-value=1.2e-31 Score=243.64 Aligned_cols=205 Identities=26% Similarity=0.501 Sum_probs=167.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+++.++. +|..||+|.+..... .......+.+|+.++++++||||+++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 366777899999987763 578999999875432 22233568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+. ++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 995 6899988753 45889999999999999999999998 9999999999999999999999999987553321
Q ss_pred CCcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|+||+.||.+.+......++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 2222234578899999887644 588999999999999999999999876654444433
No 340
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=99.98 E-value=1.6e-31 Score=242.67 Aligned_cols=198 Identities=28% Similarity=0.499 Sum_probs=166.1
Q ss_pred CcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCc
Q 016544 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~ 224 (387)
.|...+.||+|+||.++. .+..+|+|.+...... ...+.+..|+.+++.+.||||+++++++.. ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 455667899999998763 2678999999755332 456789999999999999999999999877 557
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 899999999999999998754 4899999999999999999999998 999999999999999999999999998776
Q ss_pred ccCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 304 TVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 304 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
....... .....++..|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 5222211 112234567999999988899999999999999999999999987643
No 341
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=99.98 E-value=1.3e-31 Score=247.26 Aligned_cols=200 Identities=26% Similarity=0.439 Sum_probs=164.0
Q ss_pred cccceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEE
Q 016544 157 FTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l 227 (387)
|.....||+|+||.++. .+..||+|.+...........+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 56677899999987763 5789999999864322333345677899999999999999999999988 78999
Q ss_pred EEEccCCCCHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC----CCCEEEEeec
Q 016544 228 VTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADFG 298 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~Dfg 298 (387)
||||+++ +|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999964 777777532 25788999999999999999999999 999999999999999 8999999999
Q ss_pred CccccccCCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 299 VSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 299 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
++........ .......+++.|+|||.+.+. .++.++|+|||||++|+|++|++||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 9876543222 112234567889999988764 5788999999999999999999999876544
No 342
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=99.98 E-value=4.6e-31 Score=235.99 Aligned_cols=198 Identities=31% Similarity=0.546 Sum_probs=172.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 229 (387)
|...+.||.|++|.++. ++..|++|.+...... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 56677899999987763 4889999998765432 45567889999999999999999999999988 8899999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.+++|.+++.+...+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999988778999999999999999999999998 999999999999999999999999998766543221
Q ss_pred -CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 310 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
......++..|++||.+.+...+.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457889999999998889999999999999999999999998765
No 343
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=99.98 E-value=5.8e-32 Score=251.62 Aligned_cols=205 Identities=25% Similarity=0.419 Sum_probs=168.4
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----CCce
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~ 225 (387)
.+|...+.||.|+|+.++ .+|..||+|.+..... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467777889999998776 3588999999875432 22345667789999999999999999998763 3468
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++||||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 699999987777999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCC---cccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 306 KEDRP---LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 306 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~ 222 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence 22111 123457888999999866 467899999999999999999999998766544333
No 344
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=99.98 E-value=4.3e-31 Score=241.35 Aligned_cols=205 Identities=27% Similarity=0.478 Sum_probs=165.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. +|+.||+|.+...... ......+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 466778899999987763 5789999998654322 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+. ++|.+++..... +++..+..++.|++.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 588888865443 577888899999999999999998 999999999999985 4579999999987654321
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.......+++.|+|||.+.+. .++.++|+|||||++|+|+||++||...+..+...++
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112233467889999998764 5788999999999999999999999876655544443
No 345
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=99.98 E-value=2.7e-31 Score=241.27 Aligned_cols=203 Identities=30% Similarity=0.536 Sum_probs=166.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+++.++. +|..||+|++...... ......+.+|+.+++.++|||++++++++......++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 45567899999987763 6889999998754322 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+. ++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 95 69999998765 5899999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 365 (387)
......+++.|+|||++.+. .++.++|+||||+++|+|++|++||...+......+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 12223457889999988764 568899999999999999999999987655433333
No 346
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=99.98 E-value=4.7e-31 Score=243.38 Aligned_cols=199 Identities=19% Similarity=0.337 Sum_probs=163.4
Q ss_pred cceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 159 NSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 159 ~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
..+.+|.|+++.++ .++..||+|++..... .......+..|+.++++++||||+++++++......+++|||+.++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34455666665443 3689999999876432 3455678999999999999999999999999999999999999999
Q ss_pred CHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-----
Q 016544 236 DLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED----- 308 (387)
Q Consensus 236 sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 308 (387)
+|.+++... ..+++..+..++.|+++||.|||+++ |+|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999864 34888999999999999999999999 99999999999999999999999998765432211
Q ss_pred -CCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 309 -RPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 309 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
.......++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 111233467789999998763 57889999999999999999999998765443
No 347
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=99.97 E-value=1e-33 Score=237.95 Aligned_cols=214 Identities=27% Similarity=0.386 Sum_probs=168.9
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+.+...+||.|.||+|. ..|+..|||.++.... +...+++..|.+...+. +.||||++||....++..++.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 34455689999999986 4789999999986643 56677888888866655 6999999999999999999999
Q ss_pred EccCCCCHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 230 e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
|+|. -||..+.+ ++..+++...-.|..-.+.||.||-+.- .|||||+||+|||++..|.+||||||.+....
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9995 58876654 3455888888888888899999998763 39999999999999999999999999986543
Q ss_pred cCCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHHHccCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPFKA 376 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~ 376 (387)
.+ ...+.-.|-..|||||.+... .+..+||+||||+++||+.||..||.+-+. .+-+.+++.+..|.+..
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 22 222334567789999998654 588899999999999999999999987544 33444555555554433
No 348
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=99.97 E-value=1.7e-31 Score=239.30 Aligned_cols=189 Identities=22% Similarity=0.371 Sum_probs=155.9
Q ss_pred eecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 162 EITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 162 ~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.||.|+|+.||.. ...|++|.+... .....+.+..|..+++.+.||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 5899999887632 234888887533 2344567888999999999999999999999989999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC--------EEEEeecCc
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGVS 300 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--------~kl~Dfg~~ 300 (387)
||+.+|+|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999998654 4889999999999999999999999 999999999999987665 699999987
Q ss_pred cccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCc
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEG-CPPFTMKHDNE 361 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg-~~pf~~~~~~~ 361 (387)
...... ....+++.|+|||.+.+. .++.++|+|||||++|+|++| ..||...+...
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 654321 223467889999999874 578899999999999999998 56776655443
No 349
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=99.97 E-value=4.3e-31 Score=241.42 Aligned_cols=205 Identities=28% Similarity=0.433 Sum_probs=165.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCc-----
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP----- 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~----- 224 (387)
+|...+.||.|+||.+|. +|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 467778899999998863 578999998865432 1223356778999999995 6999999999987665
Q ss_pred eEEEEEccCCCCHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeec
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG 298 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 298 (387)
.|++|||+++ +|.+++... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898888643 24789999999999999999999998 999999999999998 8899999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
++..+..... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.++.....++
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 9876533211 1122345788999998865 45789999999999999999999999887665544443
No 350
>PHA02882 putative serine/threonine kinase; Provisional
Probab=99.97 E-value=6.8e-31 Score=240.00 Aligned_cols=200 Identities=16% Similarity=0.165 Sum_probs=152.5
Q ss_pred cCcccceeecccEEEEEEEc--------CeEEEEEEcCcccCCC--HHH------HHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISD--DDR------VRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~--------g~~vavK~~~~~~~~~--~~~------~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
.+|...+.||+|+||.||.. +..+|+|+........ +.. ......+...+..+.|++|++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 46888889999999998741 3466777543221110 000 0112223445566789999999997
Q ss_pred EeeCC----ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 219 VTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 219 ~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
+.... ..++++|++. .++.+.+......++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence 66543 3477888874 478777776555788889999999999999999998 999999999999999999999
Q ss_pred EeecCccccccCCC------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 295 ADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999976542211 11123468999999999999999999999999999999999999998874
No 351
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=99.97 E-value=4.5e-31 Score=265.24 Aligned_cols=143 Identities=29% Similarity=0.526 Sum_probs=130.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.||. .+..||||++.............+..|+.+++.++||||+++++++.....+|+|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 577788999999998873 478999999986555556666788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
|+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999988778899999999999999999999998 9999999999999999999999999875
No 352
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=99.97 E-value=5.9e-31 Score=242.14 Aligned_cols=206 Identities=26% Similarity=0.412 Sum_probs=165.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------- 223 (387)
+|...+.||.|+|+.++. ++..||+|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 677888999999998763 57899999886543222 12234567999999999999999999887654
Q ss_pred -ceEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 224 -PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 224 -~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
..++||||+. ++|.+++.... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3599999995 58888877543 5899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCC---CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 302 LLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 302 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+.......+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 65432221 11233467889999998764 4688999999999999999999999877655444433
No 353
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=99.97 E-value=4.8e-31 Score=240.28 Aligned_cols=194 Identities=31% Similarity=0.473 Sum_probs=159.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
|.....||.|+||.|+. ++..||+|.+..... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 44556799999998863 578999999875432 244567888999999996 9999999999999899999999
Q ss_pred ccCCCCHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 231 YLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 231 ~~~~~sL~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
|+. +++.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 46655432 235689999999999999999999985 7 9999999999999999999999999987543
Q ss_pred cCCCCCcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||....
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 160 DSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred cCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 221 11223568889999999876 68899999999999999999999998654
No 354
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=99.97 E-value=4.7e-31 Score=242.72 Aligned_cols=208 Identities=28% Similarity=0.470 Sum_probs=171.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||.|+||.++. ++..+|+|.+...........+++.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366667899999987762 567899999875434444556678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. +++.+++.. ..++++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 588877754 445889999999999999999999998 999999999999999999999999998764322
Q ss_pred CcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+.....|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC
Confidence 2234678899999975 346788999999999999999999999877666555555554443
No 355
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=99.97 E-value=2.3e-31 Score=247.16 Aligned_cols=209 Identities=29% Similarity=0.459 Sum_probs=175.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~ 225 (387)
+|...+.||.|+++.++. ++..||+|.+.... ......+.+..|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 356678899999987762 47899999987543 22344567889999999999999999999988765 78
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|++|||+. ++|.+++.+...+++..+..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999996 589999988778999999999999999999999999 99999999999999999999999999887654
Q ss_pred CCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 306 KED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 306 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence 321 122334568889999999887 7899999999999999999999999988776666665443
No 356
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=99.97 E-value=3.7e-31 Score=246.55 Aligned_cols=206 Identities=28% Similarity=0.454 Sum_probs=167.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC--CceE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~--~~~~ 226 (387)
.+|...+.||.|+|+.++. +|..+|+|.+..... .......+..|+.+++++ +||||+++++++... ..++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3577778899999987763 578999998865322 223345677899999999 999999999988654 3589
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+||||+. ++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999996 5999988765 6888899999999999999999998 999999999999999999999999998765433
Q ss_pred CC----CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 307 ED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+......++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 22 12223457889999998765 45788999999999999999999999876655544443
No 357
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.97 E-value=9.8e-32 Score=251.43 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=164.8
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
..+|.....+|.|+|+.+.+ +++..++|++.+...+ -.+|..++.+. +||||+++.+.+.+....|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 34566667799999987754 6788999999865222 24466565555 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-CCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|||.+.|+-+.+-+....... .++..|+.+|+.|+.|||++| ++||||||+|||+ +..++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999998877776655444 788889999999999999999 9999999999999 68899999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHcc
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR 369 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~i~~~ 369 (387)
.....-|..|.|||++....+++++||||||++||+|++|+.||...... ++..+|..+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~ 529 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP 529 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC
Confidence 11223478899999999999999999999999999999999999865555 666666444
No 358
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=99.97 E-value=4e-31 Score=246.22 Aligned_cols=198 Identities=29% Similarity=0.505 Sum_probs=162.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----Cc
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~ 224 (387)
.+|...+.||.|+||.++. +|..||+|.+... ........+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3677888999999988763 5789999998642 2233445677899999999999999999987654 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999996 588887754 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCC--CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 305 VKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 305 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32211 1123457889999998755 4688999999999999999999999976543
No 359
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=99.97 E-value=6.7e-31 Score=245.27 Aligned_cols=202 Identities=27% Similarity=0.447 Sum_probs=167.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------c
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~ 224 (387)
+|+..+.||.|+||.|+. +|..||+|.+.... ........+.+|+.++++++||||+++++++.... .
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 577888999999998863 57899999986542 23334556888999999999999999999987654 3
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 7799988865 46899999999999999999999999 9999999999999999999999999987543
Q ss_pred cCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.. .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+......++.
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 170 SE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred cC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22 223356788999999876 457889999999999999999999998776554444443
No 360
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=99.97 E-value=5.9e-31 Score=245.80 Aligned_cols=204 Identities=28% Similarity=0.447 Sum_probs=166.5
Q ss_pred ccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------
Q 016544 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------ 222 (387)
..+|...+.||+|+||.++ .+|..||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3467888899999998875 3578999999875422 233345677899999999999999999988643
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3467888887 78998887654 5899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+.
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 170 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred ccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 422 2223456888999999876 467889999999999999999999998766555544443
No 361
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=99.97 E-value=5.2e-31 Score=245.46 Aligned_cols=199 Identities=27% Similarity=0.457 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----Cc
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~ 224 (387)
.+|...+.||.|+|+.++. ++..||+|.+..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3577888999999988763 578999999875432 223345667899999999999999999988654 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.++++||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999995 699999988788999999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 322 22233456888999998865 4688999999999999999999999987653
No 362
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=4.1e-31 Score=261.84 Aligned_cols=221 Identities=31% Similarity=0.516 Sum_probs=185.6
Q ss_pred ccccCccccCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcce
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV 213 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 213 (387)
.||++...+.+.. .+|.|.||.|... ...||||.++..... ...+.+..|+++++.+ +||||+
T Consensus 290 ~~e~~~~~l~~~~--~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGK--YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccccc--eeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchh
Confidence 6777777665444 8999999877531 468999999876443 6678899999999999 599999
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
.++|++...+..++|+||++.|+|..++..+. .++..+.+.++.||+.|++||++.. +|||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998765 3888999999999999999999998 9999
Q ss_pred CCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC--CCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 016544 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (387)
Q Consensus 278 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf 354 (387)
||-.+|||+..+..+||+|||+++.............. -+..|||||.+....|+.++|||||||++||++| |..||
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999999865433332222112 2456999999999999999999999999999998 99999
Q ss_pred CCCC-CCcHHHHHHccCCCCC
Q 016544 355 TMKH-DNEVPKAYAARQRPPF 374 (387)
Q Consensus 355 ~~~~-~~~~~~~i~~~~~~~~ 374 (387)
.+.. .+++.+.+..|.|...
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~ 543 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQ 543 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCC
Confidence 9866 6777777777776554
No 363
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=99.97 E-value=1.4e-30 Score=236.92 Aligned_cols=204 Identities=29% Similarity=0.506 Sum_probs=167.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEeeCCc----
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP---- 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~---- 224 (387)
|...+.||.|+|+.++. ++..||+|.+....... .....+..|+.+++++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 45567899999987752 47899999997543322 2234566677777666 59999999999988776
Q ss_pred -eEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 225 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
++++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999996 48999887643 4899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
...... ......++..|+|||.+.+..++.++|+|||||++|+|++|++||.+.+..+...++.
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence 654321 1122346788999999999889999999999999999999999999888777666663
No 364
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=2.3e-31 Score=240.11 Aligned_cols=215 Identities=29% Similarity=0.471 Sum_probs=171.0
Q ss_pred cccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC--CCCcceeeeeEEeeCC----ceEE
Q 016544 157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMMI 227 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~----~~~l 227 (387)
......+|+|.||.|+ .+++.||||++. ....+.|++|.+++... +|+||+++++.-.... .++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445678999999887 478999999996 34568899999999875 7999999999876544 7999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC------CCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------PVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
|++|.+.|||.+|++.+. ++|....+++..+++||+|||+.- .++|+|||||++|||+..+++..|+|||+|.
T Consensus 286 Vt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred EeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999999864 899999999999999999999743 3479999999999999999999999999998
Q ss_pred ccccCCC-CCcccCCCCCcccccccccCCC-CC-----CchhHHHHHHHHHHHHcCCC------------CCC-----CC
Q 016544 302 LLTVKED-RPLTCQDTSCRYVAPEVFKNEE-YD-----TKVDVFSFALILQEMIEGCP------------PFT-----MK 357 (387)
Q Consensus 302 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Dv~slG~il~elltg~~------------pf~-----~~ 357 (387)
.+..... ...-..+||.+|||||++.+.. +. .+.||||+|.++||++++-. ||. ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 7764432 2233468999999999998752 22 36899999999999997543 232 22
Q ss_pred CCCcHHHHHHccC-CCCCCCCh
Q 016544 358 HDNEVPKAYAARQ-RPPFKAPA 378 (387)
Q Consensus 358 ~~~~~~~~i~~~~-~~~~~~~~ 378 (387)
+-+++.+-++..+ ||-++...
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W 466 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAW 466 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhh
Confidence 3344555555555 77765543
No 365
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=99.97 E-value=1.2e-30 Score=242.09 Aligned_cols=202 Identities=22% Similarity=0.389 Sum_probs=162.0
Q ss_pred eeccc--EEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G--~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||+| +|+.|+ ..|+.||+|.+..... .....+.+.+|+.+++.++||||++++++|..+...++++||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45655 776665 2689999999875433 344567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC--
Q 016544 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-- 310 (387)
Q Consensus 235 ~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 310 (387)
++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998643 4888899999999999999999998 9999999999999999999999997543221111100
Q ss_pred ----cccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 311 ----LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 311 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.....++..|+|||++.+. .++.++|+|||||++|+|++|..||.+....+....+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 223 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh
Confidence 0112345679999999774 47889999999999999999999998876555444443
No 366
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=99.97 E-value=5.1e-31 Score=241.71 Aligned_cols=209 Identities=28% Similarity=0.447 Sum_probs=168.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||.|+|+.++. +|+.||+|.+...... ......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 3577778899999988763 5789999998754321 222345678999999999999999999987654
Q ss_pred ----ceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 224 ----PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 224 ----~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
.+++++||+++ ++...+... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999975 777777654 45899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
++...............++..|+|||.+.+. .++.++|+|||||++|+|++|++||...+..+.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9876544332222333457789999988653 568899999999999999999999987666555544433
No 367
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=99.97 E-value=9.8e-31 Score=237.36 Aligned_cols=201 Identities=24% Similarity=0.397 Sum_probs=161.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeC--CceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~lv 228 (387)
|...+.||.|+|+.++. ++..||+|.++.... ..... ....|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 44567899999987763 578999999875432 22222 2346888888885 99999999999987 889999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||+. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99996 5888887753 46899999999999999999999998 999999999999999 999999999987654322
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 2223456888999997654 45688999999999999999999999887665544444
No 368
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=99.97 E-value=8.8e-31 Score=243.82 Aligned_cols=205 Identities=27% Similarity=0.402 Sum_probs=167.9
Q ss_pred cceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHH-----------HHHHHHHHHHHHHcCCCCcceeeeeEEeeC
Q 016544 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 222 (387)
..+.||.|+||.+|. .++.||+|.+......... ....+.+|+.++++++||||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 345799999998863 5789999998654322110 012467899999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
...+++|||+. ++|.+++.....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence 99999999996 599999988777999999999999999999999999 99999999999999999999999999876
Q ss_pred cccCC-------------CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 303 LTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 303 ~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
..... ........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.++.+....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54111 1111223457789999998764 46889999999999999999999999887766555553
No 369
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=99.97 E-value=9.8e-31 Score=243.16 Aligned_cols=205 Identities=24% Similarity=0.386 Sum_probs=165.0
Q ss_pred cccceeecccEEEEEEE-----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC----Cc
Q 016544 157 FTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----SP 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~----~~ 224 (387)
|...+.||.|+||.++. . +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 56677899999988763 3 6689999987532 2233445677899999999 599999999875432 45
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++++|++. ++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788999985 699999988778999999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCC---CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 305 VKEDR---PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 305 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+......++
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~ 222 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH
Confidence 32211 1123457889999998766 46889999999999999999999999876654444433
No 370
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=99.97 E-value=1.1e-30 Score=236.97 Aligned_cols=205 Identities=28% Similarity=0.487 Sum_probs=171.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+++.++. +|..+++|.+...... ......+..|+.++++++||||+++++++..+..+++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 34567899999987763 5788999998765433 23446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++ +|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 975 888888763 56899999999999999999999999 9999999999999999999999999987665432 12
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+..+.+.++.
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234567889999999876 78899999999999999999999998877655555543
No 371
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=1.7e-31 Score=254.53 Aligned_cols=211 Identities=26% Similarity=0.489 Sum_probs=183.9
Q ss_pred cCcccceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+....+.||.|.||+||.. ..+||+|++.... ..+...++..|+-+|.++.|||++++++++..+. +
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 35566778999999998742 3589999987543 3455678899999999999999999999998765 8
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.||++|++.|+|.++++.+ +++.....+.|..||++||.|||.+. ++||||-.+|||+..-..+||.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 8999999999999999864 45889999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCc-ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 305 VKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 305 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
....... ....-.+.|||-|.+..+.|+.++|||||||++||++| |..||.+.+.++|...+..+.|
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence 5544332 33344778999999999999999999999999999998 9999999999999999988886
No 372
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=99.97 E-value=3.2e-30 Score=235.82 Aligned_cols=211 Identities=30% Similarity=0.463 Sum_probs=165.1
Q ss_pred cCcccceeecccEEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||.|+|+.++ + ++..||||.+..... ......+..|..++.+. .||||+++++++......+++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 356778899999998776 2 388999999875432 22344555677666666 599999999999999999999
Q ss_pred EEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|||+. +++.+++.. ...+++..+..++.|++.||+|||+ .+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99985 578877765 4568899999999999999999997 46 999999999999999999999999998755322
Q ss_pred CCCCcccCCCCCcccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHHHccCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~ 373 (387)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .+.+.++.....+.
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC
Confidence 11 12234678899999987653 78899999999999999999999976332 34555555444333
No 373
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=99.97 E-value=1.4e-30 Score=236.34 Aligned_cols=203 Identities=30% Similarity=0.542 Sum_probs=170.0
Q ss_pred ccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+....||+|+|+.++. +++.+|+|.+.... ......+.+..|+.++++++|+||+++++++......++++||+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4456789999987763 57899999998653 22333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 233 ~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
. ++|.+++.+. ..+++..+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 5999999876 56999999999999999999999999 99999999999999999999999999876543221 22
Q ss_pred ccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 312 TCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....+..|+|||.+.+. .++.++|+|||||++|++++|++||...+......++
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 233456789999998776 7889999999999999999999999887765555544
No 374
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=99.97 E-value=1.4e-30 Score=239.81 Aligned_cols=208 Identities=31% Similarity=0.473 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||.|+|+.++. ++..+|+|.+........ ....+.+|+.++++++||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4678888999999998763 578999998865432221 1234678999999999999999999875433
Q ss_pred --ceEEEEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 224 --PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 224 --~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
.+++++||+.+ +|...+.. ...+++.++..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999964 77777764 346999999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCC----------cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 301 KLLTVKEDRP----------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 301 ~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.......... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+.....+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7554322111 1223457789999988654 57889999999999999999999999877766555554
No 375
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=7.7e-31 Score=235.08 Aligned_cols=220 Identities=30% Similarity=0.475 Sum_probs=170.6
Q ss_pred cCcccceeecccEEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC--CCCcceeeeeEEeeCC----ce
Q 016544 155 LDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~----~~ 225 (387)
.+.+..+.||+|.||.| .|.|..||||++... + -+++.+|.++++.+ +|+||+.+++.-..+. .+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---d---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---D---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc---c---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 35566778999999865 599999999999743 1 25677888888765 9999999998765443 48
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-----CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-----~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
+||++|.+.|||.+|+.+. .++....++++..+++||++||. +|.+.|.|||||+.|||+.+++..-|+|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999999984 58999999999999999999995 56677999999999999999999999999999
Q ss_pred cccccCC---CCCcccCCCCCcccccccccCCC----CC--CchhHHHHHHHHHHHHcC----------CCCCCCCCC--
Q 016544 301 KLLTVKE---DRPLTCQDTSCRYVAPEVFKNEE----YD--TKVDVFSFALILQEMIEG----------CPPFTMKHD-- 359 (387)
Q Consensus 301 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~----~~--~~~Dv~slG~il~elltg----------~~pf~~~~~-- 359 (387)
-...... +......+||-+|||||++...- |. ..+||||||.++||+..+ ++||.+.-+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 7655432 23335678999999999997641 22 358999999999998732 478875322
Q ss_pred ---CcHHHHHHccC-CCCCCCChhhh
Q 016544 360 ---NEVPKAYAARQ-RPPFKAPAKLY 381 (387)
Q Consensus 360 ---~~~~~~i~~~~-~~~~~~~~~~~ 381 (387)
+++.+-+--.+ ||+++......
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~ 469 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSD 469 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccC
Confidence 22222222222 88876655443
No 376
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=99.97 E-value=4e-30 Score=238.47 Aligned_cols=197 Identities=31% Similarity=0.502 Sum_probs=163.9
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CCceE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMM 226 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~ 226 (387)
...+|+..+.||.|+|+.++. ++..||+|.+..... .....+.+..|+.++++++||||+++++++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 345688889999999998863 678999998865432 22344667889999999999999999999875 45789
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+++||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 999998 5689888765 35788888999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.....
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 122356788999998766 5688999999999999999999999986554
No 377
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=99.97 E-value=1.7e-30 Score=232.99 Aligned_cols=213 Identities=28% Similarity=0.435 Sum_probs=169.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
|...+.||+|+||.++. .+..+++|.++..... .......+..|+.+++.++||||+++++++......++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 66678899999998873 2344666665432221 1222345667899999999999999999999989999999
Q ss_pred EccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
||+++++|.+++.+ ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998864 345899999999999999999999998 999999999999985 5699999999876543
Q ss_pred CCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..........++..+..|.+
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL 225 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC
Confidence 221 22234568889999999888889999999999999999999999987666666666655444443
No 378
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=99.97 E-value=2e-30 Score=242.11 Aligned_cols=204 Identities=29% Similarity=0.441 Sum_probs=169.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-----
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 224 (387)
.+|.....||.|++|.++. ++..||+|.+..... .....+.+.+|+.+++++.||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 3677888999999988763 478999999875432 22334567789999999999999999998876554
Q ss_pred -eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 -~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799998876 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+......+.++..
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 322 223356788999999865 3678899999999999999999999988776655555544
No 379
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=99.97 E-value=1.8e-31 Score=235.17 Aligned_cols=200 Identities=27% Similarity=0.336 Sum_probs=167.7
Q ss_pred ccCcccceeecccEEEEEE--E---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC--CC----cceeeeeEEeeC
Q 016544 154 ELDFTNSVEITKGTFILAF--W---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HP----NVVQFLGAVTQS 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~--~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~l~~~~~~~ 222 (387)
...|.+...+|.|+||.|. | .+..||||+++.- ....+..+-|+++++++. .| -++++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4478888899999999875 2 4789999998732 344566677999999993 33 388889999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC------------
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------ 288 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~------------ 288 (387)
++++||+|.+ |.|+.+++..++ +++...+..+++|+++++.+||+.+ ++|.||||+|||+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 779999998765 4888999999999999999999999 999999999999842
Q ss_pred --------CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 289 --------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 289 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
+..++++|||.|.... ...+..+.|..|.|||++.+-+++.++||||+||||+||+||...|++.++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2358999999987643 2234456789999999999999999999999999999999999999988877
Q ss_pred cHHHH
Q 016544 361 EVPKA 365 (387)
Q Consensus 361 ~~~~~ 365 (387)
+-++.
T Consensus 316 EHLaM 320 (415)
T KOG0671|consen 316 EHLAM 320 (415)
T ss_pred HHHHH
Confidence 74433
No 380
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=99.97 E-value=2.4e-30 Score=241.43 Aligned_cols=202 Identities=27% Similarity=0.439 Sum_probs=163.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------c
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~ 224 (387)
+|.....||.|+||.++. +|..||+|.+..... .......+.+|+.+++.+.||||+++++++.... .
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 677778999999987762 578999999875432 2233456788999999999999999999987543 4
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++++||+. .+|..+.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 699999995 47776653 35889999999999999999999999 9999999999999999999999999987542
Q ss_pred cCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 169 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 169 A----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred C----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 1223346788999999876 4678899999999999999999999998765555544433
No 381
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=8.4e-33 Score=233.34 Aligned_cols=205 Identities=27% Similarity=0.466 Sum_probs=174.8
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ceE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 226 (387)
..-.+-||.|.||+|. .+|+.||+|++.. .+..-...+.+.+|++++..++|.|++..++..+-.. .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445679999999875 4799999999864 3444555677888999999999999999988776443 478
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+++|.|. .+|..++-....++...++.++.||++||.|||+.+ |+||||||.|.|++.+..+||+|||+++.....
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 8899995 589999888888999999999999999999999999 999999999999999999999999999987766
Q ss_pred CCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
+....+....|..|.|||++.|. .|+.+.||||.|||+.||+.++..|+..++-+-++.|
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 55555555668899999999885 6889999999999999999999999988776666655
No 382
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=99.97 E-value=7.3e-30 Score=231.83 Aligned_cols=202 Identities=25% Similarity=0.436 Sum_probs=165.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
|...+.||.|++|.++. .+..|++|.+...... . ......+|+..++++. ||||+++++++..+...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 45567899999988762 4678999998754322 1 1223456889999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+ +++|.+++.... .+++.++..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 789999888754 6899999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......++..|+|||.+.+ ..++.++|+||||+++++|++|++||...+..+...++
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 2223456788999998854 45789999999999999999999999877665555444
No 383
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=3.6e-31 Score=236.95 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=166.0
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHH----HHHHHHHHHHHHcCCCCcceeeeeEEe-eCCce
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT-QSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 225 (387)
.|.....||+|+|..|| ...+-||||+-.......++. .+...+|..+-+.+.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 45556679999997664 456789999865544333222 344567999999999999999999997 45679
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecCccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKL 302 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~ 302 (387)
|-|+|||+|.+|.-+++....+++.++..|+.||+.||.||.+.. .||||-||||.|||+.. .|.+||.|||++++
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999888999999999999999999999987 47999999999999864 56799999999998
Q ss_pred cccCCC------CCcccCCCCCcccccccccC----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 303 LTVKED------RPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 303 ~~~~~~------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
+..... ...+...||+.|++||++.- .+.+.++||||.|||+|.++.|+.||...
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 764322 22345679999999998843 36788999999999999999999999753
No 384
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=99.97 E-value=4.1e-30 Score=227.41 Aligned_cols=176 Identities=22% Similarity=0.286 Sum_probs=147.8
Q ss_pred cEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHH
Q 016544 166 GTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240 (387)
Q Consensus 166 G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~ 240 (387)
|+|+.|+ .+++.||+|.+.... .+..|...+....||||+++++++......+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 5555554 367899999987542 123344445556799999999999999999999999999999999
Q ss_pred HHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcc
Q 016544 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320 (387)
Q Consensus 241 l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 320 (387)
+.+...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++++|||.+...... .....++..|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 988777999999999999999999999998 999999999999999999999999987654322 1122346679
Q ss_pred cccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 321 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 321 ~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 999999888889999999999999999999998764
No 385
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.97 E-value=3.6e-31 Score=243.70 Aligned_cols=195 Identities=24% Similarity=0.383 Sum_probs=169.1
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHH-----HHHHHHHHHHHcCC---CCcceeeeeEEeeC
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV-----RAFRDELALLQKIR---HPNVVQFLGAVTQS 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---h~~iv~l~~~~~~~ 222 (387)
+|+..+.+|.|.||.|. .+...|+||++.++.+--...+ -..-.|+.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 68888899999999874 2567899999987655322221 22466999999996 99999999999999
Q ss_pred CceEEEEEccC-CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLP-KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~-~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
+.+||+||--. |-+|.+++..+..+++.++..|++|++.|+++||+++ |||||||-+|+.++.+|.+||+|||.+.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 99999999863 4589999999988999999999999999999999999 9999999999999999999999999986
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~ 356 (387)
... ..+...+.||..|.|||++.|.+|- ..-|||+||+++|.++..+.||..
T Consensus 719 ~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 643 3455667899999999999998874 678999999999999999999974
No 386
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.97 E-value=2.5e-29 Score=219.94 Aligned_cols=212 Identities=31% Similarity=0.530 Sum_probs=176.9
Q ss_pred ccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
.....||.|+++.++. ++..+++|.+...... ...+.+.+|+..+++++|+|++++++++......++++|++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4556789998877652 3689999999865332 24678889999999999999999999999989999999999
Q ss_pred CCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 233 ~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
.+++|.+++..... +++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999999988766 899999999999999999999998 99999999999999999999999999877654321122
Q ss_pred ccCCCCCcccccccc-cCCCCCCchhHHHHHHHHHHHHcCCCCCCC--CCCCcHHHHHHccCCCCC
Q 016544 312 TCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTM--KHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~pf~~--~~~~~~~~~i~~~~~~~~ 374 (387)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+...+.+.|..+..+++
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW 222 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence 234567789999998 666788899999999999999999999987 444467777776665544
No 387
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=99.97 E-value=5.3e-30 Score=239.16 Aligned_cols=204 Identities=26% Similarity=0.453 Sum_probs=163.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 222 (387)
.+|...+.||.|+||.|+. +|..||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4677888999999998873 578999998865432 3346678899999999999999999876544
Q ss_pred -------CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEE
Q 016544 223 -------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKV 294 (387)
Q Consensus 223 -------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl 294 (387)
...++++||+. ++|.+++.. +.+++..+..++.|+++||.|||+.+ ++|+||||+||+++ .++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34789999996 589888864 45899999999999999999999999 99999999999998 4557899
Q ss_pred EeecCccccccCCCC--CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 295 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
+|||++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.++.+....+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999998754322111 1122346788999998754 46788999999999999999999999877654444443
No 388
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.97 E-value=3e-32 Score=227.46 Aligned_cols=206 Identities=26% Similarity=0.442 Sum_probs=168.4
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--------C
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--------S 223 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--------~ 223 (387)
|.....+|+|+||.|+ .+|+.||+|+...+....+-...+ .+|++++..++|+|++.+++.|... .
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpita-lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHH-HHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4445679999999765 467889999775433332222333 4599999999999999998877532 3
Q ss_pred ceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+|+||.+|+. +|.-++... ..++..++..++.++.+||.|+|++. |+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 48999999965 888888754 55999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCC---cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 303 LTVKEDRP---LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 303 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
++...... .+..+.|..|.+||.+.|. .++++.|+|..||++.||+||.+-|++.++...+..|.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 76543322 2344568999999999875 78999999999999999999999999988877766663
No 389
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=99.96 E-value=2.5e-29 Score=241.86 Aligned_cols=211 Identities=29% Similarity=0.440 Sum_probs=174.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee-----CCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-----SSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-----~~~ 224 (387)
.|.+.+.+|.|++|.|+ .+++.+|+|+..... +..+++..|.++++.. .|||++.+|++|.. .+.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34555678999998876 367889999887543 2335678899999998 59999999999864 357
Q ss_pred eEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
++||||||.+||.-++++.. ..+.+..+..|++.++.|+.+||.+. ++|||||-.|||++.++.+||+|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 99999999999999999753 34888889999999999999999999 99999999999999999999999999877
Q ss_pred cccCCCCCcccCCCCCcccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....... .....|||.|||||++.-. .|+.++|+||||++..||-.|.+|+.++-+...+=+|-...+|.+
T Consensus 173 ldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL 248 (953)
T KOG0587|consen 173 LDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 248 (953)
T ss_pred eeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence 6544333 3446789999999998543 567789999999999999999999999998887777644444444
No 390
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.96 E-value=6.1e-29 Score=262.00 Aligned_cols=185 Identities=25% Similarity=0.430 Sum_probs=154.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+.....||+|+||.||. +|..||+|.+...... ...|+..+++++||||+++++++......++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 355567899999998873 5789999998643221 1346788999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++|+|.++++. +++.++..++.|+++||+|||...+.+|+||||||+||+++.++..++. ||.+......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9999999999964 7899999999999999999995533449999999999999998888775 6654432211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
....+++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 123568899999999999999999999999999999999999964
No 391
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=99.96 E-value=9.2e-30 Score=252.17 Aligned_cols=205 Identities=32% Similarity=0.518 Sum_probs=161.2
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-------
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 222 (387)
.+|.+...||+|+||.|+ .+|..||||++.... +......+.+|+.++.+++|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 356777789999999886 489999999998664 455667788899999999999999986533100
Q ss_pred --------------------------------------------------------------------------------
Q 016544 223 -------------------------------------------------------------------------------- 222 (387)
Q Consensus 223 -------------------------------------------------------------------------------- 222 (387)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceEEEEEccCCCCHHHHHHHcCCC-ChHHHHHHHHHHHHHHHHHHhC
Q 016544 223 --------------------------------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHEN 269 (387)
Q Consensus 223 --------------------------------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~i~~qi~~~l~~LH~~ 269 (387)
..+||-||||+..++.+++.++... ....+++++++|++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 1246889999886777777765443 4678899999999999999999
Q ss_pred CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc-----------------cCCCCCcccCCCCCcccccccccCCC--
Q 016544 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVAPEVFKNEE-- 330 (387)
Q Consensus 270 ~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~-- 330 (387)
| +|||||||.||+++.++.+||+|||++.... ...+...+...||.-|+|||++.+..
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 9 9999999999999999999999999997611 11122346678999999999998764
Q ss_pred -CCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHH
Q 016544 331 -YDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYA 367 (387)
Q Consensus 331 -~~~~~Dv~slG~il~elltg~~pf~~-~~~~~~~~~i~ 367 (387)
|+.|+|+||||++++||+. ||.. +....++....
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR 829 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR 829 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc
Confidence 8999999999999999984 4653 22233444444
No 392
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=99.96 E-value=2.6e-28 Score=215.74 Aligned_cols=198 Identities=36% Similarity=0.570 Sum_probs=165.6
Q ss_pred ccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHH
Q 016544 165 KGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242 (387)
Q Consensus 165 ~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~ 242 (387)
.|..+.+.. +|..+++|++........ .+.+.+|+..+++++|+||+++++++......++++|++.+++|.+++.
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 345555554 468999999976533221 5788999999999999999999999999899999999999999999998
Q ss_pred HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccc
Q 016544 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322 (387)
Q Consensus 243 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 322 (387)
....++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 7766899999999999999999999998 9999999999999999999999999987665432 2233456788999
Q ss_pred cccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHHcc
Q 016544 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAAR 369 (387)
Q Consensus 323 PE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~-~~~~~~~~~i~~~ 369 (387)
||.+.+..++.++|+||||++++++++|..||.. .....+.+.+...
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~ 202 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP 202 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 9999988889999999999999999999999987 4444444444333
No 393
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.96 E-value=2.7e-29 Score=216.61 Aligned_cols=203 Identities=28% Similarity=0.383 Sum_probs=165.3
Q ss_pred cCcccceeecccEEEEE----EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------Cc
Q 016544 155 LDFTNSVEITKGTFILA----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~ 224 (387)
..|...+.+|.|.-.++ ...+++||+|+...+... ....++..+|..++..+.|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCceEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555555666654222 146899999999877433 33445567799999999999999999999644 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.|+|||+|. .+|.+++.. .++-.....++.|++.|+.|||+.+ |+||||||+||++..++.+||.|||+++...
T Consensus 96 ~y~v~e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 799999995 599998884 3678889999999999999999999 9999999999999999999999999997654
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.. ...+....+..|.|||++.+..+...+||||+||++.||++|+.-|.|.+.-+-.-++
T Consensus 170 ~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki 229 (369)
T KOG0665|consen 170 TD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI 229 (369)
T ss_pred cc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence 32 3445667788999999999999999999999999999999999999987654444444
No 394
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.95 E-value=8.1e-28 Score=208.48 Aligned_cols=224 Identities=17% Similarity=0.285 Sum_probs=188.7
Q ss_pred ccccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCce
Q 016544 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 225 (387)
-.-..|.+++.||+|+||+.+ +++..||||.-.... ...+++.|...++.+ ..++|+..|-+.+...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 345579999999999999875 578999999765432 234678899999998 589999999999998888
Q ss_pred EEEEEccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-----CEEEEeecC
Q 016544 226 MIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGV 299 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-----~~kl~Dfg~ 299 (387)
.||+|++ |.||+++..-++. ++.++++.++.|++.-++++|++. +|.|||||+|+||...+ .+.++|||+
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9999999 8999999987665 999999999999999999999999 99999999999998544 489999999
Q ss_pred ccccccCCCCCc------ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC---
Q 016544 300 SKLLTVKEDRPL------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--- 370 (387)
Q Consensus 300 ~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~--- 370 (387)
++.+........ ....||.+||+-....|...+++.|+-|||-++++.|-|.+||++.......+++.+.+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 998776544332 45679999999999999999999999999999999999999999988887777776665
Q ss_pred -CCCCCCChhhhhhc
Q 016544 371 -RPPFKAPAKLYARG 384 (387)
Q Consensus 371 -~~~~~~~~~~~~~~ 384 (387)
..++......+|.+
T Consensus 256 r~T~i~~Lc~g~P~e 270 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEE 270 (449)
T ss_pred ccCCHHHHHhcCHHH
Confidence 44555555566654
No 395
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=99.95 E-value=2.3e-27 Score=227.64 Aligned_cols=200 Identities=20% Similarity=0.257 Sum_probs=146.5
Q ss_pred ccCcccceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCH-----------HHHHHHHHHH
Q 016544 154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDD-----------DRVRAFRDEL 201 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~-----------~~~~~~~~E~ 201 (387)
..+|...+.||+|+||.||. .++.||||.+........ ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 44788889999999999873 245799999864321100 0011233466
Q ss_pred HHHHcCCCCcc-----eeeeeEEee--------CCceEEEEEccCCCCHHHHHHHcC-----------------------
Q 016544 202 ALLQKIRHPNV-----VQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG----------------------- 245 (387)
Q Consensus 202 ~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~----------------------- 245 (387)
.++.+++|.++ ++++++|.. .+..++|+||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777765543 667776653 356899999999999999886421
Q ss_pred -CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccc
Q 016544 246 -ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324 (387)
Q Consensus 246 -~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 324 (387)
.+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.++|+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1345678889999999999999998 999999999999999999999999998654432222222233478999999
Q ss_pred cccCCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCCC
Q 016544 325 VFKNEEY----------------------DTKVDVFSFALILQEMIEGCP-PFTM 356 (387)
Q Consensus 325 ~~~~~~~----------------------~~~~Dv~slG~il~elltg~~-pf~~ 356 (387)
.+..... ..+.|+||+||++|+|++|.. ||.+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 8864321 124799999999999999886 7764
No 396
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.95 E-value=1.4e-28 Score=224.14 Aligned_cols=204 Identities=25% Similarity=0.362 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC------CcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH------PNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~~~~~ 224 (387)
.|.+....|+|.|+.|. ..|..||||++..+.. ..+.-..|+.+|+++.. -|+++++-.|....+
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 46666677999998775 3578999999986533 23445679999999952 389999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVS 300 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~ 300 (387)
+|||||.+ ...|.+++++-+. +....+..++.|+.-||..|-..+ |+|+||||.|||+++.- .+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999998 4699999987553 888999999999999999999998 99999999999999655 4799999999
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+..+. +.+..+..|.|||++.|-+|+...|+||.||+||||+||+..|.|.++..++.-...-+
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 87654332 33344667999999999999999999999999999999999999999988877664433
No 397
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.95 E-value=3.6e-28 Score=200.39 Aligned_cols=197 Identities=21% Similarity=0.438 Sum_probs=161.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeC--CceEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~l 227 (387)
+|+..+.+|+|.|..|+ .++..++||++++- ..+.+.+|+.+|+.+. ||||+++++...+. ....+
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 67778899999997665 46789999998742 3467899999999995 99999999998754 56889
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 306 (387)
|+|++.+.+...+... ++..++..++.+++.||.|+|+.| |.|||+||.|++++. ...++|+|+|+|.++...
T Consensus 113 iFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999988877766554 777889999999999999999999 999999999999995 456999999999988755
Q ss_pred CCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCC-CCCCCCcHHHHH
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf-~~~~~~~~~~~i 366 (387)
.. ......+..|-.||.+.. ..+..+-|+|||||++..|+..+.|| .|.++.+.+-+|
T Consensus 187 ~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 187 KE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI 246 (338)
T ss_pred ce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence 33 333455677899998865 46788999999999999999988887 466665554444
No 398
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=99.95 E-value=9.3e-29 Score=236.86 Aligned_cols=192 Identities=29% Similarity=0.432 Sum_probs=155.6
Q ss_pred cccceeecccEEE----EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFI----LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~----~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.+|.|+-| .+.+.|+.||||.+..+. .....+|+..++.- .||||+++++.-.+....||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 3444556776654 345789999999987543 24567899999998 699999999999999999999999
Q ss_pred cCCCCHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---C--CCEEEEeecCccc
Q 016544 232 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---S--GNLKVADFGVSKL 302 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~----l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~--~~~kl~Dfg~~~~ 302 (387)
|. .+|.+++...+. ...-..+.++.|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 95 599999987421 111345788999999999999998 999999999999986 3 3589999999988
Q ss_pred cccCCC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCC
Q 016544 303 LTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKH 358 (387)
Q Consensus 303 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~pf~~~~ 358 (387)
...... .......||.+|+|||++....-+.++|||||||++|+.++| ..||.+..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 765433 223556789999999999998888899999999999999985 99998643
No 399
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=99.95 E-value=3.6e-27 Score=231.62 Aligned_cols=193 Identities=21% Similarity=0.277 Sum_probs=136.1
Q ss_pred cccCcccceeecccEEEEEEE-----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE-----
Q 016544 153 HELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----- 218 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~----- 218 (387)
...+|...+.||+|+||.||. + +..||+|.+..... .+....| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 334788889999999999874 3 68999998764321 1111111 1112222222222211
Q ss_pred -EeeCCceEEEEEccCCCCHHHHHHHcCC--------------------CChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 219 -VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 219 -~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
.......++|+||+.+++|.+++..... .....+..++.|++.||.|||+++ |+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 2345679999999999999999875421 112345679999999999999998 9999
Q ss_pred CCCCCCEEeCC-CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCC----------------------CCCc
Q 016544 278 DLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE----------------------YDTK 334 (387)
Q Consensus 278 Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~ 334 (387)
||||+|||++. ++.+||+|||++...............+++.|+|||.+.... +..+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 578999999999765433333334456789999999764322 2345
Q ss_pred hhHHHHHHHHHHHHcCCCCCC
Q 016544 335 VDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 335 ~Dv~slG~il~elltg~~pf~ 355 (387)
+|||||||++|||+++..|+.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCc
Confidence 699999999999999877654
No 400
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.94 E-value=1.1e-27 Score=202.25 Aligned_cols=218 Identities=20% Similarity=0.347 Sum_probs=164.9
Q ss_pred CccccCccc--cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeee
Q 016544 146 PEYEIDPHE--LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLG 217 (387)
Q Consensus 146 ~~~ei~~~~--~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~ 217 (387)
+..|+...+ ..|.+.+.+|.|-||... ...+.+++|.+..+ ....++|.+|..---.+ .|.||+.-|+
T Consensus 13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~ 88 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYE 88 (378)
T ss_pred ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHH
Confidence 344443333 368888999999999764 35688999998865 34467888888766556 4899998877
Q ss_pred -EEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC--CCCCEEE
Q 016544 218 -AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKV 294 (387)
Q Consensus 218 -~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl 294 (387)
.|+..+.+++++||++.|+|.+-+...+ +-+.....++.|+++|+.|+|+.+ +||||||.+|||+- +...+||
T Consensus 89 vaFqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 89 VAFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred HHhhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEe
Confidence 5677788999999999999998777644 778888999999999999999999 99999999999985 3347999
Q ss_pred EeecCccccccCCCCCcccCCCCCcccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHH
Q 016544 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKA 365 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~ 365 (387)
+|||.++..+... .....+..|.+||.+..- ...+.+|+|.||+++|.++||.+||+.... ..-..+
T Consensus 165 cDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 165 CDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ 240 (378)
T ss_pred eecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence 9999986543221 112235668899876432 456889999999999999999999984222 223455
Q ss_pred HHccCCCCCC
Q 016544 366 YAARQRPPFK 375 (387)
Q Consensus 366 i~~~~~~~~~ 375 (387)
++.+..|..+
T Consensus 241 w~~rk~~~~P 250 (378)
T KOG1345|consen 241 WLKRKNPALP 250 (378)
T ss_pred HhcccCccCc
Confidence 5556655443
No 401
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.93 E-value=1.6e-26 Score=204.28 Aligned_cols=221 Identities=23% Similarity=0.313 Sum_probs=176.6
Q ss_pred cccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-Cce
Q 016544 157 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-~~~ 225 (387)
++....+.+|+||.+|. +.+.|-+|.++.. .++-....+..|.-.+..+.|||++++.+++..+ ...
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 44455678999998763 2356777777643 3456677788899999999999999999988654 467
Q ss_pred EEEEEccCCCCHHHHHHHc--------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 226 MIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
+.++.++.-|.|..|+... ..++.-+...++.|++.|++|||+++ +||.||..+|.+|++.-++||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccc
Confidence 8889999889999999832 12566678889999999999999999 999999999999999999999999
Q ss_pred cCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 298 GVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 298 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
.+++..-+.+- -.....-.+..||+||.+....|+..+|+|||||++|||+| |+.||...++.++..-++.|.|..-
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ- 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ- 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC-
Confidence 98875432211 11122234678999999999999999999999999999997 9999999999999988888875443
Q ss_pred CChhhhhhcc
Q 016544 376 APAKLYARGL 385 (387)
Q Consensus 376 ~~~~~~~~~l 385 (387)
|-+||++|
T Consensus 520 --P~NCPDeL 527 (563)
T KOG1024|consen 520 --PFNCPDEL 527 (563)
T ss_pred --CCCCcHHH
Confidence 34555554
No 402
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=1.9e-25 Score=185.80 Aligned_cols=205 Identities=19% Similarity=0.226 Sum_probs=168.5
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||..| ..|..||||+-+...- -.++..|..+++.++ -.+|+.+..++.+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 67788899999998765 4789999998764422 135677999999996 568888888888888899999
Q ss_pred EccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 305 (387)
+.. |.||+++..-+ ..++..+++-++-|++.-++|+|.++ +|||||||+|+|..- ...+.++|||+|+.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999 89999998743 44899999999999999999999999 999999999999873 34689999999987654
Q ss_pred CCCCCc------ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 306 KEDRPL------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 306 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
...... ....||.+|.+-....+-..+.+.|+-|+|.++..+--|..||++.....-.++....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 332221 3346899999998888888899999999999999999999999998776655554433
No 403
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.92 E-value=5e-24 Score=183.82 Aligned_cols=179 Identities=38% Similarity=0.650 Sum_probs=151.4
Q ss_pred ecccEEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|.++.++ .. +..+++|.+....... ..+.+.+|+..++.+.|++|+++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 4667776554 33 8899999997553221 346789999999999999999999999998999999999998999
Q ss_pred HHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccccCCCCCcccCC
Q 016544 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
.+++... ..++...+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 9999876 46899999999999999999999998 999999999999999 89999999999876543321 122244
Q ss_pred CCCcccccccccCC-CCCCchhHHHHHHHHHHH
Q 016544 316 TSCRYVAPEVFKNE-EYDTKVDVFSFALILQEM 347 (387)
Q Consensus 316 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el 347 (387)
+...|++||.+... .++.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 67789999999887 778899999999999999
No 404
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.91 E-value=4.8e-26 Score=213.30 Aligned_cols=208 Identities=27% Similarity=0.415 Sum_probs=178.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|.....+|.|+||.||. .+...|+|+++.+- .+...-++.|+-+++..+||||+.+++.+......+++||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 445556899999998874 57889999987653 3345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
||.+|+|.+..+-.+++++.+...+++..++++.|||+.+ =+|||||-.||++++.|.+|++|||.+..+...- ..
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 9999999999999999999999999999999999999999 8999999999999999999999999987655332 22
Q ss_pred cccCCCCCcccccccc---cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+.||+.|||||+- +.+.|...+|+|++|+...|+-.-++|..+..+.+.+....+-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~ 231 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG 231 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC
Confidence 3456899999999976 44578889999999999999999999988888877776665544
No 405
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.91 E-value=1.1e-23 Score=194.31 Aligned_cols=208 Identities=22% Similarity=0.326 Sum_probs=166.2
Q ss_pred CcccceeecccEEEEEEE----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC----CcceeeeeEE-eeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----PNVVQFLGAV-TQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~l~~~~-~~~~~ 224 (387)
.|...+.||+|+||.|+. . ...+|+|.......... ..+..|..++..+.. ++++.+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 788899999999998873 1 24789998765422211 156778888888862 6899999999 47778
Q ss_pred eEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-----CCEEEEee
Q 016544 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF 297 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-----~~~kl~Df 297 (387)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.| ++||||||.|+++... ..+.|.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999998 88999988654 45999999999999999999999999 9999999999999865 35999999
Q ss_pred cCcc--ccccCCCC------C-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 298 GVSK--LLTVKEDR------P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 298 g~~~--~~~~~~~~------~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|+++ .+...... . .....||.+|.++.+..+...+++.|+||++.++.+++.|..||.+........++..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 33222111 1 1234599999999999999999999999999999999999999987765544444433
Q ss_pred cC
Q 016544 369 RQ 370 (387)
Q Consensus 369 ~~ 370 (387)
..
T Consensus 252 ~~ 253 (322)
T KOG1164|consen 252 DP 253 (322)
T ss_pred Hh
Confidence 33
No 406
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.91 E-value=1.9e-24 Score=193.32 Aligned_cols=200 Identities=22% Similarity=0.367 Sum_probs=161.6
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 226 (387)
.|.....||.|+|+.|+. ....||+|.+..... ...+..|+++|..+ .+.||+++.+++..++...
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 566777899999998862 467899999875433 24588899999999 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 305 (387)
+|+||++.....++... ++..++..+++.++.||.++|.+| ||||||||+|+|.+. .+.-.|+|||++.....
T Consensus 112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999888888776 668899999999999999999999 999999999999984 45678999999862110
Q ss_pred CC------C------CC-------------------------------cccCCCCCcccccccccCC-CCCCchhHHHHH
Q 016544 306 KE------D------RP-------------------------------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFA 341 (387)
Q Consensus 306 ~~------~------~~-------------------------------~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG 341 (387)
.. . .. .....||++|.|||++... ..++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 00 0124589999999999764 568899999999
Q ss_pred HHHHHHHcCCCCCCCC-CCCcHHHHH
Q 016544 342 LILQEMIEGCPPFTMK-HDNEVPKAY 366 (387)
Q Consensus 342 ~il~elltg~~pf~~~-~~~~~~~~i 366 (387)
||+..+++++.||-.. ++...+..|
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred ceeehhhccccccccCccccchHHHH
Confidence 9999999999998643 334444444
No 407
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.91 E-value=1.7e-23 Score=192.81 Aligned_cols=167 Identities=20% Similarity=0.221 Sum_probs=126.0
Q ss_pred ccCccccCcccceeecccEEEEEEE------cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHHcCCCCccee-eeeEE
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FLGAV 219 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~-l~~~~ 219 (387)
+.......|.....||+|+||.||. ++..||||++..... ......+.+.+|+.++++++|+|+++ +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 3344455788899999999999873 356789998753321 13344567999999999999999985 443
Q ss_pred eeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEeCCCCCEEEEeec
Q 016544 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 220 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfg 298 (387)
.+..|+||||++|++|... . +.. ...++.|++++|.|||+++ |+|||| ||+|||++.++.++|+|||
T Consensus 90 --~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred --cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 2468999999999999732 1 111 2467899999999999999 999999 9999999999999999999
Q ss_pred CccccccCCCCCc-------ccCCCCCcccccccccCC
Q 016544 299 VSKLLTVKEDRPL-------TCQDTSCRYVAPEVFKNE 329 (387)
Q Consensus 299 ~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~ 329 (387)
+++.+........ ....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9987654321111 234567789999998653
No 408
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.91 E-value=1.1e-24 Score=224.28 Aligned_cols=146 Identities=16% Similarity=0.216 Sum_probs=113.0
Q ss_pred CCC-CcceeeeeEE-------eeCCceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 207 IRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 207 l~h-~~iv~l~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
++| +||++++++| .....++.++|++ +++|.+++... ..+++.+++.++.||++||.|||+++ |+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 345 5788888877 2234577889988 56999999753 45899999999999999999999999 9999
Q ss_pred CCCCCCEEeCCCC-------------------CEEEEeecCccccccCCC---------------CCcccCCCCCccccc
Q 016544 278 DLEPSNILRDDSG-------------------NLKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVAP 323 (387)
Q Consensus 278 Dlkp~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~---------------~~~~~~~~~~~y~aP 323 (387)
||||+|||++..+ .+|++|||+++....... .......+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 455666666543211000 000113468889999
Q ss_pred ccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 324 E~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
|++.+..++.++|||||||++|||++|.+||..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999999864
No 409
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.90 E-value=2.7e-23 Score=188.71 Aligned_cols=126 Identities=29% Similarity=0.377 Sum_probs=104.4
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-----C---CcceeeeeEEee
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----H---PNVVQFLGAVTQ 221 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~l~~~~~~ 221 (387)
-.|.+.+.||-|-|.+|- ...+.||+|+.+.. +-..+....|+.+|+++. | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 468888999999997763 35789999998743 334566677999999883 2 369999999975
Q ss_pred C----CceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC
Q 016544 222 S----SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (387)
Q Consensus 222 ~----~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 287 (387)
. .++++|+|++ |..|..+|... ..++...++.|++||+.||.|||+.. +|||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4 3699999999 77999999864 34999999999999999999999975 599999999999984
No 410
>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]
Probab=99.90 E-value=5.8e-24 Score=168.11 Aligned_cols=109 Identities=34% Similarity=0.341 Sum_probs=72.0
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
+.+|-.||||||+||..|+.++|+.|+.. |+|+|+.+..|.|+||+|+..|+.+|+++|+++|+.++++|..|.||||-
T Consensus 66 ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHR 145 (226)
T KOG4412|consen 66 DDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHR 145 (226)
T ss_pred CCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHH
Confidence 33344566667777777777777776666 66777666666777777776667777777777676677777777777776
Q ss_pred ccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
|+.-|..+++++|.+.|+.++.+.....++
T Consensus 146 AAavGklkvie~Li~~~a~~n~qDk~G~Tp 175 (226)
T KOG4412|consen 146 AAAVGKLKVIEYLISQGAPLNTQDKYGFTP 175 (226)
T ss_pred HHhccchhhHHHHHhcCCCCCcccccCccH
Confidence 666666667777766666665554444443
No 411
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.88 E-value=3.9e-21 Score=177.47 Aligned_cols=211 Identities=29% Similarity=0.498 Sum_probs=174.0
Q ss_pred cccceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCC-cceeeeeEEeeCCceEEEEEccC
Q 016544 157 FTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
|.....+|.|+|+.++. .-..+++|.+.............+.+|..+++.+.|+ +|+++++.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 45566789999977663 2367899999876655444677889999999999988 79999999977777899999999
Q ss_pred CCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccCCCC
Q 016544 234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 234 ~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 309 (387)
++++.+++.... .++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||++.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999998877664 6899999999999999999999999 99999999999999988 6999999998755433222
Q ss_pred -----CcccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHHHHccC
Q 016544 310 -----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQ 370 (387)
Q Consensus 310 -----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~i~~~~ 370 (387)
......++..|++||.+.+ ...+...|+||+|++++++++|..||..... ......+....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 2355678999999999988 5788899999999999999999999887664 34445444443
No 412
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.87 E-value=6.2e-22 Score=166.76 Aligned_cols=115 Identities=23% Similarity=0.358 Sum_probs=97.7
Q ss_pred CCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 235 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
|+|.+++... ..+++.+++.++.|++.||.|||+++ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999874 45999999999999999999999975 999999999999999 99987654321
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHH
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAY 366 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~i 366 (387)
..+++.|+|||++.+..++.++|||||||++|||+||+.||..... ....+.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 117 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL 117 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH
Confidence 2478999999999999999999999999999999999999976544 2334444
No 413
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.87 E-value=2.8e-22 Score=172.10 Aligned_cols=168 Identities=10% Similarity=0.171 Sum_probs=130.3
Q ss_pred CcccceeecccEEEEEEE---cCeEEEEEEcCcccCCCHHHHHH------HHHHHHHHHcCCCCcceeeeeEEeeC----
Q 016544 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS---- 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~~---- 222 (387)
+|...+.+|.|+|+.|+. ++..+|+|.+.+.....+...+. +.+|+..+.++.||+|..+.+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 677788899999988763 56789999998776655555444 57899999999999999999886643
Q ss_pred ----CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 223 ----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 223 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
+..+++|||++|.+|.++.. ++. ....+++.++..+|+.| ++|||+||+||+++.++ ++|+|||
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999988732 222 24569999999999999 99999999999999988 9999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 348 (387)
........ ... ..++....+..++|+||||+++..+.
T Consensus 180 ~~~~~~e~--~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQR--KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred Ccccccch--hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 76543211 110 11344455667899999999987543
No 414
>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]
Probab=99.87 E-value=1.1e-22 Score=160.80 Aligned_cols=108 Identities=28% Similarity=0.380 Sum_probs=100.5
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.|++..+..|.|+|||||..|..+++++|+++|+.++.+|..|.||||.|+..|+.+++++|+..|+.+|.+|++|+||
T Consensus 96 ~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~Tp 175 (226)
T KOG4412|consen 96 GADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTP 175 (226)
T ss_pred CCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccH
Confidence 56666677777888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
||.|...++.++..+|++.|++......
T Consensus 176 L~~al~e~~~d~a~lLV~~gAd~~~edk 203 (226)
T KOG4412|consen 176 LHHALAEGHPDVAVLLVRAGADTDREDK 203 (226)
T ss_pred HHHHHhccCchHHHHHHHhccceeeccc
Confidence 9999888999999999999999866554
No 415
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.85 E-value=8.6e-21 Score=159.46 Aligned_cols=186 Identities=13% Similarity=0.067 Sum_probs=135.3
Q ss_pred cceeecccEEEEEEE---cCeEEEEEEcCcccCCCHH-HHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccC
Q 016544 159 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDD-RVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
....|++|+|+.+++ .+.+++.+.+......... ....+.+|+++++++. ++++++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 345789999999885 4567777766543221111 1225789999999995 5889999886 44699999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEeCCCCCEEEEeecCccccccCCCC---
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 309 (387)
|.+|.+.... ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9998754322 12357789999999999999 999999 799999999999999999999754432210
Q ss_pred -C--------cccCCCCCcccccccccCC-CCC-CchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 310 -P--------LTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 310 -~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
. ......++.|++|+...-- ..+ .+.++++.|+-+|.++|+..|+-+..
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0112246677777643221 233 57899999999999999999876543
No 416
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.85 E-value=1e-22 Score=191.15 Aligned_cols=196 Identities=23% Similarity=0.327 Sum_probs=165.8
Q ss_pred ecccEEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccC
Q 016544 163 ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 163 lg~G~~~~v~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
+|.|.||.|+ ..|.-+|+|++.+......... ....|..++..++ ||.++++.-.++.+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 5778887664 3567899999887666544444 5677889999996 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
||.|...+.....+.+.....+...++-++.++|+.+ ++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 9999988887777888888889999999999999999 999999999999999999999999998765322211
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.||..|||||++. .+..++|+||||+++++|+||..||.+ ++..+|...+.+.
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~ 206 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM 206 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC
Confidence 6799999999999 567889999999999999999999998 6777776655333
No 417
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.85 E-value=5.5e-21 Score=162.17 Aligned_cols=137 Identities=19% Similarity=0.214 Sum_probs=105.1
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCHH-----------------------HHHHHHHHHHHHHcCCCCcce
Q 016544 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDD-----------------------RVRAFRDELALLQKIRHPNVV 213 (387)
Q Consensus 161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~iv 213 (387)
..||.|+|+.||. +|+.||||+++........ .......|...+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4689999998873 5899999999754321111 011234599999999888775
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
....... ...++||||++++++.........++..++..++.|++.+|.++ |+.+ |+||||||+|||++ ++.+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 4443322 22389999999887766544556789999999999999999999 6888 99999999999998 4789
Q ss_pred EEEeecCcccc
Q 016544 293 KVADFGVSKLL 303 (387)
Q Consensus 293 kl~Dfg~~~~~ 303 (387)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998653
No 418
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.83 E-value=1.5e-21 Score=191.58 Aligned_cols=160 Identities=32% Similarity=0.525 Sum_probs=139.8
Q ss_pred HHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 016544 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (387)
Q Consensus 197 ~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 276 (387)
+..|+-+-..++|||++..+..+.......-.||||++ +|..++.+.+.+...++..++.|++.|+.|+|+.| +.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iah 443 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAH 443 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---cee
Confidence 66788888889999998888877776666666999999 99999999878999999999999999999999999 999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccccccCCC---CCcccCCCCCcccccccccCCCCCC-chhHHHHHHHHHHHHcCCC
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCP 352 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~elltg~~ 352 (387)
||+|++|+++..+|.+||+|||.+..+..... .......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.
T Consensus 444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred ccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 99999999999999999999999877665433 2334567899999999999999986 5899999999999999999
Q ss_pred CCCCCCCC
Q 016544 353 PFTMKHDN 360 (387)
Q Consensus 353 pf~~~~~~ 360 (387)
||.-....
T Consensus 524 ~Wk~a~~~ 531 (601)
T KOG0590|consen 524 PWKVAKKS 531 (601)
T ss_pred cccccccc
Confidence 99765444
No 419
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.83 E-value=1.1e-19 Score=154.73 Aligned_cols=138 Identities=19% Similarity=0.162 Sum_probs=106.7
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCH-----------------------HHHHHHHHHHHHHHcCCCCcce
Q 016544 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDD-----------------------DRVRAFRDELALLQKIRHPNVV 213 (387)
Q Consensus 161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~~iv 213 (387)
..||+|+++.||. +|+.||||+++....... .....+..|...+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4689999988863 589999999876522100 0122346789999999999875
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
....+... ..++||||++|+++.........++..++..++.|++.++.++|+ .| |+||||||+||+++ ++.+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCE
Confidence 55444333 248999999887654443344567888999999999999999999 88 99999999999999 7899
Q ss_pred EEEeecCccccc
Q 016544 293 KVADFGVSKLLT 304 (387)
Q Consensus 293 kl~Dfg~~~~~~ 304 (387)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987643
No 420
>PRK10345 hypothetical protein; Provisional
Probab=99.82 E-value=8.3e-20 Score=156.37 Aligned_cols=136 Identities=18% Similarity=0.300 Sum_probs=104.1
Q ss_pred cccceeecccEEEEEEEc--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-----CCCcceeeeeEEeeCC---ceE
Q 016544 157 FTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---PMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~~~~---~~~ 226 (387)
+.....||+|+|+.||.. ....+||++..... ...+.+.+|+.+++.+ .||||++++++++++. .++
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEECCCCcCeEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 455678999999999852 12236887764322 2346789999999999 5799999999999874 334
Q ss_pred -EEEEc--cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCCEEeCCC----CCEEEEe-e
Q 016544 227 -IVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD-F 297 (387)
Q Consensus 227 -lv~e~--~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~D-f 297 (387)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++.. +.++|+| |
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5578999999764 45555 35678888777 9999999 9999999999999743 3799999 4
Q ss_pred cCcc
Q 016544 298 GVSK 301 (387)
Q Consensus 298 g~~~ 301 (387)
|...
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 5433
No 421
>PHA02743 Viral ankyrin protein; Provisional
Probab=99.82 E-value=5.3e-20 Score=152.84 Aligned_cols=108 Identities=19% Similarity=0.163 Sum_probs=97.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHH---HHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEG---IKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~---~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~ 103 (387)
++.+.+.++.+|+||||+||..|+.+. +++|+++|+++|.+| ..|+||||+|+..++.+++++|++ .|++++.+|
T Consensus 46 ~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d 125 (166)
T PHA02743 46 DGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAIN 125 (166)
T ss_pred cchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcC
Confidence 455667777889999999999988654 899999999999998 589999999999999999999995 799999999
Q ss_pred cCCCCccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
..|.||||+|+..++.+++++|+++|+++..+.
T Consensus 126 ~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 158 (166)
T PHA02743 126 YQHETAYHIAYKMRDRRMMEILRANGAVCDDPL 158 (166)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999999999875443
No 422
>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]
Probab=99.81 E-value=5.1e-20 Score=172.42 Aligned_cols=115 Identities=28% Similarity=0.312 Sum_probs=106.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
++.+++..|.+|.|+|||||.+++++++++||++|||||+.+ .-|.||||+||++|+..+|.+|+++|||++.+|.+|.
T Consensus 67 ~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~ 146 (600)
T KOG0509|consen 67 EGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGL 146 (600)
T ss_pred cCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCC
Confidence 367788888899999999999999999999999999999998 4599999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
||+|+|+.+++.-++.+++..++++.+......++.
T Consensus 147 ~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpL 182 (600)
T KOG0509|consen 147 TPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPL 182 (600)
T ss_pred cHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHH
Confidence 999999999999999999999999988776666653
No 423
>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]
Probab=99.79 E-value=1.4e-19 Score=142.24 Aligned_cols=97 Identities=27% Similarity=0.230 Sum_probs=77.0
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
.-+|.+|.+|+||||-|+++|+.++|+.|+..|||++++...||||||-||.+++.+|+-+||++|||+|.......|||
T Consensus 88 n~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpL 167 (228)
T KOG0512|consen 88 NHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPL 167 (228)
T ss_pred ccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhh
Confidence 34677777888888888888888888888888888888888888888888888888888888888888888888788888
Q ss_pred ccccccchH-HHHHHHHh
Q 016544 111 GDAIYYKNH-EVIKLLEK 127 (387)
Q Consensus 111 ~~a~~~~~~-~~~~~L~~ 127 (387)
|+|+...+. ..+.+|+.
T Consensus 168 hlaa~~rn~r~t~~~Ll~ 185 (228)
T KOG0512|consen 168 HLAAGNRNSRDTLELLLH 185 (228)
T ss_pred HHhhcccchHHHHHHHhh
Confidence 888765544 44455543
No 424
>PHA02741 hypothetical protein; Provisional
Probab=99.78 E-value=5.8e-19 Score=147.24 Aligned_cols=102 Identities=21% Similarity=0.274 Sum_probs=93.8
Q ss_pred CCCCCCCCCCcchHHHHHHhhCC----HHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCC
Q 016544 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~g~~~n~~d~-~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~ 103 (387)
+.+.+.++..|+||||+|+..|+ .+++++|+++|+++|.+|. +|+||||+|+..++.+++++|+. .|++++.+|
T Consensus 50 ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n 129 (169)
T PHA02741 50 AAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCN 129 (169)
T ss_pred hhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCC
Confidence 45566777788899999999999 5899999999999999985 89999999999999999999998 599999999
Q ss_pred cCCCCccccccccchHHHHHHHHhhCCC
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
..|.||||+|...++.+++++|.+.++.
T Consensus 130 ~~g~tpL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 130 ADNKSPFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999998765
No 425
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.78 E-value=1.9e-19 Score=159.28 Aligned_cols=217 Identities=19% Similarity=0.321 Sum_probs=135.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC----------CCcceeeeeEEe
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------HPNVVQFLGAVT 220 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------h~~iv~l~~~~~ 220 (387)
.+..+..||.|+++.|+. +|+++|+|++...........+++++|.-....+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 455677899999988763 67999999887655444556777877775555532 223333333322
Q ss_pred eC------------C-----ceEEEEEccCCCCHHHHHH---HcCCC----ChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 016544 221 QS------------S-----PMMIVTEYLPKGDLRAFLK---RKGAL----KPSTAVRFALDIARGMNYLHENKPVPIIH 276 (387)
Q Consensus 221 ~~------------~-----~~~lv~e~~~~~sL~~~l~---~~~~l----~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 276 (387)
.. . ..+++|+-+. ++|.+++. ..... .......+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 2367888884 58888764 22222 22334556689999999999999 999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCC--------CCCCchhHHHHHHHHHHHH
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--------EYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Dv~slG~il~ell 348 (387)
+||+|+|++++.+|.++|+||+.....+.. ......+..|.+||..... .++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999876543321 1112335678999976442 4678899999999999999
Q ss_pred cCCCCCCCCCCCcHHHHHHccCCCCCCCChhhh
Q 016544 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (387)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 381 (387)
+|..||....+.......-..++ .++++.+.+
T Consensus 245 C~~lPf~~~~~~~~~~~~f~~C~-~~Pe~v~~L 276 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEWDFSRCR-DMPEPVQFL 276 (288)
T ss_dssp HSS-STCCCGGGSTSGGGGTTSS----HHHHHH
T ss_pred HccCCCCCCCccccccccchhcC-CcCHHHHHH
Confidence 99999997766555443223334 444444443
No 426
>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain. These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....
Probab=99.78 E-value=1.1e-18 Score=129.40 Aligned_cols=87 Identities=44% Similarity=0.583 Sum_probs=82.1
Q ss_pred HHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHH
Q 016544 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123 (387)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~ 123 (387)
||+||..|+.+++++|++.+++++. |+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..++.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7999999999999999999999987 899999999999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCC
Q 016544 124 LLEKHGAKPLM 134 (387)
Q Consensus 124 ~L~~~g~~~~~ 134 (387)
+|+++|+++..
T Consensus 77 ~Ll~~g~~~~~ 87 (89)
T PF12796_consen 77 LLLEHGADVNI 87 (89)
T ss_dssp HHHHTTT-TTS
T ss_pred HHHHcCCCCCC
Confidence 99999998754
No 427
>PHA02859 ankyrin repeat protein; Provisional
Probab=99.78 E-value=1.6e-18 Score=149.54 Aligned_cols=98 Identities=21% Similarity=0.253 Sum_probs=49.9
Q ss_pred CcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--cCCHHHHHHHHHCCCCCCCCCcCCCCcccc-
Q 016544 39 KPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGD- 112 (387)
Q Consensus 39 ~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~--~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~- 112 (387)
.|+||||+|+.. ++.+++++|+++|+|+|.+|.+|.||||+|+. .++.+++++|+++|++++.+|..|.||||.
T Consensus 86 ~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~ 165 (209)
T PHA02859 86 NNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYSY 165 (209)
T ss_pred CCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCCcHHHHH
Confidence 445555554432 24555555555555555555555555555443 234555555555555555555555555552
Q ss_pred ccccchHHHHHHHHhhCCCCCCCC
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
|...++.+++++|++.|+++....
T Consensus 166 a~~~~~~~iv~~Ll~~Gadi~~~d 189 (209)
T PHA02859 166 ILFHSDKKIFDFLTSLGIDINETN 189 (209)
T ss_pred HHhcCCHHHHHHHHHcCCCCCCCC
Confidence 333445555555555555544333
No 428
>PHA02791 ankyrin-like protein; Provisional
Probab=99.77 E-value=1.4e-18 Score=155.55 Aligned_cols=100 Identities=26% Similarity=0.272 Sum_probs=92.7
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
+..|.+|+||||+||..|+.+++++|+++|+++|..| |+||||+|+..|+.+++++|+++|++++.+|..|+||||+|
T Consensus 24 ~~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~A 101 (284)
T PHA02791 24 FKADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYA 101 (284)
T ss_pred CCCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 3567789999999999999999999999999998875 68999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHhhCCCCCCC
Q 016544 114 IYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 114 ~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
+..++.+++++|+++|+++...
T Consensus 102 a~~g~~eivk~Ll~~gadin~~ 123 (284)
T PHA02791 102 VDSGNMQTVKLFVKKNWRLMFY 123 (284)
T ss_pred HHcCCHHHHHHHHHCCCCcCcc
Confidence 9999999999999999987543
No 429
>PHA02791 ankyrin-like protein; Provisional
Probab=99.77 E-value=1.6e-18 Score=155.19 Aligned_cols=91 Identities=24% Similarity=0.198 Sum_probs=63.9
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC-Cccccccccch
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN 118 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~-tpl~~a~~~~~ 118 (387)
|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|++++.++..|+ ||||+|+..++
T Consensus 61 ~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~ 140 (284)
T PHA02791 61 NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLND 140 (284)
T ss_pred CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCC
Confidence 46777777777777777777777777777777777777777777777777777777777776666664 66777776677
Q ss_pred HHHHHHHHhhCC
Q 016544 119 HEVIKLLEKHGA 130 (387)
Q Consensus 119 ~~~~~~L~~~g~ 130 (387)
.+++++|++.+.
T Consensus 141 ~eivk~LL~~~~ 152 (284)
T PHA02791 141 VSIVSYFLSEIP 152 (284)
T ss_pred HHHHHHHHhcCC
Confidence 777776666654
No 430
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.77 E-value=8.3e-19 Score=175.94 Aligned_cols=195 Identities=23% Similarity=0.308 Sum_probs=155.1
Q ss_pred ccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC---CCcceeeeeEEee
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQ 221 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~ 221 (387)
++......|.+.+++|.|+||.||+ +|+.||+|+-+...... |.-=.+++.+++ -+.|..+..++..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3334445788899999999999986 68999999987665432 111223334444 2345555555566
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-------CCCEEE
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------SGNLKV 294 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-------~~~~kl 294 (387)
.+.-++|+||.+.|+|.+++...+.+++..+..++.|++..++.||..+ |||+||||+|+||.. .-.++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 6777899999999999999998778999999999999999999999999 999999999999963 234899
Q ss_pred EeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCC
Q 016544 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~ 352 (387)
+|||.+--+..-.+. ......+|-.+-++|+..|++++..+|.|-|+.+++.||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999988655443333 4455677889999999999999999999999999999999874
No 431
>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]
Probab=99.77 E-value=1.1e-18 Score=142.52 Aligned_cols=105 Identities=27% Similarity=0.276 Sum_probs=99.3
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
+|.-|..|.|||+||+.+|++.+|++|++.|||++...+...|+|.+|+..|..+||++|++++.|+|..|.+|-|||-|
T Consensus 153 VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLly 232 (296)
T KOG0502|consen 153 VNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLY 232 (296)
T ss_pred ccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeee
Confidence 55667789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHhhCCCCCCCCc
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|+..++.++++.|+..|+++.....
T Consensus 233 Avrgnhvkcve~Ll~sGAd~t~e~d 257 (296)
T KOG0502|consen 233 AVRGNHVKCVESLLNSGADVTQEDD 257 (296)
T ss_pred eecCChHHHHHHHHhcCCCcccccc
Confidence 9999999999999999999865543
No 432
>PHA02736 Viral ankyrin protein; Provisional
Probab=99.77 E-value=6.2e-19 Score=144.97 Aligned_cols=99 Identities=20% Similarity=0.227 Sum_probs=91.4
Q ss_pred CCCCCCcchHHHHHHhhCCH---HHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCcCCCC
Q 016544 34 DGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGST 108 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~---~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~t 108 (387)
+..|..|+||||+||..|+. +++++|++.|+++|.+| .+|+||||+|+..++.+++++|++ .|++++.+|..|.|
T Consensus 49 ~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~t 128 (154)
T PHA02736 49 LEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKT 128 (154)
T ss_pred HHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCC
Confidence 34577899999999999987 46899999999999998 589999999999999999999998 49999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
|||+|+..++.+++++|++.|++.
T Consensus 129 pL~~A~~~~~~~i~~~Ll~~ga~~ 152 (154)
T PHA02736 129 PYYVACERHDAKMMNILRAKGAQC 152 (154)
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCC
Confidence 999999999999999999999875
No 433
>PHA02741 hypothetical protein; Provisional
Probab=99.77 E-value=1.6e-18 Score=144.65 Aligned_cols=110 Identities=20% Similarity=0.176 Sum_probs=95.2
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHH------cCCCCCCCCCCCCcHHHHHHHcCC----HHHHHHHHHCCCCCCCC
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK 102 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~------~g~~~n~~d~~g~t~Lh~A~~~~~----~~~~~~Ll~~ga~~~~~ 102 (387)
.+.++..|.||||+||..|+.++++.|+. .|+++|.+|..|+||||+|+..|+ .+++++|+++|++++.+
T Consensus 14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~ 93 (169)
T PHA02741 14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ 93 (169)
T ss_pred hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence 34556678899999999999999999853 378999999999999999999999 58999999999999999
Q ss_pred Cc-CCCCccccccccchHHHHHHHHh-hCCCCCCCCcccccc
Q 016544 103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHA 142 (387)
Q Consensus 103 ~~-~g~tpl~~a~~~~~~~~~~~L~~-~g~~~~~~~~~~~~~ 142 (387)
+. .|+||||+|+..++.+++++|+. .|+++........++
T Consensus 94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tp 135 (169)
T PHA02741 94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSP 135 (169)
T ss_pred CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCH
Confidence 85 99999999999999999999997 588876554443333
No 434
>PHA02878 ankyrin repeat protein; Provisional
Probab=99.75 E-value=3.8e-18 Score=166.13 Aligned_cols=107 Identities=31% Similarity=0.438 Sum_probs=100.5
Q ss_pred cCCCCCCCCCC-cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~-g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
+|.|++..+.. |.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 156 ~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~ 235 (477)
T PHA02878 156 YGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGN 235 (477)
T ss_pred cCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 57788888887 99999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-chHHHHHHHHhhCCCCCCC
Q 016544 108 TPLGDAIYY-KNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 108 tpl~~a~~~-~~~~~~~~L~~~g~~~~~~ 135 (387)
||||+|+.. ++.+++++|+++|+++...
T Consensus 236 TpLh~A~~~~~~~~iv~~Ll~~gadvn~~ 264 (477)
T PHA02878 236 TPLHISVGYCKDYDILKLLLEHGVDVNAK 264 (477)
T ss_pred CHHHHHHHhcCCHHHHHHHHHcCCCCCcc
Confidence 999999975 6899999999999998654
No 435
>KOG0508 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.75 E-value=7.9e-19 Score=158.28 Aligned_cols=104 Identities=29% Similarity=0.395 Sum_probs=96.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.++++|..+....|||--||..|+.++|++|+++|||++..|..|.|.||+||+.|+.+|+++|++.|||+|.++..|.|
T Consensus 106 ~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNT 185 (615)
T KOG0508|consen 106 RGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNT 185 (615)
T ss_pred hcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCch
Confidence 45666777777789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
+||.+++.|+.|++++|+++|+.+
T Consensus 186 ALH~caEsG~vdivq~Ll~~ga~i 209 (615)
T KOG0508|consen 186 ALHDCAESGSVDIVQLLLKHGAKI 209 (615)
T ss_pred HHHhhhhcccHHHHHHHHhCCcee
Confidence 999999999999999999988765
No 436
>PHA02874 ankyrin repeat protein; Provisional
Probab=99.75 E-value=5.7e-18 Score=163.00 Aligned_cols=109 Identities=32% Similarity=0.472 Sum_probs=102.2
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.+.|.+.++..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 113 ~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~t 192 (434)
T PHA02874 113 CGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGES 192 (434)
T ss_pred CcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 45677778888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|||+|+..|+.+++++|++.|+++.....
T Consensus 193 pL~~A~~~g~~~iv~~Ll~~g~~i~~~~~ 221 (434)
T PHA02874 193 PLHNAAEYGDYACIKLLIDHGNHIMNKCK 221 (434)
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCcCCCC
Confidence 99999999999999999999998755443
No 437
>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]
Probab=99.75 E-value=2.7e-18 Score=160.98 Aligned_cols=116 Identities=31% Similarity=0.408 Sum_probs=102.2
Q ss_pred hhhhhhcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 016544 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (387)
Q Consensus 23 ~~~~~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 102 (387)
+++|++|.... .-+.|||||||++|++.+|++|+++|||++.+|.+|.||||.|+..|+.-++-+||.+|+|+|.+
T Consensus 99 ~~gadvn~~gG----~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~ 174 (600)
T KOG0509|consen 99 SHGADVNAIGG----VLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLR 174 (600)
T ss_pred HcCCCccccCC----CCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCc
Confidence 45555555554 34678999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCccccccccchHHHHHHHHhhCCCCCCCC-cccccc
Q 016544 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP-MHVKHA 142 (387)
Q Consensus 103 ~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~-~~~~~~ 142 (387)
|.+|.|||++|+..+....+..|+..|+.+.... .+..++
T Consensus 175 D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~Tp 215 (600)
T KOG0509|consen 175 DNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTP 215 (600)
T ss_pred CCCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCch
Confidence 9999999999999999988999999999886655 444433
No 438
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.75 E-value=1.4e-18 Score=171.56 Aligned_cols=179 Identities=30% Similarity=0.465 Sum_probs=133.8
Q ss_pred ccCccccCcccceeecccEEEEEEEc-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
...+.+.+|...+.+..|.||.||.- .+.+|+|+-+.+.+ +++ ++.....|.+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li--------lRn---ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--------LRN---ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcccccchh--------hhc---cccccCCccee----------
Confidence 45566778888899999999988753 45677743221110 111 33444455444
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|+-...++.-++++..- +-+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++..
T Consensus 136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred -----------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 44445555544444432 67899999999 999999999999999999999999998754
Q ss_pred ccCCC--------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 304 TVKED--------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 304 ~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
..... .......||+.|.|||++....|+..+|||++|+|+||.+-|..||.+.+++++..++...
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 32111 0113356899999999999999999999999999999999999999999999999998766
Q ss_pred C
Q 016544 370 Q 370 (387)
Q Consensus 370 ~ 370 (387)
.
T Consensus 274 ~ 274 (1205)
T KOG0606|consen 274 D 274 (1205)
T ss_pred h
Confidence 6
No 439
>PHA02859 ankyrin repeat protein; Provisional
Probab=99.74 E-value=8.1e-18 Score=145.10 Aligned_cols=105 Identities=26% Similarity=0.279 Sum_probs=91.9
Q ss_pred CCCCCCCcchHHHHHHhhC--CHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCcCC
Q 016544 33 DDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWG 106 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g 106 (387)
.+..+..|.||||+|+..+ +.+++++|+++|+|+|.++ ..|+||||+|+.. ++.+++++|+++|+++|.+|..|
T Consensus 44 ~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G 123 (209)
T PHA02859 44 VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDG 123 (209)
T ss_pred hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCC
Confidence 3455678899999999854 8999999999999999997 4799999998864 47999999999999999999999
Q ss_pred CCccccccc--cchHHHHHHHHhhCCCCCCCCc
Q 016544 107 STPLGDAIY--YKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 107 ~tpl~~a~~--~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
.||||+|+. .++.+++++|++.|+++.....
T Consensus 124 ~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~ 156 (209)
T PHA02859 124 KNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDF 156 (209)
T ss_pred CCHHHHHHHhccCCHHHHHHHHHcCCCcccccC
Confidence 999999875 4689999999999999865443
No 440
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.74 E-value=3.9e-17 Score=141.69 Aligned_cols=134 Identities=23% Similarity=0.362 Sum_probs=111.5
Q ss_pred eeecccEEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 161 ~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+.||+|++|.|| +.|..+++|.......... .....+.+|+.++..+.|++|+....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 358999998776 5688999998765433222 12345778999999999999888777777778889999999
Q ss_pred CCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 233 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+|++|.+++..... ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999876432 78889999999999999999 99999999999999 78899999998865
No 441
>PHA02946 ankyin-like protein; Provisional
Probab=99.74 E-value=8.7e-18 Score=161.02 Aligned_cols=109 Identities=21% Similarity=0.249 Sum_probs=96.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCCCCCC-CCcC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDP-KDRW 105 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--~~~~~~~Ll~~ga~~~~-~~~~ 105 (387)
++.|++.++..|+||||+||..|+.+++++|+++|||+|.+|.+|+||||+|+..+ ..+++++|+++|++++. .|..
T Consensus 61 ~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~ 140 (446)
T PHA02946 61 RGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEE 140 (446)
T ss_pred CcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCC
Confidence 67777888888999999999999999999999999999999999999999998866 48999999999999995 6889
Q ss_pred CCCccccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 106 g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
|.|||+ |+..++.+++++|++.|+++......
T Consensus 141 g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~ 172 (446)
T PHA02946 141 GCGPLL-ACTDPSERVFKKIMSIGFEARIVDKF 172 (446)
T ss_pred CCcHHH-HHHCCChHHHHHHHhccccccccCCC
Confidence 999997 56678899999999999987655443
No 442
>PHA02875 ankyrin repeat protein; Provisional
Probab=99.74 E-value=1e-17 Score=160.33 Aligned_cols=101 Identities=24% Similarity=0.224 Sum_probs=93.1
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
.+..|.||||+||..|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 98 ~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~ 177 (413)
T PHA02875 98 FYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMA 177 (413)
T ss_pred ccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 34568999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCCC
Q 016544 116 YKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~ 136 (387)
.|+.+++++|++.|+++....
T Consensus 178 ~g~~eiv~~Ll~~ga~~n~~~ 198 (413)
T PHA02875 178 KGDIAICKMLLDSGANIDYFG 198 (413)
T ss_pred cCCHHHHHHHHhCCCCCCcCC
Confidence 999999999999999886544
No 443
>PLN03192 Voltage-dependent potassium channel; Provisional
Probab=99.74 E-value=8.4e-18 Score=173.24 Aligned_cols=111 Identities=27% Similarity=0.282 Sum_probs=99.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--------------------------
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC-------------------------- 82 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~-------------------------- 82 (387)
.+.|.+..|..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.
T Consensus 547 ~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~~~L 626 (823)
T PLN03192 547 AKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDLL 626 (823)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCchHH
Confidence 577888888899999999999999999999999999999999999999886554
Q ss_pred -----cCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccc
Q 016544 83 -----QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 83 -----~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
.|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|+++.......
T Consensus 627 ~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g 688 (823)
T PLN03192 627 CTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD 688 (823)
T ss_pred HHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence 555666777888999999999999999999999999999999999999987665443
No 444
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.74 E-value=3.3e-17 Score=140.81 Aligned_cols=130 Identities=25% Similarity=0.367 Sum_probs=105.5
Q ss_pred ecccEEEEEE---EcCeEEEEEEcCcccCCC-----HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAF---WRGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~---~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||+|+++.|| ++|..|++|......... .....++.+|+.+++.+.|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7899998776 578899999865433222 12245678899999999988766665566667778999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998765321 78899999999999999 99999999999999 789999999988653
No 445
>PHA02884 ankyrin repeat protein; Provisional
Probab=99.74 E-value=1.1e-17 Score=149.83 Aligned_cols=91 Identities=21% Similarity=0.140 Sum_probs=47.9
Q ss_pred HHHHHhhCCHHHHHHHHHcCCCCCCCC----CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC-CcCCCCccccccccch
Q 016544 44 LMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPK-DRWGSTPLGDAIYYKN 118 (387)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~g~~~n~~d----~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~-~~~g~tpl~~a~~~~~ 118 (387)
||.|+..|+.+++++|+++|||+|.++ ..|.||||+|+..++.+++++|+++||++|.+ +..|.||||+|+..++
T Consensus 37 L~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~ 116 (300)
T PHA02884 37 LYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGC 116 (300)
T ss_pred HHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCC
Confidence 334444455555555555555555542 34555555555555555555555555555553 2345555555555555
Q ss_pred HHHHHHHHhhCCCCCC
Q 016544 119 HEVIKLLEKHGAKPLM 134 (387)
Q Consensus 119 ~~~~~~L~~~g~~~~~ 134 (387)
.+++++|+..|+++..
T Consensus 117 ~eivklLL~~GAdin~ 132 (300)
T PHA02884 117 LKCLEILLSYGADINI 132 (300)
T ss_pred HHHHHHHHHCCCCCCC
Confidence 5555555555555543
No 446
>PHA02795 ankyrin-like protein; Provisional
Probab=99.73 E-value=7.4e-18 Score=156.78 Aligned_cols=98 Identities=26% Similarity=0.210 Sum_probs=90.2
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~ 116 (387)
+..|.||+|.|+..++.+++++|+++|||+|.+|..|.||||+|+..|+.+++++|+++||+++.+|..|.||||+|+..
T Consensus 185 ~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~ 264 (437)
T PHA02795 185 KIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDR 264 (437)
T ss_pred hhhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHc
Confidence 34578999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred c--------hHHHHHHHHhhCCCCCC
Q 016544 117 K--------NHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 117 ~--------~~~~~~~L~~~g~~~~~ 134 (387)
| +.+++++|+++|+++..
T Consensus 265 g~~~~~~~~~~eIvelLL~~gadI~~ 290 (437)
T PHA02795 265 GSVIARRETHLKILEILLREPLSIDC 290 (437)
T ss_pred CCcccccccHHHHHHHHHhCCCCCCc
Confidence 7 46999999999987754
No 447
>PHA02884 ankyrin repeat protein; Provisional
Probab=99.73 E-value=2.4e-17 Score=147.59 Aligned_cols=98 Identities=22% Similarity=0.261 Sum_probs=88.0
Q ss_pred cCCCCCCC----CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 016544 29 NGLDDDGE----EIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (387)
Q Consensus 29 ~~~~~~~~----~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~-d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (387)
+|+|++.+ +..|.||||+|+..|+.+++++|+++|||+|.+ +..|.||||+|+..++.+++++|+++|++++.+|
T Consensus 55 ~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdin~kd 134 (300)
T PHA02884 55 LGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADINIQT 134 (300)
T ss_pred CCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence 45555554 347999999999999999999999999999996 4679999999999999999999999999999999
Q ss_pred cCCCCccccccccchHHHHHHHH
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLE 126 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~ 126 (387)
..|.||||+|+..++.+++..+.
T Consensus 135 ~~G~TpL~~A~~~~~~~~~~~~~ 157 (300)
T PHA02884 135 NDMVTPIELALMICNNFLAFMIC 157 (300)
T ss_pred CCCCCHHHHHHHhCChhHHHHhc
Confidence 99999999999988888876554
No 448
>PHA02875 ankyrin repeat protein; Provisional
Probab=99.72 E-value=2e-17 Score=158.37 Aligned_cols=106 Identities=25% Similarity=0.325 Sum_probs=100.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC-
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS- 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~- 107 (387)
.|.|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..|.
T Consensus 124 ~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~~ 203 (413)
T PHA02875 124 RGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGCV 203 (413)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCc
Confidence 5778888888899999999999999999999999999999999999999999999999999999999999999998875
Q ss_pred CccccccccchHHHHHHHHhhCCCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~ 134 (387)
||+|+|+..++.+++++|+++|+++..
T Consensus 204 t~l~~A~~~~~~~iv~~Ll~~gad~n~ 230 (413)
T PHA02875 204 AALCYAIENNKIDIVRLFIKRGADCNI 230 (413)
T ss_pred hHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence 789999999999999999999999854
No 449
>PHA02716 CPXV016; CPX019; EVM010; Provisional
Probab=99.72 E-value=1.5e-17 Score=165.07 Aligned_cols=109 Identities=21% Similarity=0.199 Sum_probs=82.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCC--HHHHHHHHHcCCCCCCCCCCCCcHHHHH--------------------------
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA-------------------------- 80 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~--~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A-------------------------- 80 (387)
+|.|++.++..|+||||+|+..|+ .++|++|+++|||+|.+|..|+||||+|
T Consensus 201 ~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~ 280 (764)
T PHA02716 201 NGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKN 280 (764)
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhcccccccc
Confidence 566777777778888888888874 4788888888888888888888888864
Q ss_pred -----------HHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc--cchHHHHHHHHhhCCCCCCCCc
Q 016544 81 -----------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 81 -----------~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~--~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
+..|+.+++++|+++|++++.+|..|+||||+|+. .++.+++++|++.|+++.....
T Consensus 281 ~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~ 350 (764)
T PHA02716 281 IPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDN 350 (764)
T ss_pred chhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCC
Confidence 34467778888888888888888888888887653 4567888888888887755443
No 450
>PHA02743 Viral ankyrin protein; Provisional
Probab=99.72 E-value=1.1e-17 Score=138.88 Aligned_cols=109 Identities=20% Similarity=0.197 Sum_probs=92.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH---HHHHHHCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV---VSLLLERGADVDP 101 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~----~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~---~~~Ll~~ga~~~~ 101 (387)
|+.|.+..+.++.++||.||+.|+. +++++|++.|+++|.+|.+|+||||+|+..|+.++ +++|+++|++++.
T Consensus 9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~ 88 (166)
T PHA02743 9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINA 88 (166)
T ss_pred cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCC
Confidence 3444444455566779999999998 67778889999999999999999999999988654 8999999999999
Q ss_pred CC-cCCCCccccccccchHHHHHHHHh-hCCCCCCCCc
Q 016544 102 KD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPM 137 (387)
Q Consensus 102 ~~-~~g~tpl~~a~~~~~~~~~~~L~~-~g~~~~~~~~ 137 (387)
+| ..|.||||+|+..++.+++++|+. .|+++.....
T Consensus 89 ~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~ 126 (166)
T PHA02743 89 RELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINY 126 (166)
T ss_pred CCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCC
Confidence 98 589999999999999999999995 7988765443
No 451
>PHA03095 ankyrin-like protein; Provisional
Probab=99.72 E-value=2.3e-17 Score=160.73 Aligned_cols=111 Identities=29% Similarity=0.335 Sum_probs=100.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC-CHHHHHHHHHCCCCCCCCCc
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~-~~~~~~~Ll~~ga~~~~~~~ 104 (387)
+|.|++.++..|.||||+|+..+ +.+++++|+++|+|+|.+|..|+||||+|+..| +.+++++|+++|++++.+|.
T Consensus 36 ~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~ 115 (471)
T PHA03095 36 AGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDK 115 (471)
T ss_pred cCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCC
Confidence 56777778888999999999998 999999999999999999999999999999999 59999999999999999999
Q ss_pred CCCCcccccc--ccchHHHHHHHHhhCCCCCCCCccc
Q 016544 105 WGSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 105 ~g~tpl~~a~--~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
.|.||||+|+ ..++.+++++|++.|+++.......
T Consensus 116 ~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g 152 (471)
T PHA03095 116 VGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYG 152 (471)
T ss_pred CCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCC
Confidence 9999999999 5668899999999999986654443
No 452
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.72 E-value=2.2e-18 Score=170.53 Aligned_cols=194 Identities=23% Similarity=0.311 Sum_probs=143.0
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
++...+.+|++.|-++. -+...|+||++-+.. ..=....++++ |++ ...+++||++++.-+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 45566789999996543 233449999886543 11122223333 444 566689999999888777888899999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.. +|.+.+....-+..-+.+-|+.|++.||..+|..| |.|||||.+|||++.=..+.|+||..-+..-.+++.+
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9954 99998887666777788889999999999999999 9999999999999988889999997644322222222
Q ss_pred c--cc----CCCCCcccccccccCC----------C-CCCchhHHHHHHHHHHHHc-CCCCCC
Q 016544 311 L--TC----QDTSCRYVAPEVFKNE----------E-YDTKVDVFSFALILQEMIE-GCPPFT 355 (387)
Q Consensus 311 ~--~~----~~~~~~y~aPE~~~~~----------~-~~~~~Dv~slG~il~ellt-g~~pf~ 355 (387)
. .. ...-..|+|||.+... + .+++-||||+||++.||++ |++||.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1 11 1112249999987541 2 5778999999999999996 899995
No 453
>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]
Probab=99.72 E-value=2.3e-17 Score=129.89 Aligned_cols=94 Identities=35% Similarity=0.449 Sum_probs=88.9
Q ss_pred HHHHHhhCCHHHHHHHHHcCCC-CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHH
Q 016544 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (387)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~g~~-~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~ 122 (387)
+.+|+..+....|+.||+..|| +|.+|.+|.||||.|+++|+.+|++.|+..||+++.+...||||||-||...+.+++
T Consensus 67 ~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va 146 (228)
T KOG0512|consen 67 LLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVA 146 (228)
T ss_pred HHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHH
Confidence 6789999999999999998776 899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCc
Q 016544 123 KLLEKHGAKPLMAPM 137 (387)
Q Consensus 123 ~~L~~~g~~~~~~~~ 137 (387)
.+|+++|+++.....
T Consensus 147 ~~LLqhgaDVnA~t~ 161 (228)
T KOG0512|consen 147 GRLLQHGADVNAQTK 161 (228)
T ss_pred HHHHhccCccccccc
Confidence 999999999865543
No 454
>PHA02878 ankyrin repeat protein; Provisional
Probab=99.72 E-value=3.7e-17 Score=159.25 Aligned_cols=112 Identities=24% Similarity=0.249 Sum_probs=100.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-CCHHHHHHHHHCCCCCCCCCc-CC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDR-WG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~-~~~~~~~~Ll~~ga~~~~~~~-~g 106 (387)
.+.|.+..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+.. ++.+++++|+++|++++.++. .|
T Consensus 190 ~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g 269 (477)
T PHA02878 190 YGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILG 269 (477)
T ss_pred CCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 4667777888899999999999999999999999999999999999999999975 789999999999999999986 79
Q ss_pred CCccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
.||||+| .++.+++++|+++|+++........++
T Consensus 270 ~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp 303 (477)
T PHA02878 270 LTALHSS--IKSERKLKLLLEYGADINSLNSYKLTP 303 (477)
T ss_pred CCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 9999999 567899999999999997766555544
No 455
>PHA02798 ankyrin-like protein; Provisional
Probab=99.72 E-value=2e-17 Score=161.48 Aligned_cols=107 Identities=25% Similarity=0.306 Sum_probs=98.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhh-----CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC---CHHHHHHHHHCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVD 100 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~-----~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~---~~~~~~~Ll~~ga~~~ 100 (387)
+|.|++..+..|.||||+|+.+ ++.+++++|+++|||+|.+|.+|+||||+|+..+ +.+++++|+++||+++
T Consensus 60 ~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn 139 (489)
T PHA02798 60 LGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTT 139 (489)
T ss_pred CCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCcc
Confidence 6788888888999999998864 6799999999999999999999999999999875 7899999999999999
Q ss_pred CCCcCCCCccccccccch---HHHHHHHHhhCCCCCCC
Q 016544 101 PKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 101 ~~~~~g~tpl~~a~~~~~---~~~~~~L~~~g~~~~~~ 135 (387)
.+|..|.||||+|+..++ .+++++|++.|+++...
T Consensus 140 ~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 140 LLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred ccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 999999999999999887 89999999999997543
No 456
>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]
Probab=99.71 E-value=1e-17 Score=169.48 Aligned_cols=105 Identities=35% Similarity=0.375 Sum_probs=101.6
Q ss_pred hcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 28 ~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
-.+++.+-++.+|+||||.||..|+.++|++||++|||+|.+|+.|+||||.||..|+.+|+++|+++||++|..|.+|.
T Consensus 528 ~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~ 607 (1143)
T KOG4177|consen 528 EHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGF 607 (1143)
T ss_pred hcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCc
Confidence 36889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
|||++|+..|..++++.+...++++
T Consensus 608 TpL~iA~~lg~~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 608 TPLHIAVRLGYLSVVKLLKVVTATP 632 (1143)
T ss_pred chhHHHHHhcccchhhHHHhccCcc
Confidence 9999999999999999999999983
No 457
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.71 E-value=1.7e-16 Score=156.39 Aligned_cols=135 Identities=24% Similarity=0.227 Sum_probs=109.3
Q ss_pred cccceeecccEEEEEEE---cCeEEEEEEcCcccCCC-----HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
|...+.||+|+|+.||. .+..+++|+........ ....+.+.+|+.+++.++|++++.+..++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 35567899999999875 45566666533222111 12345688999999999999999888877777788999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999876 34678999999999999999 9999999999999 5778999999998764
No 458
>smart00090 RIO RIO-like kinase.
Probab=99.71 E-value=7.5e-17 Score=141.51 Aligned_cols=140 Identities=20% Similarity=0.143 Sum_probs=105.7
Q ss_pred cccceeecccEEEEEE------EcCeEEEEEEcCcccCCC---------------------HHHHHHHHHHHHHHHcCCC
Q 016544 157 FTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIRH 209 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~------~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h 209 (387)
|...+.||.|+++.|+ .+|..||+|.+....... ......+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4455679999998764 357899999987542210 0012346789999999975
Q ss_pred C--cceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC
Q 016544 210 P--NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (387)
Q Consensus 210 ~--~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 287 (387)
. .++++++. ...++||||+.+.+|..+......+...++..++.|++.++.+||+++ .++|+||||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence 3 34455543 235899999999888776544455666677899999999999999986 399999999999999
Q ss_pred CCCCEEEEeecCcccc
Q 016544 288 DSGNLKVADFGVSKLL 303 (387)
Q Consensus 288 ~~~~~kl~Dfg~~~~~ 303 (387)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 788999999987654
No 459
>PHA03095 ankyrin-like protein; Provisional
Probab=99.71 E-value=3.6e-17 Score=159.47 Aligned_cols=104 Identities=23% Similarity=0.270 Sum_probs=75.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCH--HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDV--EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~--~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 106 (387)
.+.|++.++..|+||||+||..|+. .+++.|+..|+++|.+|..|+||||+|+..|+.+++++|+++||+++.+|..|
T Consensus 211 ~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g 290 (471)
T PHA03095 211 AGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDG 290 (471)
T ss_pred cCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC
Confidence 4556666666777777777777653 56677777777777777777777777777777777777777777777777777
Q ss_pred CCccccccccchHHHHHHHHhhCCCC
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
.|||++|+..++.++++.|++.++++
T Consensus 291 ~tpl~~A~~~~~~~~v~~LL~~~~~~ 316 (471)
T PHA03095 291 NTPLSLMVRNNNGRAVRAALAKNPSA 316 (471)
T ss_pred CCHHHHHHHhCCHHHHHHHHHhCCCH
Confidence 77777777777777777777776654
No 460
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.70 E-value=6e-17 Score=144.47 Aligned_cols=170 Identities=22% Similarity=0.292 Sum_probs=122.2
Q ss_pred CCCcceeeeeEEeeC---------------------------CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHH
Q 016544 208 RHPNVVQFLGAVTQS---------------------------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260 (387)
Q Consensus 208 ~h~~iv~l~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~ 260 (387)
+|||||++..+|.++ ..+|+||.... .+|.+++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 599999998887542 34789999885 49999998765 46677888999999
Q ss_pred HHHHHHHhCCCCCeEeCCCCCCCEEeCC--CC--CEEEEeecCccccccCCC-----CCcccCCCCCcccccccccCCC-
Q 016544 261 RGMNYLHENKPVPIIHRDLEPSNILRDD--SG--NLKVADFGVSKLLTVKED-----RPLTCQDTSCRYVAPEVFKNEE- 330 (387)
Q Consensus 261 ~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~- 330 (387)
+|+.|||.+| |.|||+|++|||+.- ++ .+.|+|||.+-......- +..-...|....||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 999999999999863 33 378999997643222111 1111234566789999986532
Q ss_pred ----C-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHHHHccCCCCCCCChhhhhhcc
Q 016544 331 ----Y-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 331 ----~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
. -.++|.|+.|.+.||+++...||.+.....+ ...++..+-|++ +..+|+.+
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPal---p~~vpp~~ 486 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPAL---PSRVPPVA 486 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCC---cccCChHH
Confidence 1 2479999999999999999999987333222 223444556665 34455544
No 461
>PHA03100 ankyrin repeat protein; Provisional
Probab=99.69 E-value=7.6e-17 Score=157.53 Aligned_cols=109 Identities=37% Similarity=0.514 Sum_probs=71.4
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCC------CcHHHHHHHcCC--HHHHHHHHHCCCCCCC
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------RTALHVAACQGF--TEVVSLLLERGADVDP 101 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g------~t~Lh~A~~~~~--~~~~~~Ll~~ga~~~~ 101 (387)
+.|.+.++..|.||||+|+..|+.+++++|+++|++++..+..| .||||+|+..++ .+++++|+++|++++.
T Consensus 166 g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~ 245 (480)
T PHA03100 166 GVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINI 245 (480)
T ss_pred CCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCC
Confidence 44555555566666666666666666666666666666666666 666666666666 6666666666677777
Q ss_pred CCcCCCCccccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 102 ~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
+|..|.||||+|+..++.+++++|++.|+++......
T Consensus 246 ~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~~ 282 (480)
T PHA03100 246 KDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKY 282 (480)
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCC
Confidence 7777777777777777777777777777766544433
No 462
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.69 E-value=4.9e-16 Score=136.63 Aligned_cols=139 Identities=19% Similarity=0.202 Sum_probs=106.8
Q ss_pred cccceeecccEEEEEEEcCeEEEEEEcCcccC----------CCHHHHHHHHHHHHHHHcCCCCcc--eeeeeEEeeCCc
Q 016544 157 FTNSVEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSSP 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~~ 224 (387)
+..++..|.|+++.++..+..++||.+..... .+......+.+|+.++.++.|++| ++++++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 33345678899999999999999998854221 112334567889999999998875 677776543322
Q ss_pred ----eEEEEEccCC-CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 225 ----MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 225 ----~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
.++|||+++| .+|.+++... +++.. .+.+++.+|.+||+.| |+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 3599999997 6999888653 44443 3578999999999999 99999999999999988999999998
Q ss_pred cccc
Q 016544 300 SKLL 303 (387)
Q Consensus 300 ~~~~ 303 (387)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 7653
No 463
>PHA02716 CPXV016; CPX019; EVM010; Provisional
Probab=99.69 E-value=1e-16 Score=159.11 Aligned_cols=85 Identities=22% Similarity=0.225 Sum_probs=76.8
Q ss_pred cC-CCCCCC-CCCcchHHHHHHh--hCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC--HHHHHHHHHCCCCCCCC
Q 016544 29 NG-LDDDGE-EIKPEFRLMFLAN--ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF--TEVVSLLLERGADVDPK 102 (387)
Q Consensus 29 ~~-~~~~~~-~~~g~t~l~~a~~--~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~--~~~~~~Ll~~ga~~~~~ 102 (387)
++ .|++.+ +..|.||||+|+. .++.+++++|+++|+|+|.+|..|+||||+|+..|+ .+++++|+++|||+|.+
T Consensus 164 ~G~ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~k 243 (764)
T PHA02716 164 VGIVNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMK 243 (764)
T ss_pred CCCCCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCC
Confidence 45 677777 7789999999865 467999999999999999999999999999999995 59999999999999999
Q ss_pred CcCCCCccccc
Q 016544 103 DRWGSTPLGDA 113 (387)
Q Consensus 103 ~~~g~tpl~~a 113 (387)
|..|.||||+|
T Consensus 244 D~~G~TPLh~A 254 (764)
T PHA02716 244 CVNGMSPIMTY 254 (764)
T ss_pred CCCCCCHHHHH
Confidence 99999999975
No 464
>PHA03100 ankyrin repeat protein; Provisional
Probab=99.69 E-value=1.1e-16 Score=156.48 Aligned_cols=107 Identities=27% Similarity=0.421 Sum_probs=88.9
Q ss_pred cCCCCCCCCCCcchHHHHHH--hhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCCCCCCCCc
Q 016544 29 NGLDDDGEEIKPEFRLMFLA--NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~--~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--~~~~~~~Ll~~ga~~~~~~~ 104 (387)
++.|.+..+..|.||||+|+ ..|+.+++++|+++|++++.+|..|.||||+|+..| +.+++++|+++|++++.+|.
T Consensus 95 ~ga~i~~~d~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~ 174 (480)
T PHA03100 95 YGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNR 174 (480)
T ss_pred CCCCCCCCCCCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccC
Confidence 45666666777888888888 888888888888888888888888888888888888 88888888888888888888
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCC
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
.|.||||+|+..++.+++++|+++|+++...
T Consensus 175 ~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~ 205 (480)
T PHA03100 175 YGYTPLHIAVEKGNIDVIKFLLDNGADINAG 205 (480)
T ss_pred CCCCHHHHHHHhCCHHHHHHHHHcCCCccCC
Confidence 8888888888888888888888888877544
No 465
>KOG4214 consensus Myotrophin and similar proteins [Transcription]
Probab=99.68 E-value=7.6e-17 Score=113.41 Aligned_cols=77 Identities=22% Similarity=0.245 Sum_probs=66.2
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
...|+||||+||-.|+.+++++|+..|||++.+|++|.|||.-|++.||.++|++|++.||+-..+..+|.+.+..+
T Consensus 31 ~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~~~~eat 107 (117)
T KOG4214|consen 31 IYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGTALIEAT 107 (117)
T ss_pred HhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCchhHHhhc
Confidence 34788889999999999999999999999999999999999999999999999999999998888888887766544
No 466
>KOG0508 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.68 E-value=1.2e-16 Score=144.46 Aligned_cols=130 Identities=28% Similarity=0.270 Sum_probs=111.5
Q ss_pred cccCCCcchhhhhhhhc---CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHH
Q 016544 13 KQSSLAPDRERKEAELN---GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89 (387)
Q Consensus 13 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~ 89 (387)
.-..+.+..++-++++. ...-++.+..|-+||..|+..||.++|+.|+++||+||.......|||--||.-|+.+++
T Consensus 54 H~~vVeyLle~~~a~~e~~GsV~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leiv 133 (615)
T KOG0508|consen 54 HADVVEYLLEHCRASPEQGGSVRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIV 133 (615)
T ss_pred cHHHHHHHHHHhcCCccCCceEEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHH
Confidence 33344444454444443 234567788899999999999999999999999999999988889999999999999999
Q ss_pred HHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 90 ~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
++|+++|||+++.|+.|.|.|++|+..|+.+++++|++.|++++.......++
T Consensus 134 KyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 134 KYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred HHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchH
Confidence 99999999999999999999999999999999999999999998776555444
No 467
>PHA02874 ankyrin repeat protein; Provisional
Probab=99.68 E-value=2.8e-16 Score=151.34 Aligned_cols=104 Identities=36% Similarity=0.411 Sum_probs=59.1
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcC-----------------------CCCCCCCCCCCcHHHHHHHcCCH
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-----------------------IDVNFRDIDNRTALHVAACQGFT 86 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g-----------------------~~~n~~d~~g~t~Lh~A~~~~~~ 86 (387)
|.|.+..+..|.||||+|+..|+.+++++|+++| +|+|.+|..|.||||+|+..|+.
T Consensus 58 Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~~~~~~ 137 (434)
T PHA02874 58 GADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDL 137 (434)
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCcCCCCCCCCCCccHHHHHHHCCCH
Confidence 3444444444555555555555555555555443 23444555566666666666666
Q ss_pred HHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCC
Q 016544 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 87 ~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
+++++|+++|++++.+|..|.||||+|+..++.+++++|++.|+++.
T Consensus 138 ~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n 184 (434)
T PHA02874 138 ESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYAN 184 (434)
T ss_pred HHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCC
Confidence 66666666666666666666666666666666666666666655543
No 468
>KOG0514 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.67 E-value=1.1e-16 Score=140.12 Aligned_cols=86 Identities=37% Similarity=0.448 Sum_probs=45.0
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCCcCCCCccccccccch
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKN 118 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~tpl~~a~~~~~ 118 (387)
|+|+|++|+.+|..++|+.||.+|||||.+|.+|.|+|++||.+||+||+++||.. +.|+...|.+|.|+|.+|...|+
T Consensus 340 gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IAleagh 419 (452)
T KOG0514|consen 340 GQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIALEAGH 419 (452)
T ss_pred cchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhHHhcCc
Confidence 45555555555555555555555555555555555555555555555555555543 44555555555555555555555
Q ss_pred HHHHHHH
Q 016544 119 HEVIKLL 125 (387)
Q Consensus 119 ~~~~~~L 125 (387)
.||..+|
T Consensus 420 ~eIa~ml 426 (452)
T KOG0514|consen 420 REIAVML 426 (452)
T ss_pred hHHHHHH
Confidence 5544333
No 469
>PHA02876 ankyrin repeat protein; Provisional
Probab=99.66 E-value=2.8e-16 Score=159.62 Aligned_cols=114 Identities=28% Similarity=0.313 Sum_probs=95.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC-HHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~-~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
.+.|++.++..|.||||+|+..|+.+++++|+++|++++..+..|.||||+|+..++ ..++++|+++|+++|.+|..|+
T Consensus 364 ~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~ 443 (682)
T PHA02876 364 LGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLS 443 (682)
T ss_pred cCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCC
Confidence 466677777788888999999999999999999999999888888999999887665 5678899999999999999999
Q ss_pred Cccccccccc-hHHHHHHHHhhCCCCCCCCcccccc
Q 016544 108 TPLGDAIYYK-NHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 108 tpl~~a~~~~-~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
||||+|+..+ +.+++++|++.|+++........++
T Consensus 444 TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp 479 (682)
T PHA02876 444 TPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP 479 (682)
T ss_pred hHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999998866 6799999999999887665544443
No 470
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.66 E-value=2e-16 Score=148.83 Aligned_cols=165 Identities=28% Similarity=0.465 Sum_probs=133.0
Q ss_pred HHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 016544 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (387)
Q Consensus 204 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~ 282 (387)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ...+++.....++++++.||+|||+.- . ..|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccc
Confidence 3567899999999999999999999999999999999987 445888889999999999999999974 2 299999999
Q ss_pred CEEeCCCCCEEEEeecCccccccC-CCCCcccCCCCCcccccccccCCC-------CCCchhHHHHHHHHHHHHcCCCCC
Q 016544 283 NILRDDSGNLKVADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKNEE-------YDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 283 Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~elltg~~pf 354 (387)
|.+++....+||+|||+....... ............-|.|||.+.+.. .+.+.|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765421 111111112345699999997741 356799999999999999999999
Q ss_pred CC----CCCCcHHHHHHccC
Q 016544 355 TM----KHDNEVPKAYAARQ 370 (387)
Q Consensus 355 ~~----~~~~~~~~~i~~~~ 370 (387)
.. .++.+++.++..++
T Consensus 159 ~~~~~~~~~~eii~~~~~~~ 178 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGG 178 (484)
T ss_pred ccccccCChHHHHHHHHhcC
Confidence 75 22345777776634
No 471
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.66 E-value=6.2e-16 Score=132.68 Aligned_cols=134 Identities=21% Similarity=0.120 Sum_probs=101.5
Q ss_pred cccceeecccEEEEEEE----cCeEEEEEEcCcccCCCH-------------------HHHHHHHHHHHHHHcCCCC--c
Q 016544 157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHP--N 211 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~--~ 211 (387)
|...+.||.|+|+.+|. +|+.||||++........ ........|..++..+.++ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55567799999998862 588999998764321100 1112356788888888777 4
Q ss_pred ceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 212 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
++..++ ....+++|||++|++|...... .....++.+++.++.++|+.+ ++|+||||+||+++.++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence 455544 2456899999999998765331 345678899999999999998 999999999999999999
Q ss_pred EEEEeecCcccc
Q 016544 292 LKVADFGVSKLL 303 (387)
Q Consensus 292 ~kl~Dfg~~~~~ 303 (387)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998543
No 472
>PHA02730 ankyrin-like protein; Provisional
Probab=99.66 E-value=3.3e-16 Score=152.67 Aligned_cols=108 Identities=18% Similarity=0.151 Sum_probs=92.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCC----HHHHHHHHHcCC--CCCCCCCCCCcHHHH---HHHcC---------CHHHHH
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG---------FTEVVS 90 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~g~--~~n~~d~~g~t~Lh~---A~~~~---------~~~~~~ 90 (387)
+|+|++.. ..|.||||+|+..++ .+++++||++|+ |+|.+|.+|.||||. |...+ ..++++
T Consensus 368 ~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk 446 (672)
T PHA02730 368 NGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFD 446 (672)
T ss_pred CCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHH
Confidence 56666654 579999999998875 899999999998 699999999999994 33332 235799
Q ss_pred HHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 91 ~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
+|+++||++|.+|..|.||||+|+..++.+++++|+++|+++.....
T Consensus 447 ~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~ 493 (672)
T PHA02730 447 ILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR 493 (672)
T ss_pred HHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence 99999999999999999999999999999999999999999866553
No 473
>KOG0510 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.65 E-value=2.5e-16 Score=150.99 Aligned_cols=113 Identities=32% Similarity=0.320 Sum_probs=89.8
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHH-cC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCC---CCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD---PKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~-~g-~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~---~~~~ 104 (387)
|.|++.++.++.||||.||..|+.++|+.|++ .| ..+|..|-.|.||||+|+..||..++++||+.||+.. ..|.
T Consensus 296 Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~~e~D~ 375 (929)
T KOG0510|consen 296 GASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNMSEADS 375 (929)
T ss_pred CCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhccccccc
Confidence 44555555666677888888888888888888 43 4578888888999999998899999999999998877 5588
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
+|.||||.|+.+|+...++.|+++|+++........++
T Consensus 376 dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~SA 413 (929)
T KOG0510|consen 376 DGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKSA 413 (929)
T ss_pred CCchhhhHHHHhccHHHHHHHHHcCCceeecccccccc
Confidence 89999999999999999999999999886554444444
No 474
>PHA02917 ankyrin-like protein; Provisional
Probab=99.65 E-value=5.3e-16 Score=154.60 Aligned_cols=106 Identities=21% Similarity=0.190 Sum_probs=92.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC---------------------
Q 016544 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--------------------- 84 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--------------------- 84 (387)
++.+.+.+|.+|+||||+||.. |+.++|++||++|+|++.+|..|+||||+|+..|
T Consensus 21 ~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~ 100 (661)
T PHA02917 21 DRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNI 100 (661)
T ss_pred ccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCC
Confidence 5666677788899999997665 8899999999999999999999999999887644
Q ss_pred --------------CHHHHHHHHHCCCCCCCCCcCCCCccccc--cccchHHHHHHHHhhCCCCCC
Q 016544 85 --------------FTEVVSLLLERGADVDPKDRWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 85 --------------~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a--~~~~~~~~~~~L~~~g~~~~~ 134 (387)
+.+++++|+++|+|+|.+|..|.||||.| +..++.+++++|+++|+++..
T Consensus 101 ~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~ 166 (661)
T PHA02917 101 NDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLY 166 (661)
T ss_pred CCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccc
Confidence 45788999999999999999999999954 467899999999999999864
No 475
>PHA02798 ankyrin-like protein; Provisional
Probab=99.64 E-value=7.4e-16 Score=150.46 Aligned_cols=107 Identities=24% Similarity=0.331 Sum_probs=96.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC---HHHHHHHHHCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVDPK 102 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~---~~~~~~Ll~~ga~~~~~ 102 (387)
+|.|++.++..|+||||+|+..+ +.+++++|+++|||+|.+|.+|.||||+|+..++ .+++++|+++|++++.+
T Consensus 98 ~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 98 NGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred CCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 67888888888999999999975 7899999999999999999999999999999998 99999999999999988
Q ss_pred C-cCCCCcccccccc----chHHHHHHHHhhCCCCCCC
Q 016544 103 D-RWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 103 ~-~~g~tpl~~a~~~----~~~~~~~~L~~~g~~~~~~ 135 (387)
+ ..|.||||.+... ++.+++++|+++|+++...
T Consensus 178 ~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~~~ 215 (489)
T PHA02798 178 NNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIINKE 215 (489)
T ss_pred cCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCcccC
Confidence 5 5789999987653 4799999999999988654
No 476
>PHA02989 ankyrin repeat protein; Provisional
Probab=99.64 E-value=8.2e-16 Score=150.36 Aligned_cols=105 Identities=24% Similarity=0.290 Sum_probs=85.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC------CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ---GFTEVVSLLLERGADV 99 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~------~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~ 99 (387)
+|+|++.++ .+.||||.|+..+ +.+++++|+++|||+|.+|..|+||||.|+.. ++.+++++|+++|||+
T Consensus 59 ~GAdvn~~~-~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadi 137 (494)
T PHA02989 59 NGADVNYKG-YIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINV 137 (494)
T ss_pred cCCCccCCC-CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCc
Confidence 455555544 4678899887654 46889999999999999999999999987765 6789999999999999
Q ss_pred -CCCCcCCCCccccccc--cchHHHHHHHHhhCCCCCC
Q 016544 100 -DPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 100 -~~~~~~g~tpl~~a~~--~~~~~~~~~L~~~g~~~~~ 134 (387)
+.+|..|.||||+|+. .++.+++++|+++|+++..
T Consensus 138 n~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~ 175 (494)
T PHA02989 138 NDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE 175 (494)
T ss_pred ccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence 7888999999998764 3578999999999988765
No 477
>PHA02917 ankyrin-like protein; Provisional
Probab=99.64 E-value=1.1e-15 Score=152.45 Aligned_cols=105 Identities=30% Similarity=0.253 Sum_probs=94.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC-----------------------CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER-----------------------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~-----------------------~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~ 85 (387)
+|.+.+..+.+|+||||.||+.+ ..+++++|+++|||+|.+|..|+||||+|+..++
T Consensus 385 ~ga~~~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~ 464 (661)
T PHA02917 385 EGGDAVNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNK 464 (661)
T ss_pred cCCCccccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCC
Confidence 56666666667999999998543 3678899999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCCcCCCCccccccc-cchHHHHHHHHhhCCCCC
Q 016544 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIY-YKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 86 ~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~-~~~~~~~~~L~~~g~~~~ 133 (387)
.+++++|+++|++++.+|..|.||||+|+. .++.+++++++++|+++.
T Consensus 465 ~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 465 QSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred HHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 999999999999999999999999999996 678999999999998864
No 478
>PHA02736 Viral ankyrin protein; Provisional
Probab=99.64 E-value=1.4e-16 Score=130.92 Aligned_cols=105 Identities=26% Similarity=0.332 Sum_probs=84.2
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCC--C-----CCCCCCCCCcHHHHHHHcCCH---HHHHHHHHCCCCCCCC
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGI--D-----VNFRDIDNRTALHVAACQGFT---EVVSLLLERGADVDPK 102 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~--~-----~n~~d~~g~t~Lh~A~~~~~~---~~~~~Ll~~ga~~~~~ 102 (387)
.+..+.+|.||||+||..|+. +++++..+. + ++.+|.+|+||||+|+..|+. +++++|+++|++++.+
T Consensus 10 ~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~ 87 (154)
T PHA02736 10 ASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGK 87 (154)
T ss_pred HHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCcccc
Confidence 445566789999999999983 444433332 2 345789999999999999987 4689999999999999
Q ss_pred C-cCCCCccccccccchHHHHHHHHh-hCCCCCCCCccc
Q 016544 103 D-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHV 139 (387)
Q Consensus 103 ~-~~g~tpl~~a~~~~~~~~~~~L~~-~g~~~~~~~~~~ 139 (387)
| ..|+||||+|+..++.+++++|+. .|+++.......
T Consensus 88 ~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g 126 (154)
T PHA02736 88 ERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAF 126 (154)
T ss_pred CCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCC
Confidence 8 599999999999999999999997 488876554433
No 479
>PHA02989 ankyrin repeat protein; Provisional
Probab=99.64 E-value=9.5e-16 Score=149.90 Aligned_cols=108 Identities=20% Similarity=0.253 Sum_probs=96.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhh---CCHHHHHHHHHcCCCC-CCCCCCCCcHHHHHHHc--CCHHHHHHHHHCCCCCCC-
Q 016544 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP- 101 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~-n~~d~~g~t~Lh~A~~~--~~~~~~~~Ll~~ga~~~~- 101 (387)
+|.|++.++..|.||||.|+.. |+.+++++|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|++++.
T Consensus 97 ~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~ 176 (494)
T PHA02989 97 FGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEK 176 (494)
T ss_pred CCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 6788888888999999988765 6899999999999999 89999999999998764 689999999999999998
Q ss_pred CCcCCCCcccccccc----chHHHHHHHHhhCCCCCCCC
Q 016544 102 KDRWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 102 ~~~~g~tpl~~a~~~----~~~~~~~~L~~~g~~~~~~~ 136 (387)
.+..|.||||+|+.. ++.+++++|++.|+++....
T Consensus 177 ~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~~ 215 (494)
T PHA02989 177 TSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETNN 215 (494)
T ss_pred ccccCCChHHHHHhcccccccHHHHHHHHhCCCCccccC
Confidence 688999999988654 48999999999999986544
No 480
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.63 E-value=5.1e-17 Score=150.30 Aligned_cols=120 Identities=32% Similarity=0.514 Sum_probs=103.7
Q ss_pred ceEEEEEccCCCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
.+||.|++|...+|.+|+.... ..+....+.++.|++.++.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 4789999999999999997433 26778889999999999999 77 999999999999999999999999997
Q ss_pred cccccCC-----CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc
Q 016544 301 KLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349 (387)
Q Consensus 301 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 349 (387)
....... ....+...||..||+||.+.+..|+.++||||||++++||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 6544332 223355678999999999999999999999999999999997
No 481
>PHA02795 ankyrin-like protein; Provisional
Probab=99.63 E-value=1.1e-15 Score=142.35 Aligned_cols=111 Identities=17% Similarity=0.047 Sum_probs=89.2
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC------CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD------IDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d------~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 102 (387)
+|+|++.. ++.||||.|+..|+.+++++|+++|++.+... ..|.|++|.|+..++.+++++|+++||++|.+
T Consensus 140 ~GADIn~~--~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~k 217 (437)
T PHA02795 140 HGAVIYKI--ECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQL 217 (437)
T ss_pred CCCCCCCC--CCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcC
Confidence 45555443 33678888888888888888888887433221 34778888888888999999999999999999
Q ss_pred CcCCCCccccccccchHHHHHHHHhhCCCCCCCCccccc
Q 016544 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 103 ~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
|..|.||||+|+..|+.+++++|+++|+++........+
T Consensus 218 D~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~T 256 (437)
T PHA02795 218 DAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYT 256 (437)
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 999999999999999999999999999998765544433
No 482
>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain. These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....
Probab=99.63 E-value=1.2e-15 Score=112.96 Aligned_cols=64 Identities=42% Similarity=0.587 Sum_probs=59.7
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (387)
|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 7889999999999999999999999999999999999999999999999999999999999876
No 483
>PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A ....
Probab=99.63 E-value=8.1e-16 Score=102.13 Aligned_cols=54 Identities=39% Similarity=0.524 Sum_probs=46.4
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll 93 (387)
|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++||
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 689999999999999999999999999999999999999999999999999986
No 484
>PHA02946 ankyin-like protein; Provisional
Probab=99.62 E-value=1.3e-15 Score=146.07 Aligned_cols=112 Identities=18% Similarity=0.246 Sum_probs=87.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC--CHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNF-RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~g~~~n~-~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~ 105 (387)
++.|++.++..|+||||+|+..+ +.+++++|+++|+++|. .|.+|.|||| ||..++.+++++|+++|++++.+|..
T Consensus 94 ~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~ 172 (446)
T PHA02946 94 HGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKF 172 (446)
T ss_pred CcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCC
Confidence 56677777778888899888765 47888889988988885 5788888887 66678888888888888888888888
Q ss_pred CCCccccccccc--hHHHHHHHHhhCCCCCCCCccccc
Q 016544 106 GSTPLGDAIYYK--NHEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 106 g~tpl~~a~~~~--~~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
|+||||+|+..+ +.+++++|++.|+++........+
T Consensus 173 G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~T 210 (446)
T PHA02946 173 GKNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNT 210 (446)
T ss_pred CCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 888888876544 457888888888887655444333
No 485
>PHA02730 ankyrin-like protein; Provisional
Probab=99.62 E-value=1.1e-15 Score=149.08 Aligned_cols=103 Identities=16% Similarity=0.168 Sum_probs=89.5
Q ss_pred CCC-CCCCCcchHHHHHHhhC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCC--CCCCCC
Q 016544 32 DDD-GEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGA--DVDPKD 103 (387)
Q Consensus 32 ~~~-~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--~~~~~~~Ll~~ga--~~~~~~ 103 (387)
+++ .+|..|+||||+|+..| +.++|++||++|||+|.+|..|+||||+|+..+ +.+++++|+++|+ +++..+
T Consensus 32 ~in~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~ 111 (672)
T PHA02730 32 NLSKHIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTS 111 (672)
T ss_pred chhhhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccccc
Confidence 444 66778999999999997 599999999999999999999999999999977 7999999999965 557888
Q ss_pred cCCCCccccccc--cchHHHHHHHHh-hCCCCCC
Q 016544 104 RWGSTPLGDAIY--YKNHEVIKLLEK-HGAKPLM 134 (387)
Q Consensus 104 ~~g~tpl~~a~~--~~~~~~~~~L~~-~g~~~~~ 134 (387)
..+.+||+.++. .++.+++++|+. .++++..
T Consensus 112 ~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~ 145 (672)
T PHA02730 112 NINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPSK 145 (672)
T ss_pred ccCCchHHHHHHhcCCcHHHHHHHHHhcCCChhh
Confidence 889999998877 889999999996 5666543
No 486
>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A.
Probab=99.62 E-value=2.4e-16 Score=105.21 Aligned_cols=55 Identities=53% Similarity=0.668 Sum_probs=28.0
Q ss_pred HHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 59 Ll~~g-~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
||++| +++|.+|..|.||||+||..|+.+++++|++.|+|++.+|..|+||+|+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 56666 77888888888888888888888888888888888888888888888776
No 487
>KOG4214 consensus Myotrophin and similar proteins [Transcription]
Probab=99.61 E-value=8.4e-16 Score=108.19 Aligned_cols=92 Identities=28% Similarity=0.504 Sum_probs=86.6
Q ss_pred HHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHH
Q 016544 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (387)
Q Consensus 43 ~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~ 122 (387)
-+.|++++|.++-|+..+..|.|||..- .|+||||+|+-.|..+++++|+..||+++.+|+.|-|||-.|++.|+.+.+
T Consensus 5 ~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cV 83 (117)
T KOG4214|consen 5 SVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCV 83 (117)
T ss_pred hHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHH
Confidence 3789999999999999999999999775 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCC
Q 016544 123 KLLEKHGAKPLMA 135 (387)
Q Consensus 123 ~~L~~~g~~~~~~ 135 (387)
++|++.|++-...
T Consensus 84 klLL~~GAdrt~~ 96 (117)
T KOG4214|consen 84 KLLLQNGADRTIH 96 (117)
T ss_pred HHHHHcCccccee
Confidence 9999999986443
No 488
>PHA02876 ankyrin repeat protein; Provisional
Probab=99.61 E-value=2.9e-15 Score=152.28 Aligned_cols=108 Identities=33% Similarity=0.370 Sum_probs=87.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC-CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-CCHHHHHHHHHCCCCCCCCCcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~-~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~-~~~~~~~~Ll~~ga~~~~~~~~g 106 (387)
.+.|.+.++..|.||||+|+..| +.++++.|+..|+++|.+|..|+||||+|+.. ++.+++++|+++|++++.+|..|
T Consensus 296 ~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G 375 (682)
T PHA02876 296 RGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCD 375 (682)
T ss_pred CCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCC
Confidence 45666667777888888888888 58888888888888888888888888888875 46888888888888888888888
Q ss_pred CCccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
.||||+|+..++.+++++|+++|+++....
T Consensus 376 ~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~ 405 (682)
T PHA02876 376 KTPIHYAAVRNNVVIINTLLDYGADIEALS 405 (682)
T ss_pred CCHHHHHHHcCCHHHHHHHHHCCCCccccC
Confidence 888888888888888888888888875443
No 489
>KOG0514 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.60 E-value=2e-15 Score=132.36 Aligned_cols=120 Identities=28% Similarity=0.248 Sum_probs=97.3
Q ss_pred hhhhhhhcCCCCCCCCCCcchHHHHHHhh-----CCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHC
Q 016544 22 ERKEAELNGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLER 95 (387)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~g~t~l~~a~~~-----~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ 95 (387)
=+.-.|...-|++..+.-|+||+++|+.. .+.++|+.|.+.| |||++- ..|+|+|++|+.+|++++|+.||..
T Consensus 284 V~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLac 362 (452)
T KOG0514|consen 284 VSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTALMLAVSHGRVDMVKALLAC 362 (452)
T ss_pred HHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-CcchhhhhhcchhhhhhhhcCcHHHHHHHHHc
Confidence 34555566777777777888888887763 4678888888876 888874 5699999999999999999999999
Q ss_pred CCCCCCCCcCCCCccccccccchHHHHHHHHhh-CCCCCCCCcccccc
Q 016544 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMAPMHVKHA 142 (387)
Q Consensus 96 ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~-g~~~~~~~~~~~~~ 142 (387)
|||+|++|.+|.|+|+.|+.+|++|++++|+.. ++++........++
T Consensus 363 gAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTA 410 (452)
T KOG0514|consen 363 GADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTA 410 (452)
T ss_pred cCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchh
Confidence 999999999999999999999999999999864 44554444444443
No 490
>KOG0510 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.60 E-value=2e-15 Score=144.87 Aligned_cols=100 Identities=29% Similarity=0.346 Sum_probs=92.8
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CC-CCCCCCCcCCCCccc
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RG-ADVDPKDRWGSTPLG 111 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~g-a~~~~~~~~g~tpl~ 111 (387)
+-+|.+|.||||+||+.|+.+.++.|+..|+++|.++.++.||||.||..|+.++++-||+ .| ...|..|-.|.||||
T Consensus 267 ~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLH 346 (929)
T KOG0510|consen 267 NDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLH 346 (929)
T ss_pred hcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchh
Confidence 4456678899999999999999999999999999999999999999999999999999998 44 567899999999999
Q ss_pred cccccchHHHHHHHHhhCCCCC
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
+|+..|+.++++.|+..|+...
T Consensus 347 laa~~gH~~v~qlLl~~GA~~~ 368 (929)
T KOG0510|consen 347 LAAKSGHDRVVQLLLNKGALFL 368 (929)
T ss_pred hhhhcCHHHHHHHHHhcChhhh
Confidence 9999999999999999999876
No 491
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.60 E-value=8.3e-15 Score=124.51 Aligned_cols=133 Identities=23% Similarity=0.223 Sum_probs=92.7
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHH---------------------HHHHHHHHHcCCCC--cce
Q 016544 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NVV 213 (387)
Q Consensus 161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~iv 213 (387)
+.||+|+|+.+|. +|+.||||++............. ...|...+..+.+. .++
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 4689999998874 58999999987543221111111 13466666666433 345
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHH-HHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCC
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
+++++ ...+++|||++++++.. .+.... . ..++..++.+++.++.++|+ .+ ++|+||||+||+++ ++.
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCc
Confidence 55543 24589999999854321 111111 1 15678899999999999999 88 99999999999999 889
Q ss_pred EEEEeecCcccc
Q 016544 292 LKVADFGVSKLL 303 (387)
Q Consensus 292 ~kl~Dfg~~~~~ 303 (387)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998644
No 492
>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]
Probab=99.59 E-value=6.9e-16 Score=126.26 Aligned_cols=129 Identities=21% Similarity=0.117 Sum_probs=113.2
Q ss_pred cccccccccccccCCCcchhhhhhhhcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 016544 3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (387)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~ 82 (387)
++-+++|+..|...+.+-.--+-.--+|.|++.-..+..|+|.+|++.|..++|++|+..+.|||.-|.+|-|||-+|+.
T Consensus 156 ~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvr 235 (296)
T KOG0502|consen 156 CDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVR 235 (296)
T ss_pred ccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeeeec
Confidence 57789999999988887766555556788888888888899999999999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCC
Q 016544 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 83 ~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
-|+.+|++.|++.||+++..+..|.+++.+|+..|.. +++..++..+..
T Consensus 236 gnhvkcve~Ll~sGAd~t~e~dsGy~~mdlAValGyr-~Vqqvie~h~lk 284 (296)
T KOG0502|consen 236 GNHVKCVESLLNSGADVTQEDDSGYWIMDLAVALGYR-IVQQVIEKHALK 284 (296)
T ss_pred CChHHHHHHHHhcCCCcccccccCCcHHHHHHHhhhH-HHHHHHHHHHHH
Confidence 9999999999999999999999999999999999988 444444444443
No 493
>KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms]
Probab=99.59 E-value=3.1e-15 Score=137.66 Aligned_cols=71 Identities=39% Similarity=0.465 Sum_probs=49.4
Q ss_pred CCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 73 g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
|-|+||+|+.+|..+++++|+++|.+++++|.+||||||.|+..+..+++++|+.+|+++.+.......+.
T Consensus 198 G~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~D~dgWtPlHAAA~Wg~~~~~elL~~~ga~~d~~t~~g~~p~ 268 (527)
T KOG0505|consen 198 GATALHVAAANGYTEVAALLLQAGYSVNIKDYDGWTPLHAAAHWGQEDACELLVEHGADMDAKTKMGETPL 268 (527)
T ss_pred cchHHHHHHhhhHHHHHHHHHHhccCcccccccCCCcccHHHHhhhHhHHHHHHHhhcccchhhhcCCCCc
Confidence 44555556666666677777777777777777778888877777777777777777777766555444443
No 494
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.58 E-value=1.8e-14 Score=117.67 Aligned_cols=131 Identities=19% Similarity=0.182 Sum_probs=106.7
Q ss_pred ceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC--CcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.+.+|.|.++.++ ..+..+++|....... ...+..|..+++.+.+ .++++++.++...+..++++||+.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3568888887665 4567999999865432 3568889999999976 5899999988888889999999988
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+++..+ +......++.++++++.++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4556677899999999999986333499999999999999988999999998754
No 495
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.58 E-value=7.2e-15 Score=125.11 Aligned_cols=102 Identities=25% Similarity=0.355 Sum_probs=88.4
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
+|..+....||||+||..||.++|+.|++..+|+|+.+..|+|||||||.+|.-.+++-|+..||.+++.|+.|.|||.-
T Consensus 60 vn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldk 139 (448)
T KOG0195|consen 60 VNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDK 139 (448)
T ss_pred cccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhh
Confidence 33344445677999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccccchHHHHHHHHhhCCCCCC
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~ 134 (387)
|.-.-..-+.+.-.++|-.+..
T Consensus 140 akp~l~~~l~e~aek~gq~~nr 161 (448)
T KOG0195|consen 140 AKPMLKNTLLEIAEKHGQSPNR 161 (448)
T ss_pred hchHHHHHHHHHHHHhCCCCCc
Confidence 8766556666666777776643
No 496
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.57 E-value=2.1e-16 Score=155.36 Aligned_cols=202 Identities=28% Similarity=0.438 Sum_probs=162.8
Q ss_pred ccCcccceeecccEEEEEE------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceE
Q 016544 154 ELDFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~ 226 (387)
...|...+.||.|+|+.+. .....+|+|.+.... ...........|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3456666679999997653 233567777766543 33444556667888888886 999999999999999999
Q ss_pred EEEEccCCCCHHHHH-HHcC-CCChHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccc
Q 016544 227 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKL 302 (387)
Q Consensus 227 lv~e~~~~~sL~~~l-~~~~-~l~~~~~~~i~~qi~~~l~~LH-~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 302 (387)
+.+++..++++.+.+ .... ..+...+..++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999888 5443 5778888999999999999999 877 99999999999999999 999999999987
Q ss_pred ccc--CCCCCcccCCC-CCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 303 LTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 303 ~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
+.. ..........| ++.|+|||...+. ...+..|+||.|+++..+++|..||.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 765 22333344556 8999999999885 446789999999999999999999975443
No 497
>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]
Probab=99.57 E-value=6.1e-15 Score=149.62 Aligned_cols=111 Identities=36% Similarity=0.449 Sum_probs=99.7
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~ 111 (387)
+.+-....|-|+||.|+..+.+.+++.++++|++++.++..|+||||.||..|+.++|++|+++|||++.+++.|+||||
T Consensus 499 ~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH 578 (1143)
T KOG4177|consen 499 NDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLH 578 (1143)
T ss_pred ccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhh
Confidence 34444456788888888888899999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
.|+..|+.+++.+|+++|++++.......++
T Consensus 579 ~Aa~~G~~~i~~LLlk~GA~vna~d~~g~Tp 609 (1143)
T KOG4177|consen 579 QAAQQGHNDIAELLLKHGASVNAADLDGFTP 609 (1143)
T ss_pred HHHHcChHHHHHHHHHcCCCCCcccccCcch
Confidence 9999999999999999999997766555544
No 498
>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins. The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.
Probab=99.57 E-value=2.1e-14 Score=112.98 Aligned_cols=100 Identities=44% Similarity=0.573 Sum_probs=92.7
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
++.+|.||||+|+..++.+++++|++.|++.+..+..|.||||+|+..++.+++++|++.|++++..+..|.||+|+|+.
T Consensus 3 ~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~ 82 (126)
T cd00204 3 RDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAAR 82 (126)
T ss_pred cCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence 34578899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCC
Q 016544 116 YKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~ 135 (387)
.++.+++++|.+.+.+....
T Consensus 83 ~~~~~~~~~L~~~~~~~~~~ 102 (126)
T cd00204 83 NGNLDVVKLLLKHGADVNAR 102 (126)
T ss_pred cCcHHHHHHHHHcCCCCccc
Confidence 99999999999988555443
No 499
>PLN03192 Voltage-dependent potassium channel; Provisional
Probab=99.57 E-value=1.2e-14 Score=149.93 Aligned_cols=96 Identities=28% Similarity=0.460 Sum_probs=87.9
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
.+..+.++||.||..|+.++++.|+++|+|+|..|.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+.
T Consensus 521 ~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~ 600 (823)
T PLN03192 521 DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS 600 (823)
T ss_pred CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHH
Confidence 34457789999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred cchHHHHHHHHhhCCC
Q 016544 116 YKNHEVIKLLEKHGAK 131 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~ 131 (387)
.|+.+++++|.+.++.
T Consensus 601 ~g~~~iv~~L~~~~~~ 616 (823)
T PLN03192 601 AKHHKIFRILYHFASI 616 (823)
T ss_pred hCCHHHHHHHHhcCcc
Confidence 8888888877765543
No 500
>PHA02792 ankyrin-like protein; Provisional
Probab=99.56 E-value=7.5e-15 Score=141.85 Aligned_cols=103 Identities=17% Similarity=0.123 Sum_probs=78.6
Q ss_pred CCCCCCCCCC--cchHHHHHHhhCCH---HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCc
Q 016544 30 GLDDDGEEIK--PEFRLMFLANERDV---EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~--g~t~l~~a~~~~~~---~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 104 (387)
|+|++.++.+ +.||||+|+..... +++++|+++|||+|.+|..|+||||+|+..++.+++++|+++|++++.+|.
T Consensus 362 GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~kD~ 441 (631)
T PHA02792 362 GNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINITTK 441 (631)
T ss_pred CCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCcCC
Confidence 4444444433 45888887776654 357888888999999998899999999998999999999999999999999
Q ss_pred CCCCccccccc----------cchHHHHHHHHhhCCCC
Q 016544 105 WGSTPLGDAIY----------YKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 105 ~g~tpl~~a~~----------~~~~~~~~~L~~~g~~~ 132 (387)
.|.|||++|.. ....++++.+++++.++
T Consensus 442 ~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i 479 (631)
T PHA02792 442 YGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI 479 (631)
T ss_pred CCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence 99999998865 12345677888777654
Done!